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Abstract 
Abstract 
The peripheral skin microcirculation reflects the overall health status of the 
cardiovascular system and can be examined non-invasively by laser methods to 
assess early cardiovascular disease (CVD) risk factors, i.e. oxidative stress and 
endothelial dysfunction. Examples of methods used for this task are the laser 
Doppler flowmetry (LDF) and laser fluorescence spectroscopy (LFS), which 
respectively allow tracing blood flow and the amounts of the coenzyme NAD(P)H 
(nicotamide adenine dinucleotide) that is involved in the cellular production of 
ATP (adenosine triphosphate) energy. In this work, these methods were 
combined with iontophoresis and PORH (post-occlusive reactive hyperaemia) 
reactive tests to assess skin microvascular function and oxidative stress in mice 
and human subjects. The main focus of the research was exploring the nonlinear 
dynamics of skin LDF and NAD(P)H time series by processing the signals with 
the wavelet transform analysis. The study of nonlinear fluctuations of the 
microcirculation and cell energy metabolism allows detecting dynamic oscillators 
reflecting the activity of microvascular factors (i.e. endothelial cells, smooth 
muscle cells, sympathetic nerves) and specific patterns of mitochondrial or 
glycolytic ATP production. Monitoring these dynamic factors is powerful for the 
prediction of general vascular/metabolic health conditions, and can help the study 
of the mechanisms at the basis of the rhythmic fluctuations of micro-vessels 
diameter (vasomotion). In this thesis, the microvascular and metabolic dynamic 
biomarkers were characterised in-vivo in a mouse model affected by oxidative 
stress and a human cohort of smokers. Data comparison, respectively, with 
results from control mice and non-smokers, revealed significant differences 
suggesting the eligibility of these markers as predictors of risk associated with 
oxidative stress and smoke. Moreover, a relevant link between microvascular and 
metabolic oscillators was observed during vasomotion induced by α-adrenergic 
(in mice) or PORH (in humans) stimulations, suggesting a possible role of cellular 
Ca2+ oscillations of metabolic origin as drivers of vasomotion which is a theory 
poorly explored in literature. As future perspective, further exploration of these 
promising nonlinear biomarkers is required in the presence of risk factors different 
from smoke or oxidative stress and during vasomotion induced by stimuli different 
from PORH or α-adrenergic reactive challenges, to obtain a full picture on the use 
of these factors as predictors of risk and their role in the regulation of vasomotion.
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Preface 
Preface 
This work is completely based upon a research project carried out at the School 
of Medicine of the University of Dundee (Scotland), and funded by the European 
Union’s Seventh Framework Programme (FP7/2007-2013) under REA grant 
agreement n° 608133. Additional experiments were carried out at other academic 
institutions or companies that were involved in the project as associated partners. 
In particular, results of a collaboration with the Tissue Optics and Microcirculation 
Imaging group of the National University of Ireland (Galway) were published in 
two papers, which are enclosed in the appendix at the end of the thesis. 
The dissertation is structured in 5 chapters and a final appendix: 
 Chapter 1 – Literature review and aims. This section contains an introduction
to the topic and the tasks of the research. A complete overview on the non-
invasive methods for assessing skin microvascular function and oxidative
stress, and a description of the rationale and the procedures for studying the
nonlinear dynamics of microcirculation and energy metabolism are provided.
 Chapter 2 – Material and methods. This section provides a detailed
description of the workflow for the implementation of the methodology used in
this work, and of the protocols that were applied on mice and human subjects.
 Chapter 3 – Nonlinear dynamics of microcirculation and cell energy
metabolism in the Nrf2-/- mouse model. This section contains the results and
discussion related to the role of the nonlinear markers of microcirculation and
energy metabolism in mouse skin vasomotion and their potential application
as predictors of risk associated with oxidative stress.
 Chapter 4 – Nonlinear dynamics of microcirculation and cell energy
metabolism in human individuals. This section contains the results and
discussion related to the role of the nonlinear markers of microcirculation and
energy metabolism in human skin vasomotion and their potential application
as predictors of risk associated with smoke.
 Chapter 5 – Conclusions and future perspectives. This section brings together
all the findings of this research work with concluding remarks and an outline
tracing all the points that need to be addressed in the future.
 Appendix. This section contains the manuscripts, part of this doctoral project,
which have been published or submitted to peer-reviewed journals.
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Literature review and aims 
1 Literature review and aims 
 
1.1 Cardiovascular Disease burden and risk factors 
Cardiovascular disease (CVD) is the leading cause of death worldwide. Although 
the pathology affects especially older adults, the molecular events involved in the 
onset and progression of CVD start early in life making it necessary to implement 
a primary prevention from childhood [1, 2]. Many factors are involved in the 
development of CVD, including vascular cell dysfunction caused by the excess 
of circulating nutrients, the resulting inflammation, oxidative stress, thrombosis, 
and insulin resistance [1]. These processes damage the blood vessel wall and 
are associated with cellular genetic pathways supporting the beginning and 
progression of CVD [1]. Identification of CVD risk factors is powerful for the 
prediction of individuals who have a higher probability of developing the disease 
[1]. CVD risk factors can be categorised in traditional and non-traditional factors. 
The most important traditional factors are hypertension, elevated low-density 
lipoproteins (LDL) and cholesterol, obesity, glucose metabolism and insulin 
resistance, family history of CVD, age, sex, nutrition/diet, physical inactivity, 
tobacco exposure, perinatal exposures, diabetes mellitus, and chronic/end-stage 
kidney disease [1]. These factors have been combined into the Framingham Risk 
Score (FRS), which is a group of multivariate algorithms for the estimation of the 
probability to develop CVD over a range of time [2, 3]. Although this is a widely 
used method for the assessment of CVD risk, alternative functions have been 
developed such as the SCORE (European Systematic Coronary Risk Evaluation) 
and the PROCAM (Prospective Cardiovascular Munster) model [3]. 
Nevertheless, the contribution of the traditional risk factors is frequently not 
enough to explain CVD morbidity and incidence, making the evaluation of the 
absolute risk difficult [1, 2]. For this reason, cardiovascular research is focusing 
on the exploration of novel, non-traditional risk factors that might be added to the 
existing risk functions [1, 2, 3]. Assessment of endothelial microvascular function 
[4], oxidative stress [5], genomics, proteomics and metabolomics [1] represent 
examples of promising modalities for the investigation of new CVD risk factors. 
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1.2 The microcirculatory system 
The microcirculation is a network of small resistance arterioles, capillaries and 
venules in all the organs of the body, which are involved in the exchange of 
oxygen, nutrients, hormones and metabolism end-products between blood and 
the surrounding tissue [6, 7]. A general scheme of the microcirculatory system is 
provided in Fig. 1. 
 
Fig. 1 Basic structural unit in the microcirculation. The microvascular network is made of 
small blood vessels for the distribution of nutritive blood in the surrounding tissue. The arterioles 
branch out from large arteries to deliver the oxygenated nutritive blood from the heart towards the 
capillaries. The arterioles diameter is lower than 100 µm and varies depending on the tissue, for 
example arterioles size in the skin is about 17-26 µm [8]. The capillaries are the smallest vessels 
in the microcirculation (5-10 µm), where the exchange of nutrients between blood and tissue takes 
place through several mechanisms of cellular transport. The venules are small vessels (7-50 µm) 
connected to the capillaries for the delivery of deoxygenated blood back to the heart through large 
veins. 
 
In this circuit, arterioles are implicated in the regulation of blood delivery to the 
tissue through different adaptive mechanisms such as myogenic response, flow-
induced vasodilation and metabolic neural control [7]. The main function of 
capillaries is the exchange of nutrients and metabolic bio-products between blood 
and tissue, and venules contribute to the maintenance of capillary hydrostatic 
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pressure ensuring a stable exchange of substances with the tissue and the 
delivery of deoxygenated blood back to the heart [6]. 
Endothelial cells (ECs) in the most internal layer of the blood vessels 
(endothelium) play a major role in the activity of microvascular arterioles, mainly 
consistent with the modulation of the vascular smooth muscle cells (VSMCs) 
located in the median layer of the blood vessels (tunica media) (Fig. 2) [6, 7]. The 
close cell-cell interaction between ECs and VSMCs through chemical mediators 
such as nitric oxide (NO) and prostaglandins (PGs), or through the endothelial-
derived hyperpolarizing factor (EDHF) [communication by gap junctions or 
release of potassium K+ and epoxyeicosatrienoic acids (EETs)] leads to arteriole 
relaxation and contraction for the adaptation of the vascular myogenic tone and 
blood flow in response to local tissue metabolic requirements, blood pressure 
(BP) or stress conditions (Fig. 2) [7, 9, 10]. The circular layers of VSMCs are also 
connected to a control system of peripheral sympathetic nerves (Fig. 2), which 
modulate the smooth muscle activity in response to local nervous stimuli [6, 7]. 
Micro-vessel functionality is essential to maintain the normal organs’ perfusion, 
and deficiency in this task may lead to the onset of various diseases [6]. 
 
1.3 Mediators in the microcirculation related to the development 
of CVD 
Abnormal cellular conditions, e.g. oxidative stress and altered metabolism, can 
cause an impairment of the microvascular network function associated with 
failure in the preservation of arterial blood pressure and organs perfusion, leading 
to the pathogenesis of several illnesses such as CVD [6, 11]. Oxidative stress is 
a transient or permanent imbalance in the amount of reactive oxygen species 
(ROS), e.g. hydrogen peroxide (H2O2), NO, and superoxide anion (O2•−), which 
alters the cellular homeostasis and cannot be controlled by cellular antioxidant 
agents [5]. These highly reactive oxygen-containing molecules are mainly 
produced in the mitochondria, the endoplasmic reticulum (ER) or the 
peroxisomes cell compartments, and have harmful effects on the mitochondrial 
respiratory electron transport chain and ATP energy production [5, 12]. Blocking 
of the respiratory chain leads to alteration of the cellular redox state, and 
intracellular accumulation of the reduced form of the intermediate product of 
energy metabolism NAD(P)H (nicotamide adenine dinucleotide) [12]. 
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Fig. 2 Arteriole structure and adaptive mechanisms. The arteriole structure consists of three 
main layers defined as tunica intima, tunica media and tunica adventitia. The tunica intima is the 
most internal bed, which is made of a single stratum of ECs facing the vessel lumen. The tunica 
media consists of an internal elastic lamina at the interface with the endothelium made of 
structural proteins (i.e. elastin), and several layers of VSMCs which control the vessel’s diameter 
by contraction and relaxation processes. The smooth muscle is innervated by sympathetic 
nervous fibres of the autonomic nervous system. The tunica adventitia is the most external layer 
of the arterioles, consisting of fibroblasts and stem mesenchymal progenitor cells included in an 
extracellular matrix of collagen and elastic fibres. The adventitia is involved in the processes of 
vessel elongation and repair. The modulation of arteriole myogenic tone is essential to ensure 
organ perfusion, and it involves adaptive mechanisms mainly associated with the release of 
vasoactive substances (i.e. NO, PGs and EDHF) or electric signals (EDHF via gap junctions) from 
the ECs to the VSMCs in response to metabolic, mechanical and chemical stimuli. 
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An important molecular optical property of NAD(P)H coenzyme is the 
endogenous natural autofluorescence (AF), which may be used for the non-
invasive real-time monitoring of NAD(P)H concentrations to evaluate the 
mitochondrial function and oxidative stress [12]. There is growing evidence for a 
common pathway involved in the induction of oxidative stress, elevated blood 
pressure (BP) and inflammation resulting in endothelial microvascular 
dysfunction, which is a pivotal phenomenon involved in the development and 
progression of cardiovascular pathologies such as hypoxia, ischaemia, 
hypertension, coronary disease, and microvascular complications of diabetes [9, 
13]. Microvascular dysfunction is characterised by the reduction of the 
endothelium-dependent vasodilation due to the simultaneous rise of the amount 
of endothelium-derived contracting factors, e.g. endothelin-1, and reduction of 
active vasodilators levels, e.g. NO. Oxidative stress and endothelial dysfunction 
precede structural changes in blood vessels and CVD clinical manifestations, 
thus they represent powerful candidates for the early preclinical assessment of 
cardiovascular risk [11, 14]. Indeed, there is a growing recognition that the 
microcirculation contributes to the onset of atherosclerotic cardiovascular 
disease. For example, the reduction of flow reserve in the coronary micro-vessels 
is widely considered an independent prognostic factor for adverse cardiovascular 
events (e.g. myocardial infarction) [15, 16, 17, 18, 19, 20, 21], and impaired 
microvascular function predicts the conduit artery atherosclerosis and its risk 
factors [11, 22]. Additionally, many studies have linked microvascular dysfunction 
with a variety of diseases or risk factors, i.e., obstructive sleep apnea [23], 
cardiomyopathy [17, 24, 25], heart failure [26, 27], ageing [28], physical inactivity 
[29], smoking tobacco [30]. Dysfunction in the microcirculation is considered also 
the cause for no-reflow phenomenon [31], damage from cardioplegic arrest [32], 
coronary microvascular spasm [33] and angiogenesis [34, 35]. 
 
1.4 Skin model to study microcirculation and oxidative stress 
1.4.1 Rationale for using skin 
Although the high potential of microvascular function and oxidative stress as 
predictors of CVD risk, the examination of microvascular function from the central 
coronary microcirculation is difficult, relying on the use of invasive procedures 
such as coronary angiography [11, 36]. The problem may be addressed by using 
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the peripheral microcirculation as a surrogate marker of central coronary 
arteriolar dysfunction. Assessment of peripheral arteriole function may be 
performed from readily accessible sites such as skin, eye, limbs and mucosal 
tissue by non-invasive techniques [11, 14, 36]. Although these procedures are 
not largely used in clinical practice, several studies have demonstrated that the 
peripheral microcirculation reflects the general health conditions of the central 
microvasculature [11, 36]. For instance, correlations between CVD risk factors 
and femoral [37] or retinal [38] endothelial function have been reported [11], and 
the cutaneous microcirculation has been shown to be correlated with markers of 
systemic endothelial function, i.e. plasma NO (positive correlation) and plasma 
endothelin-1 (negative correlation) [39]. Hansell et al. [40] have reported a 
significant correlation between vasodilator vascular responses to acetylcholine 
(ACh) in small cutaneous micro-vessels and the brachial artery, indicating a 
systemic nature of endothelial function and the link between skin microvascular 
dysfunction and large artery endothelial dysfunction. Furthermore, cutaneous 
microcirculation and coronary function have been shown to be in a high 
relationship [36], and impaired skin microvascular endothelium-dependent 
vasodilation induced by ACh has been found associated with coronary heart 
disease (CHD) risk [41]. Additional studies have reported an association between 
skin microvascular dysfunction and a wide range of CVD risk factors including 
hypertension [42], diabetes [43, 44] and ageing [45]. 
All this evidence makes skin microvascular activity a potential index of coronary 
micro-vessel dysfunction, which could be used as a surrogate marker for the 
prediction of CVD risk. However, further investigation is needed to better 
elucidate the reasons for the link between the peripheral microcirculation, the 
activity of large conduit arteries and adverse cardiovascular events. A possible 
explanation could be that small micro-vessels are the initial site for endothelial 
damage in individuals at risk of CVD [14]. Moreover, micro-vessels play a crucial 
role in the maintenance of tissue homeostasis (by supplying nutrients and 
oxygen) and the regulation of vascular resistance and of the local parenchymal 
tissue in every organ [11]. Therefore, deficiency in these fundamental tasks may 
have a negative impact on the overall cardiovascular system. 
Skin accessibility has also been exploited for the in-vivo monitoring of oxidative 
stress [46]. Cutaneous NAD(P)H autofluorescence was found to be increased 
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during hypoxia, ischaemia or general conditions leading to blocking of the 
electron transport chain and improper delivery of oxygen to the tissue [47]. 
Assessment of skin NAD(P)H autofluorescence has also been proposed as an 
indirect tool to measure an index of widespread atherosclerosis [48]. Therefore, 
the concurrent use of non-invasive methods measuring in-vivo cutaneous 
microcirculation and skin AF of NAD(P)H is promising to address the preclinical 
evaluation of CVD risk in the future, through the early detection of endothelial 
dysfunction and oxidative stress [9, 14]. However, as mentioned above, although 
there is powerful potential application of using skin several aspects still need to 
be addressed such as understanding how much the skin peripheral 
microcirculation reflects the central cardiovascular system function [14, 49], and 
overcoming limitations due to the complex and inhomogeneous stratification of 
skin which is characterised by a spatial variety of optical properties [46]. 
1.4.2 Skin anatomy 
Skin is the outer covering part of the body whose main functions are the 
protection of organs from external agents, and thermoregulation and homeostatic 
maintenance of the body. Skin is organised in three primary layers defined as 
epidermis, dermis and hypodermis (Fig. 3). The epidermis is the outermost 
cutaneous bed, characterised by a variable thickness between 0.07-1.4 mm [50]. 
It is organised in multiple sub-layers lacking blood vessels and serving mainly as 
a protective barrier from the external environment [9]. The dermis stratum below 
the epidermis is made of connective tissue and functional components, including 
the microvascular vessels, nerves, hair follicles and sebaceous or sweat glands 
[51]. The dermal layer has a thickness between 1.5-5 mm [9], and is responsible 
for the skin mechanical properties [51]. The hypodermis or subcutaneous tissue 
is the most internal skin bed, characterised by high content of adipose tissue for 
the storage of energy in the form of fat [52]. 
The skin microvascular network is divided into two horizontal plexuses. The 
upper plexus at the epidermal-dermal junction is named papillary dermis and 
contains finger-like capillary loops (Fig. 3) [9]. The lower plexus is a network of 
horizontal arterioles and venules located at the interface between the dermal and 
subcutaneous layers and connected to the upper system by ascending and 
descending micro-vessels (Fig. 3) [9]. The various regions of the body display 
diversity in the cutaneous microcirculation anatomic structure, which can be 
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mainly classified in arteriovenous anastomoses (AVAs) containing or lacking 
areas [9]. The AVAs are microvascular functional structures characterised by the 
direct exchange of blood between arterioles and venules, bypassing the 
capillaries [53, 54]. 
 
Fig. 3 Cutaneous anatomic structure. The picture was reproduced and adapted from 
http://anatomymedicalook.com/unlabeled-skin-diagram/unlabeled-skin-diagram-unlabeled-
diagram-of-the-skin-anatomy-structure. Skin is made of three main layers defined as epidermis, 
dermis and hypodermis. The superficial epidermal layer protects the body from the external 
environment. For instance, the outermost stratum corneum functions as a permeable barrier 
selecting the molecules that pass into and out of the skin [55]. The production of melanin pigments 
by melanocyte cells in the basal epidermis protects the dermis and hypodermis from external UV 
(Ultraviolet)-B radiations [56]. The median dermal layer contains functional components (micro-
vessels, sweat or sebaceous glands, nerves, hair follicles) embedded in a connective tissue 
responsible for the structural support and elasticity of the cutaneous tissue [51]. The connective 
tissue is composed of fibroblast cells, structural proteins (collagen and elastin), and hydrophilic 
gels [51]. The most internal hypodermal layer is rich in adipocyte cells and blood vessels, and 
exerts several functions such as thermoregulation, protection of the internal tissue from external 
wounds, and energy storage in the form of fat [52]. 
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AVAs containing regions contribute to the maintenance of the thermoregulatory 
homeostasis [9, 53, 57], and are characterised by a heterogeneous density of 
capillary loops and arterioles across the vascular beds that ensure higher blood 
perfusion and intravascular pressure [9, 57]. In contrast, zones without AVAs 
show lower blood flow in the micro-vessels [57]. The palmar surface of the finger 
tips and in general hairless skin areas are examples of regions rich in AVAs, and 
the lower forearm’s medial surface is an example of an area without AVAs [9]. 
1.4.3 Skin optical properties 
As mentioned above, the non-invasive laser methods for the assessment of skin 
microcirculation and autofluorescence are limited by the complex cutaneous 
structure. Propagation of light through the skin is characterised by reflection, 
transmission, absorption and scattering events, which affect the light penetration 
depth depending on the used wavelength and on the thickness and anatomy of 
the examined skin area. When a laser beam hits the skin, the light is partially 
reflected and partially transmitted in the epidermal and dermal layers or deeper 
[58]. The transmitted light is partially scattered by heterogeneous biological 
structures with different refractive index (e.g. collagen and elastin fibres in the 
dermal connective tissue), and partially absorbed by several chemical and 
biological chromophores with different absorption coefficients (µa) (Fig. 4) [58]. 
 
Fig. 4 Absorption coefficients (µa) of skin chromophores (figure reproduced from [59]). 
Haemoglobin (Hb) in the blood, water, melanin and bilirubin represent the main light absorbers in 
the cutaneous tissue. The graph shows that the µa of each chromophore varies according to the 
wavelength. Therefore, the complex signal detected when skin is irradiated by a light source may 
be affected differently, depending on the wavelength of the laser used to illuminate the tissue. 
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A part of the light after attenuation by absorption and scattering events is 
backscattered to the skin surface [58], where it is detected as a complex output 
signal resulting from the contribution of various biological, chemical and structural 
components in the tissue which interacted with light. 
 
1.5 Non-invasive methods for the evaluation of cutaneous 
microcirculation 
1.5.1 Assessment of skin microvascular function 
Functional changes in the microcirculation precede the occurrence of structural 
microvascular abnormalities [11, 14], thus endothelial dysfunction represents a 
predictor of cardiovascular pathologic conditions more powerfully than structural 
information provides. Many studies have focused on the examination of skin 
microvascular function in both humans and animal models, by using non-invasive 
methods coupled with reactive tests to measure endothelial function [9, 14, 49]. 
The techniques mostly used for this purpose are the laser Doppler and laser 
speckle contrast imaging (LSCI), which are able to provide real-time functional 
data concerning the relative changes in skin blood perfusion [9, 49]. However, 
the use of these technologies in clinical practice is still limited by lack of 
standardisation [9, 49]. 
Laser Doppler 
The laser Doppler methods provide an index of skin blood perfusion Im calculated 
as the product between the average red blood cells (RBCs) velocity Va and their 
concentration Ner [9, 49], 
Im = Ner · Va   .                                                                                                                                         (1) 
The blood perfusion is expressed in perfusion arbitrary units (PU). The principle 
of the technique is based on the detection of the Doppler shift in wavelength 
observed when a monochromatic and coherent beam of red or infra-red (IR) laser 
light is backscattered by moving RBCs [9, 14, 49]. This is an indirect 
measurement of skin blood perfusion, and there is evidence of a linear 
relationship between the detected laser Doppler signal and the actual blood flow 
[9, 49]. The laser Doppler methods are commonly classified into two categories: 
 Laser Doppler flowmetry (LDF). The LDF technology is based on the use of a 
laser single-point probe (Fig. 5) placed at direct contact with the skin surface, 
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which measures blood flow in a small tissue volume (1-5 mm3) with a high 
sampling frequency and the ability to detect fast relative variations [9, 14, 49].  
An advantage of LDF is the constant measurement of blood flow in the 
examined location that allows obtaining continuous time series of blood 
perfusion suitable for the study of microvascular nonlinear dynamics (Fig. 6) 
[14]. However, the method is characterised by low reproducibility due to the 
spatial variability of skin perfusion related to the heterogeneous cutaneous 
anatomy [9, 14, 49]. The problem may be addressed by using integrated 
probes composed of multiple collecting fibres to cover a larger skin area and 
increase the spatial resolution, through the calculation of the average signal 
from different scattering volumes [9, 14, 49]. 
 
Fig. 5 Example of LDF instrument. LAKK-M device (Spe Lazma Ltd, Russia). The system 
is provided with a single-point multimode optical probe that must be placed at direct contact 
with the skin for recording LDF blood flow traces. A tripod is used to fix the probe 
perpendicularly to the cutaneous sample. 
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Fig. 6 LDF recordings (figure reproduced from [60]). (a-b) Examples of baseline LDF 
continuous time series measured from the human upper arm and forearm, respectively. (c) LDF 
signal recorded during stimulation of the endothelium-dependent vasodilation by iontophoresis 
delivery of acetylcholine (ACh). (d) LDF time series measured during stimulation of the 
endothelium-independent vasodilation by iontophoresis delivery of sodium nitroprusside (SNP). 
The data were collected by using a commercial single-point probe (MP1, Moor Instrument Ltd, 
UK). The amplitudes of the signals are expressed in arbitrary units (AU). Iontophoresis stimulation 
was performed by the application of a 100 µA current at intermittent intervals of 20 seconds 
highlighted by the vertical lines. 
 
 Laser Doppler imaging (LDI). The LDI technology provides 2D images by 
using the laser Doppler principle [9, 14, 49]. In this case, the light source is 
positioned at a specific distance above the skin surface (Fig. 7) and the 
system is provided with a computer-driven mirror, which reflects the laser 
beam scattered by the tissue to progressively scan the area of interest [9, 14, 
49]. The final output is a 2D image mapping skin blood flow by using coloured 
pixels which represent perfusion values (Fig. 8) [9, 14, 49]. The advantage of 
the method is the reduction of spatial variability by scanning a large skin area 
[9, 14, 49]. However, LDI is slower than LDF leading to the inability of 
recording rapid variations in blood flow [9, 14, 49]. Moreover, LDI allows only 
discrete perfusion measurements at given time points, thus it can be used 
successfully only for the study of the maximum response to a given stimulus 
but it is not suitable for the investigation of microvascular nonlinear dynamics 
[14]. 
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Fig. 7 Example of LDI instrument. MoorLDI device (Moor Instruments Ltd, UK). The system 
is fixed on a support provided with a handle to adjust the height of the device at a specific 
distance above the cutaneous sample from which the laser light is irradiated to image blood 
perfusion maps. 
 
Fig. 8 Examples of LDI images (figure reproduced from [53]). The false-colour images show 
sequential LDI maps obtained from the human finger during the different stages of the post-
occlusive reactive hyperaemia (PORH) test: baseline, occlusion of blood flow from the upper arm, 
and post-occlusion. The colour of the pixels reflects the level of skin blood flow, ranging from blue 
low perfusion regions to red high perfusion areas. The maps clearly show colour changes 
corresponding to a reduction of blood flow during occlusion, and an increase of perfusion after 
occlusion. 
 
LSCI 
Laser speckle contrast imaging is a non-contact technique based on the analysis 
of the speckle contrast pattern generated when a beam of light hits the opaque 
skin surface [9, 49]. Moving RBCs induce changes in the speckle pattern with a 
reduction in the contrast as the blood cells velocity increases [9, 49]. Therefore, 
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the analysis of the reduction in speckle contrast provides a perfusion index 
proportional to the velocity and concentration of RBCs [9, 49]. The LSCI 
technology provides a high reproducible index of blood flow with high spatial and 
temporal resolution, thus including the advantages of both LDI and LDF [9, 49]. 
However, the technique has lower penetration depth (~300 µm) in the skin than 
laser Doppler (~1-1.5 mm) and is more sensitive to movement artefacts [9, 49]. 
Furthermore, although it seems that LSCI signal and blood flow are in a linear 
relationship, a small number of experiments supporting this evidence has been 
performed [9, 49]. LSCI devices must be placed at a specific distance above the 
skin for performing blood perfusion measurements, and are characterised by a 
design similar to that of the LDI system displayed in Fig. 7. Fig. 9 shows an 
example of blood perfusion image obtained by LSCI. 
 
Fig. 9 Evaluation of blood perfusion by LSCI (image reproduced and adapted from [9]). 
Example of laser speckle contrast imaging of blood perfusion from the fingers of a patient affected 
by the Raynaud’s phenomenon. As seen in the LDI method, LSCI provides coloured maps with 
low perfusion areas in blue and high blood flow regions in red. The image shows the perfusion 
levels after stimulation of the ring finger with iontophoresis of acetylcholine, and the middle finger 
with sodium chloride. The increase in blood flow due to vasodilation is clearly visible (red area). 
 
Functional tasks 
The laser Doppler and LSCI methods provide only relative measurements of 
blood perfusion, which means that basal levels of perfusion cannot be used 
reliably to make a significant evaluation of microvascular function and 
comparisons between different subjects. For this reason, the techniques must be 
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combined with functional tasks for the assessment of skin micro-vessels reactivity 
to allow a reliable examination of microvascular function. Several reactive tests 
have been developed for the assessment of blood flow changes in response to 
mechanical, thermal and electrical stimuli or to the local administration of 
pharmacological drugs [9, 49]. Examples of reactive tests are represented by 
post-occlusive reactive hyperaemia (PORH) and iontophoresis delivery of 
vasoactive drugs [9, 14, 49]. 
PORH. The PORH functional task consists in monitoring the increase of skin 
blood perfusion after a temporary period of ischaemia artificially induced by 
mechanical arterial occlusion, to measure an index of general microvascular 
function [9, 49]. This kind of micro-vessel response is defined as post-occlusive 
reactive hyperaemia and involves multiple mediators for the adaptation of the 
myogenic tone, including major players such as the sympathetic nerves in the 
microcirculation and EDHF (NO-independent), and a small contribution of the 
endothelial NO-dependent pathway [9, 49]. The most common procedure to 
perform PORH test is placing an inflation cuff on the upper part of the arm while 
recording blood flow from the volar forearm or the fingertip locations [9, 49]. The 
cuff is then inflated at a pressure 10 mmHg higher than the systolic blood 
pressure (SBP) of the subject, generally for a period of 5 min or more [9, 49]. The 
PORH response can be evaluated as the post-occlusion absolute perfusion peak 
(PK), as the area under the curve (AUC) of the post-ischaemia peak, or 
expressing the post-occlusion peak as a function of the baseline flow (BL) (Fig. 
10) [49]. Skin PORH has been found to be decreased in a variety of 
cardiovascular diseases [9, 49]. 
 
Fig. 10 Typical PORH curve (figure reproduced from [49]). The graph describes LDF blood 
flux changes in the human forearm during the different steps of PORH test. The decrease of flow 
during the occlusion and the PORH response peak after the release of the pressure are clearly 
visible. The PORH response may be evaluated by using the raw peak response (PK), the area 
under the curve (AUC), or relating the PK to the baseline flow (BL). BZ is the biological zero that 
represents the residual flow signal observed when blood perfusion is blocked by arterial occlusion. 
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Iontophoresis. The iontophoresis functional task is designed to evaluate 
microvascular blood perfusion changes in response to the local administration of 
vasoactive drugs across the skin [9, 14, 49]. The method is based on the non-
invasive transdermal delivery of an ionic pharmacological agent solution through 
the application of an electric current, while the blood flow is measured by laser 
Doppler [9, 14, 49]. The equipment to perform iontophoresis is composed by a 
reference electrode and a ring-shaped chamber provided with an internal 
electrode (Fig. 11) [14]. The two electrodes are connected to a controller ensuring 
that the polarity of the chamber electrode has the same charge of the vasoactive 
drug [14]. The experimental setup is completed by the attachment of the chamber 
and the reference electrode on the skin of the testing subject or animal, and finally 
filling the chamber with a solution of the vasoactive agent [14]. Under the 
influence of the applied electric current, the charges of the chamber electrode will 
repel the charges of the drug inducing the transfer of the molecule into the skin 
[14]. The current used for iontophoresis is weak, generally up to a maximum of 
100 µA [14]. 
 
Fig. 11 Iontophoresis equipment. (a) Example of combination of the iontophoresis equipment 
with the MoorLDF probe (Moor Instruments Ltd, UK). (b) Example of combination of the 
iontophoresis equipment with the MoorLDI system (Moor Instruments Ltd, UK). Both of the 
reference electrode and the ring-shaped chamber must be attached to the skin and to an 
iontophoresis controller, for allowing the transdermal administration of a drug ionic solution by 
application of an electric current. 
 
The drugs mostly used to study endothelial function are the vasodilators 
acetylcholine (ACh) and sodium nitroprusside (SNP), which allow respectively the 
evaluation of endothelium-dependent and endothelium-independent vasodilation 
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[9, 14, 49]. Fig. 6c-d show examples of LDF recordings during the stimulation of 
vasodilation by iontophoresis delivery of ACh and SNP, respectively. ACh 
stimulates vasodilation mainly by endothelial NO-dependent modulation of 
VSMCs, even though the possible concurrent contribution to the response of 
endothelial NO-independent mediators such as the EDHF and PGs is not clear 
[9, 14, 49]. In general, the decrease in microvascular vasodilation induced by ACh 
is related to endothelial dysfunction but care must be taken when reporting data 
[14]. For example, the decrease in the vasodilator capacity may cause a reduction 
in the mean flux, which might be misinterpreted as endothelial dysfunction [14]. 
Reporting data as a percentage of the maximum vasodilation peak may help to 
avoid results misinterpretation [14]. SNP is a NO donor able to induce an 
endothelium-independent vasodilation by the direct stimulation of VSMCs 
relaxation [14]. The increase of NO bioavailability induced by the external 
contribution of SNP allows bypassing the endothelium-mediated vasodilation, 
providing an endothelium-independent control [14]. When ACh-mediated 
vasodilation is reduced without decrease in the control SNP-mediated 
vasodilation, data may be interpreted as the presence of endothelial dysfunction 
[14]. In contrast, the reduced response to SNP is harder to interpret because it 
might be related to either the decrease in blood vessels vasodilator capacity, or 
the reduction of NO bioavailability associated with oxidative stress and vascular 
dysfunction [14]. 
The combination of iontophoresis and laser Doppler has been used extensively 
in many studies reporting significant associations between reduced response to 
ACh in the cutaneous microcirculation and CVD risk factors or cardiovascular 
pathologic conditions, as well as correlations with systemic biomarkers of 
endothelial function [14]. Therefore the methodology may find a wide range of 
applications such as assessment of preclinical risk factors, diagnosis of vascular 
pathologic conditions, and monitoring the progression of CVD [14]. However, the 
technique suffers from lack of standardised protocols leading to contrasting 
literature evidence, the results are not reproducible from different cutaneous 
locations and are affected by the different skin resistance between subjects [14]. 
Pressure-induced vasodilation (PIV), local thermal hyperaemia (LTH) or local 
cooling, current-induced vasodilation (CIV), and microdialysis or intradermal 
injections represent other examples of reactive tests based respectively on 
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mechanical, thermal, electric and pharmacological challenges [9, 49]. However, 
these methods will not be discussed here because they are not crucial for the 
work object of this dissertation. 
1.5.2 Factors affecting the assessment of microvascular function 
The assessment of microvascular reactivity by Laser Doppler or LSCI combined 
with functional tasks requires some preliminary arrangements, to avoid the 
influence of several factors that may affect skin blood perfusion changes 
confounding the results. For example, the temperature (T) in the room where the 
experiment is performed can influence blood perfusion changes, thus it is 
recommended to use a room with controlled T and start the recordings after a 
period of acclimatisation of the testing subject [9, 57]. Research studies related 
to skin perfusion must be designed ensuring that the subjects from different 
groups are matched for age and gender. The reason for this is the major 
probability of impaired vascular reactivity in elder subjects compared to young 
individuals, and the different physiology between men and women, i.e. because 
of hormone level variations across the menstrual cycle [9]. The skin location used 
for the measurements also affects the results. For instance, the volar forearm is 
a location associated with high nutritive blood flow, the absence of AVAs and low 
perfusion due to the low density of blood vessels [57]. In contrast, the finger tips 
are areas rich in AVAs characterised by higher blood vessels density [9, 57]. 
Using the finger pad may help to reduce the spatial variability and also to record 
a higher perfusion signal [9, 57]. However, the finger tips present high density 
and regulatory activity of the sympathetic nerves [57], which might confound the 
results especially when the task is the study of nonlinear dynamics and 
oscillations of blood flow. Therefore, care must be taken to choose the 
appropriate skin location based on the objectives of the research. Blood perfusion 
can also be influenced by circadian rhythms associated with a variable flow during 
different hours of the day. Therefore, it is suggested to test all the individuals 
participating in a study at the same time of the day [57]. Another factor that might 
be taken into account when using the PORH test is the biological zero (BZ), which 
represents the residual flow signal observed when blood perfusion is blocked by 
arterial occlusion through a pressure cuff (Fig. 10) [9]. The reports about the BZ 
are controversial, and a link with the Brownian motion of residual RBCs in the 
venules or macromolecules in the vascular tissue has been hypothesised [9]. 
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Whether the BZ should be considered to correct perfusion data or to gain 
additional information is unclear [9]. However, several studies have shown that 
data correction with the BZ introduces more bias, especially when data are 
expressed as a function of the baseline [9]. 
1.5.3 Evaluation of microvascular structure 
Skin microcirculation can also be assessed by a wide range of techniques such 
as optical microscopy, 3D photoacoustic imaging, and optical coherence 
tomography (OCT). However, these technologies are commonly appropriate to 
gain structural information, and further implementation is required to extend their 
application to the assessment of microvascular function and nonlinear dynamics. 
The main focus of this work is the investigation of the skin microvascular and 
energy metabolism nonlinear dynamics, thus only a general brief description of 
the methods for the assessment of microcirculation structure will be given to 
complete the overview concerning the non-invasive tools for the study of the 
cutaneous microcirculation health conditions. 
Optical microscopy methods 
Examples of optical microscopy techniques for the assessment of skin 
microvascular structure are represented by videocapillaroscopy, orthogonal 
polarisation spectral imaging (OPS) and sidestream dark-field imaging (SDF). 
Videocapillaroscopy allows the in-vivo observation of capillaries through a 
microscope that transmits an image to a video camera, providing information 
about the capillary density and structure in the nail fold [49]. The technique shows 
several limitations such as low-contrast images and the requirement of trans-
illumination or fluorescent dyes, which makes the method invasive [49]. 
OPS and SDF overcome the limitations of the videocapillaroscopy since they 
exploit a green light source for the non-invasive illumination of the tissue and the 
detection of the photons scattered from the skin to obtain a good resolution image 
[49]. The green light is absorbed by the haemoglobin (Hb) in the RBCs providing 
a contrast tool, where blood cells are dark and the remaining microvascular tissue 
that does not absorb green light is visualised in the white or grey field (Fig. 12) 
[53]. OPS and SDF are limited by artefacts due to the high sensitivity to subject’s 
movements or to the pressure applied by the probes during the examination [49]. 
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Fig. 12 Example of SDF image (figure reproduced from [6]). Image of the sublingual 
microcirculation obtained by sidestream dark field imaging method, showing capillaries and 
venules from the imaged region. 
 
3D Photoacoustic imaging 
This technology requires the combination of pulsing lasers and ultrasound 
receivers. The principle of operation is based on the detection by the receiver of 
the pressure acoustic waves generated in all directions when the pulsed light is 
absorbed by chromophores in the tissue [61, 62]. The detected waves allow the 
reconstruction of a 3D map of the chromophores location [61, 63]. 
The major benefit of this methodology is the low scattering of ultrasound waves, 
which allows exploiting a full light penetration depth [64]. The technique also 
allows to gain in-vivo functional information about the total Hb and oxygen 
saturation (SO2) in the skin microcirculation, by tracing haemoglobin absorption 
at different wavelengths [65]. However, overall, the technology is limited by the 
low acoustic resolution leading to poor microvascular structural images, even 
though more advanced photoacoustic methods, e.g. PAM (photoacoustic 
microscopy), have improved this aspect [66]. Moreover, the requirement of a 
coupling medium to allow direct contact with the skin may affect the activity of the 
microcirculation providing confusing results. 
OCT 
Optical coherence tomography is a non-invasive and non-contact imaging 
method that overcomes some limitations of the photoacoustic technology. OCT 
is based on the employment of a broadband light source to create a low 
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coherence gate for the selection of the backscattered light from different skin 
tissue depths, to generate an in-vivo structural image [67]. The main advantage 
of this method is the ability to provide cross-sectional images similar to 
conventional optical biopsies with micrometer structural resolution [68, 69]. 
However, a disadvantage is represented by the low penetration depth (~1-2 mm) 
compared to photoacoustic [70]. Although the original application of OCT in the 
microcirculation field was mainly aimed to obtain structural information, the 
technology has been implemented to also gain functional information by adding 
contrast mechanisms based on the Doppler shift (DOCT) [71] and the speckle 
variance (svOCT) [72] principles, or by using processing techniques based on the 
separation of static and flow dynamic regions (OMAG, optical microangiography) 
[73] and on correlation mapping (cmOCT) [74]. However, these techniques have 
not yet been implemented for the study of nonlinear dynamics in the 
microcirculation, and are limited by high sensitivity to motion or long times 
required for post-processing. For these reasons, the conventional laser Doppler 
and LSCI techniques still represent the preferred choice for the study of 
microvascular function and nonlinear dynamics. 
 
1.6 Non-invasive techniques for the study of skin oxygenation 
Another approach to gain functional information about the skin microcirculation is 
represented by monitoring real time the cutaneous oxygenation. Indeed, poor 
tissue oxygenation may indicate the presence of vascular dysfunction. Several 
non-invasive methods to detect in-vivo the amount of oxygen are based on the 
measurement of the differential light absorption of oxyhaemoglobin (oxyHb) and 
deoxyhaemoglobin (deoxyHb), while other non-invasive techniques are based on 
the detection of the transcutaneous oxygen partial pressure (tcpO2) through 
electrodes. 
Overall, the laser techniques for the assessment of oxygenation may be 
classified into three categories: 
 Conventional pulse oximetry (PO). 
 Reflectance spectroscopy (RS). 
 Near infra-red spectroscopy (NIRS). 
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PO 
Pulse oximetry is the traditional method for the indirect measurement of arterial 
oxygen saturation (SpO2) [75]. The technique is based on the simultaneous 
irradiation of the tissue with both red and IR light, allowing to distinguish the 
oxyHb and deoxyHb haemoglobin forms [75]. OxyHb absorbs more the infra-red 
light while deoxyHb absorbs more the red light [75]. The absorbance ratio 
between the two forms of haemoglobin is used by manufacturing companies to 
make a calibration against direct measurements of arterial oxygen saturation 
(SaO2) to setup the pulse oximeter oxygen saturation (SpO2) [75]. 
The traditional PO probes are provided with emission (LEDs or lasers) and 
detection sensors on the opposite surface of the tested sample, allowing the 
estimation of oxygen saturation from the light transmitted through the sample [75]. 
An example is represented by the classic pulse oximeters used in the fingers [75]. 
PO provides only the estimation of the arterial oxygen saturation, based on the 
principle of the periodic contraction and relaxation of arterial blood vessels 
induced by pulse activity. Therefore, the calculation of the difference between the 
maximum and minimum haemoglobin absorption ratio from an area with pulsatile 
blood flow, e.g. the finger, will be equivalent to the arterial oxygen saturation. 
Although SpO2 may be useful for clinical applications, it reflects mostly the lung 
function rather than the local tissue oxygenation. Therefore, conventional pulse 
oximetry is not an eligible method to gain functional information about the oxygen 
amount and uptake in the skin microcirculation. 
RS 
Reflectance spectroscopy is able to provide continuous measurements of the 
local level of oxygen in the tissue. The method is based on the reflectance 
principle, which allows determining the percentage oxygen saturation (SO2) from 
the light backscattered by the skin tissue [75, 76, 77]. The examination of the 
wavelength of the backscattered light provides information on the differential 
absorption of bound and unbound haemoglobin [77]. The absorption is 
proportional to the relative concentrations of the chromophores in the local tissue, 
thus it represents an indirect measurement of the metabolic status and 
microvascular activity in the examined location [77]. RS devices are provided with 
emission and detection sensors integrated into adjacent locations of a single-
point probe [76, 77]. The sensors are separated by a short distance to provide 
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both high spatial (mm3) and high temporal (40 Hz) resolution [76], and they are 
connected to the light source and the spectrometer through optical fibres [75, 76, 
77]. This kind of probe may be applied in several skin locations of the body, i.e. 
the forearm, the hand and the foot. The light source of RS devices may vary 
depending on the application and is generally selected according to the desired 
wavelength range [77]. The assessment of oxygen saturation in-vivo requires the 
use of low power laser sources (1-5 mW) to avoid damage to the skin. For this 
reason, most biomedical RS devices are provided with laser sources in the visible 
spectral range, which allow measuring only the superficial SO2 due to the low 
penetration depth of visible light. Different kinds of device have been developed 
using the white light (e.g. moorVMS-Oxy, Moor Instruments Ltd, UK), or multiple 
laser sources with specific wavelengths in the visible range (e.g. LAKK-M, Spe 
Lazma Ltd, Russia). The white-light reflectance spectroscopy is based on the 
employment of a white LED which emits in the 450-700 nm spectral range [76], 
and takes advantage of the major red colour of oxygenated blood and the more 
prominent blue colour of deoxygenated blood to estimate Hb absorption [77]. The 
backscattered light in the 500-650 nm range is then processed to extract oxyHb 
and deoxyHb molar concentrations through the application of the Beer-Lambert 
law [57, 76], 
μa(λ) = Σ εi(λ) ∙ ci  ,                                                                                                                                          (2) 
where εi(λ) is the molar extinction coefficient of each chromophore, ci is the molar 
concentration of each chromophore, and μa(λ) is the absorption coefficient which 
can be deduced from the reflected (I) and incident (Io) lights. The percentage 
oxygen saturation is finally computed by the following formula [57, 76], 
SO2 = 
[𝑜𝑥𝑦𝐻𝑏]
[𝑜𝑥𝑦𝐻𝑏]+[𝑑𝑒𝑜𝑥𝑦𝐻𝑏]
 · 100% ,                                                                                       (3) 
where [oxyHb] is the concentration of oxygenated haemoglobin, and [deoxyHb] 
is the concentration of deoxygenated haemoglobin. More specific details on how 
the individual terms of equation 3 can be extracted from the analysis of the 
backscattered light are provided in the papers by Dunaev et al. [57], Liu et al. 
[76], Heusmann et al. [78] and Kohl-Bareis et al. [79, 80]. 
The LAKK-M device is based also on the reflectance spectroscopy principle to 
determine SO2 by using the equations 2-3 [57]. However, in this case the 
backscattered light generated by simultaneous illumination of skin with green 
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(532 nm) and red (630 nm) lasers are used to determine the differential 
absorption of oxyHb and deoxyHb fractions [57]. SO2 measured by the RS 
method is representative of the average oxygenation of small arterioles, 
capillaries and venules in the skin microcirculation, and it is closer to the venous 
oxygen saturation (SvO2) rather than the arterial oxygen saturation. 
NIRS 
The near infrared spectroscopy is a method designed for the study of the local 
deep tissue oxygenation. The main difference with the reflectance spectroscopy 
is the use of a low power (5-10 mW) light source in the red and IR spectral regions 
(650-1000 nm), which penetrates deeper in the tissue (1.5-2 cm) and allows 
monitoring the haemodynamics associated with oxygen metabolism in organs 
under the skin, i.e. skeletal muscle or brain [81, 82]. NIRS principle is similar to 
the pulse oximetry, based on the distinction of the major optical absorbance of 
oxyHb and deoxyHb respectively in the IR and red spectral ranges [81, 82]. 
However, NIRS differs from PO because it provides accurate continuous 
measurements of deep SO2 which are representative of the local microcirculation 
in the examined sample rather than the general arterial oxygen saturation. 
The method is characterised by a principle of operation similar to the reflectance 
spectroscopy with the employment of emission and detection sensors placed in 
adjacent sites of a probe, and the determination of haemoglobin concentration by 
the examination of the reflected light. However, the NIRS probes are designed 
with a separation distance between emission and detection sensors around 2-4 
cm [81] which is larger compared to RS probes, and the algorithms used for the 
signal processing and the estimation of SO2 are different. 
Advantages of the NIRS method are the large tolerance to subject’s motion 
compared to PO and RS technologies, higher temporal resolution and good intra-
subjects reproducibility [81, 82]. Limitations are represented by the sensitivity to 
biological tissue heterogeneity, and requirement of signal processing to remove 
instrumental errors, and physiological noise (e.g. skin perfusion) [81, 82]. Several 
studies have shown that the NIRS signal measured from the skeletal muscle 
microcirculation is well related with a variety of cardiovascular pathologies, e.g. 
heart failure, coronary artery disease and peripheral artery disease [82]. 
Therefore, the method is eligible as a tool for investigating CVD risk factors. 
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tcpO2 
This non-invasive method to monitor cutaneous oxygenation is based on the use 
of two electrodes (a platinum cathode and a reference silver anode) for 
measuring the partial pressure of oxygen (pO2) through the skin. The small tcpO2 
sensor is applied to the skin surface using an airtight self-adhesive ring [83]. The 
electrodes are included in an electrolyte solution and separated from the 
cutaneous tissue through a membrane permeable to oxygen. The principle of the 
technique is the outward diffusion of oxygen from the skin to the permeable 
membrane and the detection of the electric current produced by the reduction of 
O2 at the cathode, which is proportional to the amount of oxygen in the capillary 
bed of the cutaneous region under investigation. To allow the measurement of 
pO2 values representative of the arterial pO2, the diffusion of oxygen across the 
skin is more enhanced by heating the electrodes to warm up the skin at a 
temperature of 44-45°C [83]. This induces cutaneous maximal vasodilation, a 
decrease of vascular resistance, and compensatory arteriolarisation of capillary 
blood leading to increasing pO2 and decrease of carbon dioxide partial pressure 
(pCO2) toward arterial levels [83]. The time required to warm up the skin obtaining 
tcpO2 values proportional to the arterial pO2 is around 15-20 min, and the 
tolerance of the sensor at one cutaneous site is limited to 4 hours [83]. 
As in the case of pulse oximetry, the tcpO2 method is more useful for clinical 
applications reflecting the general function of the respiratory system or the 
general ability of the vascular system to deliver oxygen to the peripheral tissue. 
However, although tcpO2 and pulse oximetry measurements are correlated 
variables, they provide different measurements mainly due to the different 
principle of operation and shortcomings of these methodologies. For example, 
the tcpO2 monitor reacts slowly to sudden changes in tissue oxygenation, and 
pulse oximeters are highly sensitive to subject’s movement. 
 
1.7 Non-invasive assessment of skin autofluorescent markers of 
energy metabolism 
1.7.1 Autofluorescence (AF) 
The term autofluorescence is referred to the emission of light in the UV, visible or 
near-IR spectral regions detected when natural fluorophores in a biological 
system are excited by irradiation through light at a specific wavelength [84]. This 
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optical property characterises many biological molecules involved as substrates 
in important morpho-functional processes of living systems, providing the great 
opportunity of monitoring in-vivo specific biological processes based on detecting 
the changes in the AF emission properties of the substrate of interest [84]. 
Examples of natural fluorophores are represented by the reduced NAD(P)H and 
oxidised flavin adenine dinucleotide (FAD+) coenzymes, porphyrins, structural 
proteins (e.g. elastin and collagen), vitamin A, riboflavin, thiamin, lipofuscins, 
ceroid pigments, β-carotene, and aminoacids (i.e. tryptophan) [84]. 
Evaluating the AF signal from a live biological system may find important 
biomedical diagnostic applications. Indeed, the biological fluorophores can be 
eligible as biomarkers for the detection of alterations in the structural and 
functional features of cells and tissues [84], which are reflected in the AF emission 
spectrum. Fig. 13 shows the spectral profile of the natural fluorophores mostly 
used in biomedical research [84]. 
 
Fig. 13 AF emission profile of natural fluorophores used in biomedical research (figure 
reproduced from [84]). The spectra were measured by micro-spectrofluorimetry from in-vitro 
molecular solutions of the fluorophores (bound/unbound NAD(P)H, vitamin A, flavins, porphyrins), 
except for the spectra of the insoluble proteins collagen and elastin and the lipopigments that 
were measured respectively from connective tissue and hepatic portal of the liver cryostatic 
section. The wavelength of the excitation light was 366 nm. The graph clearly shows an overlap 
between emission spectra of different fluorophores at similar spectral regions, making it difficult 
for the assessment of the specific contribution of each fluorophore to AF spectra measured from 
the in-vivo tissue. 
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Although the powerful biomedical applications, as visible in Fig. 13 several natural 
fluorophores are characterised by an AF emission profile overlapping with the 
emission spectral region of other fluorophores, which makes it difficult the 
identification of the specific contribution of each biomarker to AF spectra 
measured from the in-vivo tissue. Excitation of the biological tissue at different 
wavelengths leads to the generation of complex AF spectral profiles, requiring 
further post-processing analysis for making reliable assumptions on the biological 
processes reflected by the AF spectrum. In addition, other factors affecting the 
AF spectral profile are also the optical properties of the different biological tissues 
(absorption, reflection, and scatter) from which depend the propagation of the 
excitation light and its interaction with the different components of the biological 
tissue, the fluorescence yield, and the overall signal collected at the tissue 
surface [84]. For these reasons, researchers are still working on the development 
of methods for characterising better the contribution of the biological fluorophores 
to the AF signal detected at the tissue surface. These methods are mainly based 
on Monte Carlo simulations to determine the effect of the tissue optical properties 
on AF spectra and the spatial resolution of the measurements, and analytical 
procedures, i.e. the spectral curve fitting for differentiating the relative overlapping 
contribution of different fluorophores to the total AF spectrum [84] (Fig. 14). 
 
Fig. 14 Example of curve-fitting analysis of an in-vivo AF spectrum from rat liver (figure 
reproduced from [84]). The graph shows the AF curve measured experimentally, the fitting curve 
estimated as the sum of the overlapping contribution of the natural fluorophores, and the spectral 
function of each fluorophore. The curve-fitting analysis was based on using an iterative non-linear 
algorithm (Marquardt-Levenberg) for the estimation of the true absolute minimum value of the 
sum of squared deviations of a combination of half-Gaussian Modified Gaussian (GMG) spectral 
functions related to the spectral AF emission profile of each fluorophore. 
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Moreover, the recent advent of multi-photon technologies based on the excitation 
of different fluorophores using multiple photons has allowed the implementation 
of techniques for a better spatial resolution, separation of the AF emission 
profiles, and quantification of different fluorophores. These novel technologies 
represent the clue for the future progress in this field of research and the 
improvement of the existent instrumentation for a better in-vivo monitoring of AF. 
1.7.2 Assessment of NAD(P)H AF for monitoring cutaneous metabolism 
As described in sections 1.3 (page 24) and 1.4 (paragraph 1.4.1, page 26), it is 
possible to take advantage of the natural endogenous autofluorescence of 
NAD(P)H for monitoring in-vivo the cutaneous metabolic status and as an 
indication of the oxidative stress level. NAD(P)H is an intracellular coenzyme 
involved in cytosolic and mitochondrial cell energy metabolic redox reactions, 
acting as an oxidising/reducing agent able to donate electrons [12]. Energy in the 
cells is produced in the form of ATP (adenosine triphosphate) by the cytosolic 
glycolysis and the mitochondrial oxidative phosphorylation (OXPHOS) (Fig. 15). 
Oxidation of NAD(P)H in NAD(P)+ by the mitochondrial electron transport chain 
and the use of glycolysis products are essential to produce ATP through the 
OXPHOS [12]. The increased amount of ROS and oxidative stress has a harmful 
effect on the respiratory chain, leading to the increase of the reduced NAD(P)H, 
and changes in the NAD(P)+:NAD(P)H ratio and the mitochondrial activity with a 
negative impact on ATP production [12]. Therefore, real-time monitoring of these 
coenzymes levels can provide information on the mitochondrial metabolic status 
associated with physiological or diseased conditions of the biological tissue [85]. 
Laser fluorescence spectroscopy (LFS) 
The autofluorescence of NAD(P)H and other biological cell fluorophores in the 
skin, i.e. the coenzyme FAD+ and the structural proteins collagen and elastin, can 
be stimulated non-invasively by laser fluorescence spectroscopy (LFS) [84, 85]. 
LFS is an optical method using a monochromatic laser source with power 
between 1-5 mW and excitation wavelengths ranging from UV, visible and IR 
spectral regions to identify AF emission peaks proportional to the tissue 
concentration of specific biomarkers [12, 46, 84, 85, 86, 87]. 
LFS biomedical systems for the in-vivo evaluation of skin AF are provided with 
a single-point probe that integrates sensors for both the irradiation of the tissue 
and the detection of the fluorescent signal [88]. 
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Fig. 15 Simple scheme of cell energy metabolism (figure reproduced from [89]). The overall 
process of energy production in the cells is defined as cell respiration. The energy is produced by 
the glycolysis and oxidative phosphorylation (OXPHOS) processes, which occur respectively in 
the cytosolic and mitochondrial cellular compartments. In these processes the activity of NAD+, 
NADP+ and flavin adenine dinucleotide (FAD+) coenzymes are crucial for oxidation and reduction 
reactions to transport electrons that represent an energy source to form ATP molecules. 
Glycolysis and OXPHOS are coupled oscillatory processes which can influence reciprocally under 
the driving effect of glucose and oxygen concentrations, respectively. Energy production starts in 
the cytosol with the glycolysis process, which allows the conversion of the glucose substrate into 
pyruvate with the production of 2 net molecules of ATP and NADH. The pyruvate produced during 
glycolysis is then employed as the substrate which enters the mitochondrial Krebs cycle. The 
cycle consists of a series of reactions for the release of more ATP and NADH, which are used to 
create a chemical gradient across the mitochondrial membrane by the activity of the electron 
transport chain. The chemical gradient is finally used as energy source to produce ATP (28 to 30 
net molecules) during OXPHOS, which has much higher efficiency compared to glycolysis. 
OXPHOS represents the preferential path for cell energy production in normal aerobic conditions 
when the tissue is well oxygenated. Anaerobic conditions due for example to disease have a 
negative impact on the functionality of the OXPHOS process that requires oxygen, and as a 
consequence enhance the production of energy by glycolysis to prevent the accumulation of 
pyruvate and NADH in the cytoplasm. Although glycolysis is less efficient than OXPHOS, it 
provides ATP rapidly and represents a quick energy source for pathologic cells, e.g. cancer cells. 
The probe must be placed in direct contact with the skin to perform the analysis 
[88]. The light source and the detector (spectrometer) of LFS devices are 
connected respectively to the irradiation and detection sensors in the single-point 
probe through optical fibres [88]. The most common unit of measurement used 
to assess endogenous autofluorescence is in arbitrary units (AU), making it 
possible to provide only relative assumptions related to the fluorophores 
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concentrations in the local tissue environment [12, 47, 90]. Since absolute 
concentrations of the fluorophores cannot be obtained, LFS systems need to be 
calibrated carefully before each experiment to reduce the variation of the signal 
between different measurements. Generally, LFS devices are already provided 
with a standard procedure for the calibration of the signal [85], which is variable 
depending on the method implemented by the manufacturer. For example, the 
LFS probe of the LAKK-M device (Spe Lazma Ltd, Russia) is calibrated through 
a procedure based on the use of the skin location chosen for the analysis as a 
template for the calibration of the probe. 
Considering the relative nature of the measurements, care must be taken when 
presenting LFS data to make comparisons between groups of subjects. 
Expression of the data as percentage relative changes in response to a functional 
task may be a suitable method, as well as the employment of a multi-parametric 
approach which combines the autofluorescence measurements with the 
assessment of other variables in the biological tissue, i.e. blood perfusion, oxygen 
saturation and blood volume. 
LFS systems can stimulate NAD(P)H autofluorescence using UV light between 
260-380 nm, and the signal is detected at emission wavelengths between 420-
490 nm [12, 85, 91]. The oxidised NAD(P)+ form is not fluorescent, thus the 
detected signal corresponds to the light emitted from the reduced NAD(P)H form 
[12]. FAD+ autofluorescence can be induced by LFS employing light sources in 
the UV and blue spectral regions (365-460 nm) with emission wavelengths 
around 530-550 nm [12, 91, 92]. Absorption of UV light by blood has a major 
impact on the in-vivo monitoring of FAD+ with reduction of the AF signal intensity 
six times greater than NAD(P)H fluorescence [85, 92]. Therefore, it is advisable 
the use of a blue excitation laser for those studies more focused on the detection 
and investigation of FAD+. LFS allows stimulating also the autofluorescence of 
structural proteins such as collagen and elastin, which are abundant in the 
connective tissue of the dermal cutaneous layer. A limitation in the assessment 
of collagen and elastin fluorescence is represented by the similar emission 
wavelength (390-460 nm collagen, 400-450 nm elastin) after excitation with UV 
light [46, 87]. Therefore, the UV AF signal in the 400-450 nm wavelength is 
characterised by the overlapping contribution of these two structural proteins. 
 
50 
 
_______________________________________________________________
Literature review and aims 
Advantages and shortcomings of LFS method 
The main benefits of LFS are the minimally invasive nature of the measurements 
from an easily accessible site (skin) without the requirement of exogenous dyes 
[12], the low cost of the technology and the portability. However, the method 
presents several disadvantages. For example, LFS UV AF spectra derive from 
the overlapping contributions of several endogenous autofluorescent 
biomolecules, making the interpretation of the contribution from every single 
fluorophore difficult [12, 84]. In addition, the signal is highly affected by the 
heterogeneous skin structure [46], events in the cutaneous microenvironment 
(e.g. vascular changes in blood volume) [85], the absorption of UV light by 
cutaneous chromophores, i.e. Hb and melanin [12], and artefacts generated by 
subject’s movement or pressure of the probe applied on the skin surface. 
Moreover, LFS suffers from spatial and temporal resolution leading to the 
impossibility to distinguish cytosolic and mitochondrial NAD(P)H, even though 
some studies have reported that NAD(P)H AF measured by LFS originates 
mostly from the mitochondria [85]. A possible approach to overcome this problem 
may be monitoring the mitochondrial activity by the calculation of the redox ratio 
(RR) index. RR is the ratio between NAD(P)H and FAD+ AF spectral peaks and 
represents an index of the balance between the reduced NAD(P)H and the 
oxidised FAD+, which reflects the activity of the mitochondrial electron transport 
chain. However, a better approach would be implementing the time-resolved AF 
spectroscopy method, based on the combination of LFS measurements with the 
fluorescence lifetime (FL) technique that allows tracing the decay rate of the AF 
signal [93]. FL measures the mean time that a fluorophore is in an excited state 
before returning to its ground state by emitting a photon [94]. The technique is 
sensitive to conformational changes of the fluorophore, i.e., due to protein binding 
[94]. Therefore, considering that the fluorescence of free (cytosolic) NAD(P)H has 
a lower decay time compared to the protein-bound (mitochondrial) form of the 
coenzyme, FL is powerful to provide a time-resolved differentiation between 
bound and unbound NAD(P)H [94, 95, 96]. Similarly, also FAD+ is characterised 
by a different FL between its free (longer decay time) and bound (shorter decay 
time) forms that can be distinguished using the FL method [94, 95]. Another FL-
based technology for the in-vivo imaging of bound and unbound NAD(P)H or 
FAD+ is the fluorescence lifetime imaging (FLIM). The technique provides two-
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dimensional images where the contrast is based on the FL of individual 
fluorophores rather than their emission spectra [97]. The advantage of FLIM over 
the time-resolved AF spectroscopy is that the FL of the fluorophores is both 
temporally and spatially resolved, providing the location of cytosolic/mitochondrial 
NAD(P)H in specific regions of the sampled image. Moreover, Blacker et al. [98] 
have demonstrated that FLIM may potentially differentiate non-phosphorylated 
NADH and phosphorylated NADPH, which is not possible by LFS. Additional 
advantages of the FL-based methods over LFS are the independence of 
fluorescence lifetime from the concentration of the fluorophore, absorption or 
thickness of the sample, photo-bleaching and excitation intensity [96, 97]. 
However, FL-based methods are sensitive to the pH, the viscosity and the 
refractive index in the environment surrounding the fluorophore [97]. Moreover, 
the traditional FL-based methods employ a one-photon (1P) excitation laser 
source with consequent ambiguous depth resolution and impossibility to monitor 
the fluorophore activity at single-cell level. 
The evaluation of NAD(P)H AF in-vivo with 3D sub-cellular and depth spatial 
resolution may be achieved by using the mutiphoton laser scanning microscopy 
(MPLSM) [99, 100], based on the use of near infra-red (NIR) two-photon (2P) 
excitation light to stimulate the AF of fluorophores of interest [99, 100]. The use 
of NIR light compared to UV 1P excitation is advantageous due to lower cellular 
photo-damage and photo-toxicity, reduced photo-bleaching, higher cell viability, 
lower scattering allowing deeper penetration into the tissue, and better separation 
of the AF emission profiles of different fluorophores [99, 100]. Balu et al. [100] 
have shown that MPLSM may be used successfully in combination with arterial 
occlusion to monitor non-invasively in-vivo NAD(P)H AF from epidermal cells of 
the human forearm. However, MPLSM alone does not allow to distinguish 
cytosolic and mitochondrial NAD(P)H [100]. For this reason, MPLSM has been 
frequently combined with FLIM [94, 96, 101] to assess NAD(P)H activity ensuring 
at the same time the differentiation between glycolytic or mitochondrial NAD(P)H, 
high temporal resolution, and high 3D spatial structural resolution allowing the 
comparison of different tissue layers. Moreover, the development of multiphoton 
FLIM systems for the rapid acquisition of data through the use of multiple scan 
beams and spinning discs is promising for the future, to allow studying dynamic 
natural processes in the cells [97], e.g., NAD(P)H metabolic oscillations. 
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1.8 Nonlinear dynamics of LDF signal to find predictors of 
vascular function 
1.8.1 Rationale for the study of LDF nonlinear dynamics 
An advantage of the LDF method compared with other modalities for the 
measurement of the peripheral blood perfusion is the opportunity to monitor the 
nonlinear dynamics of the cutaneous microcirculation. The expression “nonlinear 
dynamics” is referred to the oscillatory behaviour which characterises blood flow 
time series. Several studies have demonstrated that the LDF signal can be 
processed in the time-frequency domain, to characterise oscillatory components 
which reflect the physiological activity of different biological mediators 
contributing to the microcirculation (i.e. heart rate, respiratory rate, VSMCs, ECs 
and sympathetic nerves activities) [102, 103]. Monitoring the LDF oscillatory 
components in combination with reactive tests provides information about the 
functionality of central and local key factors involved in the regulation of the 
microcirculation, especially the endothelial cells which are the most important 
mediators associated with the health status and adaptation of the micro-vessels. 
Therefore, the main advantage of nonlinear dynamics studies is the possibility to 
reveal ‘hidden’ information related to specific microvascular components that 
would be lost by calculating the simple average value of the LDF signal. 
1.8.2 Continuous wavelet transform 
The pioneer investigators that characterised the LDF oscillatory components 
were Stefanovska and co-authors [103]. They implemented the use of the 
continuous wavelet transform (CWT) method for the processing of cardiovascular 
signals in the time-frequency domain [102, 103]. The main problem associated 
with the study of the oscillatory components of a LDF signal is the time-varying 
nature of the frequencies due to the changing period which characterises LDF 
time series. In addition, the wide range of frequencies where the specific peaks 
of the oscillatory components are located (5-2000 × 10-3 Hz) leads to difficulties 
in time and frequency resolution. The conventional method used to study the 
frequency of a signal is the fast Fourier transform (FFT). However, the technique 
is not suitable for the study of time-varying signals because it provides only one 
picture of the frequency domain of the entire signal, leading to the inability to trace 
time variations of the frequencies [102]. The short time Fourier transform (STFT) 
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was introduced to overcome the lack of time resolution, based on the use of a 
short temporal window which is shifted along the time series to obtain information 
about the time variations, and the detection of the frequency components by FFT 
within the window that has been chosen [102]. However, this methodology is still 
not appropriate to detect the oscillatory components of time-varying signals with 
a broad range of frequencies, i.e. the LDF signal (5-2000 × 10-3 Hz), because the 
time-frequency resolution of STFT is optimal only for narrow frequency windows 
leading to the inability to detect the low-frequency components [102]. For these 
reasons, Stefanovska and co-authors have implemented the CWT analysis to 
identify the LDF oscillatory components. 
The CWT is a scale-independent method which uses a wide frequency window 
suitable for the study of time-varying signals, providing a low-frequency resolution 
greater than FFT [102]. Fig. 16 shows the comparison of the spectral analysis of 
the oscillations of a heart rate variability (HRV) signal performed either using FFT 
(Fig. 16a) or CWT (Fig. 16b) analyses [102]. The graphs clearly show that the 
wavelet transform analysis provides a better frequency resolution in the low-
frequency region, allowing the identification of additional oscillatory peaks 
compared to FFT. 
 
Fig. 16 Comparison of the frequency resolution achieved using FFT or CWT (figure 
reproduced from [102]). (a) FFT energy spectrum obtained from the analysis of an HRV signal. 
The spectrum is plotted on a linear scale. (b) CWT time-averaged energy spectrum obtained from 
the wavelet analysis of the same HRV signal. The spectrum is plotted on a semi-log scale. WT = 
Wavelet Transform. Although the comparison provided in this figure is unfair due to the fact that 
the graph (a) is plotted on a linear scale while the graph (b) is shown on a semi-log scale, the 
figure clearly displays that CWT allows the identification of more oscillatory peaks than FFT, 
especially in the low-frequency region between 3-40 × 10-3 Hz. 
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To perform the CWT analysis a mother wavelet is required to define a set of 
functions of various scales, which provide a basic window scaled and shifted in 
the time domain of the signal [102]. The mother wavelet employed for the CWT 
analysis of LDF signals is the Morlet wavelet 𝜓 reported in equation 4 [102], 
𝜓(𝑢) =
1
√𝜋
𝑒−𝑖𝑢𝑒−𝑢
2/2.                                                                                       (4) 
The use of the Morlet window function is advantageous because it provides 
optimal time resolution for high frequencies, optimal frequency resolution for the 
low-frequency components, and it allows an easy conversion of the used scale 
to frequency [102]. The Morlet window is scaled by a factor s and a centred time 
t in the time domain to obtain a set of non-orthogonal basic functions 𝛹𝑠,𝑡 from 
which the CWT can be calculated [102], 
𝛹𝑠,𝑡(𝑢) =  |𝑠|
−1/2 𝜓 (
𝑢−𝑡
𝑠
),                                                                                                   (5) 
The CWT spectrum of a signal g(u) is then obtained by the equation 6, 
?̃?(𝑠, 𝑡) = ∫ ?̅?s,t
∞
−∞
 (𝑢)𝑔(𝑢)d𝑢,                                                                                        (6) 
where ?̅? is the complex conjugate of 𝛹 which removes any specific scale making 
the method independent from frequency scales, and ?̃?(𝑠, 𝑡) represents the 
wavelet spectral function from which the absolute wavelet energy Ei, the absolute 
wavelet amplitude Ai, and the instantaneous phase ɸ of a specific oscillator can 
be extracted at the frequency scale s and time t [102]. The time-averaged Ei and 
Ai at a specific frequency range from fi2 to fi1 which defines a specific oscillator, 
can be calculated according to the equations 7 and 8, respectively [102], 
𝐸𝑖(𝑓𝑖1, 𝑓𝑖2; 𝑡1, 𝑡2) =
1
(𝑓𝑖2−𝑓𝑖1)(𝑡2−𝑡1)
∫ ∫
1
𝑠2
𝑡2
𝑡1
1/𝑓𝑖2
1/𝑓𝑖1
|?̃?(𝑠, 𝑡)|2d𝑠d𝑡,                                    (7) 
𝐴𝑖(𝑓𝑖1, 𝑓𝑖2; 𝑡1, 𝑡2) =
1
(𝑓𝑖2−𝑓𝑖1)(𝑡2−𝑡1)
∫ ∫
1
𝑠2
𝑡2
𝑡1
1/𝑓𝑖2
1/𝑓𝑖1
|?̃?(𝑠, 𝑡)|d𝑠d𝑡,                                   (8) 
where (t1,t2) is the time window over which the time-averaged Ei is calculated. Ei 
is the area underneath the curve of the CWT power spectrum, expressed in 
arbitrary units (AU), which represents the average energy per unit time of the 
signal at the specific frequency range under investigation. Ai is the maximal mean 
energy in the frequency interval of interest expressed in AU. To allow reliable 
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comparisons of the Ei or Ai of an oscillator between signals from different subjects, 
these parameters are normalised by estimating the ratio between the Ei or Ai 
values extracted from the frequency range of the oscillator (fi2, fi1) and their values 
derived within the total frequency interval of the wavelet spectrum, obtaining 
dimensionless values of the time-averaged relative wavelet energy ei and 
amplitude ai, 
𝑒𝑖(𝑓𝑖1, 𝑓𝑖2) =
𝐸𝑖(𝑓𝑖1,𝑓𝑖2)
𝐸𝑡𝑜𝑡
,                                                                                                            (9) 
𝑎𝑖(𝑓𝑖1, 𝑓𝑖2) =
𝐴𝑖(𝑓𝑖1,𝑓𝑖2)
𝐴𝑡𝑜𝑡
.                                                                                                          (10) 
Finally, ei and ai are normalised by the number of frequencies nf in the interval 
(fi1, fi2) of the specific oscillator, 
𝑒𝑖 =
𝑒𝑖(𝑓𝑖1,𝑓𝑖2)
𝑛𝑓(𝑓𝑖1,𝑓𝑖2)
,                                                                                                            (11) 
𝑎𝑖 =
𝑎𝑖(𝑓𝑖1,𝑓𝑖2)
𝑛𝑓(𝑓𝑖1,𝑓𝑖2)
.                                                                                                          (12) 
In simple words, the energy and amplitude extracted from the wavelet spectrum 
represent a measure of how much of the signal is located at a specific frequency 
at the time t. Translating this concept from a physiological point of view, the 
wavelet energy and amplitude of the LDF oscillators indicate how much each 
physiological component is contributing to the overall signal at a specific time, 
which could be referred to a task (e.g. PORH response) that provides information 
on the functionality of the components. Moreover, the extraction of the phase of 
each oscillator may help to study the synchronisation, coupling or interaction 
between the different physiological components contributing to LDF signal.  
Fig. 17 displays examples of the CWT time-frequency domain (Fig. 17a) and 
the CWT time-averaged spectrum (Fig. 17b) of the LDF signal. The time-
frequency domain graph provides an overview of how the wavelet energy of the 
signal is distributed in frequency and time. The time-averaged plot allows the 
wavelet amplitude peaks corresponding to the different LDF oscillators to be 
distinguished. As visible in the plot, six intervals have been identified ranging from 
low (5 × 10-3 Hz) to high (2000 × 10-3 Hz) frequencies, which are associated with 
cardiac (I), respiratory (II), myogenic (III), neurogenic (IV) and endothelial (V-VI) 
physiological activities for the regulation of the microcirculatory blood flow. 
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Fig. 17 CWT of LDF time series (figure reproduced and adapted from [104]). (a) Example of 
CWT scalogram from a LDF time series. The graph represents how the CWT spectral energy is 
distributed in the time-frequency domain, by using a colour map which refers to the magnitude of 
the energy. In this case, as shown by the colour bar on the right, the dark red colour corresponds 
to lower wavelet energy and the brighter areas to high wavelet energy. A high power continuous 
band is clearly visible in the cardiac beat frequency (~1000 × 10-3 Hz), which confirms the basic 
contribution of heart rate to the peripheral microcirculation. (b) Comparison of time-averaged 
CWT amplitudes of LDF signals measured from a healthy skin region (red line) and from a 
melanoma cutaneous lesion (black line) of the same subject. The graph allows to distinguish the 
wavelet amplitude peaks of the LDF oscillatory components, corresponding to six different 
frequency intervals: cardiac (I), respiratory (II), myogenic (III), neurogenic (IV) and endothelial (V-
VI) physiological activities. Comparing the wavelet amplitudes of two LDF signals is powerful to 
distinguish healthy and diseased vascular conditions, gaining information on the function of 
specific vascular components. In this case for instance, relevant differences between the wavelet 
amplitudes of the two signals can be observed in the intervals V and IV, indicating a different 
functionality of the endothelial and neurogenic components between micro-vessels from healthy 
and melanoma lesion skin regions. 
1.8.3 Physiological origin of the LDF CWT oscillations 
The physiological origin of the six oscillatory components of LDF time series has 
been clarified by performing several experiments, which involved the application 
of the CWT analysis to electrocardiograph (ECG), heart rate variability (HRV) and 
LDF signals measured simultaneously, or to the LDF signal recorded during the 
iontophoresis of vasoactive drugs (e.g. ACh, SNP) [60, 102, 103, 105, 106, 107, 
108]: 
(I) 600-2000 × 10-3 Hz, a component related to the heart rate. The physiological 
origin of this oscillation was determined by the simultaneous measurement 
of ECG, HRV and LDF signals [109]. The ECG basic frequency corresponds 
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to the heart rate and is generally located around 1000 × 10-3 Hz, it may vary 
from 600 × 10-3 Hz in athletes to 1600 × 10-3 Hz in individuals with 
cardiovascular dysfunction [102, 109]. All the three measured signals 
showed a CWT component located at the same frequency around 1000 × 
10-3 Hz, demonstrating that the cardiac pumping activity is reflected also in 
the peripheral microcirculation [109]. 
(II) 145-600 × 10-3 Hz, a component corresponding to the respiratory rate. The 
cardiac beat is modulated by the respiration with a general breathing 
frequency around 200-300 × 10-3 Hz which is visible in the HRV signal [102, 
109]. Both of HRV and LDF signals measured simultaneously showed a 
CWT component located around 200 × 10-3 Hz, providing direct evidence of 
the effect of breathing activity in the peripheral microvasculature [109]. 
(III) 52-145 × 10-3 Hz, a component representing the VSMCs myogenic activity. 
This oscillation reflects the local myogenic control of vascular tone and blood 
perfusion, mediated by the spontaneous contraction and relaxation of the 
smooth muscle cells in the micro-vessels wall in response to blood pressure 
changes [102, 109]. The oscillatory activity is induced by cellular Ca2+ 
(calcium) fluctuations throughout the VSMCs plasma membrane and 
sarcoplasmic reticulum (SR) [109, 110]. The oscillation is visible in both the 
HRV and LDF signals around 100 × 10-3 Hz, and the myogenic origin has 
been demonstrated through studies in isolated vessels based on the 
measurement of spontaneous oscillations in the vessels diameter 
(vasomotion) or in Ca2+ concentrations, which exhibited a frequency 
between 70-100 × 10-3 Hz [102, 109]. Moreover, the CWT analysis of LDF 
signal displayed significant changes of the myogenic oscillation in response 
to exercise and local cooling [102]. 
(IV) 21-52 × 10-3 Hz, a component related to the neurogenic activity of the local 
sympathetic nerves in the microcirculation. The autonomous nervous 
system contributes to the regulation of micro-vessels vasoconstriction at rest 
by the release of mediators modulating VSMCs activity [102]. The 
neurogenic component has been detected in blood pressure, LDF and HRV 
signals at ~30-40 × 10-3 Hz [102, 109]. The neurogenic origin has been 
proved indirectly through several studies showing the disappearance of the 
oscillation in this frequency range after blockade of local and ganglionic 
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nerves in sympathectomised human tissue, or after denervation in rats [102, 
109]. Furthermore, significant changes of the CWT neurogenic oscillation 
amplitude have been observed on transplanted compared to intact skin and 
under the effect of local anaesthesia [102]. 
(V) 9.5-21 × 10-3 Hz, a component associated with the ECs NO-dependent 
regulatory activity. The endothelial cells constitute the most internal layer 
(endothelium) of the blood vessels facing the vascular lumen (Fig. 2). The 
endothelial activity is stimulated by the concentration of metabolic mediators 
in the blood such as oxygen and carbon dioxide, which influence the 
regulation of the vascular tone [102]. Based on the concentration of 
metabolites in the blood, ECs are stimulated to mediate the relaxation or 
contraction of VSMCs by the release of agonist substances, i.e. NO, PGs, 
EDHF, endothelin-1, etc. which modulate VSMCs activity (Fig. 2). As 
discussed in section 1.5 (paragraph 1.5.1, page 35), the iontophoretic local 
delivery of the vasodilators ACh and SNP in the skin microcirculation 
stimulates respectively the endothelium-dependent and endothelium-
independent vasodilation of the micro-vessels [9, 14, 49]. ACh induces 
vasodilation mainly by enhancing the endothelial release of NO, in addition 
to the concurrent contribution from endothelial NO-independent mediators 
such as the EDHF and PGs [9, 14, 49]. Several studies that combined the 
CWT analysis of the cutaneous LDF signal with the iontophoresis of the 
vasodilator ACh reported significant changes in the oscillation around 9.5-
21 × 10-3 Hz after the inhibition of the endothelial NO synthesis by NG-
monomethyl-L-arginine (L-NMMA), suggesting a possible endothelial NO-
dependent origin of this LDF oscillatory component [102]. 
(VI) 5-9.5 × 10-3 Hz, a component related to the NO-independent ECs 
modulatory activity. The origin of this oscillation has not been completely 
clarified. It has been reported a difference in the wavelet amplitude of this 
component between healthy individuals and heart failure patients during 
iontophoresis of ACh [102], and a major increase of the amplitude with ACh 
stimulation compared to the amplitude with SNP in healthy subjects [105]. 
These findings suggest an endothelial origin of the oscillation [102, 105]. 
However, the inhibition of the endothelial NO synthesis by L-NMMA did not 
show a difference between ACh and SNP response, suggesting that the 
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activity of other endothelium-derived NO-independent mediators might be 
associated with the oscillation in the 5-9.5 × 10-3 Hz interval, i.e. PGs or 
EDHF [105]. Kvandal et al. [105] performed an experiment where PGs 
synthesis was inhibited by aspirin and the difference between ACh and SNP 
response was not affected in both the oscillatory intervals V and VI, 
suggesting a more likely involvement of the EDHF rather than PGs in the 
oscillatory activity between 5-9.5 × 10-3 Hz. 
The study of the LDF oscillatory components by CWT has found different kinds 
of applications, such as the investigation of vasomotion or the use of LDF 
oscillators as predictors of cardiovascular risk. 
1.8.4 CWT for the study of vasomotion 
The term vasomotion refers to spontaneous rhythmic variations in the diameter 
of the microcirculatory blood vessels, which are responsible for changes in the 
myogenic vascular tone and blood flow [110, 111]. The physiological role of this 
phenomenon is not clear, and it has been associated with both pathologic and 
healthy vascular conditions [110, 111]. The oscillations in vessel diameter 
observed during vasomotion are determined by the local contraction and 
relaxation of the VSMCs due to Ca2+ fluctuations throughout the plasma 
membrane and the SR [110, 111]. Vasomotion can be investigated directly by 
technologies measuring the micro-vessels diameter, i.e. the intravital video-
microscopy [112, 113, 114]. However, the phenomenon can be studied also 
indirectly by the use of LDF in combination with the CWT analysis [111]. The use 
of CWT for the investigation of vasomotion is advantageous because it does not 
take into account only the oscillatory activity of VSMCs but it allows the 
examination of other mediators which can modulate and drive the smooth muscle 
activity, e.g. endothelial cells. 
1.8.5 CWT for the study of CVD risk factors 
Several studies have reported significant changes in the spectral energy of the 
CWT oscillatory components in relation to sex, age or pathologic conditions, 
suggesting the eligibility of LDF oscillators as markers of cardiovascular 
dysfunction. For example, Shiogai et al. [102] described a decrease of the 
endothelial, myogenic and respiratory wavelet energies with aging, and greater 
endothelial wavelet amplitudes in young women compared to young men. These 
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data were interpreted assuming that lower wavelet amplitudes might be 
associated with reduced vascular function [102]. The spectral amplitudes of the 
endothelial wavelet components were found to be reduced during iontophoresis 
delivery of ACh also in patients affected by congestive heart failure compared to 
healthy subjects [115]. 
1.8.6 Limitations in the study of LDF oscillatory components 
The coupling between vascular oscillators has been suggested as possible 
description of the cardiovascular system [102, 109]. However, the main 
disadvantage related to the assessment of blood flow oscillations is that they are 
highly time-varying and not constant, making the direct assessment of the 
interactions between different oscillators difficult [116, 117]. The problem may be 
addressed by using specific methods to study the interactions between the 
oscillators. For example, the extraction of the wavelet phase coherence (WPCO) 
as a function of time and frequency is a relevant analysis to study the functional 
coupling between different signals or oscillators, providing information on the 
behaviour and interaction between different components of the nonlinear system 
[118, 119]. Moreover, a better interpretation of the data may be achieved through 
a multi-parametric approach, by integrating the study of vascular oscillators with 
a quantification of the complexity of cardiovascular signals, based on computing 
a set of parameters such as entropy and the dimension that are considered 
potential predictors of CVD risk [116, 117, 120, 121]. 
1.8.7 Wavelet phase coherence (WPCO) analysis 
Functional coupling and synchronisation of cardiovascular oscillators may be 
studied by several methods such as the analysis of synchronisation or coupling 
direction [118]. However, the limitation when using these techniques is the 
requirement of well-separated oscillators, which could be distinguished by 
decomposition from the background noise and the other oscillators of the signal, 
or that can be sampled independently [118]. Unfortunately, in the case of the LDF 
cardiovascular oscillators this is possible only for the cardiac and respiratory 
components which can be measured independently, e.g. by ECG or HRV. In 
contrast, low-frequency LDF oscillators cannot be decomposed from the 
background noise or sampled independently [118]. For these reasons, wavelet 
phase coherence analysis has been implemented, which provides information on 
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the phase ɸ relationship between oscillators in the same frequency interval of two 
time series recorded simultaneously [118]. The main advantage of WPCO 
analysis is the possibility to gain information on the coupling/synchronisation 
between oscillators in time-frequency regions with relevant background noise 
[118]. Another advantage is the chance to study the interaction between 
oscillators involved in the regulation of different biological mechanisms, i.e. the 
WPCO has been used to examine the interaction between cutaneous blood 
perfusion and temperature oscillators [118].  
The method is based on the use of the continuous wavelet transform that has 
been described in the equations 4-6, from which the phase ɸk,n can be extracted 
for each time tn and frequency ωk [118]. Considering the CWT of two different 
signals x1(t) and x2(t) measured simultaneously, the phases ɸ1k,n and ɸ2k,n can be 
extracted for the two time series and their relative difference calculated as [118], 
∆ɸk,n = ɸ2k,n - ɸ1k,n .                                                                                               (13) 
From the phase difference it is possible to calculate the coefficients cos ∆ɸk,n and 
sin ∆ɸk,n that can be time-averaged for the entire length of the signals, allowing 
the definition of the time-averaged wavelet phase coherence Cɸ function at the 
frequency ωk [118], 
Cɸ(𝜔𝑘) = √(𝑐𝑜𝑠∆ɸ𝑘,𝑛)2 + (𝑠𝑖𝑛∆ɸ𝑘,𝑛)2 .                                                       (14) 
The Cɸ(ωk) function returns values between 0 and 1, where Cɸ(ωk) ≈ 0 indicates 
absence of phase coherence (no interaction/coupling), Cɸ(ωk) ≈ 1 represents 
complete coherence (perfect interaction/coupling), and 0 < Cɸ(ωk) < 1 is 
associated with partial coherence (partial interaction/coupling) [118]. 
1.8.8 Assessment of the complexity of a signal 
In the last 25 years, several studies approached the vascular system as a natural 
spatially distributed, complex and nonlinear system. The behaviour of the 
vascular system was characterised according to chaos theory, which provides 
methods for the computation of a set of mathematical, statistical and physical 
parameters describing the complexity of the system, defined as attractors [102]. 
Examples of attractors are represented by the Hurst index (H), fractal dimension 
(D), entropy (H0), information dimension (Hi) and correlation dimension (D2) [102, 
120]. These variables describe how a dynamic nonlinear system evolves over 
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time, by iterations predicting the behaviour of the system at intervals subsequent 
to an initial current state [122]. For example, this is the case of entropy that is a 
measure of the quantity of information required for the prediction of the future 
status of the dynamic system [102]. The fractal dimension describes the 
complexity of a nonlinear physiological signal by characterising fractions of the 
system showing the self-similarity property, which is the ability to reproduce the 
entire structure of the analysed signal [102, 123]. The Hurst index allows the 
evaluation of the complexity by quantifying the scaling properties of the nonlinear 
system [102]. According to the assumptions above, increased values of fractal 
dimension and entropy correspond to a greater complexity of the signal [102]. 
The assessment of attractors can help to get more insight about the functionality 
of the microvascular system, by providing information on the ability of the system 
to assume a particular state at a specific time or in response to functional tasks 
[122, 123]. For instance, the complexity analysis of blood pressure and HRV 
signals revealed major complexity in young individuals compared to aged people, 
and more complexity in women versus men [102]. Based on this evidence, it has 
been proposed that a loss of complexity in the physiological system might be 
related to a dysfunction or impaired coupling between the components [116, 121]. 
Attractors of cardiovascular signals may be quantified by several methods, 
which are all based on the initial integration of the signal g(i) according to equation 
15, where i = 1,…,N , and N is the length of the time series [102], 
𝑦(𝑖) = ∑ [𝑔(𝑗) − ?̅?],𝑖𝑗=1                                                                                                            (15) 
where, 
?̅? =
1
𝑁
∑ 𝑔(𝑗).𝑁𝑗=1                                                                                                                               (16) 
The integration of the signal is necessary to make the time series unbound, which 
is a fundamental requirement to reveal the scaling and dimensional properties of 
the system [102]. The next step is computing the standard deviation S(N) and the 
range R(N) that can be used for the calculation of the Hurst index and the fractal 
dimension [102], 
𝑆(𝑁) = [
1
𝑁
∑ {𝑔(𝑖) − ?̅?}2𝑁𝑡=1 ]
  
1/2
 
,                                                                     (17) 
𝑅(𝑁) = max 𝑦(𝑖)
                     1 ≤ i ≤ N
− min 𝑦(𝑖).
1 ≤ i ≤ N
                                                                         (18) 
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The Hurst index H can be then extracted from the following equation [102], 
𝑅/𝑆 = (𝑐𝑁)𝐻 ,                                                                                                  (19) 
where c is a coefficient equal to 0.5. 
The Hurst index provides information on scaling properties for the prediction of 
the persistence of a signal, with values between 0.5 and 1 indicating a persistent 
behaviour and values 0 < H < 0.5 associated with anti-persistent behaviour [102]. 
The fractal dimension D can be finally calculated from the Hurst index because 
the two parameters are linked by the following relation [102], 
𝐷 = 2 − 𝐻.                                                                                                      (20) 
The dimension of nonlinear systems can be assessed also by using several other 
methods, including statistical physics techniques [102]. Other ways to express 
the complexity of dynamic systems are represented by the calculation of the 
correlation dimension D2, information dimension Hi and entropy H0. The 
equations for the computation of these parameters are discussed in several 
papers from Grassberger and Procaccia that introduced methods and algorithms 
for the calculation of dimensional attractors and entropy [124, 125, 126, 127]. 
However, the mathematical details for computing these parameters will not be 
discussed, as the most important aspect related to this dissertation is 
understanding overall why attractors are important for the study of vascular 
function and evaluating their applicability as predictors of CVD risk. 
 
1.9 Nonlinear nature of the glycolytic and mitochondrial 
intermediate product of energy metabolism NAD(P)H 
1.9.1 Cellular metabolic oscillations 
As discussed in section 1.7 (paragraph 1.7.2, page 47), NAD(P)H is involved in 
the mitochondrial and cytosolic reactions responsible for cellular energy 
production in the form of ATP. Dysfunction in the cell metabolic processes of 
energy production enhances the onset of several pathologies. An example is 
represented by the impairment of the electron transport chain induced in the 
presence of oxidative stress, which may evolve in a variety of illness including 
CVD and cancer. Recently, scientists have drawn particular attention on the 
oscillatory nature of energy metabolism. According to the latest reports, 
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monitoring the dynamics of cell energy metabolism may be powerful to predict 
specific cell and tissue metabolic states that might be associated with healthy and 
altered conditions, or with transition states [89]. The hypothesis is that by 
examining the dynamic properties of cell energy metabolism, specific patterns 
can be observed which may help to identify and predict the potential switch of the 
cell/tissue from a normal to a diseased phenotype [89]. 
The basic concept for the study of metabolic dynamics is assuming the 
oscillatory time-dependent nature of energy metabolism due to the continuous 
production and consumption of ATP in the cells [89]. Metabolic oscillations have 
been previously investigated in a variety of cellular specimens, i.e. yeast [128, 
129], cardiac myocytes [130] and β-cells [131, 132]. They can be classified in 
glycolytic and mitochondrial oscillations detectable indirectly by the assessment 
of fluctuations in the autofluorescence of NAD(P)H stimulated by 1P [128, 129, 
131, 133] or 2P [130, 134] excitation, or fluctuations of the mitochondrial 
membrane potential ∆Ψm, respectively [89]. Limited research has described 
metabolic oscillations also in live tissue from animal models. For example, 
mitochondrial fast oscillations have been detected in in-vivo rat by intra-vital 2P 
microscopy measurements of NAD(P)H from the cutaneous salivary glands [135], 
and circadian diurnal metabolic oscillations of NAD(P)H have been studied from 
the stem cells of the basal epidermal skin layer of live mice by combination of 2P 
excitation and FLIM [136]. Nonetheless, skin metabolic oscillations have never 
been investigated in-vivo in humans or animal models (e.g. mouse) by using 
autofluorescence single-point readouts. 
Recent reports have suggested that glycolytic oscillations derive from the 
activity of the enzyme phosphofructokinase (PFK), and might be driven by 
external glucose availability and uptake [89, 128, 133, 137]. On the other hand, 
the mitochondrial oscillations may be mediated by Ca2+ fluctuations in response 
to oxidative stress that destabilise the mitochondrial membrane potential ∆Ψm 
[129, 131, 134]. The external oxygen necessary for sustaining the electron 
transport chain has been proposed as the force driving mitochondrial oscillations 
[89]. The interaction and coupling between glycolytic and mitochondrial 
oscillators are strictly linked and can be regulated differently depending on the 
cellular metabolic state [89]. For example, in the presence of oxygen normal cells 
use mitochondrial ATP as the primary source of energy, while altered cells (e.g. 
65 
 
_______________________________________________________________
Literature review and aims 
potential cancerous cells) switch to a preferential glycolytic ATP production [89]. 
As a consequence, it can be supposed that specific patterns of glycolytic and 
mitochondrial oscillations should reflect and help the identification of particular 
metabolic states [89]. The interaction between glycolytic and mitochondrial 
oscillators may be affected also by environmental conditions. For instance, it has 
been reported a driving force of the glycolytic on mitochondrial fluctuations in 
absence of oxygen, reflecting the switch of cells to an altered metabolic state 
which promotes the preferential production of ATP through the glycolysis process 
[89]. In contrast, during normoxic conditions mitochondrial metabolic oscillations 
drive glycolytic fluctuations [89]. 
1.9.2 Potential applications of metabolic oscillators 
As discussed in the first part of this chapter (section 1.3, page 22), one of the 
factors involved in the onset of CVD at the cellular level is metabolic dysfunction 
in the mitochondrial electron transport chain. Therefore, the study of metabolic 
oscillators in the microcirculation may have the potential to find specific oscillatory 
patterns associated with the early alteration in the metabolic state of vascular 
cells due to oxidative stress and endothelial dysfunction. Metabolic oscillators 
may represent novel preclinical predictors of CVD risk, providing information on 
intrinsic altered conditions that are not visible at phenotypic level and which may 
reflect the potential of the tissue to switch towards a diseased state. 
Another interesting application may be the investigation of the role of metabolic 
oscillators in vasomotion. In the previous section (section 1.8, paragraph 1.8.4, 
page 59), vasomotion has been described as a spontaneous oscillatory 
phenomenon affecting micro-vessels which are characterised by rhythmic 
fluctuations in the vessels diameter. Vasomotion is mainly determined by the 
contraction and relaxation of VSMCs, even though modulation of VSMCs by ECs 
may also play a relevant role in this phenomenon [138, 139, 140]. Ca2+ 
oscillations in VSMCs and ECs have been considered as the main factor driving 
vasomotion at a cellular level [110, 111]. Specifically, three cellular oscillators 
have been proposed as causal mechanisms to explain the Ca2+ fluctuation at the 
basis of this phenomenon: cytosolic oscillator, membrane oscillator and 
metabolic oscillator [110, 111]. 
The activity and interaction of cytosolic and membrane oscillators during 
vasomotion have been proved extensively [110, 111, 141, 142, 143, 144], with 
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evidence of oscillatory release of Ca2+ induced respectively through the SR [110, 
142, 143] and by the opening activity of Ca2+ or K+ channels in the cell plasma 
membrane [110, 111, 144]. In contrast, although the presence of a metabolic 
oscillator has been hypothesised, little focus has been given to the investigation 
of this mechanism which has never been considered crucial for vasomotion [110, 
111]. However, recent studies have proved the involvement of the glycolytic 
enzyme PFK in reactions responsible for Ca2+ oscillations of glycolytic origin [89, 
145, 146], and oscillations of the mitochondrial membrane potential associated 
with Ca2+ fluctuations have been observed [129, 131, 134]. These recent findings 
show the presence in the cells of Ca2+ fluctuations of metabolic origin. Thus, a 
possible role of metabolic oscillators for driving vasomotion cannot be excluded. 
Considering that the physiological role and the mechanisms of vasomotion are 
still not completely understood, the possible involvement of metabolic oscillators 
may help to further elucidate this phenomenon. 
Although the potential applications of cellular metabolic oscillators, further 
implementation of the present technologies is still needed to improve the in-vivo 
assessment of energy metabolism oscillatory dynamics. As already discussed in 
paragraph 1.9.1 (page 64), most of the studies on glycolytic and mitochondrial 
oscillations have been performed in in-vitro or ex-vivo cells, while limited research 
has described the metabolic oscillations in live tissue. The combination of FLIM 
and multi-photon technologies shown in the work by Stringari et al. [136] allows 
the measurement of free (glycolytic) and bound (mitochondrial) NAD(P)H with 
high spatial and temporal resolution, thus representing a powerful tool for the 
detection of metabolic oscillations at sub-cellular level. However, although 
several in-vivo applications of these technologies have been reported [94, 96, 
101], they are still not well implemented for human clinical studies and for 
providing continuous NAD(P)H time series from in-vivo tissue to study metabolic 
oscillations. The development of faster multiphoton FLIM systems based on the 
use of multiple scan beams and spinning discs [97], and the development of 
commercial systems with a better design to facilitate the scan of all the regions 
of the human body [100] are promising modalities to improve the in-vivo study of 
the dynamic natural processes in the cells associated with the oscillatory turnover 
between NAD(P)H and NAD(P)+. 
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1.10 Aims of the thesis (objectives, hypotheses) 
1.10.1 Thesis aims 
The assessment of oxidative stress and endothelial dysfunction in the 
microcirculation represent novel powerful modalities for the early preclinical 
evaluation of CVD risk. Several studies have demonstrated that oxidative stress 
and endothelial function in the peripheral skin microcirculation reflect the health 
conditions of the central cardiovascular system, and can be detected easily by 
the combination of non-invasive laser methods with reactive tests. 
Therefore, the first objective of this research was the development of protocols 
for the concurrent non-invasive assessment of cutaneous oxidative stress 
and microvascular function, by simultaneous LFS measurements of NAD(P)H, 
LDF recordings of blood flow and RS oxygen measurements during PORH and 
iontophoresis functional tasks. 
The investigation of nonlinear dynamics of LDF signals reveals information 
related to the functionality of specific microvascular components characterised by 
an oscillatory activity, i.e. endothelial and vascular smooth muscle cells. 
Moreover, recently the focus has been committed to the study of energy 
metabolism dynamics, which may reveal specific oscillatory patterns of cell 
metabolic oscillators defining the potentiality of the tissue to switch towards 
normal or diseased phenotypes. The assessment of LDF and energy metabolism 
nonlinear dynamics may find powerful applications for both the study of 
vasomotion and the prediction of CVD risk. 
Therefore, the second objective of this research was the implementation of 
methods for the simultaneous in-vivo detection of LDF blood flow 
oscillators and NAD(P)H metabolic oscillations. 
The final goal of the study was the application of the implemented protocols and 
methods for the investigation of microvascular and cell energy metabolism 
nonlinear dynamics in a relevant physiological mouse model characterised by 
increased oxidative stress (Nrf2-/-, nuclear factor erythroid 2–related factor 2 
knock-out) due to the knock-out (KO) of the transcription factor Nrf2 that is a major 
activator of the cellular antioxidant defence, and in a cohort of healthy human 
subjects and smokers. 
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This is the first attempt of studying skin metabolic oscillations from live mouse 
and human cutaneous tissue by using label-free single-point autofluorescence 
readouts, as well as the first attempt of studying the interactions between 
metabolic and microvascular oscillators. 
1.10.2 Specific objectives and hypotheses of the research in animal models 
The specific aims for this part of the work were: 
1. Study the role of the endothelial oscillatory activity in cutaneous vasomotion. 
2. Investigate the relationship between metabolic oscillators and vasomotion. 
3. Evaluate the difference in cutaneous blood flow and metabolic oscillatory 
patterns between normal mice and animals with increased oxidative stress. 
The first hypothesis is that both endothelial and metabolic oscillators may play an 
important role to enhance skin vasomotion for the adaptation of microvascular 
tone in response to specific stimuli. The second hypothesis is that both 
microvascular and metabolic oscillators show different oscillatory patterns 
between normal and Nrf2-/- mice, thus representing powerful markers to 
distinguish healthy and oxidative stress phenotypes. 
1.10.3 Specific objectives and hypotheses of the research in human 
subjects 
The specific aims for this part of the study were: 
1. Assessing the potential application of microvascular and metabolic oscillators 
as preclinical predictors of CVD risk. 
2. Study the relationship between metabolic oscillators and vasomotion in 
humans. 
The first hypothesis is that microvascular and metabolic oscillators show different 
patterns between healthy subjects and individuals with higher CVD risk 
(smokers), thus they might find application as early preclinical predictors of risk. 
The second hypothesis is that cell energy metabolism dynamics are correlated 
with microvascular oscillations, suggesting a role of cell metabolic oscillators in 
human cutaneous vasomotion.
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2 Material and methods 
 
2.1 Timeline of the project and milestones 
Table 1 shows a graphic representation of the various steps and milestones 
during the 36 months duration of the research project for the implementation and 
application of the methodology used in this study. 
Table 1 Timeline of the research project and milestones (M). Twenty milestones related to 
various activities were achieved during the 36 months duration of the project: acquisition of 
theoretical background, technical training, development of the methodologies, obtaining of ethical 
approvals for animal and human work, subject recruitment, data collection, data analysis. 
 
M1                                     
M2                                     
M3                                     
M4                                     
M5                                     
M6                                     
M7                                     
M8                                     
M9                                     
M10                                     
M11                                     
M12                                     
M13                                     
M14                                     
M15                                     
M16                                     
M17                                     
M18                                     
M19                                     
M20                                     
 
Milestone 1 (M1) – Initial acquisition of literature background on the burden of 
CVD, biophotonics and non-invasive laser methods for the examination of skin 
microvascular function and skin autofluorescence of oxidative stress biomarkers. 
(Months 1-3, August-October 2014). 
Milestone 2 (M2) – Secondment period at Aston University (Birmingham, 
England): Introduction to the components, principles of operation and practical 
use of the laser fluorescence spectroscopy (LFS), laser Doppler flowmetry (LDF) 
and reflectance spectroscopy (RS) modalities of the LAKK-M commercial 
biomedical device (Spe Lazma Ltd, Russia). (Month 4, November 2014). 
Months 1   2   3   4   5   6   7   8   9  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36  
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Milestone 3 (M3) – Theoretical and practical training on the application of 
experimental procedures on mouse models (e.g. handling and shaving mice, 
performing iontophoresis reactive test and laser scans on live mouse skin), and 
obtaining approvals of the experimental plan on mouse models from the 
University of Dundee Ethical Review Process (Project Licence PPL No. 60/4265, 
Personal Licence No. IACEC4BB2). (Months 4-10, November 2014-May 2015). 
Milestone 4 (M4) – Evaluation of the robustness of NAD(P)H autofluorescence 
measurements by LFS in in-vitro molecular solutions and in-vivo human and 
mouse tissue, and development of a ratiometric normalisation method to reduce 
blood volume (BV) effects. (Months 5-18, December 2014-January 2016). 
Milestone 5 (M5) – Obtaining approvals of the experimental plan on human 
subjects from the University of Dundee Research Ethics Committee (UREC, 
Study Protocol No. 15064). (Months 8-16, March-November 2015). 
Milestone 6 (M6) – Optimisation of the examination of microvascular function 
with LDF method, by comparison with the LDI technique and preliminary testing  
on three different mouse models (Months 13-16, August-November 2015). 
Milestone 7 (M7) – Initial acquisition of literature background related to the 
examination of microvascular nonlinear dynamics and identification of blood flow 
oscillators by continuous wavelet transform (CWT) spectral analysis of LDF 
signal. (Months 15-16, October-November 2015). 
Milestone 8 (M8) – Collaboration with a research group from St. Andrews 
University (Scotland) to obtain Monte Carlo simulations of LAKK-M device 
measurements for gathering information on the skin tissue depth and 
microvascular bed from which the analysed signals were originating. (Months 15-
36, October 2015-August 2017). 
Milestone 9 (M9) – Draft of protocols for the concurrent evaluation of oxidative 
stress and microvascular function, respectively by LFS recordings of NAD(P)H 
autofluorescence and LDF/RS recordings of blood flow and oxygen saturation in 
combination with reactive tests, i.e. iontophoresis delivery of phenylephrine (PE) 
in mice and PORH test in humans. The protocols were designed based on the 
outcomes of M4, M6 and M7. (Month 16, November 2015). 
Milestone 10 (M10) – Experimental application of the protocol implemented for 
testing human subjects (M9) to a cohort of 20 healthy individuals for determining 
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the basal normal ranges of microvascular and metabolic biomarkers. (Months 17-
25, December 2015-August 2016). 
Milestone 11 (M11) – Experimental application of the protocol implemented for 
testing mouse models (M9) on 5 wild-type (WT) and 6 Nrf2-/- mice to compare the 
dynamics of microvascular and metabolic markers between normal animals and 
mice affected by high oxidative stress. (Months 19-20, February-March 2016). 
Milestone 12 (M12) – Secondment at Moor Instruments Ltd (Axminster, England) 
company: Exploration of commercial equipment for the imaging of cutaneous 
microcirculation and skin oxygenation. (Month 21, April 2016). 
Milestone 13 (M13) – Acquisition of literature background on the potential 
application of “attractors” as predictors of CVD risk, exploration of the LDF 
3.1.1.404 software (Spe Lazma Ltd, Russia) as tool for the estimation of various 
attractors from LDF time series, and implementation of a R-Studio script code for 
plotting the LDF attractor in the phase-space. (Months 21-23, April-June 2016). 
Milestone 14 (M14) – Obtaining ethics approvals from UREC to extend the 
human study to smokers. (Months 22-23, May-June 2016). 
Milestone 15 (M15) – Acquisition of strong literature background on: 
(1) Vasomotion. 
(2) The oscillatory nature of cell glycolytic and mitochondrial metabolic reactions 
of NAD(P)H for the production of ATP energy. 
(3) The possible link between vasomotion and cellular metabolic oscillators. 
(4) The wavelet phase coherence (WPCO) analysis as a tool for the investigation 
of the interaction between oscillators identified in the same frequency interval of 
different signals measured simultaneously. 
(Months 23-28, June-November 2016). 
Milestone 16 (M16) – Secondment at the National University of Ireland Galway 
(NUIG): Validation of correlation mapping optical coherence tomography 
(cmOCT) method for the concurrent study of structural and functional dynamics 
of cutaneous microcirculation (Months 26-27, September-October 2016). 
Milestone 17 (M17) – Implementation of methods for performing the nonlinear 
dynamics analysis of metabolic and microvascular signals measured 
simultaneously from mice models (M11) and human individuals (M10): 
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(1) Reconstruction of continuous NAD(P)H and RR time series by piecewise 
cubic spline interpolation of discrete autofluorescence data points. 
(2) Continuous wavelet transform (CWT) spectral analysis of LDF, NAD(P)H and 
RR time series for the characterisation and examination of blood flow and 
metabolic oscillators. 
(3) Exploration of the use of the open-source code for performing the WPCO 
analysis provided by the research group lead by Professor Stefanovska, available 
from the Lancaster University website (http://py-biomedical.lancaster.ac.uk). 
(Months 27-31, October 2016-February 2017). 
Milestone 18 (M18) – Experimental application of the protocol implemented for 
testing human subjects (M9) to a cohort of 20 healthy smokers for establishing 
early skin microvascular and metabolic dynamic biomarkers of vascular 
dysfunction, through the comparison with previous data collected from the 
healthy control group (M10).  (Months 30-33, January-April 2017). 
Milestone 19 (M19) – Application of the nonlinear dynamics analysis (M17) and 
statistical analysis on data collected from WT and Nrf2-/- mice (M11) for the study 
of dynamic markers of microcirculation and cell energy metabolism in mice 
models. (Months 32-33, March-April 2017). 
Milestone 20 (M20) – Application of the nonlinear dynamics analysis (M17), 
analysis of the attractors (M13), and statistical analysis on data collected from 
non-smoker (M10) and smoker (M18) healthy individuals for the study of dynamic 
markers of microcirculation and cell energy metabolism in human subjects. 
(Months 31-36, March-August 2017). 
 
2.2 Optical measurements 
2.2.1 Multifunctional device for data collection (LAKK-M) 
Non-invasive optical measurements were performed by using the multifunctional 
commercial biomedical device LAKK-M (Spe Lazma Ltd, Russia) (Fig. 18). The 
system combines laser Doppler flowmetry (LDF), laser fluorescence 
spectroscopy (LFS) and reflectance spectroscopy (RS) methods for the in-vivo 
evaluation of cutaneous blood perfusion, autofluorescent biomarkers and oxygen 
saturation, respectively. The apparatus is provided with 5 narrow-band 
semiconductor laser sources at the following wavelengths: 
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 1064 nm (power ~2-5 mW), IR continuous wave laser for LDF recordings. 
 365 nm (power ~1 mW), continuous wave laser for the measurement of AF 
emission induced by UV light. 
 532 nm (power ~2-4 mW), green multimode laser working in continuous wave 
mode for the measurement of AF stimulated by green light and in pulsed mode 
for RS recordings. 
 630 nm (power ~2-4 mW), red multimode laser working in continuous wave 
mode for the measurement of AF stimulated by red light and in pulsed mode 
for RS recordings. 
 480 nm (power ~2-4 mW), continuous wave laser for the measurement of AF 
stimulated by blue light. 
 
Fig. 18 LAKK-M device (picture reproduced and adapted from Spe Lazma Ltd user’s 
manual). The apparatus is provided with a flexible optical fibre including a single-point probe at 
the tip. To perform the measurements the optical fibre must be fixed in a tripod ensuring a position 
of the probe perpendicular to the skin surface. The probe must be placed at direct contact with a 
specific site of interest in the skin surface. 
 
The laser beams are delivered to the cutaneous sample through a flexible optical 
fibre provided at the extremity with a single-point probe (diameter ~4 mm) 
targeting a tissue volume of ~1-3 mm3. The probe includes specific sensors for 
the delivery of the different laser beams, and detectors for the collection of the 
light coming from the tissue (Fig. 19). The general principles of operation for 
LAKK-M measurements are described in Fig. 20. 
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Fig. 19 Scheme of the LAKK-M single-point probe. The apparatus is provided with a 
multimodal single-point probe which includes 7 sensors: 4 irradiating sensors (IR, UV, green/blue, 
red laser sources), 2 detectors and a spectrometer. The distance between each irradiating sensor 
and the correspondent detector is around 1 mm. The probe is designed to test a skin tissue 
volume around 1-3 mm3. 
 
Fig. 20 General operation scheme of LAKK-M device (figure reproduced from [147]). (1) 
Optical radiation source with wavelength λ and power Ps(λ). (2) Optical fibre to transfer the 
radiation from the laser source to the skin. (3) The radiation interacts with the skin tissue through 
absorption and scattering events. (4) The backscattered radiation emitted from the tissue with 
power Pr(λ) < Ps(λ) is transmitted to a photodetector by an optical fibre system. (5) The 
photodetector converts the Pr(λ) power into voltage Ic(λ). (6) The electric signal Ic(λ) is filtered 
and digitised in an electronic block. (7) The digital data is transferred to a computer for 
mathematical processing. 
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2.2.2 LDF and RS recordings 
The LAKK-M system allows concurrent LDF and RS measurements to be 
performed according to the principles that have been discussed in sections 1.5 
(paragraph 1.5.1, page 29) and 1.6 (page 41), respectively. Before collecting 
measurements the single-point probe was calibrated through a fluoroplastic 
oscillating disk located at the bottom of the device which simulates Brownian 
motion (Fig. 21). The LDF signal was obtained by the irradiation of the skin with 
the IR (1064 nm) laser source at a sampling frequency of 20 Hz. The blood 
perfusion Im, calculated according to equation 1 (section 1.5, paragraph 1.5.1, 
page 29), was expressed in arbitrary perfusion units (PU). Fig. 22 shows an 
example of LDF blood perfusion continuous time series obtained by LAKK-M. 
 
Fig. 21 LAKK-M system calibration before LDF and RS analyses (picture reproduced from 
the Spe Lazma Ltd user’s manual). The calibration method is insensitive to environmental 
vibration artefacts, based on the detection of the Doppler shift generated in a layered structure 
with tissue-like optical properties. The layers are made of an oscillating fluoroplastic disk (PTFE) 
and a fixed light transparent upper plane-parallel plate used to create a constant component of 
the signal by the passage of the radiation through the transparent plate. 
 
Fig. 22 LDF time series. Example of 10 min LDF recording from the human volar forearm 
collected by LAKK-M single-point probe. The technique allows to monitor continuously blood 
perfusion dynamics and is suitable for the study of nonlinear dynamics by wavelet analysis. 
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Oxygen saturation (SO2) was obtained by RS, through the simultaneous 
irradiation of the skin with green (532 nm) and red (630 nm) lights which are 
absorbed differently by oxygenated and deoxygenated Hb fractions. The 
percentage SO2 (equation 3, section 1.6, page 42) is extracted from green and 
red backscattered lights by the application of the Beer-Lambert law (equation 2, 
section 1.6, page 42). The software associated with the LAKK-M system (LDF 
3.1.1.404) allows extracting raw data of the LDF signal for subsequent processing 
by using additional software (e.g. Matlab). In contrast, the software does not allow 
the extraction of SO2 raw data for customised analysis. 
2.2.3 Workflow to evaluate the reliability of LDF measurements 
The workflow of this research study included preliminary experiments to evaluate 
the robustness and reliability of LAKK-M LDF measurements for monitoring skin 
blood perfusion (M6): 
(1) Comparison of LDF measurements with blood perfusion recordings obtained 
using a standard optimised LDI protocol available at the School of Medicine 
of the University of Dundee. 
(2) Examination of microvascular function by applying the LDF technique on three 
mouse phenotypes for which different microvascular reactivity was expected. 
LDF vs LDI 
The LAKK-M LDF perfusion measurements were compared with LDI recordings 
obtained using the MoorLDI imaging commercial system (Moor Instruments Ltd, 
UK), for which established optimised protocols were available at the facilities of 
the School of Medicine of the University of Dundee. The principles of LDI method 
have been already discussed in section 1.5 (paragraph 1.5.1, page 31). Fig. 23 
displays a scheme of the experimental setup for the collection of LDI 
measurements from mice skin during iontophoresis transcutaneous delivery of 
vasoactive drugs. Fig. 24 shows the LDI protocol used to assess the 
microcirculation from the mouse flank. The protocol was consistent with the 
collection of 22 temporal LDI perfusion maps at a sampling rate of a map every 
32 s, while challenging micro-vessels with iontophoresis administration of 
vasoactive drugs. The first 3 maps were imaged without administration of 
pharmacological agents to determine the baseline perfusion, then 6 maps were 
acquired during constriction of micro-vessels induced by iontophoresis 
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administration of 1% PE, 6 maps were acquired during vasodilation of micro-
vessels induced by delivery of 2% ACh, and the last 7 maps were imaged to 
monitor the restoration of baseline perfusion after stopping ACh delivery. 
 
Fig. 23 Scheme of the experimental setup for LDI data acquisition. LDI is a method sensitive 
to light absorption from hair or pigmentation in the skin. Thus, the flank of the tested mice was 
shaved 48 hours prior to performing the experiments by using an electric shaver and removing 
the remaining hair with depilatory cream (Veet®, Reckitt-Benckiser) to obtain an intact hair-free 
skin. Before the experiments mice were anaesthetised through a standard Boyle’s Apparatus to 
prevent movement artefacts, and were laid on a heat mat at 37°C with the flank facing the upper 
side. A general light anaesthesia was maintained by delivering 1.5-2% isoflurane (Abbott 
Laboratories) in oxygen (1.5 L/min) through an inhalation nose cone. An iontophoresis chamber 
(ION6 probe, Moor Instruments Ltd, UK) of 20 mm internal diameter was attached to the mouse 
flank using double-adhesive tape, and a reference electrode was placed underside of the animal. 
The iontophoresis chamber was filled with a 2 ml solution of vasoactive drug and sealed with a 
clear Perspex cap (Moor Instruments Ltd, UK). The delivery of the vasoactive drug was induced 
by the application of a continuous 100 µA anodal current through an iontophoresis controller 
(MIC2, Moor Instruments Ltd, UK) connected to the electrodes. LDI images were acquired using 
the commercial system MoorLDI (Moor Instruments Ltd, UK), which employs a stable helium-
neon (HeNe) laser source (633 nm, 2 mW nominal power) coupled with a diode laser source (780 
nm, 1 mW nominal power) to irradiate the skin sample. The laser was positioned 50 cm above 
the mouse skin, and the internal mirror distance was accounted for a height of 32 cm from laser 
hood to tissue. The light scattered from the moving RBCs and the static scattering from the skin 
surface were detected through an imaging lens, focused on two photodetectors, and finally 
processed as a photocurrent to provide skin perfusion coloured maps. 
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Fig. 24 Protocol to examine microvascular function by LDI during iontophoresis. LDI 
coloured maps of skin blood perfusion imaged in resting conditions (maps 1-3), during PE-induced 
vasoconstriction (maps 4-9), during ACh-induced vasodilation (maps 10-15), and during the 
restoration of baseline flow (maps 16-22). The coloured pixels of the images reflect the degree of 
blood perfusion in the cutaneous tissue, expressed in arbitrary perfusion units (PU) ranging from 
0 (dark blue, low-perfusion) to 1000 (dark red, high-perfusion). The average perfusion values were 
extracted from the maps by using the LDI software v5.3 (Moor Instruments Ltd, UK). 
 
Considering that LDI provides only discrete measurements of blood perfusion, 
the comparison with LDF was performed by acquiring 10 s LDF measurements 
from the same skin location at specific key steps of the test and evaluating the 
relative trends of the average perfusion values obtained with the two techniques. 
A total of 4 discrete time points were chosen to compare LDI and LDF 
measurements, which are highlighted by the coloured squares in Fig. 24: 
(1) Baseline perfusion (yellow square, LDI map 3). At this time point the LDI was 
paused, to allow removing the Perspex cap and placing quickly the LAKK-M 
single-point probe in the skin inside the chamber to collect a 10 s LDF trace. 
Then, the LDF probe was removed and the experiment was continued by 
applying a 100 μA current to administrate the 1% PE solution. At this point 
LDI recordings were restarted. 
(2)  Perfusion after PE delivery (purple square, LDI map 9). At this time point the 
delivery of PE and LDI recordings were paused, to allow again placing quickly 
the LDF probe in the skin inside the chamber for collecting a 10 s LDF trace. 
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Then, both of the LDF probe and the PE solution were removed from the 
chamber. The skin was quickly washed with sterilised water and the chamber 
filled with a 2% ACh solution. The experiment was continued by applying a 
100 μA current to deliver ACh. At this point LDI recordings were restarted. 
(3) Perfusion after ACh delivery (red square, LDI map 15). At this time point the 
delivery of ACh and LDI recordings were paused, to allow a 10 s LDF trace to 
be collected. Then, both of the LDF probe and the ACh solution were removed 
from the chamber, the skin was quickly washed with sterilised water and the 
chamber filled with water solution. The experiment was continued by 
restarting LDI recordings to monitor the restoration of baseline perfusion. 
(4) Restoration of baseline perfusion (green square, LDI map 22). This was the 
final time point of the experiment. After the acquisition of the last LDI map, the 
LDF single-point probe was placed quickly in the skin inside the chamber and 
a 10 s trace was collected. 
The experiments were repeated in duplicate from the skin of 5 WT mice (10 
experiments), collecting a total of 40 pairs of discrete LDF and LDI mean 
perfusion values (4 time points for each experiment) that were used to estimate 
the Pearson’s correlation coefficient r. The correlation analysis performed by R-
Studio software provided a robust positive correlation coefficient between LDF 
and LDI data (r=0.8, p < 0.001, number of samples n=40). 
Fig. 25 shows the trends of the average relative perfusion (dimensionless 
values obtained as a function of the baseline perfusion) measured by LDF and 
LDI. Both of the methods were able to detect the expected trend of relative 
perfusion, showing a decrease of flow after vasoconstriction induced by PE, an 
increase of flow after administration of ACh, and restoration of the baseline flow 
after stopping the delivery of ACh. Although the two techniques provided quite 
similar results, the values of relative perfusion were different during ACh time 
point with higher perfusion values (9% higher) detected by the LDI technique. 
This observation could be due to different reasons: 
(1) Because it was not possible to collect LDI and LDF data simultaneously, it 
may be possible that during the time period passing between the last ACh LDI 
recording (Fig. 24, map 15), the application of the LDF probe to the skin, and 
the collection of the LDF measurement the effect of ACh was already 
diminished, thus explaining the lower perfusion detected by LDF. 
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(2) As displayed in Fig. 26, the LDI scans reflect the average blood perfusion in 
the entire skin area inside the iontophoresis chamber providing better 
reproducibility of measurements compared to the LDF single-point recordings. 
This could also explain the detection of different perfusion values with the two 
methods during ACh time point, which is the reason why LDI is the preferred 
choice when the goal is evaluating the maximal blood flow peak response. 
 
Fig. 25 Comparison of LDI and LDF measurements. Relative mean blood perfusion values 
measured in duplicate from 5 WT mice (n=5, n. of experiments=10) by LDI and LDF methods 
during the different time points of iontophoresis test. Data are expressed as a function of the 
baseline (dimensionless units) and presented as line plots of the mean values with error bars 
corresponding to the standard deviation (SD). Red line = LDI. Blue line = LDF. B = Baseline. PE 
= Phenylephrine. ACh = Acetylcholine. RB = Restored baseline. 
 
Fig. 26 Spatial distribution of LDF and LDI scans. LDI and LDF recordings cover skin areas of 
different size. As shown on the left side of the image, LDF provides recordings reflecting the mean 
perfusion of a single cutaneous point inside the iontophoresis chamber, while LDI (right side of 
the image) measures the average perfusion of the whole skin area inside the chamber. The slow 
sampling of a larger skin area typical of LDI recordings allows reducing the variability of perfusion 
measurements caused by the heterogeneous structure of skin, providing a better data 
reproducibility. In contrast, single-point measurements provide the advantage of fast continuous 
recordings suitable to track the non-linear oscillatory behaviour of the microcirculation. 
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Based on the results obtained from these preliminary experiments, the LAKK-M 
LDF recordings were considered sufficiently reliable to evaluate skin blood 
perfusion. Indeed, the measurements showed a relevant correlation with the 
standard LDI recordings used at the University of Dundee for assessing 
endothelial function in mice. Moreover, although the single-point nature of LDF 
recordings might be a shortcoming leading to inaccurate detection of the maximal 
perfusion peak response, this does not represent a major problem in this work 
that is aimed at investigating the nonlinear dynamics of the microcirculation. 
Indeed, LDF is more suitable than LDI for assessing the oscillatory behaviour of 
blood flow due to the high sampling frequency of continuous perfusion traces. 
Examination of microvascular function by LDF in different mouse models 
To confirm further the reliability of LAKK-M LDF measurements for the study of 
microcirculation function, the probe was also tested on three different mouse 
models that are expected to display different patterns of microvascular reactivity: 
 WT mice (n=4), characterised by a normal functioning microvascular system. 
 Nrf2-/- mice (n=4), characterised by impaired antioxidant defence and 
increased oxidative stress that should impact negatively the microcirculation. 
 Kelch-like ECH-associated protein 1 KO (Keap-1-/-) mice (n=4), characterised 
by overexpression of the Nrf2 transcription factor and enhanced antioxidant 
defence that should impact positively the microcirculation. 
The experiments were performed combining the LDF probe with iontophoresis, 
as displayed in Fig. 27. Also in this case mice were shaved and anaesthetised 
prior to performing the experiments, and the iontophoresis equipment was set up 
with the same modalities described in Fig. 23. However, in this case the chamber 
was not sealed with the Perspex cap to allow placing the LDF probe in direct 
contact with the skin. A continuous LDF signal was recorded during the 
iontophoresis test that was divided into three steps: baseline (1 min and 30 s), 
vasoconstriction induced by delivery of 1% PE (3 min), vasodilation induced by 
delivery of 2% ACh (6 min). The relative mean perfusion values were estimated 
for each time point of the test and compared between the three groups of mice. 
The results displayed clearly different microvascular patterns between groups, 
reflecting the expected functional trends for the examined phenotypes (Fig. 28). 
Nrf2-/- knock-out animals displayed a major vasoconstriction during PE 
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administration and lower vasodilation during ACh delivery compared to both WT 
and Keap-1-/- animals, confirming the negative impact of oxidative stress on 
microvascular function. Moreover, Keap-1-/- mice showed the highest relative 
increase of blood perfusion in response to ACh stimulation, confirming the 
positive effect of enhanced antioxidant defence on the functional dynamics of the 
microcirculation. These preliminary results confirmed further the reliability of 
LAKK-M LDF measurements for the assessment of microvascular function. 
 
Fig. 27 Experimental setup to test microvascular function by LAKK-M LDF probe. The probe 
was placed in direct contact with the skin. A continuous 10 min and 30 s perfusion recording was 
collected during iontophoresis. The test was divided in 3 steps: baseline, transdermal delivery of 
1% PE, and delivery of 2% ACh. Mice were anaesthetised and laid in a heat mat at 37°C prior to 
performing the test. The anaesthesia was maintained during the test by an inhalation nose cone. 
 
Fig. 28 Microvascular function in WT, Nrf2-/- and Keap-1-/- mice. Relative blood perfusion 
values measured in duplicate by LDF from WT (n=4, n. of experiments = 8), Nrf2-/- (n=4, n. of 
experiments = 8) and Keap-1-/- (n=4, n. of experiments = 8) mice during iontophoresis test. Data 
are expressed as a function of the baseline (dimensionless units) and presented as line plots of 
the mean values with error bars corresponding to the SD. Blue line = WT. Red line = Nrf2-/-. Yellow 
line = Keap-1-/-. B = Baseline. PE = Phenylephrine. ACh = Acetylcholine. 
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2.2.4 LFS measurements 
As discussed in paragraph 2.2.1 (pages 72-73), the LAKK-M device allows the 
measurement of UV, blue, green and red autofluorescence by the employment 
of 365 nm, 480 nm, 532 nm and 630 nm laser sources, respectively. The 
calibration of LFS laser was performed by using the skin location chosen for the 
measurement as template. NAD(P)H skin autofluorescence was assessed by 
using the UV laser source, which is able to induce also the autofluorescence of 
structural proteins (e.g. collagen and elastin) and FAD+ (Fig. 29). Therefore, the 
detected UV autofluorescence spectrum was the result of the overlapping 
contribution from different fluorophores with the central AF peak reflecting mainly 
NAD(P)H emission. Raw data of the UV spectra were processed by Matlab 
R2015a (The MathWorks Inc.) software to extract the amplitude of each 
fluorophore’s emission peak expressed in arbitrary units. 
 
Fig. 29 Typical UV AF measured by LAKK-M LFS probe. Example of UV autofluorescence 
spectrum measured for 10 s from the flank of a mouse. The fluorescence amplitudes of the 
biomarkers were extracted at the following emission wavelengths: NAD(P)H 490 nm, FAD+ 550 
nm, elastin 450 nm. Data were expressed in arbitrary units (AU). 
A disadvantage of the LAKK-M device is the impossibility to run simultaneously 
LFS and LDF/RS measurements. Therefore, to perform simultaneous recordings 
of AF, blood perfusion and oxygen saturation two single-point probes of two 
different LAKK-M devices were combined, a probe to measure LDF/RS signals 
and another probe to collect contemporary AF spectra. 
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Another aspect to consider is the discrete nature of LFS measurements which 
does not allow obtaining time series of NAD(P)H. For this reason, to monitor the 
changes of the biomarker over time, several discrete spectral measurements 
were collected in a specific time window and the fluorescence amplitude of 
NAD(P)H was extracted at 490 nm from each spectrum. 
In addition, as discussed in the section 1.7 (paragraph 1.7.2, page 50), 
NAD(P)H cutaneous AF is affected by UV light absorption from Hb in the blood, 
leading to sensitivity of the signal to changes in blood volume (BV). To reduce 
BV influence, the NAD(P)H autofluorescence peak was normalised by the 1:1 
ratio with the fluorescence amplitude of elastin (450 nm), 
𝑁𝐴𝐷(𝑃)𝐻𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 =
𝑁𝐴𝐷(𝑃)𝐻𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
𝐸𝑙𝑎𝑠𝑡𝑖𝑛𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
                                                                               (21) 
Elastin is a structural protein that should maintain constant amounts in the tissue 
during the time-window while the recordings are collected (20-25 minutes). Thus, 
when evaluating the relative change of the NAD(P)Hnormalised (dimensionless 
variable) over time this should reflect the trend of NAD(P)H with a reduced effect 
of BV. The spectral emission region around 450 nm should contain also an 
overlapping contribution of collagen. However, this does not represent a major 
problem because collagen is also a structural protein of the cutaneous tissue 
characterised by a non-variable biological turnover in the short time frame of 20-
25 minutes employed in this study for data collection. 
The redox state of the skin tissue was assessed by calculating the redox ratio 
(RR), defined as the ratio between NAD(P)H and FAD+ autofluorescence peaks, 
𝑅𝑅𝑖𝑛𝑑𝑒𝑥 =
𝑁𝐴𝐷(𝑃)𝐻𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
𝐹𝐴𝐷+𝑎𝑚𝑝𝑙𝑖𝑡𝑢𝑑𝑒
                                                                                                         (22) 
RR (dimensionless variable) is an index of the balance between the reduced 
NAD(P)H and the oxidised FAD+, reflecting the mitochondrial activity. More 
specific details on the reasons for normalising NAD(P)H AF by elastin and FAD+ 
AF are provided in the section 2.3 (paragraph 2.3.2, page 99). 
An alternative better method the normalisation could have been done was 
performing the same calculations described in equations 21-22 by using data on 
the contributions of NAD(P)H, FAD+ and elastin to the UV AF spectrum extracted 
with a more precise technique. A possible approach to achieve this goal could be 
computing the contribution of the fluorophores to the emission spectrum through 
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the curve-fitting analysis described in Fig. 14 of paragraph 1.7.1 (page 46). 
However, the implementation of the curve-fitting technique was not part of the 
main objectives of this project and will be certainly considered as future 
perspective to improve the methodology, allowing a better differentiation of the 
overlapping contributions of different natural dyes to the UV emission spectrum. 
2.2.5 Workflow to evaluate the robustness of LFS measurements 
An important aspect when evaluating autofluorescence is to determine the 
reliability, accuracy and reproducibility of the measurements. Indeed, LFS 
recordings are notoriously fickle measurements affected by several factors in the 
biological tissue, i.e. the location used for data collection, the temperature, the 
physiological state of the tested subject, and the absorption of light by absorbers 
in the cutaneous tissue. Therefore, the workflow for the design of the protocols 
used in this study was consistent with preliminary experiments to determine the 
reliability of LAKK-M LFS recordings for the final purpose of this research, which 
was the assessment of nonlinear dynamics of cellular energetic metabolism by 
the examination of NAD(P)H oscillatory behaviour. The preliminary work to 
determine the reliability of LFS recordings and possible normalisation techniques 
to improve the assessment of AF included different kind of experiments: 
(1) Evaluation of the reproducibility of the technique for measuring NAD(P)H 
fluorescence in both in-vitro molecular solutions and in-vivo cutaneous tissue. 
(2) Preliminary experiments comparing UV LFS recordings between WT and 
Nrf2-/- mice to evaluate the potential of the technique to distinguish between 
normal conditions and increased degree of oxidative stress in the skin. 
(3) Monte Carlo modelling studies for determining the spatial resolution of 
autofluorescence single-point measurements. 
(4) Application of correction methods to reduce the negative effect of natural skin 
absorbers, i.e. Hb, on AF recordings (section 2.3, paragraph 2.3.2, page 99). 
Reproducibility of LFS measurements in-vitro 
The variability of LFS recordings in-vitro was examined by measuring the UV 
fluorescence of molecular solutions of NADH. Specifically, 1 mM of fresh solution 
was prepared at a T of 4°C mixing w/v β-NADH (Sigma-Aldrich) with a solvent. 
The solvent used to prepare the solution was a Trizma® base buffer (Sigma-
Aldrich) that according to the guidelines from Sigma-Aldrich allows obtaining 
stable solutions of β-NADH. 0.1 mM, 0.01 mM, 0.001 mM and 0.0001 mM 10-fold 
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serial dilutions were prepared from the starting 1mM solution as shown in Fig. 30. 
300 μl of each solution/dilution and of the solvent (control) were analysed in 
triplicate using the matte black cuvette (Spe Lazma Ltd, Russia) described in Fig. 
31, which is specifically designed for performing in-vitro fluorescence analysis 
using the LAKK-M LFS probe. 
 
Fig. 30 Preparation of NADH solutions at different concentrations. Scheme of the 10-fold 
serial dilutions of β-NADH obtained starting from a 1 mM fresh solution. The Trizma® base solvent 
at pH 9 was used to produce stable solutions. The eppendorf tubes were covered with aluminium 
foil to avoid molecular photo-degradation induced by environmental light. 
 
Fig. 31 Black cuvette for in-vitro fluorescence measurements. The image shows the matte 
black cuvette that was used to measure the fluorescence of in-vitro β-NADH solutions. The 
cuvette included a well for spotting the solution, and a cuvette sealing for protecting the sample 
from the external environmental light. The sealing was provided with a hole at the top, which was 
specifically designed with the same size of the LAKK-M single-point LFS probe to allow the 
insertion of the probe for collecting the fluorescence measurements. 
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For each analysed solution, five 10 s NADH fluorescence spectra were collected 
over 5-min (1 spectrum per min) by irradiating the solution inside the cuvette with 
the LFS 365 nm UV light. The well of the cuvette was washed three times with 
sterilised water between subsequent analyses to remove residuals of the solution 
examined previously. Fig. 32 displays the results of in-vitro fluorescence 
recordings of NADH, the peak was found at 490 nm for the 1 mM, 0.1 mM and 
0.01 mM solutions (Fig. 32a-c), while a shift of the peak to 460 nm was observed 
for the 0.001 mM and 0.0001 mM solutions (Fig. 32d-e). A possible explanation 
for the shift of NADH emission peak may be that the fluorophore absorbs its own 
fluorescence at high concentrations. A control solution of the solvent (Trizma® 
base) was analysed prior to the examination of NADH solutions, to make sure 
that any contamination from external fluorophores was absent. No fluorescence 
peaks were observed in the control solution (Fig. 32f). The variability of NADH 
fluorescence measurements repeated over 5-min was estimated as the ratio 
between the standard deviation (SD) and the mean of NADH emission peak, 
revealing a coefficient of variation between 1-6% that is close to the 2-4% random 
error reported in the literature for LFS measurements on non-alive gauges 
performed by using the LAKK-M device [148]. The in-vitro experiments revealed 
also that the LFS is able to distinguish correctly different concentrations of NADH, 
at least for the range of concentrations tested in this study (0.0001-1 mM). Data 
on the sensitivity of LFS to different NADH concentrations are shown in Fig. 33. 
Reproducibility of LFS measurements in-vivo 
The variability of LFS measurements in-vivo was examined by measuring the UV 
AF from human subjects at two different skin locations: the forearm and the 
palmar side of the middle finger. Specifically, 10 s sequential UV spectra were 
collected over a temporal period of 10-min (1 spectrum per min) in resting 
conditions. The experiments were performed in a room with controlled T (23 ± 
1°C), while the subject was resting in a clinical bed with the arm laid in a soft 
cushion. The forearm location was tested from 53 individuals and the middle 
finger from 10 individuals. The variability of the measurements over 10-min was 
estimated as the ratio between the SD and the mean of the AF emission peaks, 
revealing a coefficient of variation between 1-8% from the forearm and between 
9-20% from the middle finger. 
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Fig. 32 UV fluorescence of NADH molecular solutions. 300 μl of each solution were tested 
over 5 min (experiment repeated in triplicate). (a) Fluorescence of 1 mM β-NADH. (b) 
Fluorescence of 0.1 mM β-NADH. (c) Fluorescence of 0.01 mM β-NADH. (d) Fluorescence of 
0.001 mM β-NADH. (e) Fluorescence of 0.0001 mM β-NADH. (f) Fluorescence of a control 
solution of Trizma® base. The control solution did not show any fluorescence peak from external 
contaminations. NADH peak was located at 490 nm for 0.01-1 mM solutions and at 460 nm for 
0.0001-0.001 mM solutions. Data are expressed as function of the backscattered light 
(dimensionless units). The variability over 5 min for the fluorescence recordings of each NADH 
solution was respectively 4-6% (a), 3-4% (b), 2-6% (c), 1-6% (d), 2-5% (e). 
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Fig. 33 Sensitivity of LFS optical measurements to NADH concentration. (a) β-NADH UV 
fluorescence spectra measured from solutions at different concentrations: 1 mM (yellow), 0.1 mM 
(light blue), 0.01 mM (red), 0.001 mM (blue), 0.0001 mM (green). The graph clearly shows a trend 
of fluorescence amplitude matching with the analysed concentrations, characterised by 
sequential increasing peaks from 0.0001 mM to 1 mM solutions. However, the increase of the 
spectral amplitude is nonlinear, probably due to the high concentration of NADH in a small testing 
volume (300 μl) for the 1 mM, 0.1 mM and 0.01 mM solutions. This may cause absorption of its 
own fluorescence by NADH and a consequent nonlinear increase of the emitted fluorescence.   
(b) Analysis of a control Trizma® base solution at pH 9. No contaminant fluorescence peaks were 
detected. Data are expressed as function of the backscattered light (dimensionless units). 
Fig. 34 shows examples of sequential UV AF spectra measured from the two 
analysed locations over a period of 10-min. The results from these experiments 
clearly outlined that LFS measurements from the in-vivo tissue are characterised 
by a major variability compared to measurements from in-vitro molecular 
solutions, making it difficult the accurate quantification of the concentration of the 
autofluorescent biomarkers and the biological interpretation of the data. Indeed, 
several environmental factors affect the AF signal, e.g. the heterogeneous 
anatomy of the skin characterised by different thickness and functional structures 
depending on specific locations, and the absorbance of UV light by melanin in 
the skin and Hb in the blood of cutaneous micro-vessels. The LFS measurements 
were more stable from the forearm location (Fig. 34a-34c), which showed less 
variability compared to the middle finger (Fig. 34b-34d) over a period of 10-min. 
The higher variability observed from the middle finger could be due to a major 
number of physiological environmental factors affecting the autofluorescence 
signal at this location. Indeed, the palmar side of the fingers is rich of AVAs, 
capillaries and sympathetic nerves that can cause fast and frequent changes of 
blood perfusion and blood volume highly affecting LFS signal. 
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Fig. 34 UV autofluorescence from in-vivo human skin. (a) Example of AF spectra collected 
over 10 min (1 spectrum per min) from the forearm. (b) Example of AF spectra collected over 10 
min (1 spectrum per min) from the middle finger. Data are expressed as function of the 
backscattered light (dimensionless units). The panel (c) shows the fluorescence intensity peak (λ 
= 490 nm), extracted from the spectra in the panel (a), expressed as function of time. The panel 
(d) shows the fluorescence intensity peak (λ = 490 nm), extracted from the spectra in the panel 
(b), expressed as function of time. The graphs clearly outline less variability of LFS measurements 
from the forearm location (1-8%) compared to the middle finger (9-20%). The spectra from the 
middle finger were characterised by a major intensity of the signal and a shift of the central peak 
from 490 nm to 480 nm compared to the AF spectra from the forearm. 
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Moreover, the middle finger location is more sensitive than the forearm to 
artefacts due to the pressure of the probe applied at direct contact with the skin 
or movements of the fingers. The AF signal was characterised by a major 
intensity in the middle finger compared to the forearm, probably due to higher 
content of melanin in the forearm which is an absorber of UV light. 
The central AF peak was located at 490 nm in the spectra from the forearm, 
which should reflect mainly the autofluorescence of NAD(P)H, even though the 
spectrum is characterised by the overlapping contribution of the autofluorescence 
signal from other biological fluorophores (i.e. FAD+, elastin, collagen). The central 
AF peak was located at 480 nm in the UV spectra from the middle finger, showing 
that the peak may be shifted in different cutaneous sites due to the effect of 
biological factors affecting the signal (e.g. changes of BV, anatomy, etc.). 
Another aspect to consider, which is crucial for the final purpose of this work, is 
that part of the variability over time of the in-vivo skin AF signal is due to the 
natural turnover of the fluorophores in the biological tissue. For example, the 
coenzyme NAD(P)H which is the fluorophore contributing more to the UV LFS 
signal is fluctuating continuously in the biological tissue due to its involvement in 
the production of ATP energy in the cells, consistent with cyclic redox reactions 
converting the reduced NAD(P)H in the oxidised NAD+ (non-fluorescent) and 
vice-versa. Therefore, part of the variability of NAD(P)H autofluorescence 
measured in-vivo reflects the natural oscillatory behaviour of this fluorophore. 
Considering that one of the main goals of this research was the in-vivo 
assessment of cutaneous NAD(P)H nonlinear dynamics, the temporal collection 
of LFS measurements was an optimal approach to achieve this objective allowing 
tracking the oscillatory behaviour of this cellular coenzyme over time. However, 
to allow obtaining an acceptable reliable assessment of NAD(P)H oscillatory 
dynamics several points were addressed, aimed at reducing the variability of the 
autofluorescence signal associated with the negative effect of environmental 
factors (i.e. blood volume), and at implementing the methodology for the 
characterisation of NAD(P)H oscillations. This was achieved in different steps: 
1. First, choice of the location for collecting LFS recordings. Based on the results 
reported above in Fig. 34, the forearm location was chosen as preferential site 
for assessing NAD(P)H dynamics in human subjects. Indeed, the recordings 
from the forearm were more stable, characterised by less variability over time 
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probably reflecting a lower effect of blood volume changes compared to the 
middle finger due to lower density of micro-vessels and sympathetic nerves. 
Moreover, although the intensity of the signal from the forearm location was 
reduced, which could be a shortcoming when the goal is the absolute 
quantification of NAD(P)H concentrations, this is not a major problem for the 
purpose of evaluating the oscillatory behaviour of the fluorophore over time. 
2. Second, development of a method for reconstructing a continuous NAD(P)H 
AF signal from the discrete UV spectra collected over time (see section 2.3, 
paragraph 2.3.1, page 96). This was a key step to allow the characterisation 
of NAD(P)H oscillations by performing the continuous wavelet transform 
(CWT) analysis, which can be applied exclusively on continuous signals. 
3. Third, application of a multi-parameter approach for assessing the effect of 
blood volume on the temporal changes of NAD(P)H AF signal. Specifically, 
simultaneous recordings of LFS and skin blood flow signals were performed 
during PORH test to examine the effect of a massive increase of blood volume 
on NAD(P)H autofluorescence (see section 2.3, paragraph 2.3.2, page 99). 
4. Fourth, comparison of data from subjects with white and dark coloured skin 
for assessing the effect of melanin on the temporal changes of NAD(P)H 
autofluorescence signal (see section 2.3, paragraph 2.3.2, page 99). 
5. Fifth, application of a 1:1 ratiometric correction of NAD(P)H autofluorescence 
signal by elastin autofluorescence in order to reduce the effect of blood 
volume and improve the assessment of NAD(P)H temporal dynamics (see 
section 2.3, paragraph 2.3.2, page 104). 
6. Sixth, estimation of the redox ratio index to allow tracking the mitochondrial 
cellular energetic dynamics (see section 2.3, paragraph 2.3.2, page 104). 
Evaluation of LFS potential to detect oxidative stress 
Preliminary experiments comparing UV LFS baseline recordings between 
different mouse phenotypes were performed to explore the potential of the 
technique to distinguish between normal conditions and increased degree of 
oxidative stress in the skin. The groups of mice used for this purpose were: 
 WT normal mice (n=4). 
 Nrf2-/- KO animals (n=4) affected by impaired antioxidant defence. 
 Sik (Salt-inducible kinases) knock-in (KI) mice (n=4), characterised by a 
protective anti-inflammatory phenotype. 
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Specifically, for each experiment 10 s UV autofluorescence LFS baseline spectra 
were collected over 10 min at a rate of 1 spectrum per min. The experiments were 
carried out in duplicate for each mouse under general isofluorane anaesthesia to 
avoid movement artefacts. Fig. 35 shows the experimental setup used for 
performing the recordings. The mean spectrum representative of the baseline AF 
was estimated by averaging the 10 spectra collected during the experiment. 
 
Fig. 35 Experimental setup to explore the potential use of LFS method for assessing 
cutaneous oxidative stress. The single-point probe was placed at direct contact with the skin in 
the flank of the mouse that was shaved 48 hours prior to performing the test. Multiple 10 s UV 
baseline spectra were collected over a 10 min time period (1 spectrum per min) by irradiation of 
the skin with the 365 nm LFS laser source. Mice were anaesthetised and laid in a heat mat at 
37°C prior to performing the experiment. The anaesthesia was maintained during the experiment 
through an inhalation nose cone. Four mice were tested for each group repeating the experiment 
in duplicate (a total of 8 experiments for each group of mice). 
Fig. 36 shows the comparison of the UV average baseline spectra between the 
three groups of examined mice. The results clearly outline a greater AF emission 
peak in Nrf2-/- KO animals compared to both WT and Sik KI anti-inflammatory 
phenotypes, which reflects the higher degree of oxidative stress in Nrf2-/- mice 
associated with accumulation of the reduced form of NAD(P)H. These preliminary 
findings confirmed the potential and reliability of LFS technique for evaluating 
cutaneous oxidative stress. 
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Fig. 36 Comparison of baseline AF between Sik KI, WT and Nrf2-/- mice. Mean baseline UV 
autofluorescence estimated for each group of mice by averaging the spectra obtained from 
duplicate experiments (n=4, n. of experiments = 8, n. of spectra collected for each experiment = 
10). Data are expressed as a function of the backscattered light (dimensionless units). Yellow line 
= Sik KI mice. Blue line = WT mice. Red line = Nrf2-/- mice. The maximal emission peak was 
located at 490 nm, which should reflect mainly NAD(P)H contribution to the AF signal. 
Spatial resolution of LFS measurements 
A limitation of LFS method is the impossibility to determine the specific 
contribution to the AF signal coming from different cell types in the cutaneous 
tissue. The reason for this shortcoming is the uncertain spatial resolution of LFS 
recordings and the heterogeneous anatomy of the cutaneous tissue, which is 
made of multiple cell types that are part of the different skin layers and of the 
functional structures in the skin, i.e. micro-vessels. According to the literature, the 
365 nm UV-A laser light might penetrate at a skin depth corresponding to the 
upper dermal layer in human subjects [149, 150]. Mouse skin structure includes 
an epidermal layer thinner than human epidermis [151], thus in this case the UV-
A light might reach a tissue depth corresponding to the median dermal layer. As 
described in the section 1.4 (paragraph 1.4.2, page 26), the dermis contains 
functional microvascular structures (capillaries and arterioles). Therefore, a 
relevant part of the AF detected by LFS might take origin from the microcirculation 
that was the main tissue of interest in this study. 
To get information on the spatial resolution of the 365 nm laser of the LFS 
device used in this study, the penetration depth of the LAKK-M UV laser source 
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was simulated in a 5 layer human skin model including various absorbers and 
scatterers in each stratum. This experiment was part of a collaborative work with 
a research group from the University of St. Andrews (Scotland), based on 
performing Monte Carlo simulations of LFS LAKK-M measurements for gathering 
information on the skin tissue depth from which the detected signal was 
originating. The simulation was performed by adopting the exact parameters 
related to the UV laser source and geometry of the LAKK-M probe: 365 nm 
source wavelength, 0.4 mm beam radius, 0.4 mm detector radius, 1 mm probe-
detector center separation. The specific properties of the skin model used in the 
simulation are listed in Table 2. 
Table 2 Parameters of the human skin model used to simulate the LAKK-M UV light 
propagation. The skin model used in the experiment was made of 5 layers: stratum corneum, 
epidermis, papillary dermis, reticular dermis and hypodermis. Various absorbers and scatterers 
at specific concentrations were distributed in each layer: water, blood (including both oxygenated 
and deoxygenated Hb fractions), melanin (including both eumelanin and pheomelanin), bilirubin, 
β-carotene, and a baseline absorber. Data were provided by Mr Lewis McMillan and Dr Kenneth 
Wood from the Astronomy group at the University of St. Andrews (Scotland). 
Skin layer Thickness Absorbers 
Stratum corneum 0.030 mm 5% water, baseline absorber 
Epidermis 0.080 mm 20% water, 0.5% melanin, 2.1 × 10-4 g/L β-Carotene, 
baseline absorber 
Papillary dermis 0.180 mm 50% water, 0.05 g/L bilirubin, 7 × 10-5 g/L β-Carotene, 
6% blood, baseline absorber 
Reticular dermis 1.800 mm 70% water, 0.05 g/L bilirubin, 7 × 10-5 g/L β-Carotene, 
4.5% blood, baseline absorber 
Hypodermis 2.900 mm 70% water, 7% blood, baseline absorber 
 
The blood oxygenation level considered in the experiment was 75%, the skin type 
used was the Fitzpatrick skin type I, and the age of the modelled skin was ~30 
years. The thickness of the tissue model described in Table 2 is similar to that of 
the skin at 1/3 length of the forearm. Indeed, as shown by my research group in 
a recent paper [152], the thickness of the superficial epidermal skin layer at 1/3 
length of the forearm imaged by cmOCT technique was ~0-100 μm, followed by 
the epidermal-dermal junction (papillary dermis) at a depth of ~100-200 μm. 
Thus, considering that the human LAKK-M data in this thesis were collected from 
1/3 of the forearm, the results of this Monte Carlo simulation can be used to 
discuss implications associated to the AF measurements performed in this study. 
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The results of the simulation are displayed in Fig. 37, showing a penetration depth 
of the 365 nm light around 0.2 mm (human dermal-epidermal junction), even 
though the graph suggests that ~99% of the photons are coming from a depth of 
0.1 mm. Based on these observations, it can be stated that most of the AF signal 
measured by LAKK-M from the human forearm location is of epidermal origin with 
a partial smaller contribution of the papillary dermis region where the capillaries 
are located. Considering that mouse skin is characterised by a thinner epidermis 
than humans, it can be hypothesised a major contribution of the upper dermis to 
the AF signal in mouse models compared to humans. 
 
Fig. 37 UV laser penetration depth. Monte Carlo modelling of the LAKK-M 365 nm laser 
penetration depth. The result shows a penetration depth up to 0.2 mm with most of the light 
coming from a depth of 0.1 mm. Data were provided by Mr Lewis McMillan and Dr Kenneth Wood 
from the Astronomy group at the University of St. Andrews (Scotland). 
 
2.3 Nonlinear dynamics analysis of LDF and LFS time series 
2.3.1 Reconstruction of NAD(P)H and RR signals by spline interpolation 
The LDF method is able to provide blood flow signals (Fig. 22) suitable for the 
study of nonlinear dynamics by application of the CWT spectral analysis. This is 
due to the fast sampling rate of perfusion values that in the case of the LAKK-M 
device are acquired at a sampling frequency of 20 Hz (one sample every 0.05 s). 
In contrast, LFS allows obtaining only single discrete AF spectra (Fig. 29). Thus, 
for the study of nonlinear cellular metabolic dynamics, NAD(P)H and RR signals 
were reconstructed from the discrete UV spectra collected over time in order to 
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obtain the same temporal sampling rate (one sample every 0.05 s) as the LDF 
data. The reconstruction was carried out by using the software Matlab R2015a 
(The MathWorks Inc.). The technique employed for the reconstruction was the 
piecewise cubic spline interpolation, a methodology that was also tested 
successfully by my research group for reconstructing continuous blood flow 
signals at a specific temporal sampling rate from discrete experimental data 
points [152, 153]. 
Piecewise cubic spline interpolation 
The spline interpolation is a mathematical process employing a piecewise low-
degree composite polynomial, defined spline, to approximate a continuous 
function g by interpolation of equally spaced discrete data points of g [153]. The 
main benefit of spline interpolation is the optimal accuracy in the approximation 
of g over wide ranges, reducing the occurrence of errors during the approximation 
process such as the generation of oscillatory artefacts (Runge’s phenomenon) 
that can occur when using a single high-degree polynomial [153]. The spline 
interpolation addresses the shortcomings of the polynomial interpolation by 
subdividing the interval [a, b] where the function g is continuous in smaller sub-
intervals, and approximating g in every sub-interval employing low-degree 
polynomial pieces that define a composite spline function s [153]. 
In this dissertation, a cubic spline s was employed that is optimal for the 
reconstruction of continuous natural processes, and requires four coefficients to 
define a piecewise polynomial between each pair of discrete data points, as 
shown by equation 23 [153], 
p3(x) = a1x3 + a2x2 + a3x + a4,                                                                          (23) 
where p3 is the piecewise cubic polynomial, and a1, a2, a3 and a4 are the four 
coefficients defining p3. The curve obtained from the approximation process is 
composed of a number of pieces reconstructed between each pair of data points 
equal to 1-n, where n is the number of data points [153]. 
In this work, the time series were reconstructed by using the cftool in Matlab. 
Specifically, discrete values of NAD(P)Hnormalised (equation 21) or RRindex 
(equation 22) extracted from sequential AF spectra measured over time were 
used for the reconstruction, applying an interval of 60 s between each pair of 
consecutive data points that corresponds to the sampling frequency used during 
the experiments for the temporal acquisition of the spectra (1 spectrum per min). 
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The 4 coefficients defining the piecewise cubic polynomial of each pair of discrete 
data points (equation 23) were extracted from the cftool and saved in the Matlab 
workspace for the subsequent estimation of the reconstructed curve by using the 
Matlab function ppval. Fig. 38 shows examples of NAD(P)Hnormalised and RRindex 
signals reconstructed by applying the procedure described above. 
 
Fig. 38 Examples of signals reconstructed by spline interpolation. (a) 20 min NAD(P)H signal 
reconstructed from 20 sequential UV spectra (1 per min) collected  from the flank of a mouse 
during iontophoresis of PE. The discrete data points represent dimensionless NAD(P)Hnormalised 
values estimated by correction of NAD(P)H AF peak by elastin AF (equation 21). The curve covers 
the time-window of 20 min used to sample the UV spectra. (b) 20 min RR signal reconstructed 
from 20 sequential UV spectra (1 per min) collected from the flank of a mouse during 
iontophoresis of PE. The discrete data points represent dimensionless RR values estimated by 
ratiometric correction of NAD(P)H AF peak by FAD+ AF (equation 22). The curve covers the time 
window of 20 min used to sample the UV spectra. Considering that the n data points used for the 
reconstruction were 20, each curve in this graph is composed of 19 reconstructed pieces (n-1). 
As discussed previously, the advantage of spline interpolation is that the 
approximation process does not generate oscillatory artefacts between each pair 
of data points [153]. Therefore, by applying this method it was ensured that the 
results of the subsequent CWT spectral analysis were representative of the real 
fluctuations of NAD(P)H and RR detected by discrete LFS AF measurements, 
without the effect of artefacts introduced during the reconstruction. Nonetheless, 
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a shortcoming of this technique is poor accuracy in the reconstruction of the right 
and left ends of the function [153] because of the presence of a single known 
discrete data point at each extremity. Thus, to prevent the generation of artefacts 
at the edges of the signal, the time series was broken off at the right and left 
extremities making sure that the beginning and ending points of the curve were 
corresponding respectively to the initial and final experimental discrete data 
points employed in the reconstruction process [153]. 
Finally, it should be noted that here the spline interpolation was not applied as 
a numerical analysis to fit a model but the technique was employed as a technical 
procedure for obtaining continuous time series, which is a mandatory condition 
to allow the application of the CWT spectral analysis [13]. However, a limitation 
of using reconstructed time series was the possibility to study only low-frequency 
dynamics, due to the slow sampling frequency of the discrete data points used 
for the reconstruction (1 spectrum per min). 
2.3.2 Normalisation of NAD(P)H AF signal to remove artefacts and improve 
the evaluation of the temporal dynamics 
As discussed in section 1.7 (paragraph 1.7.2, page 50), the UV autofluorescence 
measured from in-vivo skin is highly affected by physiological and biological 
factors in the cutaneous tissue such as natural absorbers of UV light, i.e. Hb in 
the blood of micro-vessels and skin pigmentation (melanin) [46, 85]. As a 
consequence, the evaluation of the temporal dynamic changes of NAD(P)H AF 
may be inaccurate and unreliable, especially due to the variability and artefacts 
of the signal associated with the temporal fluctuations of blood volume (BV). 
Here, the effect of Hb on the dynamic changes of AF signal was tested by 
applying a multi-parameter approach. Specifically, simultaneous recordings of 
skin LFS signal and blood flow were performed in combination with the PORH 
reactive test to monitor how NAD(P)H AF emission is affected by massive 
changes of BV. Indeed, the PORH response is characterised by a substantial 
increase of blood flow and BV that is optimal to assess the effect of Hb UV light 
absorption on the AF signal. The effect of melanin was assessed by testing 
people with different coloured skin. As shown in Fig. 39, the study was designed 
by enrolling a total of 16 subjects (8 with white skin and 8 with dark skin), which 
signed an informed consent form before being tested. All the subjects were first 
examined as single group, to assess the effect of BV on the AF signal. Finally, 
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the subjects were divided in two groups with different coloured skin (8 subjects 
with white skin and 8 with dark skin), to compare data with the purpose of 
evaluating the effect of melanin on the AF signal. Fig. 40 shows the experimental 
setup used to collect simultaneous LFS and LDF recordings. The test was divided 
in three steps: baseline (10 min), occlusion of flow through the brachial artery (5 
min), monitoring PORH response after stopping the occlusion (10 min). 
 
Fig. 39 Study design to assess BV and melanin effect on the AF signal. 16 healthy individuals 
(8 with white skin and 8 with dark skin) were enrolled in the study by signing an informed consent 
form. The subjects were initially tested as single group by collecting simultaneous LFS and LDF 
data during a 25-min PORH test to assess the effect of BV on the AF signal. Finally, the subjects 
were allocated in two different groups (white vs dark skin) to compare data with the aim of 
evaluating the effect of melanin on the AF signal. 
 
Fig. 40 Experimental setup for multi-parameter data collection in human subjects. LDF and 
LFS probes were placed gently in two adjacent locations at 1/3 length of the left forearm by using 
double adhesive tape. A pressure cuff was placed in the upper part of the arm to occlude blood 
flow through the brachial artery during PORH test by inflating the cuff at 200 mmHg. Subjects 
were tested in a room with controlled temperature while resting in a clinical bed. The arm was laid 
in a cushion to ensure a comfortable position and avoid movement artefacts. 
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Fig. 41a-b display the effect of BV changes on NAD(P)H AF signal during PORH 
test. The AF data clearly outline a reduction of NAD(P)H signal concurrent to the 
increase of BV shown in the LDF data during PORH response. This is attributed 
to the absorption of UV light by Hb that leads to artefacts on the NAD(P)H signal 
that make the evaluation of the temporal dynamics unreliable. 
Fig. 42a-b display the effect of melanin on NAD(P)H AF signal during PORH 
test. The simultaneous LDF and AF traces clearly outline that while the colour of 
skin does not impact LDF signal, the intensity of NAD(P)H signal is reduced in 
subjects with dark skin because of the major amount of melanin absorbing UV 
light. However, while the reduction of the AF signal intensity may be a major 
problem for the absolute quantification of skin NAD(P)H concentrations, this does 
not seem an issue for evaluating the relative temporal dynamics of the 
fluorophore. Indeed, considering the constant amount of melanin present in the 
cutaneous tissue for the entire duration of the experiment, the degree of UV light 
absorbed by melanin is constant throughout the measurement allowing the 
detection of temporal fluctuations of the signal due to the biological turnover of 
the coenzyme. Therefore, as visible in Fig. 42a-b, also in this case the changes 
in blood volume seem to be the major factor leading to the introduction of 
artefacts in the temporal trace of NAD(P)H signal due to the continuous 
physiological fluctuations of BV. 
Ratiometric approach for normalising NAD(P)H autofluorescence signal 
The observations discussed above raised the need for implementing a 
normalisation method to correct NAD(P)H AF data with the purpose of reducing 
BV artefacts and obtaining acceptable time series reflecting the biological 
temporal dynamics of NAD(P)H more reliably. The method chosen for this 
purpose was the ratiometric correction, which has been previously employed for 
removing artefacts on NAD(P)H AF signal. The method consists in the 1:1 ratio 
between NAD(P)H AF and another variable affected by the same environmental 
artefacts, i.e. skin reflectance [85], to compensate for factors unrelated to 
NAD(P)H and obtain a dimensionless signal reflecting the dynamics of the 
fluorophore with more confidence. In this work, it has been taken advantage of 
the overlapping contributions in the UV spectrum of elastin (450 nm) and FAD+ 
(550 nm) AF to perform a 1:1 ratiometric correction of NAD(P)H AF, as already 
described in equations 21-22 (section 2.2, paragraph 2.2.4, page 84). 
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Fig. 41 Evaluation and correction of BV effects on NAD(P)H AF. Median (a) LDF signal and 
(b) NAD(P)H, (c) FAD+ and (d) elastin reconstructed AF time series from the forearm of 16 
subjects during a 25-min PORH test. Data are expressed in arbitrary units. A clear reduction in 
the intensity of NAD(P)H AF signal is visible during PORH response, associated with the increase 
of BV and absorption of UV light by Hb. (e) 1:1 ratiometric correction of NAD(P)H AF by elastin 
AF (dimensionless NAD(P)Hnormalised, equation 21). (f) 1:1 ratiometric correction of NAD(P)H AF 
by FAD+ AF (dimensionless RRindex, equation 22). The corrected signals were characterised by 
minimal effect of BV and temporal traces showing the expected trends for NAD(P)H and RR 
dynamics during PORH stimulation. 
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Fig. 42 Effects of melanin on NAD(P)H AF. Median (a) LDF and (b) reconstructed NAD(P)H AF 
signals from the forearm of 8 subjects with white skin (orange lines) and 8 subjects with dark skin 
(green lines) during a 25 min PORH test. Data are expressed in arbitrary units. LDF signal was 
not affected by skin melanin content, while the intensity of NAD(P)H signal was highly reduced in 
subjects with dark high-pigmented skin. (c) 1:1 ratiometric correction of NAD(P)H AF by elastin 
AF (dimensionless NAD(P)Hnormalised, equation 21). (d) 1:1 ratiometric correction of NAD(P)H AF 
by FAD+ AF (dimensionless RRindex, equation 22). The corrected signals displayed reduced BV 
effect and temporal traces comparable between subjects with different coloured skin. 
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Ratiometric correction of NAD(P)H AF signal by elastin autofluorescence 
The reason for choosing the autofluorescence of elastin as correction factor is 
the structural nature of this protein, which is abundant in the dermal layer of the 
skin [46, 87]. The structural components of the cutaneous tissue are supposed to 
remain unchanged during the temporal period while NAD(P)H AF is measured. 
Thus, the correction of NAD(P)H autofluorescence peak by elastin AF represents 
an intra-subject compensation for environmental factors unrelated to NAD(P)H, 
i.e. absorption of UV light by Hb, and the corrected signal should reflect NAD(P)H 
temporal dynamics because of the unchanged amount of cutaneous elastin 
during the short time period of 25 min employed to perform the experiment. The 
AF emission of elastin after stimulation with UV light is between 400-450 nm, a 
spectral region that may contain also the overlapping contribution of collagen AF 
(emission between 390-460 nm) [46, 87]. However, collagen is also a structural 
protein abundant in the cutaneous tissue that should remain unchanged during 
the temporal collection of LFS UV spectra. Fig. 41e displays the dynamics of 
NAD(P)H AF signal during PORH test after 1:1 ratiometric correction by elastin 
AF. A reduction of BV effect compared to Fig. 41b is clearly shown, and the 
dynamics of the normalised signal seems to reflect more reliably the biological 
turnover of NAD(P)H during PORH test. Indeed, an increase of NAD(P)Hnormalised 
signal was observed during occlusion of blood flow, which can reflect the 
inhibition of ATP energy production through the oxidative phosphorylation 
because of reduced tissue oxygenation, uncoupling of the electron transport 
chain and accumulation of NAD(P)H [85]. In contrast, the moderate decrease of 
normalised NAD(P)H signal during PORH in this case may indicate the oxidation 
of NAD(P)H to NAD(P)+ and reactivation of the aerobic production of ATP [85], 
rather than an artefact due to blood volume changes. The same results are shown 
in Fig. 42c, displaying that NAD(P)Hnormalised signal is characterised by reduced 
blood volume effect and is comparable between subjects with different coloured 
skin for the purpose of assessing the temporal oscillatory behaviour of NAD(P)H. 
Ratiometric correction of NAD(P)H AF signal by FAD+ autofluorescence 
The estimation of the RRindex as the 1:1 ratio between NAD(P)H and FAD+ AF 
emissions has been used in the past as correction method for both minimising 
the interfering effect of Hb and BV on the AF signal and providing specific 
information on the energetic metabolic dynamics of mitochondria [154]. Indeed, 
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RRindex is able to reflect specifically the activity of the mitochondrial electron 
transport chain and the degree of ATP energy production through the OXPHOS 
process [12, 85], thanks to the opposite response of reduced NAD(P)H and 
oxidised FAD+ to changes in mitochondrial metabolic states [154]. However, care 
must be taken when interpreting RRindex data that may be variable depending on 
several factors in the environment of the biological system under investigation: 
kind of stimulus affecting the mitochondrial metabolism, absence or presence of 
oxygen, absence or presence of a specific disease. Moreover, because the 
efficiency in the detection of FAD+ AF is much lower than NAD(P)H AF, the 
RRindex cannot be taken as value for performing absolute comparisons, unless 
the efficiency of FAD+ autofluorescence detection is optimised relative to that of 
NAD(P)H autofluorescence. Therefore, evaluating the relative changes of RRindex 
over time concurrently to the assessment of other parameters (i.e. NAD(P)H, 
blood flow, etc.) may be more advantageous to gain reliable information on 
mitochondrial function. Fig. 41f displays the temporal dynamics of RRindex during 
PORH test. The signal seems to reflect reliably the mitochondrial metabolic 
dynamics associated with a temporary period of low oxygen intake and the 
hyperaemic response, with minimised effect of BV compared to Fig. 41b. A 
substantial growth of RRindex  was observed during occlusion of blood flow, 
probably indicating a preferential biosynthesis of ATP energy through the 
glycolysis process due to low oxygen intake, accumulation of mitochondrial 
NAD(P)H and uncoupling of the electron transport chain. The baseline RRindex 
dynamics were restored during PORH, probably indicating the re-oxygenation of 
the tissue and the preferential production of ATP through the mitochondrial 
OXPHOS. Fig. 42d displays the comparison of the temporal dynamics of RRindex 
between subjects with dark and white skin during PORH test. Although the 
intensity of RRindex signal was slightly lower in individuals with dark skin, the 
signals seem to be comparable for the purpose of evaluating the temporal 
oscillatory dynamics of RRindex that was the main task of this research. 
Based on the results discussed above, it can be concluded that the simultaneous 
assessment of LDF and LFS signals was an optimal approach allowing the 
characterisation of the effect of some factors unrelated to NAD(P)H (Hb and 
melanin) on the cutaneous autofluorescence signal. The artefacts associated to 
fluctuations in blood volume were minimised by performing a 1:1 ratiometric 
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correction of the autofluorescence signal, which provided acceptable results for 
a reliable assessment of the temporal dynamics of NAD(P)H and mitochondrial 
function allowing a reasonable explanation of the physiological processes 
reflected by LFS measurements. Therefore, this correction method was used in 
the final protocols implemented in this study for the characterisation and 
examination of the nonlinear oscillations of cellular energetic metabolism. 
However, despite the ratiometric normalisation provided acceptable results for 
the purpose of assessing temporal oscillations of the autofluorescence signal, the 
implementation of more accurate normalisation methods is still challenging for 
the future. A promising approach might be the Monte Carlo modelling of skin LFS 
recordings to study the propagation of the UV light in the skin and its interaction 
with the different components of the cutaneous tissue, exploring possible novel 
correction techniques based on the findings from Monte Carlo investigations. 
2.3.3 Implementation of continuous wavelet transform (CWT) analysis 
In this work, the CWT method was employed to study the nonlinear dynamics of 
both LDF and NAD(P)Hnormalised or RRindex signals. Literature reports have already 
described applications of the CWT for processing the LDF cutaneous signal [60, 
102, 103, 105, 106, 107], to monitor oscillatory vasomotor perturbations of the 
signal associated with the physiological activity of biological factors in the 
microcirculation (e.g. endothelial cells, vascular smooth muscle cells, 
sympathetic nerves). In contrast, the CWT method has never been used to 
process the in-vivo cutaneous NAD(P)H signal either in animal models or 
humans. Therefore, a novelty of the research work presented in this thesis is the 
first attempt to apply the CWT on NAD(P)Hnormalised or RRindex in-vivo cutaneous 
signals from mouse models and human individuals with the purpose of studying 
metabolic oscillations associated with the cyclic cellular redox reactions and 
energy metabolism. 
Here, the CWT technique was implemented through Matlab R2015a (The 
MathWorks Inc.) software by using the principles (equations 4-12) that have been 
discussed in details in the section 1.8 (paragraph 1.8.2, page 54). Fig. 43 and 
Fig. 44 display examples of CWT time-frequency domain graphs and 
corresponding time-averaged spectra obtained from LDF and NAD(P)Hnormalised 
signals, respectively in mice and humans. A wavelet central frequency of 1 was 
used. The relative spectral energy ei and amplitude ai were extracted according 
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to the equations 9-12, to evaluate the contribution of each LDF or metabolic 
oscillator during specific microvascular tasks, e.g. iontophoresis or PORH and to 
compare data between different groups of mice or human subjects. The CWT of 
LDF signals showed results in agreement with the components reported in 
literature (Fig. 17). Similar oscillatory frequency intervals related to tissue and 
cells activity were found between mice and humans (Fig. 43 and Fig. 44): 
 Myogenic oscillator, 50-150 × 10-3 Hz in mice, 52-145 × 10-3 Hz in humans. 
 Neurogenic oscillator, 20-50 × 10-3 Hz in mice, 21-52 × 10-3 Hz in humans. 
 Endothelial NO oscillator, 9-20 × 10-3 Hz in mice, 9.5-21 × 10-3 Hz in humans. 
 Endothelial NO-independent oscillator, 5-9 × 10-3 Hz in mice, 5-9.5 × 10-3 Hz 
in humans. As discussed in the section 1.8 (paragraph 1.8.3, page 58), the 
physiological origin of this oscillator is unclear [102, 105]. However, the results 
from this dissertation support indirectly an association of this component with 
the EDHF endothelial pathway. For this reason, here this oscillator has been 
named as “Endothelial EDHF”. Details about this hypothesis are discussed in 
sections 3.3 (paragraph 3.3.1, page 132) and 4.4 (paragraph 4.4.2, page 177). 
The cardiac and respiratory oscillators were characterised by higher frequency 
ranges in mice compared to human individuals, which is in agreement with faster 
heart and breath rates reported in literature for mice [155, 156]: 
 Cardiac oscillator, 1350-5000 × 10-3 Hz in mice, 600-2000 × 10-3 Hz in 
humans. 
 Respiratory oscillator, 150-1350 × 10-3 Hz in mice, 145-600 × 10-3 Hz in 
humans. 
One of the goals of this work was the detection and study of metabolic oscillations 
in-vivo. This task was achieved by applying the CWT signal processing method 
on skin NAD(P)Hnormalised and RRindex reconstructed time series. As visible in Fig. 
43b and Fig. 44b, the time-frequency domain graph of NAD(P)H time series was 
characterised by high wavelet energy in the slow frequency intervals, thus low-
frequency fluctuations dominate the reconstructed trace. Despite the time 
resolution is poor in the low-frequencies, three distinct ranges of heterogeneous 
metabolic oscillations were clearly identified in both mice and humans. These 
components were defined as metabolic oscillator-1 (MO-1) (5-9.5 × 10-3 Hz), MO-
2 (2.5-5 × 10-3 Hz), and MO-3 (1.5-2.5 × 10-3 Hz) (Fig. 43b and Fig. 44b). 
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Fig. 43 CWT analysis of simultaneous LDF and NAD(P)H signals in mice. Data were collected 
for 20 min from the flank of a mouse while challenging micro-vessels by iontophoresis delivery of 
the vasoconstrictor drug PE (10 min). (a) Example of time-frequency domain scalogram and 
corresponding time-averaged CWT spectrum from LDF signal. The scalogram describes how the 
CWT power (energy, AU) is distributed in the time-frequency domain by using a gradient coloured 
map. The dark blue colour corresponds to low energy and the dark red to high energy. The graph 
shows a high power continuous band in the cardiac frequency range, confirming that data were 
collected correctly. Physiologically, the wavelet energy represents a measure of how much an 
oscillator defined by a frequency range contributes to blood flow signal at a specific time. The two 
transparent areas in the corners at the bottom of the graph represent sites outside of the “cone 
of influence” where data might not be reliable (frequencies < 5 × 10-3 Hz). The cone of influence 
is a “safe” time-frequency area where distortions of the CWT due to the finite time duration of the 
measured signal are irrelevant [157]. In contrast, the areas outside of the cone are close to the 
time limits of the signal, where the CWT suffers of boundary effects making the calculations from 
this time-frequency area inaccurate [157]. The time-averaged plot (right) allows to distinguish the 
wavelet amplitude peaks and energy (AUC of the peaks) of the specific physiological oscillators. 
The typical oscillators reported in literature were found: (I) cardiac, (II) respiratory, (III) myogenic, 
(IV) neurogenic, (V) endothelial NO-dependent, (VI) endothelial NO-independent (EDHF). 
Comparing the wavelet components of different LDF signals is powerful to distinguish healthy and 
diseased vascular conditions by quantifying the contribution of specific microvascular 
components. (b) Example of time-frequency domain scalogram and corresponding time-averaged 
CWT spectrum from NAD(P)H signal. Three low-frequency murine skin metabolic oscillators were 
characterised, which may reflect specific patterns of cellular ATP energy production that may vary 
depending on the health status of the tissue: Metabolic oscillator-1 (MO-1), MO-2 and MO-3. 
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Fig. 44 CWT spectral analysis of simultaneous LDF and NAD(P)H signals in humans. Data 
were measured for 25 min from the human forearm during PORH test. (a) Time-frequency domain 
scalogram (left) and corresponding time-averaged CWT chart (right) from LDF signal. (b) CWT 
time-frequency domain scalogram and corresponding time-averaged spectrum from NAD(P)H 
reconstructed time series. The LDF scalogram displays a high-power band in the cardiac 
frequency range at baseline and during PORH, suggesting that data were collected correctly. 
Also in this case the typical LDF oscillators reported in literature were identified: (I) cardiac, (II) 
respiratory, (III) myogenic, (IV) neurogenic, (V) endothelial NO-dependent, (VI) endothelial NO-
independent (EDHF). Moreover, three dominant human skin metabolic low-frequency oscillations 
contributing to NAD(P)H and RR signals were characterised for the first time, which may reflect 
specific dynamics of cellular ATP energy production that may be variable depending on the health 
status of the tissue: MO-1, MO-2, MO-3. 
Although the CWT analysis allowed the detection of three distinct slow metabolic 
oscillators, only the study of the spectral wavelet peaks of the MO-1 is reported 
in this dissertation. The reason for this is that MO-2 and MO-3 frequency intervals 
fall in the time-frequency domain area outside of the cone of influence, where 
data might not be reliable (see Fig. 43 caption for more details on the cone of 
influence). Another metabolic oscillatory wavelet peak was also found in the 
frequency range 9.5-21 × 10-3 Hz which appears during PORH response in 
human subjects. This oscillatory component was simply defined as metabolic 
oscillator (MO). This is the first application of the CWT to characterise 
heterogeneous metabolic oscillations from live skin tissue. 
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Application of CWT analysis on signals reconstructed from simulated noise 
An important aspect to consider when performing the CWT analysis is that the 
low-frequency regions of the CWT spectrum are characterised by the presence 
of a relevant background noise [118]. In this thesis, the characterisation of 
metabolic oscillations was performed especially from low-frequency regions of 
the CWT spectra of NAD(P)Hnormalised and RRindex signals. Therefore, an important 
aspect to address was verifying if the reconstructed metabolic signals represent 
a reliable measure containing some biological information or if they are composed 
exclusively by noisy artefacts resulting from the post-processing procedures 
applied on the raw autofluorescence data. 
To verify if the NAD(P)Hnormalised and RRindex reconstructed signals were 
containing only noise or a combination of noise and biological information, a small 
simulation was run to show how the CWT analysis performs when raw data 
consist of simulated noise alone and to test the cross-correlation (CC) between 
signals reconstructed from the experimental data and signals reconstructed from 
simulated noise. The simulation was performed according to the following steps: 
1. Representative NAD(P)Hnormalised and RRindex experimental data collected 
during a 25 min PORH test (each dataset made of 25 discrete temporal data 
points, one value per minute) were taken from 4 human subjects. For each 
dataset the mean and the standard deviation (SD) were measured over the 
experimental time series. 
2. 4 data series (each of 25 points) were simulated by Matlab R2015a (The 
MathWorks Inc.) using Gaussian noise with the same mean and SD measured 
from the representative experimental data mentioned in the bullet point above. 
The noise was simulated according to the following formula, 
𝑆𝑖𝑚𝑢𝑙𝑎𝑡𝑒𝑑 𝑛𝑜𝑖𝑠𝑒 = [𝑆𝐷 × 𝑟𝑎𝑛𝑑𝑛(𝑛)] + 𝑀𝑒𝑎𝑛,                                                  (24) 
where SD and mean are respectively the standard deviation and the mean of 
the experimental time series, n is the number of data points (25 in this case), 
and randn is the Matlab function to generate a random Gaussian distribution 
with n data points. 
3. The cubic spline interpolation fitting described in paragraph 2.3.1 (page 96) 
was performed on both experimental and simulated data to reconstruct 
signals of NAD(P)Hnormalised, RRindex and their respective simulated noise. 
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4. The spline-fitted data were passed into a cross-correlation analysis to 
evaluate what value is returned between pairs of simulated time series 
[NAD(P)Hnormalised versus its respective simulated noise, and RRindex versus its 
respective simulated noise] (Table 3). The cross-correlation analysis was 
performed using the Matlab function crosscorr. 
5. The spline-fitted data were passed into the CWT analysis described at page 
106, to assess how much the CWT spectrum varies over 4 repeats for 
NAD(P)Hnormalised, RRindex and their respective noise, and to verify if the signals 
change differently in response to a biological stimulus (Fig. 45 and Fig. 46). 
Table 3 reports the results concerning the cross-correlation analysis between 
signals reconstructed from the experimental data points and signals 
reconstructed from simulated noise. The analysis revealed very low cross-
correlation values between NAD(P)Hnormalised or RRindex spline-fitted time series 
and their respective simulated noise. This is a good indication that the signals 
reconstructed by spline interpolation from the experimental data points are not 
made exclusively by noise but may still contain the biological information derived 
from the raw autofluorescence measurements. 
Table 3 Cross-correlation analysis between metabolic and simulated noise signals. The 
cross-correlation analysis was performed between spline-fitted reconstructed time series 
obtained from 4 experimental datasets of NAD(P)Hnormalised (n=25) or RRindex (n=25) values 
acquired during a PORH test and 4 datasets of simulated Gaussian noise (n=25) generated using 
the same mean and SD of the experimental datasets. The cross-correlation analysis was run 
using the Matlab function crosscorr. CC = Cross-correlation. n = number of data points of each 
dataset used for the reconstruction of the signals by spline interpolation. -0.4 < CC values < 0.4 
were considered as indicating low/absence of cross-correlation.  
Simulation for 
NAD(P)Hnormalised data 
Mean SD 
CC value 
(experimental vs simulated 
noise spline-fitted data) 
CC 
bounds 
Signal 1 (dimensionless) 1.798 0.141 -0.0810 ± 0.011 
Signal 2 (dimensionless) 1.923 0.329 -0.1580 ± 0.011 
Signal 3 (dimensionless) 1.795 0.105 -0.0330 ± 0.011 
Signal 4 (dimensionless) 1.725 0.097 0.1770 ± 0.012 
Mean signal over 4 
repeats 
1.810 0.168 -0.0238 ± 0.011 
Simulation for 
RRindex data 
Mean SD 
CC value 
(experimental vs simulated 
noise spline-fitted data) 
CC 
bounds 
Signal 1 (dimensionless) 2.005 0.121 0.1630 ± 0.012 
Signal 2 (dimensionless) 2.043 0.114 0.0300 ± 0.011 
Signal 3 (dimensionless) 1.708 0.054 -0.0460 ± 0.011 
Signal 4 (dimensionless) 1.799 0.075 -0.1490 ± 0.011 
Mean signal over 4 
repeats 
1.888 0.091 -0.0005 ± 0.011 
112 
 
_______________________________________________________________
Material and methods 
Fig. 45 and Fig. 46 show respectively the comparison of wavelet analysis 
between NAD(P)Hnormalised or RRindex time series and their respective simulated 
noise signals during all the stages of the PORH functional test: baseline (Fig. 45-
46a), ischaemia (Fig. 45-46b) and post-occlusion (Fig. 45-46c). 
 
Fig. 45 Comparison of CWT spectra between NAD(P)Hnormalised signal and its respective 
simulated noise signal. Average spectra obtained from the CWT analysis of 4 NAD(P)Hnormalised 
signals (blue line) reconstructed by spline interpolation of raw autofluorescence data generated 
during a PORH functional test, and CWT analysis of 4 simulated noise signals (red line) generated 
using the same standard deviation and mean values of the raw autofluorescence data.                    
(a) Baseline CWT spectra. (b) CWT spectra during occlusion of blood flow. (c) CWT spectra 
during PORH response. The shaded blue and red areas around the lines of the average spectra 
represent the range of variability (standard deviation over 4 repeats) of the CWT spectra. 
113 
 
_______________________________________________________________
Material and methods 
 
Fig. 46 Comparison of CWT spectra between RRindex signal and its respective simulated 
noise signal. Average spectra obtained from the CWT analysis of 4 RRindex signals (blue line) 
reconstructed by spline interpolation of raw autofluorescence data generated during a PORH 
functional test, and CWT analysis of 4 simulated noise signals (red line) generated using the same 
standard deviation and mean values of the raw autofluorescence data. (a) Baseline CWT spectra. 
(b) CWT spectra during occlusion of blood flow. (c) CWT spectra during PORH response. The 
shaded blue and red areas around the lines of the average spectra represent the range of 
variability (standard deviation over 4 repeats) of the CWT spectra. 
Overall, the variability (SD of the spectrum over 4 repeats) of the CWT spectra 
from the biological signals and their simulated noise was spread with some 
degree of overlapping and some differentiated regions. Based on these 
observations, it could be assumed that the regions of the spectra showing a major 
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separation of the SD range may represent regions containing biological 
information. This is particularly true for some areas of the spectrum in the 
frequency range 5-9.5 × 10-3 Hz, especially during PORH response (Fig. 45c-
46c) where it is visible a shift in the oscillatory peak between the biological 
metabolic signals and their respective noise, as well as a relevant difference in 
the distribution of the variability of the spectrum especially in the simulation 
associated with the RRindex signal. Based on the discussion above, it can be 
concluded that the reconstructed NAD(P)Hnormalised and RRindex signals contain 
both noisy and biological information, and following the application of the CWT 
analysis some regions of the spectrum are dominated by the noisy component 
and other regions by perturbations of biological origin, which are mainly 
manifested during the response to particular biological stimuli (in this case the 
PORH response). 
2.3.4 Performing the wavelet phase coherence (WPCO) analysis 
As discussed already in the section 1.8 (paragraph 1.8.7, page 61), the WPCO 
analysis provides information on the phase relationship between oscillators in the 
same frequency interval of two signals recorded simultaneously. The analysis 
returns values between 0 and 1, where Cɸ(ωk) ≈ 0 indicates absence of phase 
coherence (no interaction), Cɸ(ωk) ≈ 1 indicates complete coherence (full 
interaction), and 0 < Cɸ(ωk) < 1 indicates partial coherence (partial interaction). 
The main advantage of WPCO analysis is the possibility to gain information on 
the coupling/synchronisation between oscillators in time-frequency regions with 
relevant background noise. Another advantage is the chance to study the 
interaction between oscillators involved in the regulation of different biological 
mechanisms, i.e. in this dissertation the analysis was used to examine the 
interaction between cutaneous blood perfusion and NAD(P)H or RR metabolic 
oscillators. Specifically, the Cɸ(ωk) between the MO-1 of metabolic time series 
and the endothelial EDHF oscillator of LDF signal, and between MO and the 
endothelial NO oscillators were examined because they are falling in the same 
frequency ranges. The analysis was performed through the WPCO Matlab code 
provided in the Lancaster University website http://py-biomedical.lancaster.ac.uk  
by the Stefanovska et al. research group. The code estimates the phase 
coherence according to the principles (equations 13-14) that were explained in 
section 1.8 (paragraph 1.8.7, page 61). 
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2.3.5 Examination of the complexity of LDF time series 
Attractors of LDF time series were computed by using the software associated 
with the LAKK-M device (LDF 3.1.1.404), which allows the calculation of a set of 
parameters such as the fractal dimension (D), the Hurst index (H), the entropy 
(H0), the information dimension (Hi) and the correlation dimension (D2) according 
to the principles discussed in section 1.8 (paragraph 1.8.8, page 61). 
 
2.4 Protocol for the assessment of microvascular and energy 
metabolism nonlinear dynamics in mouse models 
2.4.1 Animals included in the study 
Work on mouse models was conducted at the animal facility of the School of 
Medicine of the University of Dundee (Scotland). The study was approved by the 
local ethics committee (University of Dundee Ethical Review Process) and the 
experimental procedures were carried out according to the United Kingdom 
Home Office rules under the auspices of the Project Licence PPL No. 60/4265 
and the Personal Licence No. IACEC4BB2. Animals included in the research were 
wild type (WT) (n=5) and nuclear factor erythroid 2–related factor 2 KO (Nrf2-/-) 
female mice (n=6) on a C57Black/6 background aged 36-60 weeks. Mice were 
maintained under a 12:12-h light/dark cycle at 22 ± 1°C and 50% humidity, and 
were fed ad libitum on a standard rodent chow diet regime and water. 
2.4.2 Nrf2-/- mouse model 
The Nrf2 transcription factor is a key regulator of the cell redox state, involved in 
the resistance to oxidative stress by activating the cell antioxidant defence system 
[158]. Nrf2 KO leads to abnormal mitochondrial activity, altered redox status, 
increased oxidative stress, and has an impact on the functionality of the vascular 
system [158, 159]. Therefore, the rationale for using the Nrf2-/- strain was the 
chance to compare results between normal mice and a model characterised by 
altered functionality of the antioxidant defence that may impact the energetic 
metabolism and the cardiovascular system in the long term. 
2.4.3 Skin preparation and anaesthesia 
LFS and LDF techniques are sensitive to light absorption by hair and skin 
pigmentation. Therefore, a hair-free non-pigmented intact skin is required to 
obtain reliable measurements. Forty-eight hours prior to performing the 
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experiments, hair from the mice flanks was shaved using an electric shaver, and 
the residual hair was removed using a depilatory cream (Veet®, Reckitt-
Benckiser). Before collecting measurements, mice were anaesthetised through a 
standard Boyle’s Apparatus to prevent movement artefacts, and were laid on a 
heat mat at 37°C with the left flank facing the upper side (Fig. 47). A general light 
anaesthesia was maintained by delivering 1.5-2% isoflurane (Abbott 
Laboratories) in oxygen (1.5 L/min) through an inhalation nose cone (Fig. 47). 
 
Fig. 47 Example of experimental setup for simultaneous recordings during iontophoresis. 
Anaesthetised mouse laid in a heat mat at 37 °C. Anaesthesia was maintained by delivering 
isoflurane through an inhalation nose cone. A 20 mm iontophoresis chamber was attached on the 
mouse flank by using a double-adhesive tape, and filled with a 2 ml solution of 1% PE. LFS and 
LDF probes were placed at two adjacent sites on the skin area inside the chamber to measure 
simultaneously autofluorescence, blood flow and oxygen saturation signals. The delivery of 
phenylephrine was induced by the application of a continuous 100 µA anodal current. 
2.4.4 Iontophoresis 
The principles of iontophoresis have been already discussed in the section 1.5 
(paragraph 1.5.1, page 35). In this part of the work, iontophoresis was used to 
deliver phenylephrine (PE) and induce a local cutaneous vasoconstriction 
process. The reason for challenging skin micro-vessels by using this 
pharmacological agent was associated with the objective of studying the role of 
endothelium in vasomotion. Indeed, literature reports have described that PE is 
able to stimulate a vasomotion phenomenon specifically modulated by 
endothelium in rat small mesenteric artery, with the contribution of both NO and 
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EDHF signalling pathways [160]. Therefore, here a low dose 1% PE was 
delivered by iontophoresis for stimulating specifically an endothelium-mediated 
vasomotion phenomenon avoiding off-target effects. An iontophoresis chamber 
(ION6 probe, Moor Instruments Ltd, UK) of 20 mm internal diameter was used, 
which was attached to the mouse flank using double-adhesive tape, and the 
reference electrode was placed underside of the animal to complete the circuit 
(Fig. 47). The experimental setup was completed by filling the chamber with a 2 
ml solution of 1% PE, and placing the LFS and LDF probes at two adjacent sites 
on the skin area inside the chamber to measure simultaneously 
autofluorescence, blood flow and oxygen saturation parameters during the 
challenging test (Fig. 47). The delivery of PE was induced by the application of a 
continuous 100 µA anodal current through an iontophoresis controller (MIC2, 
Moor Instruments Ltd, UK) connected to the electrodes. 
2.4.5 LDF, RS and LFS measurements 
NAD(P)H autofluorescence, blood flow and oxygen saturation were measured 
simultaneously by using two single-point LAKK-M optical probes, one for LFS 
recordings and one for LDF/RS measurements. As described by Fig. 47, the 
probes were placed in two adjacent locations on the left flank of the mouse. The 
measurements were performed for 20 min, 10 min without application of electric 
current to determine the baseline oscillatory dynamics, and the remaining time 
during the delivery of phenylephrine. LDF/RS and LFS simultaneous recordings 
were collected according to the modalities explained in section 2.2 (paragraph 
2.2.2 at page 75, and paragraph 2.2.4 at page 83 respectively). A total of 20 
discrete UV spectra (1 spectrum per min) and a continuous LDF time series were 
sampled during the 20 min period of the iontophoresis test (Fig. 48a-b). NAD(P)H 
and RR time series were reconstructed from the discrete data points (Fig. 48a) 
by the methodology explained in section 2.3 (paragraph 2.3.1, page 96) for the 
study of metabolic oscillations. 
2.4.6 Nonlinear dynamics analysis 
CWT and WPCO analyses were performed on LDF, NAD(P)H and RR signals 
according to the methods discussed in section 2.3 (paragraph 2.3.3 at page 106, 
and paragraph 2.3.4 at page 114 respectively). Fig. 43 shows examples of CWT 
analyses of mouse LDF and NAD(P)H signals measured during delivery of PE. 
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2.4.7 Statistics 
Statistical analysis was performed by R-Studio and Matlab R2015a software. The 
R-Studio package Hmisc was used to evaluate data normality by the Shapiro-
Wilk test. All the analysed variables were normally distributed, thus correlations 
were evaluated by calculating the Pearson’s correlation coefficient r which was 
estimated through the Matlab function corr. Statistical differences between 
baseline and phenylephrine time points were examined through the R-Studio 
software by using a paired t-test. Differences between mouse groups were 
assessed by unpaired t-test. All the analysis were considered significant at p-
value < 0.05 with a statistical power of 0.8 which was calculated by R-Studio. 
 
Fig. 48 Example of simultaneous data recordings from mouse flank during iontophoresis. 
(a) NAD(P)H 20-min signal reconstructed from 20 discrete data points collected during 
iontophoresis. Data are expressed in dimensionless units because the signal was reconstructed 
from the discrete NAD(P)Hnormalised values estimated according to equation 21.       (b) 20-min LDF 
time series measured during iontophoresis. Data are expressed in perfusion arbitrary units (PU). 
The graph shows a slight reduction of blood perfusion at the beginning of phenylephrine delivery. 
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2.5 Protocol for the examination of microvascular and energy 
metabolism nonlinear dynamics in human individuals 
2.5.1 Study population 
The study on human subjects was approved by the Research Ethics Committee 
of the University of Dundee (UREC, Study Protocol No. 15064), according to the 
rules of the Declaration of Helsinki. The participants signed an informed consent 
form before being included in the research. 
Fig. 49 displays a scheme of the recruitment process and allocation of the 
subjects to different study groups. A total of 70 volunteers were recruited among 
the students or staff members at the University of Dundee, which were divided in 
two groups: 48 non-smokers and 22 smokers. Sixteen non-smokers were 
allocated to a preliminary study group to evaluate the effect of blood volume and 
melanin on the autofluorescence measurements and implement an appropriate 
normalisation method. The data related to this preliminary study have been 
discussed previously in the paragraph 2.3.2 (page 99). The remaining volunteers 
were enrolled for the examination of skin microvascular and metabolic nonlinear 
dynamics and comparison of data between non-smokers and smokers. The 
inclusion criteria for non-smokers were the absence of hypertension, CVD or any 
pathological condition that may affect the vascular and respiratory systems. The 
inclusion criteria for smokers were smoking traditional cigarettes and absence of 
CVD or any pathological condition related to the respiratory system. Based on 
the criteria above, 3 non-smokers were excluded prior to the examination 
because of hypertensive conditions. Therefore, only 29 non-smokers and 22 
smokers were tested according to the final protocol that will be discussed in the 
following paragraphs of this section. After the examination, 11 subjects (9 non-
smokers and 2 smokers) were excluded from the data analysis mainly because 
of movement artefacts affecting LDF recordings or to match the age, gender and 
ethnicity distribution between the two groups. Indeed, as already discussed in the 
introduction (section 1.5, paragraph 1.5.2, page 37), the research studies related 
to skin blood perfusion must be designed ensuring that the individuals from 
different groups are matched for age and sex to allow obtaining comparable data. 
The reason is that in general elder subjects have impaired vascular reactivity 
compared to young individuals, and men and women may show physiological 
differences due to hormone level variations across the menstrual cycle. 
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Fig. 49 Scheme of subjects’ recruitment and design of study groups. 70 volunteers were 
enrolled in the project, divided in non-smoker (n=48) and smoker (n=22) groups. A part of non-
smoking subjects (n=16) was allocated to a preliminary study for the implementation of a 
correction method of autofluorescence data aimed at reducing blood volume (BV) and melanin 
effects. The remaining subjects were allocated to the study of nonlinear dynamics of 
microcirculation and energy metabolism. Three non-smokers were excluded from the study prior 
to the examination due to hypertensive conditions. The experiments were performed on the 
remaining non-smokers (n=29) and smokers (n=22). Data from 9 non-smokers and 2 smokers 
were excluded from the study due to movement artefacts in the optical signals and to match the 
two groups according to age, gender and skin colour. The final groups were composed of 20 non-
smokers and 20 smokers. 
Additionally, in the section 1.7 (paragraph 1.7.2, page 50), it has been outlined 
that the content of melanin in the skin can affect AF measurements, thus the 
groups were matched also for ethnicity to avoid differences in the AF data related 
to a different degree of UV light absorption by melanocyte cells. The majority of 
the volunteers were of British ethnicity, and the remaining minority was composed 
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of Italian, Indian and Arabian ethnic groups, which were distributed equally and 
balanced between smoker and non-smoker groups. 
All the points discussed above explain why in this study the allocation of the 
subjects in the smoker and non-smoker groups was not blinded, to ensure that 
optical data for the final comparison were not affected by differences associated 
with age, sex, colour of the cutaneous tissue and movement artefacts in the 
recorded signals. The groups employed for the final comparison were made of 
20 smokers (42.6 ± 15.6 years old, 15 females and 5 males) and 20 non-smokers 
(41 ± 14 years old, 15 females and 5 males). 
2.5.2 Preliminary arrangements and experimental setup 
Preliminary arrangements. Subjects were tested between 11.00-13.00 hours. 
The room temperature was maintained constantly at 23 ± 1°C, and 20‐30 min of 
acclimatisation were applied to allow body adaptation to the room environment. 
Food, drinks, and medications were avoided 4-6 hours before the test to prevent 
physiological changes due to diet habits or treatments that might had affected the 
results. Weight, height, blood pressure (BP) and skin temperature were 
measured before the test to check any correlation with vascular and 
autofluorescence data, and also to make sure that the differences between the 
two groups were mainly due to smoking rather than to differences in those 
general parameters. The BP was measured three times after the acclimatisation 
period using a traditional sphygmomanometer while the subject was resting on a 
clinical bed. The last two measurements were averaged to get the final BP value. 
Experimental setup. Subjects were tested in resting supine position on a clinical 
bed and the data were collected from the volar surface of the left forearm. The 
tested arm was rested on a cushion to ensure a comfortable and static position 
during the analysis. The site of measurement was chosen avoiding areas with 
hair, huge veins and injured regions, and skin was disinfected using an alcohol 
strip before placing the probes. Two LAKK-M probes were placed in two adjacent 
sites for the simultaneous measurement of blood perfusion, oxygen saturation 
and autofluorescence. The probes were placed perpendicularly to the skin at 1/3 
length of the left volar forearm by using tripods and adhesive tape. The probes 
were placed gently to avoid pressure artefacts. A pressure cuff was placed in the 
upper part of the tested arm for performing the PORH test while collecting LDF, 
RS and LFS measurements. In addition, arterial oxygen saturation (SpO2) was 
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monitored through a pulse oximeter probe placed in the index finger. An example 
of the experimental setup has been already shown in Fig. 40 of section 2.3 
(paragraph 2.3.2, page 100) for the discussion of the effects of blood volume and 
melanin on NAD(P)H autofluorescence signal. 
2.5.3 PORH test 
The principles of PORH test have been already discussed in details in the section 
1.5 (paragraph 1.5.1, page 34). In this part of the work, this technique was used 
for two reasons: 
1. PORH represents an established challenging test for the evaluation of 
microvascular function. 
2. PORH response is characterised by the induction of a vasomotion 
phenomenon involving several mediators (e.g. endothelial and smooth 
muscle cells, and the local sympathetic innervation). 
Therefore, using this reactive test allowed to study both the applicability of 
nonlinear dynamic markers as putative CVD risk factors and their role in human 
cutaneous vasomotion. 
The PORH test was performed in a time window of 25 min while measuring 
simultaneously blood perfusion, tissue oxygen saturation, arterial oxygen 
saturation and autofluorescence. During the first 10 min baseline measurements 
were collected. Then, blood flow was occluded through the brachial artery by 
inflating at 200 mmHg the pressure cuff placed in the upper left arm (Fig. 40) to 
induce ischaemia. After 5 min of occlusion the pressure of the cuff was released 
to monitor PORH response for 10 min. 
2.5.4 LDF, RS and LFS recordings 
Simultaneous NAD(P)H autofluorescence, blood perfusion and oxygen saturation 
measurements were collected during all the stages of PORH test by using two 
single-point LAKK-M optical probes. The recordings were performed according 
to the same modalities described in section 2.2 (paragraph 2.2.2 at page 75, and 
paragraph 2.2.4 at page 83 respectively). The measurements were collected for 
25 min, 10 min to determine the baseline oscillatory dynamics, 5 min to monitor 
the parameters during the ischaemia stress condition, and 10 min during PORH 
response. A total of 25 discrete UV spectra (1 spectrum per min) and a 
continuous 25 min LDF trace were sampled simultaneously during the 25 min 
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period of the PORH test (Fig. 50a-b). NAD(P)H and RR time series were 
reconstructed from the discrete data points (Fig. 50a) by using the methodology 
explained in section 2.3 (paragraph 2.3.1, page 96) for the study of metabolic 
oscillations. 
 
Fig. 50 Example of simultaneous data recordings from the human forearm during PORH. 
(a) NAD(P)H 25 min signal reconstructed from discrete data points collected during PORH test. 
Data are expressed in dimensionless units because the signal was reconstructed from the 
discrete NAD(P)Hnormalised values estimated according to equation 21. (b) 25 min LDF continuous 
signal measured during PORH test. Data are expressed in perfusion arbitrary units (PU). The 
graph shows clearly the typical PORH curve obtained after a period of arterial occlusion. 
2.5.5 Nonlinear dynamics of LDF, NAD(P)H and RR time series 
CWT and WPCO analyses were performed on LDF, NAD(P)H and RR time series 
according to the methods discussed in the section 2.3 (paragraph 2.3.3 at page 
106, and paragraph 2.3.4 at page 114 respectively). Fig. 44 displays examples 
of wavelet analyses of human LDF and NAD(P)H signals measured during PORH 
functional test. The analysis of LDF attractors was performed by using the LAKK-
M software LDF 3.1.1.404 (Spe Lazma Ltd, Russia). 
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2.5.6 Tissue oxygenation dynamics 
The simultaneous assessment of local cutaneous blood flow (Im), oxygen 
saturation (SO2), and arterial oxygen saturation (SpO2) in combination with the 
wavelet spectral analysis allowed the estimation of skin oxygen extraction (O2ER) 
and oxygen consumption (VO2). These variables provide information on the local 
transport and uptake of oxygen in the tissue. O2ER represents a measure of the 
fraction of oxygen removed from the blood that diffuses from capillaries/arterioles 
to tissue, while VO2 is a measure of tissue oxygen consumption or uptake. 
The estimation of both O2ER and VO2 requires the calculation of the venous 
oxygen saturation (SvO2). The classic formula for the calculation of O2ER is the 
following [161, 162], 
𝑂2𝐸𝑅 =  
(𝐶𝑎𝑂2−𝐶𝑣𝑂2)
𝐶𝑎𝑂2
 ,                                                                                         (25) 
where CaO2 and CvO2 represent respectively the arterial and venous oxygen 
saturation in the blood expressed in (mL O2/mL) [161]. The values of percentage 
SO2 measured by RS method are proportional to the CO2 (oxygen saturation 
expressed in mL) due the low variability of oxygen volume in the blood [161]. 
Therefore, equation 25 can be modified as follow [57, 161], 
𝑂2𝐸𝑅 =  
(𝑆𝑎𝑂2−𝑆𝑣𝑂2)
𝑆𝑎𝑂2
 .                                                                                         (26) 
Although SO2 measured by RS method is closer to the venous oxygen saturation 
SvO2, overall it is representative of the average oxygenation of small arterioles 
and venules in the skin microcirculation. Therefore, the correct estimation of SvO2 
requires the exclusion of the arterial contribution from SO2. This can be achieved 
by calculating the SO2 wavelet oscillations which allow to estimate correctly SvO2. 
Indeed, the arterial component of SO2 is modulated by the absolute amplitude of 
the cardiac SO2 wavelet oscillation Acardiac(SO2), in contrast the venous 
contribution to SO2 is modulated by the absolute amplitude of the respiratory SO2 
wavelet oscillation Arespiratory(SO2) [161]. Therefore, when the ratio between SO2 
cardiac and respiratory wavelet amplitudes Acardiac(SO2)/Arespiratory(SO2) ≤ 1, there 
is a predominant contribution of the venous component to oxygen saturation and 
SvO2 can be considered approximately equal to SO2 [57, 161], 
𝑆𝑣𝑂2 =  𝑆𝑂2 .                                                                                                    (27) 
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This situation is predominant in the cutaneous regions characterised by absence 
of arteriovenous anastomoses (AVAs), e.g. the forearm [57, 161]. The AVAs are 
microvascular functional structures characterised by the direct exchange of blood 
between arterioles and venules bypassing the capillaries [53, 54]. The 
microcirculation in AVAs containing regions is mainly depending on sympathetic 
vasomotor regulatory mechanisms, on the other hand free-AVAs regions are 
characterised by various vasomotor regulatory mechanisms of endothelial, 
sympathetic or myogenic origin [161]. 
Values of the ratio Acardiac(SO2)/Arespiratory(SO2) > 1 indicate a predominant 
contribution of the arterial component to oxygen saturation [57, 161]. In this case, 
the venous oxygen saturation is estimated by normalising SO2 for the size of the 
arterial contribution according to the following equation [57, 161], 
𝑆𝑣𝑂2 =  
𝑆𝑂2
𝐴𝑐𝑎𝑟𝑑𝑖𝑎𝑐(𝑆𝑂2) 𝐴𝑟𝑒𝑠𝑝𝑖𝑟𝑎𝑡𝑜𝑟𝑦(𝑆𝑂2)⁄
 .                                                                         (28) 
This situation is predominant in skin regions characterised by the presence of 
AVAs, e.g. palmar surface of the fingers [57, 161]. 
In some cases the cardiac and/or the respiratory oscillators may be not 
expressed in the SO2 wavelet spectrum, e.g. when there is synchronisation 
between oxygen saturation and blood flow oscillations in the endothelial, 
neurogenic and myogenic spectral intervals [57, 161]. In this case, the formulas 
for the calculation of SvO2 must be amended. If the synchronisation phenomenon 
involves endothelial and neurogenic oscillators, SO2 represents the oxygenation 
of the afferent arterioles, thus it is roughly equal to the arteriolar oxygen saturation 
[161]. Therefore, SvO2 can be considered approximately equal to 0 which means 
that the oxygen extraction is maximal [161], 
𝑂2𝐸𝑅 =
𝑆𝑎𝑂2
𝑆𝑎𝑂2
= 1.                                                                                                       (29) 
If the synchronisation phenomenon involves the myogenic or respiratory 
oscillators, SvO2 is approximately equal to SO2 in the skin without AVAs, as 
shown in equation 27 [57, 161]. In contrast, in the regions with AVAs that are 
specifically controlled by the sympathetic innervation, SvO2 is equal to SO2 only 
in the absence of the neurogenic oscillation [161]. In the presence of the 
neurogenic oscillation SvO2 is calculated taking into account the bypass index for 
the oxygen saturation BI(SO2) [57, 161], 
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𝑆𝑣𝑂2 =
𝑆𝑂2
𝐵𝐼(𝑆𝑂2)
 ,                                                                                                      (30) 
where BI(SO2) is estimated according to equation 31, taking into consideration 
the components involved in the sympathetic vasomotor regulatory mechanisms, 
𝐵𝐼(𝑆𝑂2) = 1 +
𝐴𝑛𝑒𝑢𝑟𝑜𝑔𝑒𝑛𝑖𝑐(𝑆𝑂2)
𝐴𝑚𝑦𝑜𝑔𝑒𝑛𝑖𝑐(𝑆𝑂2)
,                                                                             (31) 
where Aneurogenic(SO2) and Amyogenic(SO2) are the absolute amplitudes of the 
neurogenic and myogenic SO2 wavelet oscillations, respectively. 
The formula for the calculation of oxygen consumption VO2 by using arterial and 
venous oxygen saturation values is the following [161], 
𝑉𝑂2 = 𝑄 ∙ (𝑆𝑎𝑂2 − 𝑆𝑣𝑂2),                                                                                       (32) 
where Q is the volume blood flow rate (mL/min x 100 g) and (SaO2 - SvO2) is the 
arteriovenous difference. Considering that the nutritive blood of arterioles and 
capillaries in the microcirculation contributes to the diffusion of oxygen in the 
tissue more than the blood in the venules, the perfusion rate value Q in equation 
32 can be replaced by the nutritive blood perfusion value Imn [161]. Thus the 
formula for the calculation of VO2 is modified as follow [57, 161], 
𝑉𝑂2 = 𝐼𝑚𝑛 ∙ (𝑆𝑎𝑂2 − 𝑆𝑣𝑂2).                                                                                       (33) 
The nutritive blood flow Imn is estimated according to equation 34 [57, 161], 
𝐼𝑚𝑛 =
𝐼𝑚
𝐵𝐼(𝐼𝑚)
 ,                                                                                                                        (34) 
where Im is blood perfusion, and BI(Im) is the bypass index for blood perfusion 
estimated as shown in equation 35 for skin regions without AVAs, and as 
described in equation 36 for skin regions with AVAs [57, 161], 
𝐵𝐼(𝐼𝑚) =
𝐴𝑚𝑎𝑥(𝐼𝑚)
𝐴𝑚𝑦𝑜𝑔𝑒𝑛𝑖𝑐(𝐼𝑚)
 ,                                                                                                        (35) 
where Amax(Im) is the maximal LDF wavelet spectral amplitude in the frequency 
interval 5-150 x 10-3 Hz which reflects the activities of all the local microvascular 
components (endothelial, neurogenic and myogenic) that may be involved in the 
regulation of the vascular tone of free-AVAs regions, and Amyogenic(Im) is the 
wavelet amplitude of the myogenic LDF oscillator. 
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𝐵𝐼(𝐼𝑚) = 1 +
𝐴𝑛𝑒𝑢𝑟𝑜𝑔𝑒𝑛𝑖𝑐(𝐼𝑚)
𝐴𝑚𝑦𝑜𝑔𝑒𝑛𝑖𝑐(𝐼𝑚)
 ,                                                                                               (36) 
where Aneurogenic(Im) is the absolute wavelet amplitude of the neurogenic LDF 
oscillator [57]. In this case, the formula takes into account the components 
involved in the sympathetic vasomotor regulatory mechanism that is typical of 
AVAs cutaneous regions. 
In this study, the amplitudes of SO2 wavelet oscillators were extracted from 
LAKK-M SO2 recordings by using the software provided with the device (LDF 
3.1.1.404), and the amplitudes of LDF wavelet oscillators were computed as 
described in section 2.3 (paragraph 2.3.3, page 106). 
Considering that the measurements were collected from a region without AVAs 
(volar forearm), SvO2 was mainly estimated by equation 27 and O2ER according 
to equation 26, expressed in arbitrary units (AU). The oxygen consumption VO2, 
expressed in AU, was calculated as shown in equation 33 by using Imn values 
estimated according to equations 34-35. 
2.5.7 Statistics 
Statistical analysis was performed by R-Studio and Matlab R2015a software. The 
R-Studio package Hmisc was used to evaluate data normality by the Shapiro-
Wilk test. Correlations were evaluated through the Matlab function corr, by 
calculating the Pearson’s correlation coefficient r for normal variables and the 
Spearman’s coefficient ρ for non-parametric variables. Statistical differences 
between PORH test time points were examined through R-Studio software by 
using paired t-test for normal variables and paired Wilcox-test for non-parametric 
variables. Differences between smokers and non-smokers were assessed by 
unpaired t-test or Wilcox-test, respectively for normal or non-parametric 
variables. All the analysis were considered significant at p-value < 0.05 with a 
statistical power of 0.8, which was calculated by R-Studio.
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3 Nonlinear dynamics of microcirculation and cell 
energy metabolism in the Nrf2-/- mouse model 
 
3.1 Introduction and aims 
In the first part of this dissertation, it has been outlined the importance of 
investigating the nonlinear dynamics of both blood flow (LDF) and NAD(P)H 
cutaneous signals. Indeed, the wavelet spectral analysis of LDF time series 
reveals information on the functionality of specific microvascular components 
characterised by an oscillatory activity, i.e. endothelial and vascular smooth 
muscle cells. On the other side, the wavelet examination of NAD(P)H and redox 
ratio (RR) signals may be powerful to detect specific metabolic oscillations 
reflecting dynamic patterns of cellular ATP energy production. 
Both LDF and metabolic oscillations may show different functional patterns 
between healthy or diseased vascular/metabolic conditions, or reflect the cellular 
and tissue mechanisms at the basis of vasomotion. Thus, the study of LDF and 
energy metabolism nonlinear dynamics could find powerful applications for the 
study of vasomotion and the prediction of CVD risk. 
Based on the discussion above, the objectives of this part of the work were: 
(1) Simultaneous characterisation of LDF oscillators and NAD(P)H and RR 
metabolic oscillations from mouse skin. 
(2) Study of mouse cutaneous vasomotion with particular focus on the role of the 
endothelium and metabolic oscillators in the modulation of this phenomenon. 
(3) Comparison of skin LDF and metabolic oscillators between normal mice and 
animals affected by oxidative stress, to test their potential use as predictors 
of vascular dysfunction associated with oxidative stress. 
The work was carried out on two groups of animals: 5 control WT mice and 6 KO 
Nrf2-/- animals characterised by impaired antioxidant defence. The mice were 
tested from the skin of the left flank by evaluating the dynamics of microcirculatory 
and metabolic biomarkers during transdermal iontophoresis delivery of the 
vasoconstrictor drug phenylephrine (PE), which according to Okazaki et al. [160] 
is able to induce a vasomotion oscillatory phenomenon mediated specifically by 
NO and EDHF endothelial regulatory mechanisms. 
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3.2 General microcirculatory and cell energy metabolism 
biomarkers during iontophoresis administration of PE 
3.2.1 Blood flow and oxygen saturation 
Table 4 and Fig. 51a-b show the comparison of results between Nrf2-/- and WT 
mice related to the microcirculatory variables. Both groups showed a similar 
statistically significant decrease of blood flow (p < 0.05 WT, p < 0.01 Nrf2-/-) during 
vasoconstriction stimulated by administration of PE with a stronger p-value in 
animals affected by oxidative stress. Oxygen saturation showed a minimal 
decrease during PE stimulation in both groups with non-statistical significance 
from baseline to post PE stimulation. 
3.2.2 NAD(P)H and redox ratio (RR) 
Both of NAD(P)Hnormalised and RR did not change significantly during PE 
stimulation either in WT or Nrf2-/-  mice, as shown in Fig. 51c-d. However, the 
mean RRindex (ratio NAD(P)H/FAD+) was higher in WT mice compared to the 
knock-out animals (p < 0.05) (Table 4). This relevant difference confirmed that 
the phenotype of Nrf2-/- mice is characterised by an altered balance between 
mitochondrial NAD(P)H and flavins due to impairment of the molecular pathway 
involved in the antioxidant defence, increased amounts of ROS, and oxidative 
stress which may impact negatively the dynamics of cellular ATP production. 
 
Table 4 Comparison of microvascular and metabolic variables between WT and Nrf2-/- mice. 
Data are presented as mean ± standard deviation (SD). PE = phenylephrine. Im = Blood perfusion 
expressed in perfusion arbitrary units (PU). SO2 = Oxygen saturation expressed in percentage 
arbitrary units (AU). NAD(P)Hnormalised = Reduced nicotamide adenine dinucleotide expressed in 
dimensionless units (equation 21). RR = Redox ratio expressed in dimensionless units (equation 
22). Differences between WT and Nrf2-/- groups were calculated by unpaired t-test and are 
outlined by red asterisks. Differences between baseline and PE time points were calculated by 
paired t-test and are outlined by black asterisks. *p < 0.05, **p < 0.01. 
 WT (n=5) Nrf2-/- (n=6) 
Variable Baseline PE Baseline PE 
Im [PU] 174.0 ± 30.40 162.8 ± 26.80* 197.6 ± 20.50 184.0 ± 16.70** 
SO2 [%] 47.3 ± 9.60 44.9 ± 10.7 48.3 ± 9.60 45.5 ± 6.10 
NAD(P)Hnormalised 1.7 ± 0.2 1.7 ± 0.2 1.9 ± 0.2 1.8 ± 0.1 
RRindex *2.2 ± 0.1 *2.2 ± 0.1 *2.0 ± 0.1 *2.0 ± 0.1 
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Fig. 51 Trends of microvascular and metabolic biomarkers during iontophoresis of PE.      
Graphic representation of the data reported in Table 4. (a) Blood perfusion (PU). (b) SO2 (%).     
(c) NAD(P)Hnormalised (dimensionless units). (d) RRindex (dimensionless units). Data are presented 
as bar plots of the mean with error bars corresponding to two standard errors (SE) (~95% 
confidence interval). The black lines/asterisks refer to significant changes during PE stimulation. 
The red lines/asterisks refer to significant differences between WT (n=5) and Nrf2-/- (n=6) mice. 
Black bars = baseline. White bars = PE. The p-values were calculated by paired t-test to compare 
baseline and PE time points and unpaired t-test to compare animal groups. *p < 0.05, **p < 0.01. 
 
3.3 Wavelet spectral analysis of LDF and metabolic signals 
measured during iontophoresis administration of PE 
3.3.1 LDF oscillators in mice 
Fig. 52 illustrates the median time-averaged LDF wavelet spectra from WT and 
Nrf2-/- mice during iontophoresis reactive test. The typical wavelet peaks of local 
cutaneous LDF physiological oscillators reported in the literature were 
characterised: endothelial NO-independent (EDHF), endothelial NO, neurogenic 
and myogenic. The specific features that characterise each LDF oscillator peak 
are the absolute energy Ei, the absolute amplitude Ai and the frequency location 
f of the peak, expressed in arbitrary units (AU) and hertz (Hz) respectively. 
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Fig. 52 Comparison of time-averaged blood flow CWT spectra during iontophoresis test. 
(a) Median CWT spectra of WT (n=5) and Nrf2-/- (n=6) mice at baseline. The dotted line indicates 
an example of amplitude Ai (maximal energy of the peak) located at a specific frequency f of the 
endothelial EDHF oscillator’s interval. The yellow area (AUC of the peak) indicates an example 
of Ei (average energy underneath the peak) from the neurogenic oscillator’s frequency range. (b) 
Median CWT spectra during transdermal iontophoresis delivery of phenylephrine (PE). The dotted 
line indicates an example of Ai located at a specific frequency f of the endothelial EDHF oscillator’s 
range. The yellow area indicates an example of Ei from the endothelial NO oscillator’s frequency 
interval. Both of Ei and Ai are expressed in arbitrary units (AU). The plots outline clearly 
differences in Ei, Ai and f of the LDF oscillatory peaks between the two groups of mice. 
The graphs clearly outline differences between groups associated with the Ei, Ai 
or f of the various LDF oscillators. Ai is the maximum (peak) energy Ei in the 
frequency range of a specific oscillator, reflecting the maximal oscillatory activity 
in the frequency interval of interest. Instead, Ei (area under the curve of the peak) 
represents the total average energy in the frequency range of a specific oscillator, 
reflecting the overall oscillatory activity in the frequency interval under 
investigation. Although most of the times Ai and Ei trends are similar, sometimes 
the maximum oscillatory amplitude Ai reached during a specific task (e.g. 
response to PE) might not reflect the overall Ei trend in the interval of interest. 
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For this reason, the examination of both Ai and Ei provides a better overview of 
the data avoiding misinterpretations. In addition, the frequency location f of the 
oscillator’s peak provides a different information compared to Ai and Ei, mostly 
reflecting the rate of the oscillatory activity rather than the magnitude of the 
oscillation. Thus, it is worth examining all of these three parameters (Ai, Ei, f) to 
gain a complete overview on the oscillatory activity of a specific wavelet oscillator. 
Another important aspect to consider is that the absolute Ai and Ei wavelet data 
might not be reliable for comparing different animals because of the 
heterogeneous anatomy of the single-point analysed skin regions. The problem 
is addressed by using the relative wavelet amplitude ai and energy ei of each 
oscillator for comparisons between different groups of mice, which are 
dimensionless variables. The normalisation of Ai and Ei for obtaining the relative 
ai and ei has been discussed in the section 1.8 (paragraph 1.8.2, page 55) 
(equations 9-12). It is based on normalising the value of Ai or Ei extracted from 
the frequency interval of a specific oscillator by the Ai or Ei of the total wavelet 
spectrum, and by the number of frequencies in the interval of the oscillator. The 
experimental data of ai, ei, and f of the LDF oscillators’ peaks characterised in this 
study for mice are reported in Table 5. 
Characterisation of the endothelial EDHF oscillator 
As discussed in section 1.8 (paragraph 1.8.3, page 58), the physiological origin 
of the endothelial NO-independent oscillator (5-9.5 × 10-3 Hz) is not clear. 
Although the endothelial origin of this oscillator has been proved [102, 105], in 
literature it has been reported that either the inhibition of the NO pathway by L-
NMMA or inhibition of the PG pathways by aspirin does not affect the wavelet 
peak of this oscillator, suggesting a physiological origin related to a different 
endothelial mechanism that may be the EDHF [102, 105]. The results obtained in 
this thesis are in agreement with this hypothesis and support indirectly the 
possible EDHF origin of this oscillator. Indeed, Okazaki et al. [160] have reported 
that the vasoconstriction induced by PE in rat mesenteric artery is able to 
enhance a vasomotion phenomenon mediated specifically by NO and EDHF 
mechanisms but not by PG pathways. In this thesis a different microcirculatory 
bed (skin micro-vessels) from the mesenteric artery has been used, however, the 
results agree with what has been reported by Okazaki et al. [160]. Indeed, as 
displayed in Table 5, the wavelet components showing the most statistically 
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significant changes during PE administration were the endothelial NO oscillator 
(9-20 × 10-3 Hz) and the endothelial NO-independent (5-9 × 10-3 Hz) oscillator. 
Considering the recognised origin of the endothelial NO peak, by exclusion the 
high significant changes observed in the NO-independent interval after PE 
stimulation should be ascribed to the EDHF activity. 
Table 5 Wavelet ai, ei and f of LDF oscillators during iontophoresis of PE. Data are presented 
as mean ± SD. Endo = Endothelial. NO = Nitric oxide. EDHF = Endothelial-derived hyperpolarizing 
factor. The relative ai and ei are expressed in dimensionless units. The frequency f is expressed 
in hertz (Hz). Differences between WT and Nrf2-/- groups were calculated by unpaired t-test and 
are outlined by red asterisks. Differences between baseline and PE time points were calculated 
by paired t-test and are outlined by black asterisks. *p < 0.05, **p < 0.01. 
 WT (n=5) 
Variable Baseline PE 
ai Myogenic (14.8 ± 6.60) × 10-3 (9.70 ± 4.30) × 10-3 
ai Neurogenic (12.9 ± 7.60) × 10-3 (5.50 ± 1.80) × 10-3 
ai Endo-NO (10.6 ± 4.40) × 10-3 (6.00 ± 2.60) × 10-3 
ai Endo-EDHF (11.0 ± 2.30) × 10-3 (6.10 ± 1.50) × 10-3 * 
ei Myogenic (4.50 ± 1.50) × 10-3 (3.20 ± 1.10) × 10-3 
ei Neurogenic (1.90 ± 0.80) × 10-3 (1.00 ± 0.30) × 10-3 * 
ei Endo-NO (1.10 ± 0.30) × 10-3 (0.60 ± 0.20) × 10-3 ** 
ei Endo-EDHF *(0.70 ± 0.20) × 10-3 (0.40 ± 0.10) × 10-3 ** 
f Myogenic [Hz] (10.4 ± 1.30) × 10-2 (9.30 ± 2.10) × 10-2 
f Neurogenic [Hz] (2.80 ± 0.50) × 10-2 (3.00 ± 0.70) × 10-2 
f Endo-NO [Hz] (1.40 ± 0.10) × 10-2 (1.50 ± 0.30) × 10-2 
f Endo-EDHF [Hz] *(8.00 ± 0.60) × 10-3 (6.90 ± 0.90) × 10-3 * 
 Nrf2-/- (n=6) 
Variable Baseline PE 
ai Myogenic (11.2 ± 2.40) × 10-3 (12.4 ± 5.30) × 10-3 
ai Neurogenic (8.40 ± 1.90) × 10-3 (8.40 ± 4.70) × 10-3 
ai Endo-NO (7.60 ± 3.90) × 10-3 (9.50 ± 5.60) × 10-3 * 
ai Endo-EDHF (7.10 ± 4.10) × 10-3 (8.90 ± 4.00) × 10-3 * 
ei Myogenic (3.40 ± 0.60) × 10-3 (3.80 ± 1.10) × 10-3 
ei Neurogenic (1.30 ± 0.40) × 10-3 (1.50 ± 0.80) × 10-3 
ei Endo-NO (0.80 ± 0.30) × 10-3 (1.00 ± 0.50) × 10-3 
ei Endo-EDHF *(0.40 ± 0.20) × 10-3 (0.60 ± 0.30) × 10-3 * 
f Myogenic [Hz] (9.20 ± 1.70) × 10-2 (9.20 ± 1.60) × 10-2 
f Neurogenic [Hz] (3.50 ± 1.00) × 10-2 (4.00 ± 1.00) × 10-2 
f Endo-NO [Hz] (1.40 ± 0.20) × 10-2 (1.50 ± 0.20) × 10-2 
f Endo-EDHF [Hz] *(6.30 ± 1.00) × 10-3 (7.70 ± 0.80) × 10-3 * 
134 
_______________________________________________________________
Nonlinear dynamics of microcirculation and cell energy metabolism in the Nrf2-/- 
mouse model 
Moreover, in literature it has been reported that EDHF plays a more important 
role than NO in the vaso-reactivity of small resistance arterioles [140, 163, 164]. 
The results have displayed changes that are more significant for the endothelial 
NO-independent frequency range (EDHF) compared to the endothelial NO 
interval (Table 5), which would confirm a major involvement of EDHF in the 
reactivity of small arterioles [140, 163, 164]. Finally, additional indirect proof of 
the possible EDHF origin of this oscillator is provided by experimental data that 
will be discussed in section 4.4 (paragraph 4.4.2, page 177), which describe the 
contribution of each LDF wavelet oscillator to the post-occlusive reactive 
hyperaemia (PORH) response in human subjects. For all the reasons discussed 
above, in this thesis the endothelial NO-independent oscillator was named as 
“Endothelial EDHF”. 
Study of vasomotion dynamics and role of the endothelium in this phenomenon 
Fig. 53-54 describe the trends of the relative ai, ei, and f of the LDF oscillators’ 
during iontophoresis reactive test. Blood flow oscillators were characterised by 
opposite dynamics in the two groups of mice during PE-induced vasomotion. 
Indeed, the values of the endothelial EDHF ai, ei and f increased in Nrf2-/- mice (p 
< 0.05) and decreased in the WT group (p < 0.01 or p < 0.05) after stimulation 
with PE. The endothelial NO component showed trends similar to those observed 
for the EDHF oscillation. However, statistical significance was found only for the 
decrease of amplitude/energy during delivery of PE in WT mice (p < 0.01), while 
the increase of NO ai/ei observed in the Nrf2-/- model was non-significant and 
could be due to the small number of tested animals. The neurogenic and 
myogenic oscillators showed also patterns similar to those of the endothelial 
oscillations. The ei for the neurogenic oscillator was significantly reduced in WT 
mice during the response to PE (p < 0.05), with a non-significant trend for a 
reduction in the myogenic oscillator (p=0.08). Overall, these findings indicate 
different microvascular reactivity between the normal phenotype and a phenotype 
characterised by altered antioxidant defence. Moreover, the most relevant 
differences from a statistical point of view were observed for the endothelial 
oscillators, which are the most important factors associated with microvascular 
function. This suggests that the impairment of antioxidant defence may affect 
early the endothelial function of skin microcirculation. 
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Fig. 53 Trends of ai and ei of LDF oscillators during iontophoresis. Graphic representation 
of the ai and ei data reported in Table 5. (a,e) Endothelial EDHF. (b,f) Endothelial NO. (c,g) 
Neurogenic. (d,h) Myogenic. Data are presented as bar plots of the mean with error bars 
corresponding to 2SE (~95% confidence interval). Both ai and ei are expressed in dimensionless 
units. The black lines/asterisks refer to significant changes during PE delivery. The red 
lines/asterisks refer to significant differences between WT (n=5) and Nrf2-/- (n=6) mice. Black bars 
= Baseline. White bars = PE. The p-values were estimated by paired or unpaired t-test to compare 
baseline and PE time points or WT and Nrf2-/- mice, respectively. *p < 0.05, **p < 0.01. 
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Fig. 54 Trends of LDF oscillators’ peak frequency f during delivery of PE. Graphic 
representation of the frequency data reported in Table 5. (a) Endothelial EDHF. (b) Endothelial 
NO. (c) Neurogenic. (d) Myogenic. Data are presented as bar plots of the mean value with error 
bars corresponding to 2SE (~95% confidence interval). Data of f are expressed in hertz (Hz). The 
black lines/asterisks refer to significant changes during PE stimulation. The red lines/asterisks 
refer to significant differences between WT (n=5) and Nrf2-/- (n=6) groups. Black bars = baseline. 
White bars = PE. The p-values were calculated by paired t-test to compare baseline and PE time 
points, and by unpaired t-test to compare WT and Nrf2-/- groups. *p < 0.05. 
According to literature reports related to the wavelet spectral analysis of LDF time 
series, in general the increase of wavelet amplitude/energy is associated with 
vasodilation dynamics [60, 102, 105, 107]. Based on this assumption, the 
expected trend for LDF oscillators during vasoconstriction should be a decrease 
of the oscillatory amplitude/energy, which is indeed what has been observed in 
this work for WT animals (Fig. 53). In contrast, although Nrf2-/- mice showed a 
decrease of blood flow during PE-induced vasoconstriction (Fig. 51), the wavelet 
amplitude/energy of LDF oscillators was increased in this group of mice (Fig. 53). 
A possible explanation for this paradoxical response might be a vasomotion 
counter-mechanism to limit vasoconstriction by enhancing the vasodilation 
pathways modulated by the endothelium. A similar resistance mechanism to 
attenuate vasoconstriction has been already described in literature and is defined 
myoendothelial feedback [140], which is a bidirectional communication between 
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VSMCs and ECs enhanced after stimulation by vasoconstrictors, leading to the 
increase of Ca2+ in endothelial cells and the activation of both EDHF and NO 
signalling to moderate the constriction tone. A possible reason for the activation 
of this counter-regulatory mechanism in Nrf2-/- mice may be a counter-regulatory 
response to the impairment of antioxidant defence and the increase of oxidative 
stress, which are factors able to impact negatively the function of the endothelium 
and the overall pathways involved in microvascular reactivity. These observations 
may indicate a major tendency to constriction or a pre-existent vasoconstriction 
in the Nrf2-/- mice due to oxidative stress. However, this cannot be proved by 
evaluating the trends of blood flow, as shown in Fig. 51, which allows to account 
only the relative vasoconstriction induced by PE but does not allow to evaluate 
the presence of a pre-existent constriction status of micro-vessels. 
Finally, it cannot be excluded that using higher concentrations of PE (> 1%) to 
induce stronger vasoconstriction also WT mice may show an increase of the LDF 
wavelet amplitudes/energies, reflecting the activation of a myoendothelial 
feedback and vasomotion to enhance vasodilation mechanisms, counteract the 
excessive constriction and maintain the normal skin perfusion and oxygenation. 
Differences of LDF oscillators between normal and oxidative stress phenotypes 
The most relevant statistically significant difference between groups was found 
for the endothelial EDHF oscillator, which showed greater wavelet energy (p < 
0.05) and frequency (p < 0.05) in WT mice compared to Nrf2-/- at baseline (Table 
5). This may indicate a general reduced basal activity of the EDHF vasodilator 
dynamics in Nrf2-/- mice due to impaired antioxidant defence and leading to major 
constriction of skin micro-vessels. Overall, also all the other oscillators 
(endothelial NO, neurogenic, myogenic) showed greater baseline 
amplitude/energy or f in WT compared to Nrf2-/- mice, suggesting a general 
reduced basal vasodilator potential in the knock-out animals, even though non-
significant p-values were observed for these components (Table 5). Thus, LDF 
oscillators may be potential predictors of vascular dynamics associated with 
oxidative stress. 
3.3.2 Metabolic oscillators in mice 
Rationale for the study of metabolic oscillators in mouse models 
NAD(P)H is a coenzyme involved in the cellular energy metabolism that is 
accumulated in the cells in the presence of oxidative stress. Monitoring the 
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relative amounts of NAD(P)H in the skin provides the potential to gain information 
on possible cell metabolic alterations associated with vascular/metabolic illness. 
Moreover, the estimation of the redox ratio (RR) index that is the balance between 
cellular NAD(P)H and flavins coenzymes provides specific information on 
mitochondrial function. NAD(P)H has an oscillatory time-dependent nature due 
to the continuous production and consumption of ATP energy in the cells [89].  
As discussed in the paragraph 1.9.1 (page 64), monitoring the cellular 
oscillations of NAD(P)H levels may be powerful for the early prediction of 
metabolic dysfunction in the tissue that could be associated to the onset of many 
diseases (i.e. cancer or CVD) [89]. Metabolic oscillations have been studied from 
in-vitro or ex-vivo cell cultures, i.e., yeast [128, 129], cardiac myocytes [130] and 
β-cells [131, 132] by measuring the AF of NAD(P)H [128, 129, 130, 131, 133, 
134]. Limited research on metabolic oscillations has been carried out also in live 
animals, i.e., detection of mitochondrial fast oscillations from rat skin salivary 
glands using intra-vital 2P microscopy [135], and study of circadian diurnal 
NAD(P)H oscillations from mouse stem cells of the basal epidermal skin layer by 
multiphoton FLIM method [136]. However, skin metabolic oscillations have never 
been investigated in-vivo in humans or mouse models by using AF single-point 
readouts, and no research has focused on the possible relationship between 
metabolic oscillators and skin microvascular reactivity or on the use of these 
nonlinear markers as predictors of risk for CVD. Based on the discussion above, 
the main novelties that the present work has added to the current knowledge are: 
1. The application for the first time of the wavelet spectral analysis on skin 
NAD(P)H and RR signals obtained by label-free single-point autofluorescence 
readouts, to characterise in-vivo mouse skin metabolic oscillators. 
2. The comparison for the first time of the dynamic patterns of skin metabolic 
oscillators between different animal groups to evaluate their potential 
applicability as CVD risk factors associated with oxidative stress. 
3. The first attempt to study the role of metabolic oscillators in skin vasomotion 
by assessing their interaction/correlation with microvascular oscillators. 
Characterisation of a slow metabolic oscillator from mouse skin 
Fig. 55 shows the median time-averaged CWT spectra from NAD(P)Hnormalised and 
RRindex reconstructed signals of WT and Nrf2-/- mice during iontophoresis task. 
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Fig. 55 Comparison of WT and Nrf2-/- NAD(P)H and RR CWT spectra during iontophoresis. 
(a-b) Median CWT NAD(P)H spectra of WT (n=5) and Nrf2-/- (n=6) mice during iontophoresis: (a) 
baseline and (b) PE response. (c-d) Median CWT RR spectra of WT (n=5) and Nrf2-/- (n=6) mice 
during iontophoresis: (c) baseline and (d) PE response. The shaded blue and red areas around 
the lines of the median spectra represent the inter-quartile range of the CWT spectra. MO-1 = 
Metabolic oscillator-1. Both Ei and Ai are expressed in AU. The plots show slight differences in 
the Ai, Ei and f of MO-1 peak between groups. 
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A relevant slow metabolic oscillation in the 5-9 × 10-3 Hz frequency range of 
NAD(P)H and RR signals was identified, named metabolic oscillator-1 (MO-1), 
which should reflect the biological cyclic turnover between the reduced and 
oxidised forms of NAD(P)H and FADH2 coenzymes. The graphs outline some 
differences between groups associated with the absolute wavelet amplitude Ai 
and energy Ei of metabolic oscillators, especially for the RR MO-1 oscillator 
during both baseline and PE delivery time points. 
Comparisons between groups were examined by evaluating the dimensionless 
relative amplitude ai and energy ei, which were estimated normalising the values 
of Ai and Ei extracted from the frequency interval of the MO-1 by the values of Ai 
and Ei derived from the total wavelet spectrum, and by the number of frequencies 
in the frequency interval of MO-1 (equations 9-12). Also the frequency location f 
of the MO-1 wavelet peak was compared between mice groups. The 
experimental data of ai, ei and f of the MO-1 are reported in Table 6. 
Table 6 Wavelet ai, ei and f of NAD(P)H MO-1 and RR MO-1 during iontophoresis of PE. Data 
are presented as mean ± SD. NAD(P)H = Nicotamide adenine dinucleotide. RR = Redox ratio. 
MO-1 = Metabolic oscillator-1. The relative ai and ei are expressed in dimensionless units. The 
frequency f is expressed in hertz (Hz). Non-significant differences were found between WT and 
Nrf2-/- groups. Differences between baseline and PE time points were estimated by paired t-test 
and are outlined by black asterisks. *p < 0.05. 
 WT (n=5) 
Variable Baseline PE 
ai NAD(P)H MO-1 (10.7 ± 2.70) × 10-3 (11.7 ± 3.50) × 10-3 
ai RR MO-1 (8.10 ± 4.40) × 10-3 (12.4 ± 2.30) × 10-3 * 
ei NAD(P)H MO-1 (12.8 ± 1.40) × 10-3 (16.1 ± 1.50) × 10-3 * 
ei RR MO-1 (11.7 ± 4.60) × 10-3 (14.9 ± 2.50) × 10-3 
f NAD(P)H MO-1 [Hz] (6.10 ± 1.10) × 10-3 (6.60 ± 0.60) × 10-3 
f RR MO-1 [Hz] (6.70 ± 1.10) × 10-3 (6.40 ± 1.20) × 10-3 
 Nrf2-/- (n=6) 
Variable Baseline PE 
ai NAD(P)H MO-1 (9.60 ± 5.40) × 10-3 (13.8 ± 5.50) × 10-3 
ai RR MO-1 (11.2 ± 3.90) × 10-3 (8.60 ± 4.20) × 10-3 
ei NAD(P)H MO-1 (12.3 ± 4.60) × 10-3 (15.8 ± 2.40) × 10-3 
ei RR MO-1 (14.6 ± 3.90) × 10-3 (12.0 ± 3.10) × 10-3 
f NAD(P)H MO-1 [Hz] (6.80 ± 1.40) × 10-3 (6.30 ± 0.90) × 10-3 
f RR MO-1 [Hz] (6.30 ± 0.80) × 10-3 (7.00 ± 1.30) × 10-3 
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Biological meaning of NAD(P)H MO-1 and RR MO-1 dynamics 
The interpretation of the data reported in Table 6 is difficult considering that this 
is the first attempt to investigate in-vivo metabolic oscillations detected by CWT 
spectral analysis. In general, from a biochemical point of view, NAD(P)H and RR 
oscillations reflect the oxido-reductive dynamics of the biological tissue, which 
consist in the continuous fluctuation of the cellular coenzymes NAD(P)H and 
FADH2 from the reduced status to their respective oxidised forms (NAD(P)+ and 
FAD+) and vice-versa. These cyclic reactions are part of glycolysis (only NAD(P)H 
reactions) and oxidative phosphorylation (OXPHOS) (both NAD(P)H and FAD+ 
reactions) cellular processes for the production of ATP energy, taking place in the 
cytoplasm and in the mitochondria cell compartments, respectively. Therefore, 
evaluating the metabolic oscillations makes it possible to gather information on 
the dynamics of cellular energetic metabolism. Based on the trends of MO-1 
observed during human PORH test that will be discussed in section 4.4 
(paragraph 4.4.3, page 184), as clue for mouse model data interpretation, it can 
be proposed the increase of MO-1 wavelet amplitude/energy as a general 
indicator of enhanced aerobic energy metabolism, and the decrease of the MO-
1 amplitude/energy as indicator of a protective mechanism for the preferential 
production of cellular ATP through glycolysis in the presence of stress conditions. 
Trends of the metabolic oscillator MO-1 during PE-induced vasomotion and 
differences between normal and oxidative stress phenotypes 
Fig. 56 shows the trends of the relative wavelet amplitude ai, energy ei and 
frequency f of NAD(P)H MO-1 and RR MO-1 oscillators during iontophoresis of 
PE in mouse models. The data are partially in agreement with the interpretation 
of MO-1 trends proposed above. Indeed, ai or ei increased significantly in WT 
mice during PE challenge either for NAD(P)H MO-1 (p < 0.05) or RR MO-1 (p < 
0.05) oscillators (Fig. 56a-d), indicating the maintenance of “normal” aerobic 
cellular energetic dynamics in the presence of a low-dose vasoconstriction 
stimulus. In contrast, although NAD(P)H MO-1 showed a “normal” response also 
in the Nrf2-/- mice, the ai or ei of RR MO-1 decreased in this group during PE-
induced vasoconstriction (Fig. 56a-d). This finding may suggest a preferential 
production of part of the total ATP through glycolysis as protective mechanism to 
maintain a sufficient energy intake in response to oxidative stress and the 
consequent vasoconstriction, which are factors that may cause lower tissue 
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oxygenation. This would agree also with the more relevant vasomotion observed 
in Nrf2-/- mice compared to WT that has been explained in paragraph 3.3.1 (page 
136) as a resistance mechanism to counteract vasoconstriction. 
 
Fig. 56 Trends of the wavelet ai, ei and f of MO-1 during iontophoresis. Graphic 
representation of the data reported in Table 6. (a, c, e) NAD(P)H MO-1 wavelet data. (b, d, f) RR 
MO-1 wavelet data. NAD(P)H = Nicotamide adenine dinucleotide. RR = Redox ratio. MO-1 = 
Metabolic oscillator-1. Data are presented as bar plots of the mean value with error bars 
corresponding to 2SE (~95% confidence interval). Both ai and ei are expressed in dimensionless 
units. The frequency f is expressed in hertz (Hz). Non-significant differences were found between 
WT (n=5) and Nrf2-/- (n=6) mice. The black lines/asterisks refer to significant changes during PE 
stimulation. Black bars = baseline. White bars = PE. The p-values to compare baseline and PE 
time points were calculated by paired t-test. *p < 0.05. 
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However, the baseline wavelet energy/amplitude of RR MO-1 oscillator was 
found to be lower in WT animals compared with Nrf2-/- mice (p = 0.097). This 
finding would be in contrast with the hypothesis proposed above of lower wavelet 
amplitude/energy of RR MO-1 reflecting a protective mechanism to ensure 
suitable ATP production during oxidative stress. Indeed, in this case data might 
be misinterpreted as indicating the presence of higher basal oxidative stress in 
WT mice leading to lower baseline RR MO-1 oscillatory amplitude/energy and 
preferential production of ATP by glycolysis. These contrasting observations 
suggest that baseline wavelet data should be interpreted with caution, and a 
better approach for making reliable comparisons would be monitoring the 
changes of wavelet oscillators’ dynamics in response to a challenging test (e.g. 
iontophoresis of PE or PORH). 
The wavelet frequency of both NAD(P)H MO-1 and RR MO-1 oscillators did not 
show significant differences either between mouse groups or in relation to 
challenge of skin micro-vessels with iontophoretic delivery of PE (Fig. 56e-f). 
In summary, the data have revealed different dynamics of metabolic oscillators 
between the two mice models, especially in relation to the RR MO-1 that was 
characterised by opposite trends in the two groups of animals during PE 
challenge showing greater differences compared to NAD(P)H MO-1. The reason 
why the RR MO-1 shows more relevant differences might be due to the fact that 
it reflects specifically the mitochondrial oxido-reductive dynamics. Indeed, the 
RRindex (dimensionless variable) was calculated as the NAD(P)H/FAD+ ratio 
(equation 22) that is a measure of the mitochondrial activity and may undergo 
relevant changes when the cells switch towards a preferential anaerobic 
glycolytic metabolism taking place in the cytoplasm. In contrast, the 
autofluorescence of NAD(P)H itself may be less informative considering that the 
laser fluorescence spectroscopy (LFS) method does not allow to distinguish 
cytosolic and mitochondrial NAD(P)H, as well as the bounded (NADPH) and 
unbounded (NADH) forms of the coenzyme. Therefore, the oscillations of 
NAD(P)H in this case may reflect the overall cellular energetic dynamics rather 
than the oxido-reductive reactions of a specific cellular compartment.  
In conclusion, the inter-group differences that were observed in relation to RR 
MO-1 dynamics may reflect an early alteration of cell energy metabolism in the 
Nrf2-/- mice due to oxidative stress. It cannot be excluded that this may explain 
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why the Nrf2-/- mice compared to WT have higher probability of developing 
metabolic illness (i.e. diabetes) in the presence of risk factors, i.e. high fat diet 
(HFD). Therefore, metabolic oscillators may be potential predictors of risk for 
metabolic dysfunction and the vascular complications derived from this condition. 
However, the lack of antioxidant protection of the Nrf2-/- mice used in this work 
has not been fully tested, for example by challenging the mice with a significant 
oxidative stress load (i.e. treatment with HFD). Thus, because their baseline 
phenotype may not reveal the full picture on the dynamics of metabolic oscillators 
in response to oxidative stress, future work is required on larger groups of mice 
treated with HFD or affected by metabolic or vascular disorders to elucidate 
further these aspects. Another perspective is translating the research to human 
clinical studies to assess and validate metabolic oscillators as CVD risk factors. 
 
3.4 Interactions and correlations between microvascular and 
metabolic oscillators in mice 
The main goal of this section was investigating the possible link between 
metabolic and microvascular oscillators to gather information on the role of 
NAD(P)H and RR cellular nonlinear dynamics in the vasomotion process induced 
by administration of the α-adrenergic vasoconstrictor PE. In order to achieve this 
objective two kind of analyses were performed: 
(1) The wavelet phase coherence (WPCO) analysis. The WPCO allows studying 
the degree of interaction between oscillators that reflect specific biological 
functions, with the potential of revealing the cooperation between these 
components for the regulation of particular biological mechanisms. For 
example, in this case the WPCO examination may be useful to detect 
interactions between metabolic and microvascular oscillators associated with 
PE-induced vasomotion, which may reflect dynamic patterns of cellular ATP 
production able to drive the regulation of the vascular tone in response to the 
given stimulus. Moreover, the analysis may potentially reveal different 
patterns of interaction in WT and Nrf2-/- mice due to the effect of oxidative 
stress and ROS on the mitochondrial energetic dynamics of Nrf2-/- animals. 
(2) Analysis of correlations. The traditional analysis of correlations allows 
gathering more information than the WPCO on the association between 
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microvascular and metabolic oscillators. This is due to the fact that the WPCO 
is restricted to the study of phase relationship between oscillators that are 
located in the same frequency range, i.e. in this case it was possible 
investigating only the WPCO between MO-1 and the endothelial EDHF 
oscillators. Instead, the correlation analysis allows investigating the 
relationship between all the parameters that have been included in the study. 
Considering that the variables analysed in mouse models work were normally 
distributed, here the analysis of correlation was carried out by estimating the 
parametric Pearson’s correlation coefficient r. 
3.4.1 Phase coherence between metabolic and EDHF oscillators 
The WPCO analysis is used to study the phase relationship Cɸ(ωk) between 
oscillations in a specific frequency range of two signals measured 
simultaneously. The analysis allows gathering information on the degree of 
interaction/synchronisation between the oscillators under investigation, by 
returning coherence values ranging from 0 to 1 that respectively indicate absence 
of interaction and maximal interaction. In this work on animal models, the analysis 
was applied to examine the phase relationship between the endothelial EDHF 
oscillator of the LDF signal and the MO-1 of NAD(P)H (Cɸ(ωk)NAD(P)H MO-1/EDHF) or 
RR (Cɸ(ωk)RR MO-1/EDHF) reconstructed signals, which are located in the same 
frequency range (5-9 × 10-3 Hz). Table 7 displays the WPCO data of 
Cɸ(ωk)NAD(P)H MO-1/EDHF and Cɸ(ωk)RR MO-1/EDHF during an iontophoresis test. The 
table shows baseline phase coherence mean values for the analysed interactions 
between 0.74 and 0.79 in both WT and Nrf2-/- groups, indicating a relevant basal 
partial relationship between metabolic and microvascular endothelial oscillators. 
This finding might suggest a relevant interaction between cellular metabolic 
oscillatory processes and microvascular dynamics in the skin. However, because 
the WPCO analysis in this dissertation does not include the surrogate data testing 
described recently by Gruszecki et al. [165], the assumptions above on the 
degree of baseline coherence might not be reliable due to bias affecting the 
WPCO values at the low frequencies. Nonetheless, cautious comparisons of the 
differences between mouse groups and changes in response to PE stimulation 
can be made. 
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Differences of phase coherence between WT and oxidative stress phenotypes 
Also in this case, as discussed in the previous section (paragraph 3.3.2, page 
143), the RR MO-1 oscillator was more informative than NAD(P)H MO-1 showing 
relevant differences between WT and Nrf2-/- animals. Indeed, non-significant 
differences were found between groups (Table 7) or between baseline and PE 
iontophoresis time points (Fig. 57) for the Cɸ(ωk)NAD(P)H MO-1/EDHF. In contrast, the 
Cɸ(ωk)RR MO-1/EDHF was significantly lower in the Nrf2-/- compared with WT mice 
at baseline (p < 0.01) (Table 7), indicating a major interaction between 
mitochondrial reactions and the EDHF vasodilation pathway in the WT group. 
Table 7 Phase coherence between metabolic and EDHF oscillators during iontophoresis. 
Data are expressed as mean ± SD. Cɸ(ωk) = Wavelet phase coherence. PE = phenylephrine. 
MO-1 = Metabolic oscillator-1. EDHF = Endothelial-derived hyperpolarizing factor. NAD(P)H = 
Nicotamide adenine dinucleotide. RR = Redox ratio. Differences between groups were calculated 
by unpaired t-test and are outlined by red asterisks. Differences between baseline and PE time 
points were estimated by paired t-test and are outlined by black asterisks. **p < 0.01. *p < 0.05. 
 WT (n=5) Nrf2-/- (n=6) 
Variable Baseline PE Baseline PE 
Cɸ(ωk)NAD(P)H MO-1/EDHF 0.78 ± 0.03 0.76 ± 0.05 0.76 ± 0.05 0.79 ± 0.05 
Cɸ(ωk)RR MO-1/EDHF **0.79 ± 0.04 0.76 ± 0.02* **0.74 ± 0.06 0.78 ± 0.02** 
The Cɸ(ωk)RR MO-1/EDHF changed significantly in both groups also during PE 
delivery, showing a decrease of coherence in WT mice (p < 0.05) and an increase 
of coherence in Nrf2-/- animals (p < 0.01) (Fig. 57b). Overall, these results outline 
a different interaction and coupling between RR MO-1 and the EDHF oscillators 
in WT mice compared to animals with altered redox conditions and impaired 
antioxidant defence. The multi-parametric integration of these data with the 
results obtained for the LDF oscillators highly indicates that the different phase 
interaction between metabolic and EDHF oscillators observed in WT and Nrf2-/- 
mice may be a factor determining the different microvascular reactivity to PE 
vasoconstriction stimulus found between the tested groups. 
Phase coherence data may reflect the mechanisms of activation of EDHF 
In summary, the wavelet phase coherence data have outlined a relevant degree 
of interaction between mitochondrial metabolic cyclic reactions (RR MO-1) and 
the EDHF endothelium-mediated vasodilation (EDHF oscillator), which may 
change depending on the presence of a specific phenotype (i.e. high oxidative 
stress) or the challenge with a particular stimulus (i.e. administration of PE). 
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The EDHF mechanism may be activated by different cellular pathways, 
including the electric signalling through gap junctions, chemical signalling through 
K+ channels, or signalling pathways associated with the release of chemical 
metabolites, i.e. epoxyeicosatrienoic acids (EETs). Considering the metabolic 
origin of RR MO-1 oscillations, it could be hypothesised that the coherence 
between RR MO-1 and the EDHF oscillator may reflect the degree of activation 
of the EDHF mechanism mediated by metabolic factors such as EETs. However, 
these hypotheses are proposed based on indirect assumptions suggested by the 
integration of multi-parametric data. Therefore, as future perspective, further 
experiments are required to better clarify the physiological meaning of Cɸ(ωk)RR 
MO-1/EDHF  and any possible link with the activation/inactivation of EDHF by EETs 
or through other cellular pathways (gap junctions or K+ channels). This may be 
achieved by using the methodology implemented in this study in combination with 
the local administration of drugs for the specific inhibition of EETs biosynthesis, 
or for the inhibition of K+ channels. 
 
Fig. 57 Trends of phase coherence Cɸ(ωk) between metabolic and EDHF oscillators during 
iontophoresis. Graphic representation of the data reported in Table 7. (a) Phase coherence 
between NAD(P)H MO-1 and EDHF oscillators. (b) Phase coherence between RR MO-1 and 
EDHF oscillators. NAD(P)H = Nicotamide adenine dinucleotide. MO-1 = Metabolic oscillator-1. 
EDHF = Endothelial-derived hyperpolarizing factor. RR = Redox ratio. Data are presented as bar 
plots of the mean value with error bars corresponding to 2SE (~95% confidence interval). The 
black lines refer to significant differences between baseline and PE time points. The red lines 
refer to significant differences between WT (n=5) and Nrf2-/- (n=6) mice. Differences between 
baseline and PE time points were calculated by paired t-test. Differences between mice groups 
were calculated by unpaired t-test. *p < 0.05, **p < 0.01. 
 
148 
_______________________________________________________________
Nonlinear dynamics of microcirculation and cell energy metabolism in the Nrf2-/- 
mouse model 
3.4.2 Relevant correlations and role of the endothelium and metabolic 
oscillators in vasomotion 
Correlations in the WT mouse model 
Negative correlations were observed between the wavelet energy of NAD(P)H 
MO-1 and the wavelet energy of endothelial EDHF (r=-0.82, p < 0.01), endothelial 
NO (r=-0.77, p < 0.01), neurogenic (r=-0.71, p < 0.05) and myogenic (r=-0.68, p 
< 0.05) oscillators (Fig. 58). 
 
Fig. 58 Relevant correlations in the WT group.  All the parameters analysed in this part of the 
work showed a Gaussian distribution. Thus, correlations were assessed by the calculation of the 
parametric Pearson’s coefficient r. The analysis was performed using the function corr of Matlab 
R2015a (The MathWorks Inc.) software. The correlations were considered significant for p < 0.05 
and values of r > 0.5 or < -0.5. Black dots = Baseline (n=5). White triangles = PE challenge (n=5). 
*p < 0.05, **p < 0.01. 
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The wavelet amplitude/energy of RR MO-1 also showed negative correlations 
with the energy/amplitude of endothelial EDHF (r=-0.84, p < 0.01), endothelial 
NO (r=-0.65, p < 0.05) and myogenic (r=-0.69, p < 0.05) oscillators, and with 
blood perfusion (r=-0.70, p < 0.05) (Fig. 58). None of these correlations between 
metabolic and microvascular oscillators were observed in the Nrf2-/- mice, except 
for the correlation between the energy/amplitude of RR MO-1 and blood perfusion 
which was positive in the KO mice (r=0.67, p < 0.05). These findings point to an 
involvement of the cellular oxido-reductive oscillatory processes in the vasomotor 
response enhanced by α-adrenergic stimulation. The results suggest a strong link 
between the cellular fluctuations of NAD(P)H involved in the production of ATP 
energy and the activation/inactivation of the microvascular pathways for the 
modulation of vascular tone. Indeed, the correlations indicate that during the 
response to a low-dose of PE in WT mice the energy/amplitude of microvascular 
oscillators decreases as the energy/amplitude of slow metabolic oscillators 
increases. This may reflect a change in the turnover between NAD(P)+ and 
NAD(P)H promoting the decrease of the vasodilator activity mediated by EDHF 
and NO endothelial pathways, and inducing contraction of the smooth muscle 
and vasoconstriction. 
Role of endothelium and metabolic oscillators in vasomotion 
The fact that the strongest correlations were found for the EDHF and NO 
endothelial oscillators suggests an important role of endothelium in the 
modulation of small arterioles diameter during α-adrenergic stimulation, probably 
due to the direct targeting of ECs by PE. However, correlations were also found 
between metabolic oscillators and the neurogenic and myogenic wavelet 
components, suggesting a global involvement of all the microvascular 
components for the modulation of the vascular tone in response to an external 
vasoconstrictor stimulus. In this context, the EDHF could represent the key 
signalling pathway for the myoendothelial bidirectional communication by gap 
junctions or K+ Ca2+-dependent channels [140], which may promote Ca2+ 
fluctuations in VSMCs and vasomotion in response to primary Ca2+ oscillations 
of metabolic origin arising from ECs. These findings, could offer a novel 
mechanism for describing vasomotion. Indeed, in the literature vasomotion has 
always been described as a process mainly induced by the spontaneous 
pacemaker activity of VSMCs [111], originating from the interaction between 
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cellular cytosolic and membrane Ca2+ oscillations due respectively to the release 
of Ca2+ through the sarcoplasmic reticulum [110, 142, 143] and the opening 
activity of Ca2+ or K+ channels in the cell plasma membrane [110, 111, 144]. 
However, the results in this dissertation suggest that vasomotion may have a 
different origin depending on the nature of the stimulus affecting the 
microcirculation and the microvascular bed under investigation. For example in 
this case, a role of the endothelium in vasomotion of skin micro-vessels has been 
observed, which is in agreement with other studies in rat mesenteric artery that 
have proposed an important contribution of ECs to vasomotion [138, 139, 140].  
Moreover, the outcomes of this study open a novel scenario for the elucidation of 
the cellular mechanisms at the basis of vasomotion. Indeed, the results have 
outlined a possible role of cellular metabolic oscillators for driving vasomotion in 
response to specific stimuli. Although in the past the existence of metabolic 
oscillators involved in the cellular origin of vasomotion has been proposed, this 
aspect has never been examined in depth [110, 111]. This is probably due to the 
underestimation of the role of endothelial cells in vasomotion, which according to 
the observations in this work seem to be the microvascular component mostly 
associated with slow metabolic oscillators. The hypothesis proposed in this work 
is supported further by recent studies that have proved the existence of cellular 
fluctuations of Ca2+ of glycolytic [89, 145, 146] or mitochondrial [129, 131, 134] 
metabolic origin. Therefore, the obtained results raise the interest for the further 
study of cellular mitochondrial and glycolytic oscillators as possible factors that 
may drive the Ca2+ oscillations at the basis of vasomotion. This would allow 
obtaining a more complete overview of the cellular mechanisms involved in 
vasomotion, including also the possible involvement of ECs and metabolic 
oscillations depending on the vascular bed under investigation and the kind of 
stimulus challenging the microcirculation. Furthermore, a shortcoming of the 
method used in this study is the under sampling of NAD(P)H autofluorescence 
spectra leading to the impossibility of tracing fast metabolic oscillations. 
Therefore, it cannot be excluded the existence of faster NAD(P)H oscillations of 
glycolytic and mitochondrial origin that may arise also from VSMCs, leading to 
Ca2+ oscillations and vasomotion events of metabolic origin mainly mediated by 
the smooth muscle. 
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Novel concept of vasomotion 
According to the previous comments (pages 149-150), vasomotion could be 
defined as an adaptive mechanism of the microvascular tone in response to the 
energetic requirements of the surrounding tissue aimed at ensuring a suitable 
intake of nutrients (e.g. glucose) and oxygen for the production of ATP, rather 
than a spontaneous phenomenon due to the pacemaker activity of VSMCs. This 
definition may explain better several unclear aspects of vasomotion such as the 
contrasting fact that the oscillations of the vascular diameter might be associated 
with both healthy and diseased conditions [110, 111], and the primary 
involvement of ECs or VSMCs activity depending on the vascular bed under 
investigation or the stimulus affecting the microcirculation [110, 111]. Indeed, all 
of these aspects may be influenced by the nutritive and oxygen requirements and 
in general the molecular signalling in the environment (parenchymal tissue) 
surrounding the microvascular network, which may vary depending on the degree 
of oxygenation of the tissue, the presence of a particular pathology, and the kind 
of tissue/cells from which is arising the primary stimulus inducing the adaptation 
of microvascular tone. Based on these assumptions for example, in the presence 
of a pathology affecting blood vessels, e.g. hypertension, the primary stimulus for 
vasomotion may arise with high probability from the endothelium, which is the 
most internal microvascular layer at direct contact with the blood able to sense 
changes in blood pressure inducing the activation of the adaptive mechanisms 
for counteracting abnormal pressure conditions. In contrast, it could be supposed 
that pathologic conditions involving the cutaneous cells, e.g. melanoma cancer, 
may induce either vasomotion events mediated by VSMCs in the median layer of 
micro-arterioles that may communicate and receive signals from the surrounding 
tissue earlier than arteriolar ECs, or vasomotion events mediated by signals 
coming from the single-layer of ECs that constitutes the capillaries at direct 
contact with the diseased tissue. These examples could also explain why in some 
cases vasomotion is induced directly by VSMCs (especially for larger arteries) 
and in other cases is involving the modulation of ECs. 
Moreover, in literature it has been reported that the factors released by 
microcirculatory ECs (NO, EDHF through EETs, etc.) could diffuse to the 
underlying parenchymal tissue exerting regulatory effects on mitochondrial 
metabolism, the production of ROS and inflammation [11, 166, 167]. Therefore, 
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considering that the autofluorescence signal analysed in this dissertation has a 
prevalent epidermal origin, the correlations found between metabolic oscillations 
and vasomotion may reflect the communication/interaction between the 
cutaneous tissue and the microcirculation to satisfy the metabolic demand of the 
organ in response to a specific stimulus, which in this case is the α-adrenergic 
stimulation induced by administration of PE. 
Correlations in the Nrf2-/- model 
No significant correlations were found between metabolic and microvascular 
oscillators in Nrf2-/- mice. This suggests that oxidative stress may impact the 
interaction between these factors, probably by affecting the dynamics of the 
cellular oxido-reductive processes due to the accumulation of reactive oxygen 
species. This could induce a switch towards regulatory mechanisms of the 
microvascular tone different from the normal physiological pathways involved in 
vascular reactivity, and may promote the onset of metabolic and cardiovascular 
disorders in the long term. 
The most relevant correlations found in Nrf2-/- mice were associated with the 
wavelet frequency of the endothelial NO oscillator, which showed a positive 
correlation with the ei of the NAD(P)H MO-1 (r=0.58, p < 0.05) oscillator, and a 
negative correlation with oxygen saturation SO2 (r=-0.61, p < 0.05) (Fig. 59). 
 
Fig. 59 Relevant correlations in the Nrf2-/- group.  All the parameters analysed in this part of 
the work showed a Gaussian distribution. Thus, correlations were assessed by the calculation of 
the parametric Pearson’s coefficient r. The analysis was performed using the function corr of 
Matlab R2015a (The MathWorks Inc.) software. The correlations were considered significant for 
p < 0.05 and values of r > 0.5 or < -0.5. Black dots = Baseline (n=6). White triangles = PE 
challenge (n=6). *p < 0.05. 
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Furthermore, oxygen saturation was also in a positive correlation with the phase 
shift (ɸNAD(P)H MO-1  - ɸEndothelial NO) between NAD(P)H MO-1 and the endothelial NO 
oscillators (r=0.60, p < 0.05). The phase shift was estimated as the difference 
between the ɸ extracted from the NAD(P)H MO-1 wavelet frequency interval, and 
the ɸ estimated from the endothelial NO wavelet frequency interval. 
Considering that both SO2 and the frequency of the endothelial NO oscillator 
did not show significant changes during stimulation with PE (Fig. 51 and Fig. 54, 
respectively), this set of correlations is probably indicating a general basic link 
between these variables in the Nrf2-/- mice rather than a correlation associated 
with the response to PE. More details on the possible meaning of these findings 
are provided below. 
The NO pathway may be up-regulated in the skin microcirculation of Nrf2-/- mice 
to balance for dysfunction in the EDHF vasodilation mechanism 
The correlations mentioned above might reflect a general overexpression of the 
eNOS (endothelial nitric oxide synthase) enzyme, which has been described 
previously in Nrf2-/- mice [159]. The up-regulation of eNOS leads to increase of 
NO production, probably to balance a dysfunction in other vasodilator signalling 
pathways as an attempt to preserve vascular function in blood vessels affected 
by oxidative stress [159]. The set of correlations found in this study may support 
this evidence. Indeed, according to the literature NADPH and molecular oxygen 
participate in the reaction for NO synthesis [168], and in this dissertation the 
increase of the endothelial NO wavelet frequency (might reflect augmentation of 
NO production) was found significantly correlated with the decrease of SO2 (might 
reflect consumption of molecular oxygen) and the increase of NAD(P)H wavelet 
energy (might reflect the oxidation of NADPH in NADP+). Moreover, the positive 
correlation of SO2 with the phase shift between NAD(P)H MO-1 and endothelial 
NO oscillators supports further this hypothesis, indicating that as the coupling 
between NAD(P)H MO-1 and NO activities increases (reduction of phase shift) 
the amount of O2 decreases, which may reflect NO production. 
The correlation between augmented NO frequency and reduced SO2 might 
reflect with high probability also the formation of peroxynitrite (ONOO−) in 
response to oxidative stress and inflammation, due to a chemical reaction 
between the free radicals NO and superoxide anion (O2•−) that are produced in 
relevant amounts in the presence of oxidative damage [169]. Considering that 
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peroxynitrite is a strong oxidant [169], this would explain also the increase of 
NAD(P)H wavelet energy probably associated with oxidation of the coenzyme. 
As shown in the section 3.4 (paragraph 3.4.1, page 145), lower baseline phase 
coherence was observed between RR MO-1 and the EDHF oscillators in Nrf2-/- 
mice compared to WT (Table 7). This finding is explained as a probable lower 
baseline interaction between the EDHF and metabolic oscillators, which may 
reflect reduced basal vasodilator EDHF activity in Nrf2-/- compared to normal 
mice. Based on these findings, it could be speculated that the sustained NO 
activity/production suggested by the correlations discussed above may be a 
compensatory mechanism to counteract the reduced activity of EDHF, which is a 
dominant pathway in the peripheral microcirculation. 
As future perspective, these hypotheses may be validated by performing the 
evaluation of microvascular dynamics concurrently with molecular biology 
analysis of eNOS expression in the skin region used for testing the 
microcirculation. This would allow checking if any correlation is present between 
the degree of expression of the eNOS enzyme and the wavelet frequency or 
amplitude/energy of the endothelial NO oscillator, the wavelet amplitude/energy 
of the NAD(P)H metabolic oscillator and the average SO2. 
These interesting findings suggest in general that the multi-parametric 
integration of non-invasive microvascular data obtained by laser techniques 
might have the potential of providing specific information on the degree of 
activation/inactivation of cellular molecular pathways involved in microvascular 
function. Therefore, in the future would be highly appropriate the combination of 
these kind of studies with parallel molecular biology investigations, which could 
help to decode the molecular signalling pathways at cellular level associated with 
specific features of the physics signals obtained from laser scans. 
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4 Nonlinear dynamics of microcirculation and cell 
energy metabolism in human individuals 
 
4.1 Introduction and aims 
In this part of the work, the nonlinear dynamics of microvascular and metabolic 
cutaneous signals were investigated in human subjects. The work was carried 
out on 40 volunteers divided in two groups: 20 smokers and 20 non-smokers. The 
subjects were tested from the forearm skin location by non-invasively evaluating 
the microcirculatory and metabolic biomarkers during a PORH test. The wavelet 
spectral analysis was applied on simultaneous LDF, NAD(P)H and RR time series 
to achieve the following objectives: 
(1) Characterisation of blood flow oscillators and NAD(P)H and RR metabolic 
oscillations from human skin. 
(2) Assessing the potential application of microvascular and metabolic oscillators 
as preclinical predictors of CVD risk in smokers. 
(3) Study the relationship between metabolic oscillators and human vasomotion. 
(4) Assessing the potential use of “attractors” as predictors of risk in smokers. 
This chapter includes the analysis of a large amount of data, which could make it 
difficult to get an idea of what is the overall picture. Therefore, a brief summary 
of the main results will follow as a guide for the reader before going into details, 
to outline what are the sections/paragraphs describing the parameters that 
showed the major differences between controls and smokers, the most relevant 
findings related to the study of vasomotion, and the set of correlations and 
interactions taken into account to hypothesise the role of metabolic oscillators in 
human cutaneous PORH. 
4.1.1 Summary of the best variables eligible as predictors of CVD risk 
General microcirculation variables (section 4.3, paragraph 4.3.1, page 160) 
Within the general microcirculatory variables assessed in the study, the baseline 
perfusion and the area under the curve (AUC) of PORH peak were the best 
factors outlining differences between smokers and controls. However, these 
variables showed less significant differences compared to the nonlinear 
biomarkers. 
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Tissue oxygenation dynamics (section 4.3, paragraph 4.3.2, page 162) 
Within tissue oxygenation parameters, the oxygen consumption (VO2) displayed 
a significant difference between the examined groups, with lower values in 
smokers during PORH response probably reflecting slower oxidative metabolism. 
General metabolic variables (section 4.3, paragraph 4.3.3, page 163) 
Within the general metabolic variables, NAD(P)Hnormalised showed slight 
differences between the two groups, with higher values in smokers probably 
reflecting higher oxidative stress. 
LDF oscillators (section 4.4, paragraph 4.4.1, page 171) 
The dynamic biomarkers of microcirculation displayed robust differences 
between the two groups. Specifically, the wavelet amplitude/energy of local 
microvascular oscillators (endothelial EDHF, endothelial NO, neurogenic and 
myogenic) was significantly higher in smokers, probably reflecting an adaptive 
hyperactive microvascular response to the early risk. The respiratory oscillator 
showed also robust differences with higher spectral energy in smokers, probably 
reflecting a greater resistance of peripheral skin arterioles compared to controls. 
Metabolic oscillators (section 4.4, paragraph 4.4.3, page 187) 
The dynamic biomarkers of cellular energy metabolism did not show significant 
differences, suggesting that healthy smokers are still characterised by an overall 
functioning cell energetic metabolism. 
Attractors (section 4.6, paragraph 4.6.1, page 196) 
Within the LDF attractors analysed in this study, the fractal dimension D, the 
correlation dimension D2, and the information dimension Hi showed relevant 
differences between smokers and non-smokers. However, the interpretation of 
these parameters must be done with caution because they provide variable 
results depending on the kind of analysed signal and the health conditions of the 
subjects under examination. Therefore, more research is needed to characterise 
better the full picture of these markers. 
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4.1.2 Summary of the study of vasomotion and correlations/interactions 
between vascular and metabolic oscillators 
Role of LDF oscillators in skin PORH (section 4.4, paragraph 4.4.2, page 176) 
The analysis of the percentage increase of wavelet amplitude/energy of LDF 
oscillators allowed the characterisation of the contribution of each microvascular 
component to PORH vasomotion. The major contributor was the endothelial 
EDHF oscillator in agreement with what has been described in the literature [9]. 
Relevant correlations and role of metabolic oscillators in skin PORH vasomotion 
(section 4.5, paragraph 4.5.1 at page 189 and paragraph 4.5.2 at page 192) 
The study of correlations and interactions (phase coherence) between metabolic 
oscillators and microvascular variables has revealed a role of the RR MO-1 
oscillator in modulating the reactive hyperaemia peak concurrently with the EDHF 
oscillator. Specifically, the set of correlations suggests that during PORH the 
endothelial EDHF pathway could be activated preferentially through the release 
of EETs metabolic factors in healthy control subjects. On the other side, the 
exposure to tobacco may lead to impairment of EETs mechanism and preferential 
exogenous activation of EDHF by gap junctions or K+ channels signalling. 
 
4.2 General variables of the studied groups 
Table 8 displays a summary of the exclusion and inclusion criteria adopted for 
the recruitment of control and smoking subjects. 
Table 8 Inclusion and exclusion criteria. All the subjects were recruited ensuring the apparent 
absence of any pathological condition, especially CVD, diabetes and respiratory diseases. 
Controls (n=20) Smokers (n=20) 
Inclusion criteria Exclusion criteria Inclusion criteria Exclusion criteria 
Non-smoker Smoker Smoking traditional 
cigarettes 
Non-smoker or 
smoking e-cigarettes 
No CVD CVD No CVD CVD 
No diabetes Diabetes No diabetes Diabetes 
No respiratory 
disorders 
Respiratory 
disorders 
No respiratory 
disorders 
Respiratory disorders 
No hypertension Hypertension / / 
More details on the recruitment process and allocation of volunteers to the final 
study groups can be found in the section 2.5 (paragraph 2.5.1, page 119).The 
choice of examining healthy mild smokers was aimed at testing the potential 
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application of the nonlinear dynamic markers as preclinical predictors of 
cardiovascular risk, which could be eligible to trace the early stages of vascular 
dysfunction associated with smoke. The main clinical parameters of the control 
and smoker groups examined in this study are reported in Table 9. 
Table 9 General parameters of the studied population. Data are presented as mean ± SD. 
The p-values were calculated by unpaired t-test. BMI = Body mass index. SBP = Systolic blood 
pressure. DBP = Diastolic blood pressure. T = temperature. SpO2 = Pulse oximetry arterial oxygen 
saturation. p = p-value. NA = Not applicable. 
Variable Controls (n=20) Smokers (n=20) p 
Males 5 5 NA 
Females 15 15 NA 
Age [years] 41.0 ± 14.0 42.6 ± 15.6 0.70 
Smoking/years 0 24.1 ± 14.4 NA 
Cigarettes/day 0 12.4 ± 5.50 NA 
Pack years 0 15.7 ± 12.8 NA 
Weight [kg] 66.8 ± 12.1 70.6 ± 16.6 0.40 
Height [cm] 168.1 ± 12.20 165.9 ± 8.30 0.50 
BMI [kg/m2] 23.5 ± 2.90 25.4 ± 4.90 0.15 
SBP [mmHg] 120.9 ± 10.80 124.7 ± 15.20 0.40 
DBP [mmHg] 78.1 ± 18.4 74.9 ± 10.2 0.50 
Skin T [°C] 32.2 ± 1.80 31.8 ± 1.20 0.40 
SpO2 [%] 98.0 ± 0.90 97.8 ± 1.20 0.70 
The two groups were matched for age and sex. Smokers were aged 19 to 69 
years, while non-smokers were 18 to 64 years old. The 75% of the study 
population was made of females. From one side this could be a disadvantage 
because data can be affected by a more variable physiology due to hormone level 
variations across the menstrual cycle. However, testing a major number of 
females can be an advantage to discover novel biomarkers of risk for women. 
Indeed, women are characterised by a different aetiology and incidence of CVD 
compared to men that frequently cannot be explained by traditional risk factors, 
thus more research is required to find novel biomarkers that could improve the 
assessment of risk for females. 
Non-significant differences were observed between controls and smokers in 
relation to general variables such as weight, height, BMI (body mass index), BP 
(blood pressure), skin temperature and arterial oxygenation variables (Table 9). 
Therefore, the main feature distinguishing the tested groups was smoking. The 
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recruited smokers had a duration of smoking between 3 to 50 years, with an 
exposure to cigarette smoking between 1.5 to 40 pack years. 
 
4.3 Results of PORH test 
4.3.1 Blood flow and PORH response 
Fig. 60 displays the comparison of the median blood perfusion signals from 
controls and smoker groups. The graph shows higher basal perfusion in healthy 
subjects compared to smokers. Moreover, the image shows that although the 
absolute perfusion peak during PORH response was slightly higher in smokers, 
the time course of the hyperaemic response represented by the area under the 
curve (AUC) of the peak was greater in control individuals. 
Trends of blood perfusion during PORH test 
The trends of the median blood perfusion during reactive hyperaemia test are 
shown in Fig. 61a. Both groups showed the expected trends related to PORH test 
stimulation. Blood perfusion was significantly reduced (p < 0.001) after blocking 
of blood flow from the brachial artery to induce an ischaemic low oxygenation 
condition, and increased significantly (p < 0.001) during the adaptive PORH 
response for the restoration of the physiological cutaneous perfusion after 
removal of the occlusion. 
 
Fig. 60 LDF signals during PORH test. The graph shows the median blood perfusion signals 
from the forearm of non-smokers (blue line, n=20) and smokers (red line, n=20) during the PORH 
task: 10-min baseline, 5-min ischaemia, 10-min PORH response. Data are expressed in perfusion 
arbitrary units (PU). The chart shows the typical trend of PORH test for both groups, characterised 
by decrease of perfusion during occlusion of flow through the brachial artery and a massive 
increase of flow up to a peak during PORH response before the restoration of the basal perfusion. 
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Fig. 61 Trends of microcirculatory and oxygenation parameters during PORH test. (a) Blood 
perfusion (PU). (b) SO2 (%) (Oxygen saturation). (c) O2ER (AU) (Oxygen extraction). (d) VO2 
(AU) (Oxygen consumption). Normal data are presented as bar plots of the mean with error bars 
corresponding to the SD. Non-parametric data are presented as boxplots. Black bars/boxplots = 
Baseline. Grey bars/boxplots = Ischaemia. White bars/boxplots = PORH. The black 
lines/asterisks refer to significant changes during PORH task that were estimated by paired t-test 
and Wilcox test, respectively for normal and non-parametric variables. The red lines/asterisks 
refer to significant differences between controls and smokers that were estimated by unpaired t-
test and Wilcox test, respectively for normal and non-parametric variables. *p < 0.05, **p < 0.01, 
***p < 0.001. 
Differences of microcirculatory variables between groups 
Table 10 shows the differences in blood perfusion and PORH response between 
controls and smokers. As reported in other studies [170, 171], the baseline blood 
perfusion was significantly lower (p < 0.05) in smokers compared to non-smokers 
(31.3% lower), indicating a reduced basal microcirculation under the effect of 
tobacco. The PORH response was assessed in terms of absolute flux peak, AUC 
of the flux peak, and time to reach the flux peak. The results are similar to those 
reported in the study by Noble et al. [172] from the sacrum skin location, showing 
non-significant differences between groups in relation to the maximum perfusion 
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peak or the time to reach the peak, while the AUC of the flux peak was 
significantly higher (p < 0.05) in the controls (16.4% higher). 
Table 10 Comparison of blood perfusion and PORH response between controls and 
smokers. Data are presented as median (inter-quartile range). PU = Perfusion arbitrary units. 
AUC = Area under the curve. AU = arbitrary units. s = seconds. Differences between groups were 
evaluated by unpaired Wilcox test and are outlined by red asterisks. p = p-value. *p < 0.05. 
Variable Controls (n=20) Smokers (n=20) p 
Baseline flux [PU] 44.9 (37.9-50.1) 34.2 (31.2-40.3) *0.01 
Absolute flux peak [PU] 106.0 (90.00-127.2) 117.5 (103.0-130.2) 0.60 
AUC of the flux peak [AU] 11200 (9400-13900) 9600 (7400-11400) *0.04 
Time to peak [s] 13.8 (10.0-23.6) 11.3 (4.90-13.2) 0.10 
The results agree with a better overall microvascular function in non-smokers 
compared to healthy mild smokers, confirming the early negative effect of tobacco 
on skin microvascular reactivity. However, the differences between groups were 
not large, probably due to the lower average age of the tested subjects compared 
to other studies (41 ± 14 years controls, 42.6 ± 15.6 years smokers), the major 
number of females enrolled in the study characterised by minor CVD risk, and the 
good health status of the individuals in the smoking group who were not suffering 
of cardiovascular, respiratory or metabolic disorders. 
4.3.2 Tissue oxygenation 
Trends of tissue oxygenation parameters during PORH test 
Both groups showed similar trends of oxygen saturation (SO2), oxygen extraction 
(O2ER) and oxygen consumption (VO2) during the stages of PORH test (Fig. 61b-
d). The percentage SO2 did not decrease significantly during ischaemia (Fig. 
61b), indicating the ability to maintain tissue oxygenation during blocking of blood 
flow. SO2 increased significantly (p < 0.001) during PORH compared to both 
ischaemia and baseline (Fig. 61b) due to reperfusion of the tissue. O2ER is the 
ratio between the consumption and delivery of oxygen. O2ER decreased 
significantly (p < 0.001 controls, p < 0.01 smokers) during ischaemia (Fig. 61c) 
due to the increased delivery of O2 to tissue in response to hypoxic stress. O2ER 
was normally restored during PORH in the controls with a significant increase (p 
< 0.05) compared to ischaemia (Fig. 61c). In contrast, smokers maintained a 
significantly reduced O2ER (p < 0.05) during PORH compared to baseline (Fig. 
61c), which may indicate a slower metabolic rate leading to longer time for 
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restoring the physiological aerobic metabolism. VO2 was significantly reduced (p 
< 0.001) in both groups during ischaemia compared to baseline (Fig. 61d), due 
to anaerobic conditions reducing the conversion of O2 in ATP. Finally, oxygen 
consumption increased significantly (p < 0.001) in both groups during PORH 
response (Fig. 61d), indicating the ability to restore the normal aerobic energy 
metabolism after the stress period. 
Differences of tissue oxygenation variables between groups 
The inter-group differences related to tissue oxygenation are summarised in 
Table 11. The SO2 and O2ER were not significantly different between smokers 
and controls. However, VO2 was significantly higher in the controls during 
ischaemia (p < 0.05) and PORH (p < 0.01) time points, suggesting the ability of 
non-smokers to use and convert a major amount of oxygen in ATP energy 
compared to smokers during the response to hypoxic stress. Overall, the data 
show healthy tissue oxygenation conditions in both groups. However, the 
reduced VO2 values in smokers compared to controls, and the decreased O2ER 
during PORH time point compared to baseline in smokers might indicate a slower 
metabolism rate and reduced ability to convert oxygen in ATP, which may be due 
to early damage of the micro-vessels wall caused by the exposure to tobacco. 
Table 11 Comparison of tissue oxygenation parameters between controls and smokers. 
The table reports the same data shown in Fig. 61b-d. Normal data are expressed as mean ± SD. 
Non-parametric data are expressed as median (inter-quartile range). (B) = Baseline. (IS) = 
Ischaemia. (P) = PORH. SO2 = Oxygen saturation (%). O2ER = Oxygen extraction (AU). VO2 = 
Oxygen consumption (AU). p = p-values. Differences between groups related to normal and non-
parametric variables were assessed respectively by unpaired t-test and Wilcox test and are 
outlined by red asterisks. *p < 0.05, **p < 0.01. 
Variable Controls (n=20) Smokers (n=20) p 
(B) SO2 [%] 53.3 ± 8.10 56.5 ± 14.2 0.100 
(IS) SO2 [%] 52.3 ± 8.20 57.4 ± 12.4 0.100 
(P) SO2 [%] 61.4 ± 6.30 64.0 ± 10.6 0.350 
(B) O2ER [AU] 0.63 (0.54-0.71) 0.60 (0.50-0.66) 0.200 
(IS) O2ER [AU] 0.51 (0.40-0.56) 0.47 (0.36-0.56) 0.400 
(P) O2ER [AU] 0.62 (0.47-0.71) 0.57 (0.42-0.64) 0.200 
(B) VO2 [AU] 1340 (1060-1600) 920 (770-1610) 0.100 
(IS) VO2 [AU] 810 (650-950) 370 (250-1040) *0.020 
(P) VO2 [AU] 1510 (1090-2110) 1170 (780-1560) **0.007 
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4.3.3 NAD(P)H and redox ratio (RR) 
Trends of cellular metabolic biomarkers during PORH task 
Fig. 62 describes the trends of the NAD(P)Hnormalised and RRindex dimensionless 
variables during the different steps of reactive hyperaemia functional test. All of 
the tested groups showed similar trends of NAD(P)Hnormalised and RRindex, 
indicating an overall normal cell energy metabolism also in the smoking cohort. 
Both of the variables increased significantly (0.0001 < p < 0.01) during the 
ischaemic hypoxic stress associated with the accumulation of the reduced 
NAD(P)H, and decreased significantly (0.0001 < p < 0.05) during PORH response 
due to the oxidation of NAD(P)H to NAD(P)+ for the restoration of the 
physiological aerobic cell energy metabolism that is characterised by a more 
balanced turnover between the oxidised and reduced forms of the coenzyme. 
 
Fig. 62 Trends of biomarkers of cell energy metabolism during PORH. (a) NAD(P)Hnormalised 
(dimensionless units). (b) RRindex (dimensionless units). NAD(P)Hnormalised and RR are 
dimensionless ratiometric variables, which were calculated according to equations 21-22, 
respectively. Data are presented as bar plots of the mean with error bars corresponding to the 
SD. Black bars = Baseline. Grey bars = Ischaemia. White bars = PORH. The black lines/asterisks 
refer to significant changes during PORH task that were estimated by paired t-test. The red 
lines/asterisks refer to significant differences between controls and smokers groups that were 
estimated by unpaired t-test. *p < 0.05, **p < 0.01, ***p < 0.001. 
Differences of metabolic biomarkers between groups 
The inter-group differences related to biomarkers of energy metabolism are 
reported in Table 12. The relative amount of NAD(P)Hnormalised was significantly 
higher in smokers compared to controls at all the stages of the PORH test 
(baseline p < 0.01, ischaemia p < 0.05, PORH p < 0.05). This may indicate higher 
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degree of oxidative stress in smokers. However, non-significant differences were 
found in relation to the RRindex, suggesting that despite a slightly greater oxidative 
stress smokers presented a “normal” balance between NAD(P)H and FAD+ 
ensuring a healthy mitochondrial energy metabolism. 
Table 12 Comparison of NAD(P)Hnormalised and RRindex between controls and smokers. The 
table reports the same data shown in Fig. 62. Data are presented as mean ± SD. (B) = Baseline. 
(IS) = Ischaemia. (P) = PORH. NAD(P)Hnormalised = Reduced nicotamide adenine dinucleotide 
expressed in dimensionless units. RR = Redox ratio index expressed in dimensionless units. 
NAD(P)Hnormalised and RR were calculated according to equations 21 and 22, respectively. p = p-
values. Differences between groups were examined by unpaired t-test and are outlined by red 
asterisks. *p < 0.05, **p < 0.01. 
Variable Controls (n=20) Smokers (n=20) p 
(B) NAD(P)Hnormalised 1.9 ± 0.2 2.1 ± 0.3 **0.006 
(IS) NAD(P)Hnormalised 2.1 ± 0.3 2.3 ± 0.3 *0.040 
(P) NAD(P)Hnormalised 1.9 ± 0.2 2.0 ± 0.2 *0.020 
(B) RRindex 2.0 ± 0.2 2.1 ± 0.2 0.200 
(IS) RRindex 2.0 ± 0.2 2.1 ± 0.3 0.200 
(P) RRindex 2.0 ± 0.2 2.0 ± 0.2 0.400 
 
4.4 Wavelet spectral analysis of LDF and reconstructed 
metabolic signals measured during PORH test 
4.4.1 LDF oscillators in humans 
Fig. 63 illustrates the median time-averaged LDF wavelet spectra from smokers 
and non-smokers during reactive hyperaemia task. The typical wavelet peaks of 
cutaneous LDF physiological oscillators reported in the literature were 
characterised: endothelial NO-independent (EDHF), endothelial NO, neurogenic, 
myogenic, respiratory and cardiac. The specific features that characterise each 
LDF oscillator peak are the absolute energy Ei, the absolute amplitude Ai and the 
frequency location f of the peak, expressed in arbitrary units (AU) and hertz (Hz) 
respectively. The graphs show differences between groups associated to Ai and 
Ei of blood flow oscillators. As explained already for the wavelet analysis of mice 
LDF signals (section 3.3, paragraph 3.3.1, page 131), the wavelet amplitude Ai 
reflects the maximal oscillatory activity in the frequency interval of interest, while 
the wavelet energy Ei reflects the overall oscillatory activity in the frequency 
interval under investigation. 
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Fig. 63 Comparison of time-averaged blood flow CWT spectra during PORH test. (a) Median 
CWT spectra of controls and smokers at baseline. (b) Median CWT spectra during ischaemic 
stress. (c) Median CWT spectra during the hyperaemic response. The plots clearly outline 
differences in the amplitude Ai and energy Ei of the LDF oscillatory peaks between the two groups. 
Both of Ei and Ai are expressed in arbitrary units (AU).  
Despite in general Ai and Ei trends are similar, sometimes the maximum 
oscillatory Ai reached during a specific task (e.g. PORH response) might not 
reflect the overall Ei trend in the interval of interest. For this reason, both 
parameters were examined for obtaining a better overview of the data avoiding 
misinterpretations. Moreover, the frequency location f of the oscillator’s peak 
provides different information compared to Ai and Ei, mostly reflecting the rate of 
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the oscillatory activity rather than the magnitude of the oscillation. Thus, here all 
these three parameters (Ai, Ei, f) were taken into consideration to gain a complete 
overview on the oscillatory activity of each specific wavelet oscillator. 
As discussed already in the section 3.3 (paragraph 3.3.1, page 132), the 
heterogeneous anatomy of the cutaneous locations employed for data collection 
does not allow making reliable comparisons of Ai and Ei between different groups 
of subjects. For this reason, comparison of wavelet data between controls and 
smokers was performed by estimating the relative wavelet amplitude ai and 
energy ei of each oscillator (equations 9-12), which are dimensionless variables. 
Trends of LDF oscillators during ischaemia 
Local microvascular oscillators (EDHF, NO, neurogenic and myogenic). Fig. 64 
and Fig. 65 describe, respectively, the trends of the amplitude and energy of LDF 
oscillators at all the stages of the PORH test. During the 5 min period of 
ischaemia, ai and ei of the endothelial EDHF (Fig. 64-65a) and myogenic (Fig. 
64-65d) oscillators increased significantly (p < 0.01 or p < 0.001) in the control 
group, and the increase of endothelial NO (Fig. 64-65b) and neurogenic (Fig. 64-
65c) amplitudes/energies was close to statistical significance (p=0.07 and 
p=0.06, respectively). In contrast, none of the local components (endothelial, 
neurogenic, myogenic) showed substantial changes compared to baseline in 
smokers, except for the ei of the myogenic oscillator (Fig. 65d) which increased 
significantly (p < 0.01) during ischaemia, reflecting an overall increase of VSMCs 
activity in response to the anoxic stress conditions. These findings might indicate 
a better local reactivity and adaptation of the cutaneous micro-vessels in non-
smokers during anaerobic stress conditions. The rise in endothelial, myogenic 
and neurogenic activities observed in healthy individuals may be interpreted as a 
resistance mechanism against ischaemic damage, which might be impaired in 
smokers due to oxidative stress and the effect of tobacco. 
Respiratory oscillator. The ai and ei of the respiratory component (Fig. 64-65e) 
increased significantly in both groups during ischaemia (p < 0.001 controls, p < 
0.05 or p < 0.001 smokers). The respiratory oscillation of cutaneous LDF signal 
is correlated to the volumetric flow of second-order blood pressure wave of skin 
arterioles [173]. These fluctuations reflect the extrinsic modulation of peripheral 
arterioles resistance, exerted by coupling of the respiratory and cardiac systems 
via the autonomous nervous system or by the respiratory-dependent left cardiac 
167 
 
_______________________________________________________________ 
Nonlinear dynamics of microcirculation and cell energy metabolism in human 
individuals 
preload [173]. Thus, the increase of respiratory amplitude/energy during 
ischaemia might reflect the adaptation of skin arterioles resistance (increase of 
resistance) mediated by the coupling of the respiratory and cardiac systems in 
response to the increase of pressure induced by the occlusion of blood flow. 
 
Fig. 64 Trends of the wavelet ai of LDF oscillators during PORH test. (a) Endothelial EDHF, 
(b) Endothelial NO, (c) Neurogenic, (d) Myogenic, (e) Respiratory, and (f) Cardiac oscillators. 
Data are presented as boxplots. The relative wavelet amplitude ai is expressed in dimensionless 
units. Black boxplots = Baseline. Grey boxplots = Ischaemia. White boxplots = PORH. The black 
lines/asterisks refer to significant changes during PORH task that were estimated by paired 
Wilcox test. The red lines/asterisks refer to significant differences between controls and smokers 
groups that were estimated by unpaired Wilcox test. *p < 0.05, **p < 0.01, ***p-value < 0.001. 
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Fig. 65 Trends of the wavelet ei of LDF oscillators during PORH test. (a) Endothelial EDHF, 
(b) Endothelial NO, (c) Neurogenic, (d) Myogenic, (e) Respiratory, and (f) Cardiac oscillators. 
Data are presented as boxplots. The relative wavelet energy ei is expressed in dimensionless 
units. Black boxplots = Baseline. Grey boxplots = Ischaemia. White boxplots = PORH. The black 
lines/asterisks refer to significant changes during PORH task that were estimated by paired 
Wilcox test. The red lines/asterisks refer to significant differences between controls and smokers 
groups that were estimated by unpaired Wilcox test. *p < 0.05, **p < 0.01, ***p-value < 0.001. 
Cardiac oscillator. The relative ai and ei of the cardiac component (Fig. 64-65f) 
decreased in both groups during ischaemia (p < 0.001 controls, p < 0.01 or p < 
0.001 smokers). The cardiac oscillator of LDF cutaneous signal represents a flux 
motion component correlated to a volumetric flow of first order pressure waves, 
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reflecting cardiac actions [173], i.e. changes in the volume of blood pumped by 
the heart (cardiac output). Thus, the decrease of wavelet amplitude/energy 
probably reflects a reduction of the cardiac output due to the decrease in heart 
rate and increase in breathing rate observed during the period while the pressure 
cuff was inflated (ischaemia) (see the frequencies of the cardiac and respiratory 
oscillators in Table 13 at page 172). 
Trends of LDF oscillators during PORH response 
Local microvascular oscillators (EDHF, NO, neurogenic and myogenic). The ai 
and ei of the endothelial components showed similar trends in both groups during 
reactive hyperaemia response. A substantial increase of endothelial EDHF (Fig. 
64-65a) and NO (Fig. 64-65b) amplitudes/energies was observed compared to 
both ischaemia (p < 0.001) and baseline (p < 0.001). These data confirm the high 
contribution of the endothelium to skin PORH response. The amplitude/energy of 
the neurogenic oscillation (Fig. 64-65c) increased in both groups compared to 
baseline (p < 0.01 or p < 0.001 controls, p < 0.05 or p < 0.001 smokers) and 
ischaemia (p < 0.01 smokers, p < 0.001 controls), confirming the contribution of 
the autonomic sympathetic system to the adaptation induced by PORH stimulus, 
through the transmission of impulses stimulating the activity of the innervated 
smooth muscle cells (VSMCs). 
Both the amplitude and energy of the myogenic component (Fig. 64-65d) during 
PORH were significantly higher (p < 0.001) compared to baseline in healthy 
subjects, confirming the increased vasodilator activity of smooth muscle cells. In 
contrast, non-significant changes were found in the myogenic ai (Fig. 64d) of 
smokers compared to both baseline and ischaemia time points. Considering that 
a normal PORH curve was observed for all the smokers tested in the study (Fig. 
60), the unchanged myogenic amplitude cannot be interpreted as absence of 
vasodilator activity of VSMCs. As pointed out before, the wavelet amplitude 
represents the maximum peak response at a specific frequency interval. This 
means that in the myogenic frequency interval (52-145 × 10-3 Hz) of the smoking 
group, the maximal oscillatory activity was similar during baseline, ischaemia and 
PORH periods. However, to assess the whole activity in the myogenic range it is 
also necessary to evaluate the wavelet energy ei, which represents the overall 
response in the frequency interval under investigation. The myogenic ei in 
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smokers (Fig. 65d) showed a trend different from the ai, characterised by a 
significant increase of energy during PORH response compared to both baseline 
(p < 0.01) and ischaemia (p < 0.001) time points. This observation demonstrates 
the importance of assessing both of the wavelet amplitude and energy to gain a 
complete overview of the data and avoid misinterpretations. Indeed, in this case 
the unchanged myogenic amplitude during all the stages of the functional test 
may reflect the same maximum activity peak reached at every stage of the 
reactive test (baseline, ischaemia, PORH). In contrast, the wavelet energy 
describes the overall myogenic activity which is increased during the vasodilator 
reactive hyperaemia response compared to both baseline and ischaemia. 
Respiratory oscillator. The trend of the respiratory wavelet amplitude/energy 
(Fig. 64-65e) during PORH response was similar between the two groups, with a 
significant decrease compared to ischaemia (p < 0.001 or p < 0.01). The 
amplitude was significantly reduced also in relation to baseline in smokers (p < 
0.001 or p < 0.01), while non-significant differences were found between baseline 
and PORH respiratory ai and ei in controls. These observations may reflect the 
extrinsic respiratory modulation to reduce the resistance of skin arterioles after 
the release of the pressure applied through the cuff, leading to vasodilation, 
reperfusion of the tissue and restoration of the basal microcirculation. 
Cardiac oscillator. The cardiac amplitude ai (Fig. 64f) during PORH was 
reduced compared to baseline in both groups (p-value < 0.001). Smokers showed 
also a decrease of the PORH cardiac amplitude compared to ischaemia (p-value 
< 0.05). These data are difficult to interpret. Indeed, as discussed above, during 
ischaemia the decrease of cardiac amplitude may reflect a reduction of the 
cardiac output due to the decrease in heart rate and increase in breathing rate 
observed after the inflation of the pressure cuff. Based on this, the expected trend 
after the release of the cuff’s pressure would be an increase of the cardiac output 
instead, due to the restoration of a faster heart rate and slower breathing rate as 
observed in Table 13 (see the frequencies of the respiratory and cardiac 
oscillators during PORH compared to ischaemia). However, as previously 
discussed, the wavelet amplitude is referred to the maximal response in the 
frequency interval of interest and sometimes may not reflect the overall activity of 
the component under investigation. For this reason, it is advantageous to also 
assess the wavelet energy for gaining a better overview of the data and avoid 
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misinterpretations. Indeed, both groups showed a different trend of the cardiac ei 
(Fig. 65f) compared to the ai (Fig. 64f) during PORH response, characterised by 
a significant growth of energy compared to ischaemia (p < 0.001) indicating an 
overall increase of the cardiac output during PORH which was not reflected in the 
amplitude of the wavelet peak. Therefore, also in this case, as shown above for 
the myogenic oscillator, the examination of the wavelet energy allowed gathering 
information that was missing from the analysis of the amplitude. 
Differences of LDF oscillators between controls and smokers 
Table 13 reports the comparison of wavelet amplitude ai, energy ei and frequency 
location f of LDF oscillators’ peaks between controls and smokers. 
Table 13 Comparison of the wavelet ai, ei and f of LDF oscillators between groups. The table 
reports the same data of ai and ei shown in Fig. 64 and Fig. 65, and the frequency data of LDF 
oscillators. Data are presented as median (inter-quartile range). Both of ai and ei are expressed 
in dimensionless units, while f is expressed in hertz (Hz). (B) = Baseline. (IS) = Ischaemia. (P) = 
PORH. Endo = Endothelial. NO = Nitric oxide. EDHF = Endothelial-derived hyperpolarizing factor. 
Differences between controls and smokers were calculated by unpaired Wilcox test and are 
outlined by red asterisks. p = p-value. *p < 0.05, **p < 0.01, ***p < 0.001. 
Wavelet amplitude ai (dimensionless units) 
Variable Controls (n=20) Smokers (n=20) p 
(B) ai Cardiac 12.3 (10.8-13.4) × 10-3 6.60 (4.50-9.50) × 10-3 **0.0060 
(IS) ai Cardiac 6.20 (5.10-8.10) × 10-3 4.30 (3.20-6.50) × 10-3 **0.0040 
(P) ai Cardiac 6.90 (4.60-9.30) × 10-3 2.10 (1.30-4.50) × 10-3 ***0.0008 
(B) ai Respiratory 0.40 (0.20-1.10) × 10-3 2.80 (1.70-4.00) × 10-3 **0.0070 
(IS) ai Respiratory 3.10 (2.60-3.80) × 10-3 4.30 (2.80-4.90) × 10-3 0.1000 
(P) ai Respiratory 0.30 (0.20-0.40) × 10-3 0.50 (0.30-1.00) × 10-3 *0.0200 
(B) ai Myogenic 0.50 (0.30-1.00) × 10-3 2.20 (1.10-4.90) × 10-3 ***0.0001 
(IS) ai Myogenic 1.40 (1.10-1.90) × 10-3 2.60 (1.90-4.80) × 10-3 ***0.0005 
(P) ai Myogenic 1.60 (1.20-2.20) × 10-3 2.80 (2.40-4.20) × 10-3 **0.0010 
(B) ai Neurogenic 0.20 (0.10-0.70) × 10-3 0.60 (0.30-1.30) × 10-3 0.0800 
(IS) ai Neurogenic 0.70 (0.50-1.10) × 10-3 0.70 (0.40-1.00) × 10-3 0.9000 
(P) ai Neurogenic 0.90 (0.60-1.10) × 10-3 1.60 (0.90-2.00) × 10-3 **0.0030 
(B) ai Endo-NO 0.10 (0.06-0.40) × 10-3 0.20 (0.09-0.60) × 10-3 0.2000 
(IS) ai Endo-NO 0.40 (0.20-1.00) × 10-3 0.20 (0.10-0.70) × 10-3 0.2000 
(P) ai Endo-NO 1.90 (1.20-2.80) × 10-3 3.70 (2.80-4.00) × 10-3 **0.0010 
(B) ai Endo-EDHF 0.08 (0.03-0.30) × 10-3 0.10 (0.07-0.30) × 10-3 0.2000 
(IS) ai Endo-EDHF 0.70 (0.08-1.20) × 10-3 0.07 (0.05-0.60) × 10-3 0.2000 
(P) ai Endo-EDHF 4.50 (3.20-7.70) × 10-3 6.30 (5.10-7.90) × 10-3 0.3000 
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Wavelet energy ei (dimensionless units) 
Variable Controls (n=20) Smokers (n=20) p 
(B) ei Cardiac 13.6 (12.9-14.0) × 10-3 10.6 (8.10-12.2) × 10-3 *0.0100 
(IS) ei Cardiac 10.4 (9.90-11.0) × 10-3 8.10 (6.70-9.50) × 10-3 **0.0020 
(P) ei Cardiac 13.2 (12.5-13.6) × 10-3 9.80 (7.80-11.9) × 10-3 ***0.0004 
(B) ei Respiratory 0.60 (0.30-1.10) × 10-3 2.90 (1.60-4.30) × 10-3 *0.0100 
(IS) ei Respiratory 3.20 (2.70-3.60) × 10-3 4.50 (3.80-5.40) × 10-3 **0.0080 
(P) ei Respiratory 0.60 (0.40-0.90) × 10-3 1.70 (1.10-2.60) × 10-3 ***0.0004 
(B) ei Myogenic 0.10 (0.06-0.20) × 10-3 0.30 (0.20-1.20) × 10-3 0.0700 
(IS) ei Myogenic 0.20 (0.20-0.30) × 10-3 0.70 (0.40-1.30) × 10-3 *0.0300 
(P) ei Myogenic 0.40 (0.30-0.60) × 10-3 1.40 (0.60-2.40) × 10-3 ***0.0006 
(B) ei Neurogenic 0.020 (0.001-0.040) × 10-3 0.040 (0.020-0.090) × 10-3 *0.0200 
(IS) ei Neurogenic 0.030 (0.020-0.060) × 10-3 0.050 (0.030-0.100) × 10-3 0.1000 
(P) ei Neurogenic 0.100 (0.070-0.200) × 10-3 0.400 (0.200-0.500) × 10-3 **0.0010 
(B) ei Endo-NO 0.003 (0.001-0.007) × 10-3 0.008 (0.003-0.010) × 10-3 0.1000 
(IS) ei Endo-NO 0.008 (0.004-0.030) × 10-3 0.006 (0.003-0.020) × 10-3 0.8000 
(P) ei Endo-NO 0.070 (0.040-0.100) × 10-3 0.300 (0.100-0.400) × 10-3 ***0.0005 
(B) ei Endo-EDHF 0.0008 (0.0004-0.0020) × 10-3 0.0020 (0.0006-0.0030) × 10-3 0.2000 
(IS) ei Endo-EDHF 0.0040 (0.0006-0.0100) × 10-3 0.0008 (0.0003-0.0040) × 10-3 0.3000 
(P) ei Endo-EDHF 0.0400 (0.0200-0.1000) × 10-3 0.1000 (0.0500-0.2000) × 10-3 *0.0300 
Wavelet frequency f (Hz) 
Variable Controls (n=20) Smokers (n=20) p 
(B) f Cardiac [Hz] 
980 (860-1020) × 10-3 1030 (925-1080) × 10-3 0.3500 
(IS) f Cardiac [Hz] 
860 (780-950) × 10-3 730 (590-800) × 10-3 **0.0080 
(P) f Cardiac [Hz] 
965 (890-1000) × 10-3 980 (890-1080) × 10-3 0.6300 
(B) f Respiratory [Hz] 
260 (215-300) × 10-3 310 (1840-360) × 10-3 0.7300 
(IS) f Respiratory [Hz] 
440 (280-485) × 10-3 390 (220-470) × 10-3 0.3100 
(P) f Respiratory [Hz] 
240 (230-290) × 10-3 275 (210-340) × 10-3 0.7400 
(B) f Myogenic [Hz] 
75.0 (65.8-90.3) × 10-3 84.6 (77.3-93.6) × 10-3 0.4300 
(IS) f Myogenic [Hz] 
85.5 (74.3-129.4) × 10-3 78.3 (76.9-81.0) × 10-3 0.2500 
(P) f Myogenic [Hz] 
82.5 (76.9-89.2) × 10-3 92.3 (83.5-103) × 10-3 *0.0200 
(B) f Neurogenic [Hz] 
35.6 (29.0-39.8) × 10-3 40.5 (34.4-41.8) × 10-3 0.2800 
(IS) f Neurogenic [Hz] 
39.8 (30.7-41.6) × 10-3 36.5 (29.0-37.8) × 10-3 0.1200 
(P) f Neurogenic [Hz] 
27.9 (24.4-30.2) × 10-3 35.0 (24.8-40.5) × 10-3 0.0700 
(B) f Endo-NO [Hz] 
15.8 (14.2-17.7) × 10-3 12.4 (11.1-17.2) × 10-3 0.0800 
(IS) f Endo-NO [Hz] 
11.8 (10.1-13.6) × 10-3 13.6 (10.1-17.4) × 10-3 0.3400 
(P) f Endo-NO [Hz] 
15.3 (12.2-16.6) × 10-3 15.5 (12.4-17.9) × 10-3 0.8300 
(B) f Endo-EDHF [Hz] 
6.56 (4.97-6.80) × 10-3 6.62 (4.97-7.26) × 10-3 0.9600 
(IS) f Endo-EDHF [Hz] 
6.80 (6.77-6.80) × 10-3 6.80 (6.68-6.80) × 10-3 0.2500 
(P) f Endo-EDHF [Hz] 
5.15 (5.10-5.20) × 10-3 5.96 (5.24-7.04) × 10-3 ***0.0003 
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Local microvascular LDF oscillators (EDHF, NO, neurogenic and myogenic). 
The wavelet energy ei and frequency f of the endothelial EDHF component were 
greater (p < 0.05 and p < 0.001 respectively) in smokers during PORH response. 
The amplitudes/energies of the endothelial NO and neurogenic oscillators were 
significantly higher (p < 0.01 or p < 0.001) in smokers during PORH response. 
The myogenic amplitude/energy was greater in smokers during all the stages of 
the reactive test (p < 0.001 or p < 0.05 at baseline and ischaemia, p < 0.01 or p 
< 0.001 during PORH), and the myogenic frequency f was higher (p < 0.05) in 
smokers during PORH. These observations are in contrast with most of literature 
reports comparing the LDF spectral components between smokers and non-
smokers. Greater values of endothelial, myogenic and neurogenic wavelet 
amplitudes/energies are generally associated with a better microvascular 
function. Therefore, in this case data may be misinterpreted as showing a better 
microcirculation in smokers, which is paradoxical. However, these contrasting 
observations may be explained by the lower average age of the tested subjects 
compared to most of the studies on smokers, and by the good health conditions 
of the smoker individuals enrolled in the research which were not affected by 
additional CVD risk factors (e.g. hypertension, high BMI, etc.). The greater 
amplitudes/energies observed in smokers might reflect an adaptive response to 
the early risk associated with tobacco while the blood vessels are still responsive. 
This may stimulate an increase of the endothelial NO levels as compensatory 
defence mechanism to the smoking stress. 
Furthermore, enhanced non-specific sensitivity of the forearm’s micro-vessels 
has been described in young healthy smokers compared to non-smokers during 
reactive hyperaemia, acetylcholine and SNP vasodilation stimuli [174, 175]. 
These reports are in agreement with the findings of this work, showing higher 
endothelium-dependent and endothelium-independent responses in healthy 
smokers compared to controls. The increase of endothelial activity in smokers 
was explained by Rangemark et al. [175] as a possible indirect consequence of 
the non-specific enhanced myogenic activity induced by cigarettes smoke, rather 
than a real better endothelial function. 
Non-specific activation of myogenic vasodilation response due to smoking.        
The non-specific activation of myogenic response in the forearm’s cutaneous 
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microcirculation of smokers, hypothesised by Rangemark et al. [175], may be 
stimulated in two ways: 
(1) According to Vleeming et al. [176], cigarettes smoke or tobacco contain NO 
[176, 177]. Therefore, VSMCs may be targeted and activated non-specifically 
by the action of external NO contained in cigarettes smoke or tobacco. 
(2) As reported by Vleeming et al. [176], the nicotine contained in tobacco is able 
to stimulate the activity of nicotinic acetylcholine receptors in endothelial cells. 
Thus, VSMCs may be targeted and activated non-specifically by the action of 
endogenous NO produced as consequence of the external effect of nicotine. 
An objection to the mechanisms of activation proposed above may be that 
cigarettes smoke is inhaled through the respiratory system, thus the effect of 
exogenous NO and nicotine should impact only the respiratory airways. However, 
as reported by Bekö et al. [178], cigarettes smoke and nicotine can be absorbed 
directly from the skin reaching the dermal layer where the micro-vessels are 
located. Therefore, this would explain a local effect of NO and nicotine contained 
in cigarettes smoke on the cutaneous micro-vessels of the forearm. 
The hypotheses proposed above may also explain the observations about the 
trend of myogenic wavelet ai, which did not change significantly in smokers during 
all the stages of PORH test (Fig. 64d), as discussed previously. This is probably 
due to the hyperactivity of VSMCs induced non-specifically by NO and nicotine 
contained in tobacco and cigarettes smoke, which may cause the achievement 
of a maximal myogenic activity peak explaining the similar amplitude between 
baseline, ischaemia and PORH time points. Moreover, nicotine is able to activate 
also the peripheral autonomous nervous system [176], which may be another 
factor inducing the non-specific activation of VSMCs in smokers through the 
action of impulses transmitted by the sympathetic innervation. This may also 
explain why a higher amplitude of the neurogenic component was found in 
smokers compared to controls during PORH (Table 13). 
According to the obtained results, it cannot be excluded that the hyperactive 
cutaneous microvascular reactivity observed in smokers may be an initial factor 
causing an imbalance between vasodilator and vasoconstrictor substances in the 
microcirculation, contributing to the onset of the skin micro-vessels endothelial 
damage and dysfunction observed especially in cohorts of chronic elder smokers. 
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These findings also outline that wavelet transform data could be misinterpreted. 
Indeed, although in general lower values of endothelial, myogenic and 
neurogenic wavelet amplitudes/energies represent hallmarks of vascular 
dysfunction, especially when comparing healthy vs diseased people or elder 
smokers vs healthy controls, this is not true when testing younger healthy 
smokers. In this case, the increase of wavelet amplitude/energy of local 
microvascular components may represent a hallmark of the early stages of 
vascular dysfunction, which could be used as biomarker for the prediction of risk 
at preclinical level. 
Respiratory oscillator. The ai or ei of the respiratory wavelet component were 
significantly higher in smokers compared to controls during all the stages of the 
test (p < 0.05 or p < 0.01 baseline, p < 0.01 ischaemia, p < 0.05 or p < 0.001 
PORH) (Table 13). As discussed before, the increase or decrease of 
amplitude/energy of the respiratory wavelet oscillation could be interpreted, 
respectively, as increase or reduction of skin arterioles resistance induced by the 
extrinsic respiratory modulation exerted via the autonomous nervous system or 
via the respiratory-dependent left cardiac preload [173]. Based on these 
assumptions the higher wavelet respiratory amplitude/energy observed in 
smokers at all the stages of PORH test may reflect an overall greater resistance 
of peripheral arterioles compared to controls. Increased arterioles resistance 
leads to constriction of vascular diameter and represents a CVD risk factor 
frequently associated with hypertension. Therefore, according to these findings 
the respiratory oscillator may represent a preclinical marker of risk reflecting the 
degree of arterioles resistance which is increased in healthy mild smokers. 
Cardiac oscillator. The ai of the cardiac wavelet component was higher in the 
control group during all the stages of the reactive test (p < 0.01 or p < 0.05 at 
baseline and ischaemia, p < 0.001 during PORH) (Table 13). Also the frequency 
of the cardiac oscillator was significantly higher (p < 0.01) in non-smokers during 
ischaemia, suggesting a greater heart rate in healthy individuals compared to 
smokers. These findings may indicate a higher basal cardiac output in healthy 
individuals leading to a better distribution of blood and oxygen in the tissue 
compared to smokers. This interpretation is also supported by the results 
discussed in Table 11 about oxygen consumption (VO2). VO2 is considered an 
indirect measure of the cardiac output [179] and greater values were found in the 
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control group compared to smokers (p < 0.05 during ischaemia, p < 0.01 during 
PORH), which indicates the ability of non-smokers to use and convert a major 
amount of oxygen in ATP energy. However, these data are contrasting with 
literature reports describing a higher cardiac output in smokers compared to non-
smokers, generally associated to hypertension and increased heart rate [180, 
181, 182, 183]. The contrasting results obtained in this dissertation probably may 
be explained by the healthy conditions of the tested groups (no CVD risk factors), 
which did not show significant differences in the basal BP (Table 9) and in the 
basal heart rate as shown indirectly by data related to the wavelet frequency f of 
the cardiac oscillator reported in Table 13. Therefore, in this case the “cardiac 
output” may just reflect the efficiency in blood perfusion and oxygen distribution 
rather than the presence of a particular pathologic condition. 
4.4.2 Study of vasomotion by wavelet spectral analysis 
The wavelet spectral analysis of LDF signal is a useful tool also for the study of 
vasomotion and the contribution of each physiological component to PORH 
response. According to literature, the major mediators of the vasodilator PORH 
cutaneous response are the sensory nerves and the EDHF mechanism. The 
sensory nerves contribute to the maximum perfusion peak response and time 
course (PORH AUC and time to peak) by a local reflex [184], while the EDHF 
acts through the action of the cytochromes P450 (CYPs) metabolites (e.g. EETs, 
epoxy-eicosatrienoic acids) [9]. The CYPs are oxidase enzymes of the electron 
transport chain, involved in the oxidation of NAD(P)H for transferring the electrons 
to the P450 heme cofactor during the OXPHOS process for the production of 
ATP. The implication of EDHF and CYPs supports the involvement of metabolic 
factors in the cutaneous reactive hyperaemic response, as proposed in the study 
by Kristensen et al. [185]. The major role of EDHF in the reactivity of skin micro-
vessels is also supported by studies suggesting that NO is more implicated in the 
regulation of the vascular tone of larger arteries, while EDHF is more important 
for the control of the resistance of peripheral arterioles in the microcirculation 
[140, 186, 187, 188]. 
Although the contribution of the NO pathway to reactive hyperaemia in the 
skeletal muscle is relevant, its role in the cutaneous PORH seems to be minimal 
[9, 184], probably due to the fact that the small cutaneous blood vessels are less 
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dependent on NO and rely more on the EDHF pathway. Indeed, the inhibition of 
the eNOS (endothelial nitric oxide synthase) enzyme that is involved in the 
production of the endothelial NO does not block skin PORH response [9, 189, 
190]. According to Medow et al. the cross-talk between NO and prostaglandins 
(PGs) pathways may be the cause reducing NO contribution during skin PORH, 
due to the inhibition of eNOS by the cyclooxygenases (COXs) or COX products 
involved in the PGs-mediated vasodilator mechanism [184]. 
PGs are involved in skeletal muscle hyperaemic response, while their role in 
the cutaneous PORH is not clear as there are contrasting reports and not robust 
evidences of their involvement [9, 184]. However, it cannot be excluded that the 
attenuation of NO contribution to cutaneous PORH mediated by COXs may be a 
consequence of PGs activation during the hyperaemic response. Indeed, the 
cross-talk between NO and PGs pathways is bidirectional, and it is thought that 
NO can interfere directly with PGs production and vice-versa [184]. Moreover, 
several studies have reported a reduction of the cutaneous PORH response after 
inhibition of PGs by aspirin or ibuprofen [191, 192], suggesting the involvement 
of these substances in skin hyperaemic response. 
Finally, the involvement of the myogenic mechanism in both cutaneous and 
skeletal muscle PORH seems to depend on the duration of the occlusion. The 
myogenic activity is more relevant for reactive hyperaemic responses following 
ischemic periods below 3 minutes [185]. In contrast, prolonged occlusion periods 
exceeding 3 minutes lead to PORH responses involving the major activity of 
metabolic mediators (e.g. EDHF, CYPs) with a reduced contribution of the 
myogenic mechanism, which is in any case essential for the mechanical 
regulation of the vascular diameter to relax micro-vessels [185]. 
Contribution of blood flow LDF oscillators to vasomotion 
In this study, the individual contribution of each physiological component to 
vasomotion was evaluated (1) by estimating the percentage relative growth of the 
wavelet amplitudes and energies during PORH compared to baseline (Table 14), 
and (2) by comparing the relative contribution of each oscillator to the total energy 
of the CWT baseline and PORH spectra (Table 15). 
EDHF contribution. The results are in agreement with the major role of EDHF 
in the cutaneous reactive hyperaemia. Indeed, as shown in Table 14, EDHF was 
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the physiological factor showing the greatest percentage increase in wavelet 
amplitude and energy during PORH in both controls (76% increase of ai, 61.3% 
rise of ei) and smokers (68.7% increase of ai, 55.3% increase of ei). 
Table 14 Percentage relative increase of wavelet ai and ei during PORH compared to 
baseline. Data are expressed as median (inter-quartile range). Endo = Endothelial. NO = Nitric 
oxide. EDHF = Endothelial-derived hyperpolarizing factor. Differences between controls and 
smokers were estimated by unpaired Wilcox test and are outlined by red asterisks. p = p-values. 
*p < 0.05, **p < 0.01. 
Variable Controls (n=20) Smokers (n=20) p 
ai Myogenic increase [%] 4.60 (0.80-10.5) 0.30 (-0.20-2.20) **0.001 
ai Neurogenic increase [%] 1.30 (0.20-8.50) 1.40 (-0.01-6.60) 0.800 
ai Endo-NO increase [%] 16.2 (7.10-21.0) 20.5 (9.20-35.0) 0.300 
ai Endo-EDHF increase [%] 76.0 (57.8-88.7) 68.7 (57.6-91.0) 1.000 
ei Myogenic increase [%] 4.30 (1.60-10.0) 1.25 (0.30-4.00) 0.700 
ei Neurogenic increase [%] 6.30 (1.70-13.1) 4.90 (1.70-9.30) *0.040 
ei Endo-NO increase [%] 21.0 (11.6-28.0) 33.5 (16.5-38.3) 0.140 
ei Endo-EDHF increase [%] 61.3 (48.4-79.2) 55.3 (48.2-79.5) 0.200 
 
Table 15 Percentage relative contribution of each LDF oscillator to the total ei of baseline 
and PORH median CWT spectra. Data are expressed as median (inter-quartile range). Endo = 
Endothelial. NO = Nitric oxide. EDHF = Endothelial-derived hyperpolarizing factor. Intra-group 
differences to compare baseline and PORH data were calculated by paired Wilcox test and are 
outlined by black asterisks. Inter-groups differences to compare controls and smokers data were 
estimated by unpaired Wilcox test and are outlined by red asterisks. p = p-value. *p < 0.05, **p < 
0.01, ***p < 0.001. 
Variable Controls (n=20) Smokers (n=20) 
 Baseline PORH Baseline PORH 
ei Myogenic [%] 76.9 (73.3-82.9) 64.3 (58.6-69.1) 87.4 (82.2-93.9) 65.9 (57.5-70.9) 
ei Neurogenic [%] 18.7 (13.7-20.7) 20.0 (13.9-21.6) 10.1 (4.80-14.0) 18.3 (13.1-21.0) 
ei Endo-NO [%] 2.80 (2.20-5.10) 9.60 (7.80-13.8) 1.40 (0.75-3.60) 11.1 (8.90-12.8) 
ei Endo-EDHF [%] 0.90 (0.30-1.90) 6.40 (5.20-9.30) 0.30 (0.10-0.90) 5.60 (4.00-6.40) 
 
Variable 
Intra-group p 
(Baseline vs PORH) 
Inter-groups p 
(Controls vs Smokers) 
 Controls Smokers Baseline PORH 
ei Myogenic [%] 0.0001*** < 0.0001*** 0.001** 0.500 
ei Neurogenic [%] 0.900 0.003** 0.001** 0.800 
ei Endo-NO [%] 0.010* 0.002** 0.01* 0.500 
ei Endo-EDHF [%] 0.002** 0.002** 0.06 0.070 
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These observations represent also a relevant indirect proof of the possible EDHF 
origin of the wavelet peak in the frequency interval 5-9.5 × 10-3 Hz, as it has been 
hypothesised and discussed in the results section of this dissertation related to 
the experimental work on mice (section 3.3, paragraph 3.3.1, page 132). The 
analysis of the relative contribution of each component to the total wavelet 
spectrum showed a statistically significant increase (p < 0.01) of the EDHF 
contribution to the total energy of PORH median CWT spectrum compared to 
baseline spectrum (increase from 0.9% to 6.4% in controls, and from 0.3% to 
5.6% in smokers) (Table 15). 
Endothelial NO and PGs contributions. The results related to the NO component 
showed a complex pattern of wavelet oscillatory peaks. As visible in Fig. 63c, the 
spectral interval related to NO activity was characterised by the presence of two 
wavelet peaks during PORH response in both smokers and healthy individuals. 
In the results discussed so far, the data from the maximum peak in this frequency 
interval have been presented as corresponding to endothelial NO activity. 
However, the presence of two peaks during PORH suggests a possible 
overlapping contribution of different components in the 9.5-21 × 10-3 Hz 
frequency range. This hypothesis would not be surprising, considering that the 
wavelet peak related to the activity of PGs has never been identified and this 
might be due to an overlap with the spectral region corresponding to NO activity. 
Indeed, most of the studies for the characterisation of the physiological origin of 
the endothelial wavelet peaks have been performed by using vasoactive agents 
for the stimulation of cholinergic receptors (e.g. ACh) [102, 105], which might not 
be sufficient to separate clearly the NO contribution from other molecular 
pathways (e.g. PGs) [9, 49, 184]. Moreover, as discussed above (page 176), 
according to literature the contribution of NO to cutaneous PORH is minimal [9, 
184], and this may explain the appearance of an additional wavelet peak in the 
NO interval during PORH, which normally might be masked by the more 
prominent involvement of NO pathway in the modulation of vascular tone. The 
attenuation of NO contribution to cutaneous PORH has been suggested to be 
mediated by COXs as a consequence of PGs activation during the hyperaemic 
response [184]. Therefore, considering the bidirectional cross-talk between NO 
and PGs pathways, it would not be surprising an overlap of the wavelet peaks of 
these two endothelial molecular mechanisms at a similar frequency interval [184]. 
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Furthermore, the results from this dissertation have suggested an EDHF origin 
of the wavelet component in the frequency interval 5-9.5 × 10-3 Hz, thus by 
exclusion, we could speculate a PGs origin of one of the two peaks appearing 
during PORH in the 9.5-21 × 10-3 Hz NO interval. However, further experiments 
are necessary to better clarify this aspect based on performing the wavelet 
analysis of LDF data recorded from the forearm in combination with PORH test 
and the non-invasive local delivery of inhibitors of PGs biosynthesis. 
In view of the discussion above, in this research it is difficult to characterise 
precisely the contribution of the NO endothelial component to vasomotion 
because the origin of the two peaks observed in this frequency interval is 
ambiguous. Indeed, it is not clear which peak is associated with NO (probably the 
lower peak) and which peak may be related to another endothelial regulatory 
mechanism that is likely to be of PG origin. Considering that the wavelet energy 
is representative of the whole activity in the frequency interval of interest, it can 
be certainly stated that the cumulative percentage increase of wavelet energy 
during PORH related to the sum of NO pathway and another unknown endothelial 
mechanism (probably PGs) was 21% in the control group and 33% in smokers 
(Table 14), and the cumulative relative contribution to the total CWT spectrum 
increased during PORH from 2.8% to 9.6% in controls (p < 0.05) and from 1.4% 
to 11.1% in smokers (p < 0.01) (Table 15). These cumulative data suggest a 
lower contribution of NO and probably PGs to skin reactive hyperaemia compared 
to EDHF, confirming what has been reported in literature about the factors 
involved in cutaneous PORH. 
Neurogenic and myogenic contributions. In this work, a non-significant 
percentage growth of the neurogenic (1.3% in controls, 1.4% in smokers) and 
myogenic (4.6% in controls, 0.3% in smokers) wavelet maximal amplitudes, and 
neurogenic (6.3% in controls, 4.9% in smokers) and myogenic (4.3% in controls, 
1.25% in smokers) wavelet energies was observed during PORH response 
(Table 14). The relative neurogenic contribution to the total energy of the CWT 
spectrum was almost unchanged in the controls, and increased from 10.1% to 
18.3% in smokers (p < 0.01) (Table 15). The relative myogenic contribution to the 
total ei of the CWT spectrum was reduced from 76.9% to 64.3% in controls (p < 
0.001), and decreased from 87.4% to 65.9% in smokers (p < 0.001) (Table 15). 
Overall, these observations are in contrast with most of literature reports 
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describing the sympathetic sensory nerves as major contributors to skin PORH 
peak. However, these findings may be explained by the 5 min ischaemia period 
that was applied during the functional test. Indeed, occlusion periods longer than 
3 min stimulate a reactive hyperaemia response mainly mediated by metabolic 
factors [185], which may explain the larger variation observed in the spectral 
energy and contribution of the endothelial wavelet oscillators compared to 
neurogenic and myogenic oscillators. Nonetheless, data in Table 15 clearly 
display that the neurogenic and myogenic oscillators were the wavelet 
components showing the highest percentage contribution to the total energy of 
the CWT spectrum during both baseline and PORH time points. This outlines the 
crucial interaction between sympathetic nerves and VSMCs, which is essential 
for the mechanical vaso-relaxation of micro-vessels during the reactive 
hyperaemia process. Furthermore, smokers showed a statistically significant 
increase of the neurogenic contribution to the total CWT energy spectrum during 
PORH response that was not observed in controls. This finding is in agreement 
with a major activation of the peripheral autonomous nervous system in smokers 
favoured by tobacco, which may be one of the factors causing a non-specific 
activation of VSMCs responsible for the microvascular hyperactivity observed in 
smokers. This is confirmed further by a contribution of the myogenic oscillator to 
the total baseline CWT spectrum much higher in smokers (87.4%) compared to 
controls (76.9%) (p < 0.01) (Table 15). 
4.4.3 Metabolic oscillators in humans 
In the chapter 3 about mouse models work, it has been outlined how the 
examination of cellular oscillations of NAD(P)H concentration and of the RRindex 
may be powerful to detect specific dynamic patterns of ATP energy production 
that may reflect the switch of the tissue from a normal to a diseased phenotype. 
Here, the wavelet analysis was applied on NAD(P)H and RR signals obtained by 
single-point AF readouts to characterise for the first time in-vivo human cell 
metabolic oscillators, compare their dynamic patterns between controls and 
smokers to assess their potential use as CVD risk factors, and study their 
correlation with microvascular oscillators and vasomotion. Fig. 66 and Fig. 67 
illustrate, respectively, the median time-averaged wavelet spectra from NAD(P)H 
and RR reconstructed signals of smokers and non-smokers during PORH test. 
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Fig. 66 Comparison of NAD(P)H signal CWT spectra during PORH task. Median CWT 
NAD(P)H spectra of controls and smokers during the stages of reactive hyperaemia test: (a) 
baseline, (b) ischaemia, (c) PORH response. The shaded blue and red areas around the lines of 
the median spectra represent the inter-quartile range of the CWT spectra. MO = Metabolic 
oscillator. MO-1 = Metabolic oscillator-1. Both Ai and Ei are expressed in arbitrary units (AU). The 
graphs show very slight differences in the absolute amplitude Ai and energy Ei of the metabolic 
oscillatory peaks between the two groups at baseline. 
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Fig. 67 Comparison of RR signal CWT spectra during PORH task. Median CWT RR spectra 
of controls and smokers during the stages of reactive hyperaemia test: (a) baseline, (b) 
ischaemia, (c) PORH response. The shaded blue and red areas around the lines of the median 
spectra represent the inter-quartile range of the CWT spectra. MO = Metabolic oscillator. MO-1 = 
Metabolic oscillator-1. . Both Ai and Ei are expressed in arbitrary units (AU). The graphs show 
slight differences in the absolute amplitude Ai and energy Ei of the metabolic oscillatory peaks 
between the two groups. 
As shown in Fig. 66a-c and Fig. 67a-c, a relevant slow metabolic oscillation in the 
5-9.5 × 10-3 Hz frequency range of NAD(P)H and RR signals was identified at all 
the stages of PORH test that was named metabolic oscillator-1 (MO-1). In 
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addition, a second metabolic oscillation appeared during PORH response (Fig 
60c and 61c) that was called metabolic oscillator (MO). The graphs outline slight 
differences between groups associated with the absolute wavelet amplitude Ai 
and energy Ei of metabolic oscillators, especially for the RR MO-1 and RR MO 
oscillators. Comparisons between groups were examined by evaluating the 
relative dimensionless amplitude ai and dimensionless energy ei obtained by 
normalising Ai and Ei according to equations 9-12. 
Trends of metabolic oscillators during ischaemia 
Fig. 68 displays the trends of the wavelet amplitude and energy of MO-1 during 
the various steps of PORH test. 
 
Fig. 68 Trends of the wavelet ai and ei of metabolic oscillator-1 (MO-1) during PORH test. 
(a) NAD(P)H MO-1 wavelet amplitude. (b) RR MO-1 wavelet amplitude. (c) NAD(P)H MO-1 
wavelet energy. (d) RR MO-1 wavelet energy. Data are presented as boxplots. Both ai and ei are 
expressed in dimensionless units. Black boxplots = Baseline. Grey boxplots = Ischaemia. White 
boxplots = PORH. Non-significant differences were found between groups. The black 
lines/asterisks refer to significant changes during PORH task that were estimated by paired 
Wilcox test. *p < 0.05, **p < 0.01, ***p < 0.001. 
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During the 5 min period of ischaemia the amplitude of NAD(P)H MO-1 (Fig. 68a) 
did not change in both groups compared to baseline. In contrast, the amplitude 
of the RR MO-1 (Fig. 68b) decreased significantly in controls during the occlusion 
(p < 0.05) but did not change in smokers. A significant negative correlation (ρ=-
0.55, p=0.01) was found in controls during ischaemia between the amplitude of 
RR MO-1 and the ai of the myogenic LDF oscillator which was absent in smokers. 
Therefore, the decrease of RR MO-1 amplitude may partially reflect a protective 
mechanism against the ischemic damage in VSMCs, probably consistent in the 
attempt to reduce mitochondrial ROS production through uncoupling of the 
electron transport chain, reduction of NAD(P)+ to NAD(P)H and switch towards 
an anaerobic glycolytic metabolism. As shown previously, the wavelet amplitude 
of the myogenic oscillator increased significantly during ischaemia in controls and 
did not change in smokers instead (Fig. 64d, page 167). Therefore, the data 
related to the RR MO-1 metabolic oscillator suggest that the activation of the 
myogenic mechanism during ischaemia may be sustained by ATP produced 
through the glycolysis process, and could represent an attempt to attenuate 
vasoconstriction and ensure the distribution of the remaining nutritive blood to the 
surrounding tissue. In contrast, this mechanism might be less efficient in smokers 
due to oxidative stress caused by cigarettes smoke. The wavelet energy of 
NAD(P)H MO-1 and RR MO-1 (Fig. 68c-d) did not show significant changes 
during ischaemia in both groups. 
Fig. 69 displays the trends of the wavelet amplitude/energy of MO during the 
various steps of PORH test. Either the wavelet energy or amplitude of NAD(P)H 
and RR MO oscillators showed a decrease during ischaemia in both controls and 
smokers. However, in this case non-relevant correlations were found between 
the amplitude/energy of MO and specific blood flow oscillators, suggesting that 
MO trends probably provide a more general indication of cellular energy 
metabolism dynamics associated with aerobic and anaerobic conditions. For 
example, here the decrease of wavelet spectral power may reflect the general 
switch of cutaneous metabolism towards a glycolytic anaerobic metabolism due 
to hypoxic stress induced by occlusion of blood flow. 
Trends of metabolic oscillators during PORH response 
The amplitude of NAD(P)H MO-1 and RR MO-1 and the energy of RR MO-1 (Fig. 
68) augmented in all groups during the hyperaemic response compared to both 
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baseline and ischaemia with significant p-values (p < 0.01 or p < 0.001). Overall, 
the increase of spectral amplitudes or energies may reflect the switch towards 
the normal aerobic metabolism during PORH, consistent with the oxidation of 
NAD(P)H to NAD(P)+ for the production of ATP through the OXPHOS in the 
presence of oxygen. However, interesting correlations were found indicating that 
the RR MO-1 oscillator may partially provide specific information on the activation 
of the EDHF mechanism, which plays a major role in skin PORH response. These 
correlations will be discussed in details in the next section 4.5 (paragraph 4.5.2, 
page 192). 
 
Fig. 69 Trends of the wavelet ai and ei of metabolic oscillator (MO) during PORH test.            
(a) NAD(P)H MO and (b) RR MO wavelet amplitudes. (c) NAD(P)H MO and (d) RR MO wavelet 
energies. Data are presented as boxplots. Both ai and ei are expressed in dimensionless units. 
Black boxplots = Baseline. Grey boxplots = Ischaemia. White boxplots = PORH. Non-significant 
differences were found between groups. The black lines/asterisks refer to significant changes 
during PORH task that were estimated by paired Wilcox test. *p < 0.05, **p < 0.01, ***p < 0.001. 
The wavelet amplitude/energy of NAD(P)H and RR MO oscillators (Fig. 69) 
showed an increase during PORH compared to ischaemia but in general non-
significant differences were observed between PORH and baseline time points in 
187 
 
_______________________________________________________________ 
Nonlinear dynamics of microcirculation and cell energy metabolism in human 
individuals 
both groups. These findings also suggest the hypothesis discussed previously of 
a more general meaning of MO trends, which in this case may simply reflect the 
restoration of the aerobic metabolism during PORH response compared to 
ischaemia, consistent with the oxidation of NAD(P)H to NAD(P)+ for the 
production of ATP through the OXPHOS. 
Differences of metabolic oscillators between smokers and controls 
Table 16 shows the comparison of the wavelet amplitude, energy and frequency 
of MO-1 and MO between smokers and controls. Non-significant differences were 
found at all stages of the reactive test for all the variables. This indicates that 
healthy smokers in the average age around forties are characterised by overall 
functioning dynamics of the oxido-reductive metabolism ensuring an appropriate 
energy production. However, as will be discussed in section 4.5 (paragraph 4.5.2, 
page 192), the data reflect some differences in the correlations and interactions 
between microvascular and metabolic oscillations between non-smokers and 
smokers. This might indicate that cigarettes smoke causes initial changes in skin 
oxido-reductive dynamics and microvascular adaptive mechanisms, which may 
alter the balance of vasoactive substances and switch the pathways involved in 
microvascular reactivity leading to damage of the endothelium in the long term. 
Table 16 Comparison of the wavelet ai, ei and f of metabolic oscillators between groups. 
The table reports the same data of ai and ei shown in Fig. 68 and Fig. 69, and the frequency data 
of metabolic oscillators. Data are expressed as median (inter-quartile range). Both ai and ei are 
expressed in dimensionless units, while f is expressed in hertz (Hz). (B) = Baseline. (IS) = 
Ischaemia. (P) = PORH. NAD(P)H = Nicotamide adenine dinucleotide. RR = Redox ratio. MO = 
Metabolic oscillator. Differences between controls and smokers were calculated by unpaired 
Wilcox test. Non-significant differences were found between the two groups p = p-value. 
Wavelet ai (dimensionless units) 
Variable Controls (n=20) Smokers (n=20) p 
(B) ai NAD(P)H MO-1 9.90 (8.00-11.9) × 10-3 8.80 (6.40-11.7) × 10-3 0.7 
(IS) ai NAD(P)H MO-1 9.70 (7.40-16.6) × 10-3 9.90 (3.30-14.5) × 10-3 0.6 
(P) ai NAD(P)H MO-1 20.1 (17.4-22.2) × 10-3 19.5 (11.7-21.8) × 10-3 0.5 
(B) ai NAD(P)H MO 3.80 (2.80-6.40) × 10-3 3.00 (2.00-4.70) × 10-3 0.4 
(IS) ai NAD(P)H MO 2.00 (1.00-2.60) × 10-3 1.70 (0.90-2.10) × 10-3 0.3 
(P) ai NAD(P)H MO 2.70 (0.90-5.20) × 10-3 3.30 (1.30-10.5) × 10-3 0.5 
(B) ai RR MO-1 9.90 (5.80-11.6) × 10-3 6.80 (5.30-10.5) × 10-3 0.2 
(IS) ai RR MO-1 6.10 (5.20-8.60) × 10-3 8.30 (5.90-12.8) × 10-3 0.1 
(P) ai RR MO-1 18.7 (17.5-21.9) × 10-3 19.8 (17.6-21.2) × 10-3 0.8 
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(B) ai RR MO 4.50 (3.10-5.70) × 10-3 3.40 (2.00-5.30) × 10-3 0.7 
(IS) ai RR MO 1.10 (0.70-1.80) × 10-3 1.90 (1.00-2.30) × 10-3 0.1 
(P) ai RR MO 4.00 (1.20-5.20) × 10-3 3.00 (1.80-5.20) × 10-3 0.8 
Wavelet ei (dimensionless units) 
Variable Controls (n=20) Smokers (n=20) p 
(B) ei NAD(P)H MO-1 13.8 (11.7-15.8) × 10-3 13.0 (9.90-15.4) × 10-3 0.5 
(IS) ei NAD(P)H MO-1 13.0 (9.70-18.0) × 10-3 12.6 (5.40-15.0) × 10-3 0.5 
(P) ei NAD(P)H MO-1 16.8 (12.6-20.5) × 10-3 15.0 (7.20-20.3) × 10-3 0.5 
(B) ei NAD(P)H MO 4.40 (2.90-5.70) × 10-3 4.10 (2.10-5.60) × 10-3 0.5 
(IS) ei NAD(P)H MO 2.70 (1.70-3.50) × 10-3 2.90 (1.90-3.80) × 10-3 0.9 
(P) ei NAD(P)H MO 5.10 (1.90-8.20) × 10-3 5.80 (2.60-13.3) × 10-3 0.4 
(B) ei RR MO-1 10.7 (8.80-13.1) × 10-3 11.1 (8.20-13.2) × 10-3 0.9 
(IS) ei RR MO-1 9.00 (7.90-11.7) × 10-3 10.4 (7.80-14.6) × 10-3 0.3 
(P) ei RR MO-1 14.4 (13.2-20.5) × 10-3 16.1 (13.8-19.3) × 10-3 0.6 
(B) ei RR MO 5.70 (3.60-7.60) × 10-3 3.90 (3.20-7.30) × 10-3 0.4 
(IS) ei RR MO 1.90 (1.20-4.00) × 10-3 3.20 (2.50-4.70) × 10-3 0.06 
(P) ei RR MO 6.80 (2.40-8.40) × 10-3 5.50 (3.50-8.40) × 10-3 0.6 
Wavelet f (Hz) 
Variable Controls (n=20) Smokers (n=20) p 
(B) f NAD(P)H MO-1 [Hz] 6.74 (6.56-8.22) × 10-3 6.68 (4.97-6.83) × 10-3 0.25 
(IS) f NAD(P)H MO-1 [Hz] 6.80 (6.68-6.80) × 10-3 6.80 (6.68-6.80) × 10-3 0.42 
(P) f NAD(P)H MO-1 [Hz] 6.80 (5.15-7.04) × 10-3 5.29 (5.15-6.92) × 10-3 0.88 
(B) f NAD(P)H MO [Hz] 9.45 (9.45-9.45) × 10-3 9.45 (9.45-9.45) × 10-3 0.95 
(IS) f NAD(P)H MO [Hz] 9.78 (9.45-9.95) × 10-3 9.95 (9.70-10.1) × 10-3 0.12 
(P) f NAD(P)H MO [Hz] 9.45 (9.45-9.45) × 10-3 9.45 (9.45-9.45) × 10-3 0.14 
(B) f RR MO-1 [Hz] 6.74 (6.65-8.37) × 10-3 6.68 (6.56-7.07) × 10-3 0.50 
(IS) f RR MO-1 [Hz] 6.80 (6.68-6.80) × 10-3 6.80 (6.68-6.80) × 10-3 0.42 
(P) f RR MO-1 [Hz] 6.80 (5.15-6.95) × 10-3 6.80 (5.24-6.95) × 10-3 0.61 
(B) f RR MO [Hz] 9.45 (9.45-9.57) × 10-3 9.45 (9.45-9.78) × 10-3 0.82 
(IS) f RR MO [Hz] 9.95 (9.45-10.1) × 10-3 10.0 (9.70-10.1) × 10-3 0.54 
(P) f RR MO [Hz] 9.45 (9.45-9.45) × 10-3 9.45 (9.45-9.45) × 10-3 0.60 
 
4.5 Interactions and correlations between microvascular and 
metabolic oscillators in human individuals 
The main goal of this section was studying the possible link between metabolic 
and microvascular variables to gather information on the role of NAD(P)H and 
RR dynamics in the vasomotion process induced during PORH response. In 
order to achieve this objective two kind of analyses were performed: 
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(1) The wavelet phase coherence (WPCO) analysis, to detect specific 
interactions between metabolic and microvascular oscillators associated with 
PORH vasomotion, which may reflect dynamic patterns of cellular ATP 
production able to drive the regulation of the vascular tone in response to the 
given stimulus. 
(2) Analysis of correlations. The traditional analysis of correlations allows 
gathering more information than the WPCO on the association between 
microvascular and metabolic oscillators. This is due to the fact that the WPCO 
is restricted to the study of phase relationship between oscillators that are 
located in the same frequency range, i.e. in this case it was possible 
investigating only the WPCO between MO-1 and the endothelial EDHF 
oscillators, and MO and the endothelial NO oscillators. Instead, the correlation 
analysis allows investigating the relationship between all the parameters that 
have been included in the study. Most of the variables analysed in human 
subjects were non-parametric, thus here the analysis of correlation was 
carried out by estimating the Spearman’s correlation coefficient ρ. 
4.5.1 Phase coherence between metabolic and endothelial oscillators 
The WPCO analysis was used to study the interaction Cɸ(ωk) between the MO-
1 and the endothelial EDHF oscillators (Cɸ(ωk)NAD(P)H MO-1/EDHF, Cɸ(ωk)RR MO-
1/EDHF), and between MO and the endothelial NO oscillators (Cɸ(ωk)NAD(P)H MO/NO, 
Cɸ(ωk)RR MO/NO) that are located in the same frequency intervals. Table 17 
summarises the results of the WPCO analysis. The data show baseline 
coherence values for the analysed interactions between 0.66 and 0.75, 
suggesting a relevant basal partial relationship between metabolic and 
microvascular endothelial oscillators in agreement with data from mouse models 
(section 3.4, paragraph 3.4.1, page 145). This finding might suggest a relevant 
interaction between cellular metabolic oscillatory processes and microvascular 
dynamics in the human skin. However, because the WPCO analysis in this 
dissertation does not include the surrogate data testing described recently by 
Gruszecki et al. [165], the assumptions above on the degree of baseline 
coherence might not be reliable due to bias affecting the WPCO values in the low 
frequencies. Nonetheless, cautious comparisons of the differences between 
controls and smokers and between PORH time points can be made. 
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Table 17 Phase coherence between metabolic and endothelial oscillators during PORH 
test. Data are expressed as mean ± SD. Cɸ(ωk) = Wavelet phase coherence. (B) = Baseline. 
(IS) = Ischaemia. (P) = PORH. NAD(P)H = Nicotamide adenine dinucleotide. MO = Metabolic 
oscillator. EDHF = Endothelial-derived hyperpolarizing factor. NO = Nitric oxide. RR = Redox 
ratio. Differences between groups were calculated by unpaired t-test and are outlined by red 
asterisks. p = p-value. *p < 0.05. 
Variable Controls (n=20) Smokers (n=20) p 
(B) Cɸ(ωk)NAD(P)H MO-1/EDHF 0.73 ± 0.05 0.75 ± 0.04 0.30 
(IS) Cɸ(ωk)NAD(P)H MO-1/EDHF 0.82 ± 0.05 0.84 ± 0.04 0.50 
(P) Cɸ(ωk)NAD(P)H MO-1/EDHF 0.86 ± 0.04 0.86 ± 0.03 0.50 
(B) Cɸ(ωk)NAD(P)H MO/NO 0.66 ± 0.04 0.69 ± 0.05 0.10 
(IS) Cɸ(ωk)NAD(P)H MO/NO 0.74 ± 0.04 0.74 ± 0.06 0.60 
(P) Cɸ(ωk)NAD(P)H MO/NO 0.78 ± 0.05 0.77 ± 0.06 0.90 
(B) Cɸ(ωk)RR MO-1/EDHF 0.74 ± 0.05 0.74 ± 0.04 0.90 
(IS) Cɸ(ωk)RR MO-1/EDHF 0.83 ± 0.05 0.80 ± 0.03 0.50 
(P) Cɸ(ωk)RR MO-1/EDHF 0.88 ± 0.04 0.88 ± 0.04 1.00 
(B) Cɸ(ωk)RR MO/NO 0.66 ± 0.03 0.67 ± 0.04 0.50 
(IS) Cɸ(ωk)RR MO/NO 0.77 ± 0.04 0.70 ± 0.05 *0.02 
(P) Cɸ(ωk)RR MO/NO 0.79 ± 0.06 0.80 ± 0.06 0.60 
Trends of phase coherence data during ischaemia 
For all the interactions under investigation the phase coherence augmented with 
statistical significance (p < 0.001) during ischaemia in both groups (Fig. 70a-d), 
indicating an increase of interaction between the oscillators associated with the 
hypoxic stress. This may reflect the global cooperation between metabolic and 
endothelial components to activate protective mechanisms against the ischaemic 
damage in ECs and VSMCs, probably consistent with uncoupling of the electron 
transport chain, and preferential production of glycolytic ATP for sustaining the 
activation of vasodilator dynamics aimed at moderating vasoconstriction and 
ensure the distribution of the remaining nutritive blood to the surrounding tissue. 
This interpretation is supported also by data discussed previously showing the 
increase of both EDHF (Fig. 64-65a, pages 167-168) and myogenic (Fig. 64-65d, 
pages 167-168) wavelet amplitudes/energies in controls during ischaemia, 
indicating the activation of vasodilation dynamics to contrast vasoconstriction. 
However, the increase of EDHF wavelet energy was not observed for smokers, 
which could be consistent with less efficient activation of this mechanism as 
consequence of exposure to cigarettes smoke and increase of oxidative stress. 
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Trends of phase coherence data during PORH 
Both groups showed a significant increase of phase coherence between MO-1 
and EDHF up to 0.86 (Cɸ(ωk)NAD(P)H MO-1/EDHF) and 0.88 (Cɸ(ωk)RR MO-1/EDHF) during 
PORH compared to both baseline and ischaemia (Fig. 70a and Fig. 70c), 
indicating an additional increase of interaction between vascular and metabolic 
oscillators during cutaneous hyperaemic response. This may reflect the 
reactivation of the aerobic metabolism by oxidation of NAD(P)H in NAD(P)+, and 
the concurrent and consequent activation of EDHF, NO, neurogenic and 
myogenic vasodilation mechanisms at the basis of the hyperaemic vasomotion, 
sustained by ATP energy produced through OXPHOS process. 
 
Fig. 70 Trends of phase coherence between metabolic and endothelial oscillators during 
PORH test. Bar plots of the data reported in Table 17. (a) Coherence between NAD(P)H MO-1 
and EDHF oscillators. (b) Coherence between NAD(P)H MO and endothelial NO oscillators. (c) 
Coherence between RR MO-1 and EDHF oscillators. (c) Coherence between RR MO and 
endothelial NO oscillators. Cɸ(ωk) = Phase coherence. NAD(P)H = Nicotamide adenine 
dinucleotide. MO = Metabolic oscillator. EDHF = Endothelial-derived hyperpolarizing factor. NO 
= Nitric oxide. RR = Redox ratio. Data are presented as bar plots of the mean with error bars 
corresponding to the SD. Differences between PORH time points were calculated by paired t-test 
and are outlined by black lines/asterisks. Differences between groups were calculated by 
unpaired t-test and are outlined by red lines/asterisks. *p < 0.05, **p < 0.01, ***p < 0.001. 
192 
 
_______________________________________________________________ 
Nonlinear dynamics of microcirculation and cell energy metabolism in human 
individuals 
The phase coherence between MO and endothelial NO oscillations (Fig. 70b and 
Fig. 70d) during PORH was higher than baseline with statistical significance (p < 
0.001 or p < 0.01). However, overall non-significant differences were found 
between ischaemia and PORH time points. This suggests that the interaction 
between MO and NO oscillators is not relevant for the modulation skin PORH. 
Differences of phase coherence between controls and smokers 
Overall, non-significant differences of phase coherence values were found 
between the two groups, except for the phase coherence between RR MO and 
endothelial NO (Cɸ(ωk)RR MO/NO) that was higher in controls during ischaemia (p 
< 0.05) (Table 17). This also suggest a slightly better endothelial-mediated 
response to hypoxia in controls compared to healthy smokers due to lower 
oxidative stress and absence of exposure to cigarettes smoke. 
4.5.2 Relevant correlations and regulatory mechanism of PORH vasomotion 
The analysis of correlations between the multiple parameters examined in this 
work outlined that the vasomotion mediated by EDHF during skin PORH 
response may be regulated through different mechanisms in smokers and non-
smokers. In this context, the dynamics of RR MO-1 metabolic oscillator and its 
interaction with the EDHF oscillator may reflect the degree of activation of EDHF 
through the EETs pathway, which seems to contribute differently to vasomotion 
in smokers (less contribution) and non-smokers (more contribution). Before 
discussing in details the set of relevant correlations observed in this study, a brief 
description of the modalities of activation of the EDHF signalling is provided to 
allow a better understanding of the hypotheses proposed in this section. 
Possible mechanisms for the activation of EDHF signalling 
The EDHF released by ECs acts on VSMCs cells inducing hyperpolarisation and 
relaxation of the vascular tone. This mechanism can be activated through 
different pathways: 
(1) Pathways implicating the hyperpolarisation of ECs and transmission of the 
signal to induce VSMCs hyperpolarisation by gap junctions or K+ channels 
[193]. These mechanisms may involve also bidirectional feedbacks with 
signals transmitted from ECs to VSMCs and vice-versa [140]. 
(2) Pathways involving the production of chemical metabolic products released 
by ECs to target VSMCs and induce hyperpolarisation [193]. These 
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mechanisms mainly involve an endogenous unidirectional release of the 
metabolites from ECs to VSCMs. 
One of the main mechanisms of activation of EDHF during cutaneous PORH is 
mediated by the production and release of the epoxyeicosatrienoic acids (EETs) 
metabolites from ECs to VSMCs [9, 193]. The cytochromes P450 (CYPs) 
enzymes are involved in EETs biosynthesis through the transfer of electrons from 
NAD(P)H to the P450 cofactor. 
EDHF may be activated differently in smokers and controls during PORH 
According to Cracowski et al. [193] the endothelial EDHF activity mediated by 
EETs contributes more to the time course of the cutaneous hyperaemic response 
(PORH AUC) rather than the hyperaemic peak. The experimental data from this 
dissertation are in agreement with this hypothesis, indeed a positive significant 
correlation was found between skin PORH AUC and the wavelet 
energy/amplitude of the EDHF oscillator in both the tested groups (ρ=0.50 and 
p=0.02 or p=0.01 in controls, ρ=0.50 and p=0.03 in smokers). Furthermore, the 
same degree of correlation was found between PORH AUC and the energy of 
the myogenic oscillator in smokers (ρ=0.50, and p=0.03) but not in controls. This 
observation supports the hypothesis that the more enhanced EDHF activity 
observed in healthy smokers compared to controls during cutaneous PORH 
(Table 13, page 172) may be an indirect consequence of a basal VSMCs hyper-
stimulation caused by cigarettes smoke, which may enhance further EDHF by the 
bidirectional communication between VSMCs and ECs through gap junctions and 
K+ channels in addition to the EETs endothelial metabolic mechanism. 
The interaction between RR MO-1 and EDHF oscillators may reflect the degree 
of activation of the EETs pathway 
The correlation analysis in the control group has also revealed a relationship 
between PORH AUC and the wavelet phase coherence between RR MO-1 and 
the EDHF oscillators (ρ=-0.75, p=0.0001). This correlation was absent in 
smokers. The phase coherence is a measure of the degree of interaction between 
oscillators in the same frequency range. Therefore, this observation indicates that 
in the control group the time course of PORH response is highly influenced by 
the degree of interaction between RR MO-1 and EDHF oscillators. The negative 
correlation (ρ=-0.75) indicates that PORH AUC is higher when the interaction 
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between EDHF and RR MO-1 oscillators is lower, which may be the case when 
these oscillators are involved in opposite interfering activities. For example, in 
biological terms this opposite activity may reflect the increase in production of 
EETs during PORH time course leading to EDHF activation, and in contrast the 
simultaneous conversion of NAD(P)H in NAD(P)+ (lower NAD(P)H 
concentrations) required for both the biosynthesis of EETs and the reactivation 
of the OXPHOS. The activation of EDHF during PORH is confirmed by the 
increase of EDHF oscillator’s wavelet amplitude/energy observed in Fig. 64-65a 
(pages 167-168), while the conversion of NAD(P)H to NAD(P)+ might be partially 
reflected by the increase of RR MO-1 wavelet amplitude and the reduction of the 
relative amounts of NAD(P)H observed during PORH in Fig. 68b (page 184) and 
Fig. 62a (page 163), respectively. 
RR MO-1 and EDHF oscillators have an opposite effect on the time employed 
to reach the hyperaemic blood perfusion peak 
The hypotheses above are supported further by a set of correlations that were 
found exclusively in the control group, related to the time to reach the PORH 
peak. The time to peak was negatively correlated to the wavelet amplitude/energy 
(-0.50 < ρ < -0.40, 0.03 < p < 0.05) of RR MO-1, while it was positively related to 
the wavelet amplitude/energy (0.60 < ρ < 0.70, 0.0009 < p < 0.0020) of the EDHF 
oscillator, suggesting a concurrent opposite effect of RR MO-1 and EDHF 
oscillations on the determination of the time to reach the hyperaemic peak. 
Indeed, these correlations indicate that the aerobic mitochondrial activity restored 
during PORH response promotes a fast time to peak associated with the increase 
of RR MO-1 wavelet amplitude and conversion of NAD(P)H in NAD(P)+. However, 
the simultaneous activation of EDHF mediated by EETs affects the hyperaemic 
response in an opposite way promoting an increase of the duration of PORH and 
time to achieve the peak. Therefore, the longer time to reach the peak and larger 
PORH AUC found in the control group may be due to a major activation of EDHF 
mediated by EETs compared to smokers. 
Exposure to cigarettes smoke may impact negatively EETs pathway 
The fact that the set of correlations discussed above was not found in smokers 
may support the hypothesis proposed above about lower activation of EETs 
during PORH in favour of other EDHF signalling mechanisms that do not involve 
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the conversion of NAD(P)H in NAD(P)+ to activate EETs, and that can be 
promoted by exogenous factors (e.g. nicotine) stimulating the bidirectional 
communication between VSMCs and ECs through gap junctions and K+ 
channels. Indeed, smokers showed higher relative concentrations of reduced 
NAD(P)H (Fig. 62a, page 163) during PORH compared to controls, which may 
account for lower conversion of NAD(P)H in NAD(P)+ impacting negatively the 
EETs pathway. The lower production of EETs may be an effect of the exposure 
to cigarettes smoke and the consequent oxidative stress. Indeed, smoking and 
increased amounts of ROS have been reported as factors able to induce an 
impairment of EETs pathway associated with the aetiology of hypertension, heart 
failure, metabolic disorders, and the increase of endothelial dysfunction related 
to atherosclerosis [194]. Moreover, as shown previously, the wavelet frequency f 
of the EDHF oscillator during PORH was significantly higher (p < 0.001) in 
smokers compared to controls (Table 13, page 172), as well as the f of the 
myogenic oscillator (Table 13, page 172). Considering that the electric signalling 
is characterised by transmission rates faster than metabolic communication, 
these observations could be also a relevant indirect indication of a preferential 
activation of EDHF through gap junctions rather than EETs in smokers. 
Future perspectives 
Although the integration of multi-parameter findings in this thesis seems to 
support the interpretations above, further experiments should be performed to 
confirm the proposed hypotheses. Specifically, these aspects can be elucidated 
better by assessing RR MO-1 and EDHF oscillators in the forearm during PORH 
test combined with the local administration of inhibitors of EETs biosynthesis 
(fluconazole or sulfaphenazole [193]), and inhibitors of the EDHF mechanism 
mediated by KCa potassium channels, i.e. tetraethylammonium (TEA) [195]. 
Moreover, the study of these factors in subjects affected by different CVD risk 
factors (i.e. high BP, high BMI, high hypercholesterolemia, insulin resistance and 
diabetes) may allow the implementation of preclinical diagnostic applications of 
EDHF and RR MO-1 oscillators. Indeed, the results reported in this section 
suggest that the interaction between EDHF and RR MO-1 oscillators may be a 
nonlinear process reflecting the degree of dysfunction of the EETs pathway, 
which is a factor involved in the development of pathological conditions such as 
hypertension and metabolic disorders with cardiovascular implications [194]. 
196 
 
_______________________________________________________________ 
Nonlinear dynamics of microcirculation and cell energy metabolism in human 
individuals 
4.6 Examination of LDF attractors as predictors of CVD risk 
Brief summary on the definition of “attractors” and their use as markers of risk 
The term “attractors” indicates a series of mathematical or physical variables able 
to describe the evolution of a dynamic system over time [122]. The computation 
of attractors for nonlinear signals describing a cardiovascular process, i.e. ECG, 
heart rate variability (HVR) or LDF, is considered a powerful approach for the 
prediction of vascular dysfunction [102]. Examples of attractors for this purpose 
are dimensional features of the signal, i.e. the fractal dimension (D) and the 
correlation dimension (D2), parameters outlining the degree of order/disorder of 
a signal, e.g. entropy (H0) and the information dimension (Hi), or factors defining 
the scaling properties of the signal, i.e. the Hurst exponent (H) [102]. Greater 
values of dimensional attractors and entropy correspond to a major complexity of 
the signal [102], while the Hurst index provides information on the persistence (H 
> 0.5) or anti-persistence (H < 0.5) of the signal which may indicate respectively 
a well-functioning or impaired vascular system. The analysis of complexity of BP 
and HVR signals has revealed greater fractal dimension and entropy in young 
compared to aged individuals, and in women compared to men [102]. Based on 
these observations, it has been proposed that a loss of complexity of 
cardiovascular signals may be associated with vascular dysfunction [116, 121]. 
4.6.1 Relevant differences of LDF attractors between smokers and controls 
In this work, various attractors of LDF signal were estimated to understand their 
possible application for the prediction of skin microvascular dysfunction. Fig. 71 
shows a 3D phase-space reconstruction of the median LDF signals from the 
controls and smokers groups tested in this study. The charts provide a portrait of 
the complex nonlinear structure of LDF signal in the phase-space during the steps 
of the PORH test. Differences related to the complex nonlinear dynamic patterns 
of the signal are visible between the tested groups at all the stages of PORH test, 
which could be used for the purpose of distinguishing healthy or impaired 
vascular conditions. This may be achieved by assessing the set of variables listed 
above (D, D2, H0, Hi, H) that provide a quantitative measure of the chaotic content 
and complexity of the signal. These parameters were estimated according to the 
principles described in paragraphs 1.8.8 (page 61) and 2.3.5 (page 115), by using 
the embedding dimensions m of the phase-space reconstructed attractor. 
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Fig. 71 3D graphic visualisation of the complexity of LDF signal during PORH test. 
Reconstruction of the attractors in the m-dimensional phase-space from the median LDF signal 
of non-smokers (dark blue line) and smokers (dark red line). (a) Baseline attractors. (b) Ischaemia 
attractors. (c) PORH attractors. The graphs clearly show differences in the complex nonlinear 
dynamics of LDF signal between non-smokers and healthy mild smokers at all the stages of the 
reactive functional task. The attractors were reconstructed according to the Takens method of 
delays [196, 197], by using an appropriate time lag τ estimated by calculating the first local 
minimum value from the graph of average mutual information (AMI). The optimal time lag for the 
analysed data was τ=1 for the controls’ baseline time series (12000 samples), τ=3 for the 
smokers’ baseline and ischaemia time series (12000 and 6000 samples respectively), τ=2 for 
the controls’ ischaemia time series (6000 samples), τ=88 and τ=59 respectively for controls’ and 
smokers’ PORH time series (12000 samples). The number of embedding dimensions m of each 
attractor in the phase-space was calculated based on the optimal time lag chosen for each time 
series: 13 m for controls’ baseline signal, 17 m for smokers’ baseline signal, 20 m for controls’ 
ischaemia signal, 24 m for smokers’ ischaemia signal, 11 m for controls’ PORH signal, 14 m for 
smokers’ PORH signal. The embedding dimensions were used for the subsequent estimation of 
the quantitative parameters (D, D2, H0, Hi, H) defining the complexity of the attractors. 
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Table 18 displays the comparison of D, D2, H0, Hi, and H between controls and 
smokers during PORH test. 
 
Table 18 Comparison of LDF attractors between smokers and controls. Normal data are 
expressed as mean ± SD. Non-parametric data are presented as media (inter-quartile range). (B) 
= Baseline. (IS) = Ischaemia. (P) = PORH. D = Fractal dimension. H = Hurst exponent. H0 = 
Entropy. Hi = Information dimension. D2 = Correlation dimension. Differences between groups are 
outlined by red asterisks and were estimated by unpaired t-test or Wilcox test, respectively for 
normal and non-parametric variables. p = p-value. *p < 0.05, **p < 0.01, ***p < 0.001. 
Variable Controls (n=20) Smokers (n=20) p 
(B) D 1.08 ± 0.10 1.23 ± 0.08 ***0.0006 
(IS) D 1.17 ± 0.09 1.22 ± 0.06 0.0600 
(P) D 1.17 ± 0.08 1.23 ± 0.05 **0.0060 
(B) H 1.10 ± 0.40 1.10 ± 0.30 0.7000 
(IS) H 0.70 ± 0.30 0.70 ± 0.40 0.9000 
(P) H 1.20 ± 0.30 1.00 ± 0.20 **0.0070 
(B) H0 0.31 (0.30-0.34) 0.30 (0.28-0.33) 0.2000 
(IS) H0 0.19 (0.18-0.20) 0.24 (0.17-0.26) 0.7000 
(P) H0 0.36 (0.34-0.38) 0.35 (0.32-0.37) 0.3000 
(B) Hi 0.021 (0.019-0.031) 0.016 (0.012-0.023) ***0.0007 
(IS) Hi 0.013 (0.011-0.023) 0.006 (0.003-0.010) **0.0030 
(P) Hi 0.013 (0.011-0.015) 0.008 (0.007-0.010) ***0.0006 
(B) D2 1.50 (1.40-1.60) 1.60 (1.20-1.90) 0.7000 
(IS) D2 1.00 (0.80-1.21) 1.10 (0.60-1.60) 0.8000 
(P) D2 1.40 (1.30-1.40) 1.70 (1.30-1.80) *0.0200 
 
Differences of the fractal dimension attractor (D) between groups 
The values of D were significantly greater in smokers compared to controls during 
both baseline (p < 0.001) and PORH response (p < 0.01). These results indicate 
a major fractal complexity characterising the blood flow dynamics in healthy 
smokers, suggesting that care must be taken when evaluating the attractors as 
predictors of vascular dysfunction. Indeed, although it has been reported in 
literature that lower complexity is associated with cardiovascular dysfunction 
[116, 121], this is not true for the groups of healthy subjects examined in this 
work. As discussed in paragraph 4.4.1 (page 173), smokers were characterised 
by hyperactive adaptive microvascular reactivity in response to the exposure to 
tobacco, which may be an early indicator of risk. Therefore, lower complexity 
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cannot be considered as an absolute indicator of cardiovascular dysfunction, and 
the interpretation of this parameter may vary depending on the analysed signal, 
and the risk factors and health status characterising the tested groups. For 
cutaneous LDF signals of healthy smokers, higher values of fractal dimension D 
may be an early indicator of vascular risk. 
Differences of the correlation dimension attractor (D2) between groups 
The correlation dimension is an attractor providing variable results that may show 
different patterns and have different meanings depending on the kind of analysed 
signals. For example, the estimation of this parameter from HVR time series 
provided greater values for healthy subjects compared to individuals affected by 
cardiac arrhythmia (bigeminy) [196]. In this case, an increase in the complexity 
associated with the correlation dimension feature of the signal indicates optimal 
cardiovascular function. However, the estimation of the correlation dimension 
from ECG signals showed opposite results, with greater values of this parameter 
for diseased subjects affected by bigeminy [196]. Therefore, caution must be 
taken when presenting and interpreting data related to this attractor. In this work, 
D2 was found significantly higher (p < 0.05) in smokers compared to controls 
during PORH response (Table 18). Thus, in the case of cutaneous LDF signals 
higher values of D2 complexity may be an indicator of early microvascular 
dysfunction for healthy smokers. 
Differences of entropy (H0) and information dimension (Hi) between groups 
These two attractors are strictly linked to each other, indeed the value of entropy 
is used for estimating the information dimension. However, the meaning of these 
variables is different, as entropy is a measure of the quantity of information 
required for the prediction of the future status of the dynamic system under 
investigation [102], while the information dimension represents a measure of the 
rate of temporal growth of the information contained in the dynamic system. In 
general, the increase of H0 and Hi indicates a growth of the complexity of the 
dynamic system under investigation, less order and less predictability, even 
though the results obtained in this study suggest that attractors’ data 
interpretation may vary depending on several factors and the increase of 
complexity is not always an indicator of cardiovascular dysfunction. Here, the 
comparison of entropy values between smokers and non-smokers did not show 
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significant differences between the two groups (Table 18). In contrast, the 
information dimension was significantly higher in controls at all the stages of 
PORH test, indicating a lower growth rate of information characterising the 
microvascular dynamics of smokers, which may be an early indicator of risk. 
Differences of the Hurst index (H) attractor between groups 
Although the Hurst exponent variable is denoted by H, this is not an entropy 
related measure. As explained in section 1.8 (paragraph 1.8.8, page 61) this 
attractor is related to the fractal dimension D. Here, the values of H were > 0.5 in 
both groups during all the stages of reactive hyperaemia (Table 18), indicating a 
persistent behaviour of LDF time series that is typical of signals reflecting an 
overall healthy vascular system. The value of H was significantly higher in 
controls compared to smokers during PORH response, even though this 
observation does not seem reliable for differentiating the two groups. Indeed, the 
correlation analysis, which will be discussed in the next paragraph, has revealed 
that the increase of H is associated with the presence of several risk factors, 
including also cigarettes smoke. Therefore, it was more likely to expect greater 
values of H in healthy smokers rather than in controls. Based on these 
observations, it can be concluded that this parameter is not reliable as predictor 
of CVD risk in healthy smokers. 
4.6.2 Physiological meaning of LDF attractors 
The attractors are parameters that define mathematical features of the analysed 
signal. To use these factors as biomarkers of CVD risk, a better understanding of 
the physiological processes reflected by these mathematical variables is 
required. The multi-parameter approach that was employed in this work allowed 
getting more insights on the physiological meaning of the attractors, which was 
examined by analysing their correlation with other parameters measured in the 
study, i.e. general clinical variables (BP, age, BMI, etc.), wavelet microvascular 
and metabolic oscillators, and tissue oxygenation data (SO2, O2ER and VO2). 
Physiological meaning of the fractal dimension D of LDF signal 
Fractal dimension and systolic blood pressure (SBP). The most relevant 
correlations observed for the fractal dimension attractor indicate that the 
quantitative changes of D could reflect the regulation of the baseline systolic 
blood pressure (SBP). The control group showed a relevant negative correlation 
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between D and the SBP (r=-0.50, p=0.04), indicating that the increase of 
complexity is associated with lowering of systolic blood pressure in healthy 
subjects. In addition, the relevant negative correlation observed between the 
endothelial NO oscillator and SBP (ρ=-0.50, 0.01 < p < 0.03), and the positive 
correlation between EDHF (ρ=0.40, 0.001 < p < 0.002) or NO (0.40 < ρ < 0.50, 
0.0001 < p < 0.0004) oscillators and the fractal dimension suggest that the 
endothelial modulation of microvascular tone may be a key factor involved in the 
control of SBP in healthy individuals. Indeed, these observations indicate that the 
increase of endothelial-mediated vaso-relaxation leads to growth of complexity of 
microvascular dynamics and lowering of SBP. Furthermore, the SBP showed a 
high negative correlation with the phase coherence between RR MO-1 and EDHF 
oscillators (r=-0.60, p=0.006), suggesting an important role of the interaction 
between mitochondrial oxido-reductive oscillatory reactions and microvascular 
endothelial modulation for the control of SBP. This observation is not casual, 
indeed in section 4.5 (paragraph 4.5.2, page 193) it has been emphasised that 
the phase coherence between RR MO-1 and EDHF may reflect the degree of 
activation of EETs-mediated EDHF, and the dysfunction of the EETs pathway 
has been described as a factor involved in the development of hypertension [194]. 
The set of correlations described above was absent in smokers, which may 
indicate an alteration of the normal pathways involved in the control of SBP and 
the switch towards different regulatory mechanisms leading to the development 
of pathological hypertensive conditions in the long term. This is confirmed by the 
fact that the basal SBP in smokers was negatively correlated with the neurogenic 
(ρ=-0.45, p=0.04), myogenic (ρ=-0.50, p=0.04), and NAD(P)H MO-1 (ρ=-0.50, 
0.01 < p < 0.03) oscillators, while non-relevant correlations were found with the 
endothelial oscillators. These findings indicate a major involvement of different 
microvascular components in the regulation of SBP in smokers compared to 
controls, probably due to the direct negative effects of tobacco. Indeed, the 
myogenic and neurogenic microvascular components can be activated directly 
from exogenous factors contained in cigarettes smoke, such as nicotine that is 
able to enhance the neurogenic control by targeting cholinergic nicotinic 
receptors, and the external NO that can target directly VSMCs enhancing the 
myogenic mechanism. The non-specific activation of these factors may interfere 
with the control of SBP mediated by endothelial cells and enhance different 
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regulatory mechanisms. Further support to this hypothesis is provided by the 
relevant positive correlation found between SBP and the number of smoking 
years (r=0.70, p=0.001), and the negative correlation between the neurogenic 
(ρ=-0.50, 0.03 < p < 0.04) and myogenic (ρ=-0.50, p=0.03) oscillators and the 
number of smoking years. These correlations indicate that as the years of 
exposition to cigarettes smoke increase, the SBP growths as a consequence of 
the decrease of neurogenic and myogenic modulation, reflecting the impairment 
of the SBP control mechanisms typical of smokers which seems to rely on the 
activity of neurogenic/myogenic components. 
Fractal dimension and microvascular dynamics. Additional correlations indicate 
that the quantitative changes of D values may reflect also the general degree of 
complexity of microvascular dynamics. Indeed, positive correlations were 
observed in the control group between D and EDHF (ρ=0.40, 0.001 < p < 0.002), 
endothelial NO (0.40 < ρ < 0.50, 0.0001 < p < 0.0004), neurogenic (ρ=0.40, 
0.0005 < p < 0.0030), and myogenic (0.30 < ρ < 0.40, 0.002 < p < 0.009) 
microvascular oscillators. Overall, these findings show a global cooperation of the 
microvascular components to determine the complexity of flow dynamics in 
healthy subjects, and are in agreement with the general dogma associating the 
increase of complexity with an increase of vascular reactivity. 
Physiological meaning of the correlation dimension D2 of LDF signal 
Correlation dimension and cardiac output. The quantitative increase of correlation 
dimension may reflect higher cardiac output. Indeed, relevant positive 
correlations were found in the healthy group between D2 and some variables 
related to the cardiac output, such as the frequency f (ρ=0.45, p=0.0002) and 
amplitude/energy (0.60 < ρ < 0.70, p < 0.0001) of the cardiac oscillator, and the 
oxygen consumption VO2 (0.30 < ρ < 0.40, 0.0004 < p < 0.0400). Several 
literature reports have described higher cardiac output associated to 
cardiovascular pathologic conditions characterised by increased heart rate [180, 
181, 182, 183]. Therefore, D2 may find application as biomarker of risk for 
cardiovascular illness related with changes in the heart rate. 
Physiological meaning of the entropy H0 of LDF signal 
Entropy and cardiac output. The pattern of correlations that was found in this 
study in relation to H0 suggests an association of the increase of entropy with 
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higher cardiac output. Indeed, both groups showed positive correlations of H0 
with oxygen consumption VO2 (0.30 < ρ < 0.50, 0.0001 < p < 0.0400) and the 
cardiac oscillator (0.50 < ρ < 0.70, p < 0.0001) suggesting an increase of entropy 
associated with higher cardiac output. As discussed above for the correlation 
dimension, the increase of cardiac output is associated to cardiovascular 
pathologic conditions characterised by increased heart rate [180, 181, 182, 183]. 
Therefore, also Ho may find application as biomarker of risk for cardiovascular 
illness related with changes in the heart rate. 
Physiological meaning of the information dimension Hi of LDF signal 
Information dimension and cardiac output. As observed for D2 and H0, also Hi 
showed positive correlations with oxygen consumption VO2 (ρ=0.40, p=0.003) 
and the cardiac oscillator (0.50 < ρ < 0.60, p < 0.0001), indicating that the 
increase of information dimension values is associated with higher cardiac 
output. Therefore, also Hi may find application as biomarker of risk for 
cardiovascular illness related with changes in the heart rate. 
Information dimension and microvascular dynamics. Additional correlations 
indicate that the quantitative changes of Hi values may reflect also the general 
degree of complexity of microvascular dynamics. Both groups showed negative 
correlations with the EDHF (-0.35 < ρ < -0.60, 0.0001 < p < 0.0060), endothelial 
NO (-0.30 < ρ < -0.50, 0.0001 < p < 0.0400), neurogenic (-0.40 < ρ < -0.60, 0.0001 
< p < 0.0030), and myogenic (-0.30 < ρ < -0.60, 0.0001 < p < 0.0200) oscillators. 
This means that the increase of information dimension is associated with general 
reduced microcirculation. 
Physiological meaning of the Hurst exponent H of LDF signal 
Hurst exponent and energy metabolism. Most of the correlations found for H were 
related to metabolic factors. Indeed, H was positively correlated with the body 
mass index (BMI) (r=0.40, almost significant p=0.06) in the control group, and 
with NAD(P)H MO (ρ=0.30, 0.006 < p < 0.010), RR MO (0.40 < ρ < 0.50, 0.0002 
< p < 0.0070) and NAD(P)H MO-1 (ρ=0.30, p=0.01) metabolic oscillators in both 
groups. Moreover, a relevant positive correlation was found between H and SBP 
(r=0.50, p=0.01) in controls. Overall, these observations suggest that the Hurst 
index of LDF signal may reflect dynamics related to energy metabolism 
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processes and their effect on the control of the systolic blood pressure. Thus, the 
increase of the H could be associated with hypertension and obesity. 
Hurst exponent and smoking. Additionally, a positive correlation was found 
between H and the number of years of exposition to cigarettes smoke (r=0.50, 
p=0.02) in smokers. This indicates that increased values of H might be an 
indicator of risk for smokers, even though as discussed in paragraph 4.6.1 (page 
200), H did not provide reliable differences between controls and healthy 
smokers.
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5 Conclusions and future perspectives 
 
5.1 Conclusions 
5.1.1 Rationale and objectives of the study 
Novel biomarkers for the non-invasive assessment of CVD risk 
The peripheral skin microcirculation is a hallmark of the general health status of 
the cardiovascular system, which can be evaluated non-invasively by the 
combination of reactive tests and optical/laser methods to examine the functional 
dynamics and the degree of oxidative stress of skin micro-vessels. Many studies 
have characterised oscillators of skin blood flow signal that are potentially eligible 
as novel predictors of CVD risk. Furthermore, recently scientists have also 
focused on the study of the oxido-reductive dynamics of cell energy metabolism, 
detectable by analysing the oscillations of NAD(P)H autofluorescence. Metabolic 
oscillators may reflect specific patterns of ATP production related with normal or 
diseased vascular conditions, thus they may also be potential risk markers. 
Moreover, the concurrent evaluation of blood flow and NAD(P)H dynamics may 
outline specific links between microvascular and metabolic oscillators that could 
help to elucidate further the cellular mechanisms at the basis of vasomotion. 
Objectives 
The main goals of this research were: 
(1) The first attempt to detect simultaneously blood flow and metabolic oscillators 
in-vivo and investigating their role and interaction in skin vasomotion. 
(2) Assessing the potential use of cutaneous blood flow and metabolic oscillators 
as predictors of CVD risk associated with oxidative stress and smoke. 
This was achieved by concurrent evaluation of the nonlinear dynamics of blood 
flow and metabolic NAD(P)H and RR signals measured from the skin of mouse 
models and human subjects by single-point autofluorescence readouts. Specific 
details on the protocols implemented in this study are reported in the sections 2.4 
(mouse protocol, page 115) and 2.5 (human protocol, page 119). Additionally to 
the main objectives discussed above, the experiments carried out in this work 
allowed also the characterisation of the endothelial EDHF oscillator, as well as 
testing the potential use of the “attractors” and tissue oxygenation parameters 
(oxygen extraction, oxygen consumption) as predictors of risk in human subjects. 
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5.1.2 Mouse models results 
Characterisation of the EDHF oscillator 
In this work, the wavelet analysis of LDF signals from mice has provided indirect 
proof of the possible EDHF origin of the endothelial NO-independent oscillator (5-
9.5 × 10-3 Hz). Indeed, according to literature the stimulation of micro-vessels with 
the vasoconstrictor drug PE induces a vasomotion process mediated by NO and 
EDHF endothelial mechanisms but not by PGs [160]. The results of this thesis 
showed that the most relevant changes during PE-induced vasomotion were 
related to the endothelial NO oscillator and the endothelial NO-independent 
oscillator that by exclusion may be considered of EDHF origin because the PGs 
origin of this oscillator has been already excluded by previous studies [102, 105]. 
Role of endothelium and metabolic oscillations in skin vasomotion 
The analysis of nonlinear dynamics of the microcirculation in mouse models has 
revealed a key involvement of EDHF and NO endothelial components in PE-
induced cutaneous vasomotion. A more pronounced vasomotion was observed 
in mice affected by oxidative stress, which was explained as a resistance 
mechanism to attenuate vasoconstriction already described in literature as 
myoendothelial feedback [140]. Relevant correlations were found between 
metabolic and microvascular oscillators in WT mice, suggesting an involvement 
of the oxido-reductive oscillatory processes in vasomotion dynamics. The 
strongest correlations were observed for the endothelial oscillators, indicating an 
important role of the interaction between endothelial and metabolic factors for the 
modulation of microvascular diameter. However, correlations were observed also 
between metabolic and neurogenic or myogenic oscillations, indicating a global 
involvement of all the microvascular components in PE-induced vasomotion. 
These results raise attention on a possible role of cellular metabolic oscillators 
for driving vasomotion in response to specific stimuli, and may serve as stimulus 
to study further the cellular mitochondrial and glycolytic oscillators as possible 
factors that could drive the Ca2+ oscillations at the basis of vasomotion. 
Finally, non-relevant correlations were found between metabolic and 
microvascular oscillators in knockout mice, indicating that oxidative stress affects 
the cooperation between these factors inducing the switch towards regulatory 
mechanisms of the vascular tone different from the physiological pathways, which 
may promote the onset of metabolic/cardiovascular illness in the long term. 
207 
 
_______________________________________________________________
Conclusions and future perspectives 
LDF and metabolic oscillators as markers of risk related to oxidative stress? 
The most relevant difference between WT and Nrf2-/- mice groups for blood flow 
oscillators was found in relation to the endothelial EDHF component, which was 
characterised by higher spectral energies in control mice. This indicates reduced 
baseline functioning of the EDHF vasodilation mechanism in the presence of 
oxidative stress which could be eligible as biomarker for the prediction of CVD 
risk. Also the other microvascular oscillators (endothelial NO, neurogenic and 
myogenic) displayed greater baseline energies in WT mice suggesting a general 
reduced baseline vasodilator potential in the presence of oxidative stress and the 
possible use of all the local microvascular oscillators as early biomarkers of risk. 
The major differences between WT and Nrf2-/- groups in relation to metabolic 
oscillators were found for the RR MO-1. This oscillator displayed opposite trends 
between the two groups during PE stimulation, and the baseline “phase 
coherence” (interaction) between RR MO-1 and the EDHF vascular oscillator was 
found higher in WT mice compared to Nrf2-/- animals, indicating a different basal 
interaction between metabolic and endothelial oscillations in the presence of 
oxidative stress. Thus, RR MO-1 might be a potential preclinical indicator of risk 
for both metabolic and cardiovascular complications that might originate from 
oxidative stress conditions. 
5.1.3 Human work results 
Characterisation of the EDHF oscillator 
The indirect suggestions from mice work of the EDHF origin of the wavelet peak 
in the 5-9.5 × 10-3 frequency interval was confirmed and supported further by 
human data. Indeed, the endothelial NO-independent oscillator displayed the 
greatest percentage increase of wavelet amplitude/energy during human PORH 
hyperaemic response compared to the other LDF oscillators. This observation 
highly supports the EDHF origin of this oscillator because the EDHF mechanism 
is considered in literature as the major contributor to skin PORH response [9]. 
Possible existence of an endothelial PGs oscillator? 
The wavelet analysis of LDF signals from human subjects during PORH has 
revealed a complex pattern of oscillatory peaks in the frequency interval of the 
endothelial NO oscillator, which could be a clue for the characterisation of an 
oscillator associated with the PG endothelial pathways. Indeed, the spectral 
interval of the NO oscillator clearly displayed two oscillatory peaks during PORH 
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response. This observation may suggest a possible overlapping contribution of 
different components in the 9.5-21 × 10-3 Hz frequency range. The minimal 
contribution of NO to skin reactive hyperaemic response and the bidirectional 
cross-talk between NO and PGs endothelial mechanisms [9, 184] may be the 
reason for the appearance of an additional oscillatory peak during cutaneous 
PORH, which normally might be masked by the major activity of NO pathway in 
the regulation of microvascular tone. Therefore, it can be hypothesised a PGs 
origin of one of the two wavelet peaks appearing during skin hyperaemic 
response in the NO interval. 
Role of the endothelium and metabolic oscillations in human vasomotion 
The wavelet analysis of human LDF oscillators confirmed the primary role of the 
endothelial EDHF pathway and lower involvement of NO, PGs, neurogenic and 
myogenic modulatory mechanisms in skin PORH response to a 5 min ischaemia 
period. Indeed, the vasomotion response to occlusion periods > 3 min is mainly 
mediated by metabolic factors [185]. The set of correlations and interactions 
(phase coherence) found between microvascular and metabolic oscillators 
suggested that the endothelial EDHF pathway may be activated through different 
mechanisms in non-smokers and smokers during PORH. The correlations 
observed in controls suggested a more prominent activation of EDHF through the 
release of metabolic factors (EETs). In contrast, data from smokers suggested 
that the exposure to tobacco may impact this mechanism in favour of signalling 
pathways for the exogenous activation of EDHF by gap junctions or K+ channels, 
probably due also to the higher degree of oxidative stress in smokers which is a 
factor leading to impairment of EETs production [194]. 
LDF and metabolic oscillators as predictors of CVD risk in smokers? 
The wavelet LDF data displayed a hyperactive microvascular reactivity of local 
blood flow oscillators (endothelial, neurogenic, myogenic) in healthy smokers 
compared to non-smokers, which may be an early factor provoking an imbalance 
between vasodilator and vasoconstrictor agents contributing to the onset of the 
skin microvascular endothelial dysfunction observed in chronic elder smokers. 
These results indicate that wavelet data may be easily misinterpreted. Indeed, 
generally lower endothelial, myogenic and neurogenic wavelet energies are 
hallmarks of microvascular dysfunction when comparing healthy and diseased 
groups or elder smokers and controls but this is not true for healthy younger 
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smokers. Therefore, the increase of wavelet energy of local LDF oscillators may 
represent an early biomarker of CVD risk for healthy smokers. In this study, 
higher wavelet energies of the cardiac oscillator were found in the control group 
compared to smokers. Generally, higher values of the cardiac output are a 
hallmark of diseased conditions such as hypertension but in this case seemed to 
reflect a more efficient delivery and consumption of oxygen in controls compared 
to smokers. Thus, also data of the cardiac oscillator may be easily misinterpreted. 
The respiratory oscillator displayed clearly different patterns between the two 
groups with greater wavelet energy in smokers, which could reflect increased 
resistance of skin peripheral arterioles. This oscillator seems to be suitable for 
performing an early assessment of CVD risk for healthy smokers. 
The metabolic oscillators did not show significant differences between the 
tested groups, indicating overall well-functioning oxido-reductive dynamics in 
healthy smokers that ensure a normal cell energy metabolism. Therefore, 
metabolic oscillators cannot be considered early biomarkers of risk for healthy 
smokers, even though differences were found in the trends of metabolic 
oscillators and correlations between metabolic and microvascular oscillators, 
which may indicate an impact of smoke in the mechanisms for the mediation of 
PORH response. 
Tissue oxygenation biomarkers 
The analysis of tissue oxygenation dynamics showed relevant differences in the 
oxygen consumption VO2 that was lower in smokers compared to controls during 
both ischaemia and PORH tasks. This may reflect a slower metabolism rate and 
conversion of oxygen in ATP energy in smokers, due to early microvascular 
damage induced by exposure to nicotine. Therefore, VO2 might be eligible as 
early biomarker of risk for healthy smokers. Non-significant differences were 
found for the oxygen extraction O2ER parameter. 
Evaluation of LDF attractors as predictors of CVD risk 
The results of LDF attractors’ analysis outlined that these parameters are variable 
factors which must be interpreted with caution. Indeed, according to the findings 
in this study, lower complexity cannot be considered as an absolute indicator of 
cardiovascular dysfunction and the meaning of the attractors may vary depending 
on the kind of analysed signal, the risk factors and the general health status 
characterising the groups of individuals under investigation. 
210 
 
_______________________________________________________________
Conclusions and future perspectives 
The values of the fractal dimension D were significantly higher in smokers, 
indicating that increased fractal dimension of LDF signals could be an early 
indicator of CVD risk for healthy smokers. The correlation dimension D2 showed 
significant differences between the analysed groups with higher D2 values found 
for smokers during PORH, indicating a potential eligibility of this LDF attractor as 
predictor of CVD risk for healthy smokers. The LDF entropy attractor H0 did not 
show relevant differences between groups, indicating that this attractor is not 
suitable for the preclinical prediction of risk in younger healthy smokers. The 
information dimension Hi was significantly lower in smokers compared to controls 
at all the stages of PORH test, indicating that decreased Hi may be an early 
indicator of risk for healthy smokers. Finally, the Hurst index attractor H did not 
show reliable differences, indicating that this LDF attractor is not suitable as early 
indicator of risk in healthy smokers. 
 
5.2 Future perspectives 
5.2.1 Improvement of the methodology 
Detection of fast metabolic oscillations 
A shortcoming of the method used in this work was the employment of 
reconstructed NAD(P)H and RR signals, allowing only the study of low-frequency 
metabolic oscillators due to the slow sampling frequency of the discrete 
autofluorescence spectra employed for the reconstruction of the signal. This 
aspect can be improved in the future reducing the sampling time to a spectrum 
every 6-7 s for the detection of fast metabolic oscillations up to 145 × 10-3 Hz. 
Characterising fast metabolic oscillators may be useful for two reasons. First, it 
would allow studying the phase coherence (interactions) of myogenic or 
neurogenic oscillators with metabolic oscillators falling in their frequency ranges, 
which was not possible in this study. Secondly, fast metabolic oscillations may be 
associated with the activity of cells with higher glycolytic or mitochondrial 
metabolic rates. This could provide the opportunity for the study of a range of 
metabolic oscillations arising from different cell types during vasomotion. 
Improvement of autofluorescence data normalisation 
In this study, the negative effects of factors affecting autofluorescence signal (i.e. 
absorption of UV light by Hb) were addressed by applying ratiometric correction 
methods. The normalised signals were considered acceptable for the final 
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purpose of the work that was examing the oscillations of NAD(P)H over time. 
However, in the future a more precise correction may be achieved performing 
Monte Carlo modelling studies to trace specifically the path of the light through 
the cutaneous tissue and determine what the detected signal is accounting for. 
Tracing the cellular origin of metabolic oscillators 
Another point to address is the characterisation of the cellular origin of metabolic 
oscillators. Indeed, the skin includes a variety of heterogeneous cells, which are 
part of the different cutaneous layers (i.e. epidermis) or of functional structures 
(e.g. micro-vessels). The correlations between vascular and metabolic oscillators 
found in this work may be an indirect indication that (1) part of the skin metabolic 
oscillations are of microvascular origin, and that (2) vasomotion may be 
influenced also by metabolic dynamics related to the energetic requirements of 
the surrounding cutaneous tissue. The employment of imaging techniques for the 
spatial localisation of cutaneous NAD(P)H may better clarify these observations. 
Fluorescence lifetime imaging microscopy (FLIM) and multiphoton laser scanning 
microscopy (MPLSM) seem promising methods for this purpose. 
Improvement of the wavelet phase coherence (WPCO) analysis 
Although the potential for gathering information on the interaction between 
biological oscillators, the WPCO analysis from noisy regions of the wavelet 
spectrum (e.g. EDHF and RR MO-1 low-frequency ranges) may be affected by 
some bias. As future perspective, the interpretation of WPCO data may be 
improved by including the surrogate data testing described recently by Gruszecki 
et al. [165], making the assumptions on the degree of baseline coherence more 
reliable. Moreover, decomposition methods for the separation of the oscillators of 
interest from the original signal and the background noise may be implemented. 
The empirical mode decomposition (EEMD) may be an example of method useful 
for this purpose, to obtain time series of EDHF, NO, and slow metabolic 
oscillators separated from their original signal, which could be used to perform 
the WPCO analysis. 
5.2.2 Direct characterisation of EDHF and PGs blood flow oscillators 
EDHF oscillator 
The experimental data from this study have suggested indirectly a possible EDHF 
origin of the endothelial NO-independent LDF wavelet oscillator. As future 
perspective, direct proof of this hypothesis may be provided in both mouse 
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models and human subjects. This may be achieved in mice by monitoring this 
wavelet oscillator during inhibition of the EDHF mechanism through a 
combination of the inhibitors of K+ channels apamin and charybdotoxin (APA + 
ChTX) [198]. The same result can be obtained in human subjects by monitoring 
this wavelet oscillator during PORH in the presence/absence of inhibitors of the 
EDHF mechanism. Examples of substances that could be used for this purpose 
in humans are the fluconazole or sulfaphenazole inhibit the EDHF mechanism 
mediated by EETs metabolites [193], and the tetraethylammonium (TEA) for the 
inhibition of the EDHF mechanism mediated by KCa potassium channels [195]. 
PGs oscillator 
The wavelet analysis of LDF oscillators during PORH test in human subjects has 
revealed the possible existence of an endothelial PGs oscillator peak in the same 
frequency range of the endothelial NO oscillator. As future perspective, this 
hypothesis may be tested directly by performing the wavelet analysis of LDF 
signals measured from the human forearm during PORH test in combination with 
the administration of inhibitors of PGs biosynthesis. Examples of pharmaceutical 
drugs that can be used for this purpose are aspirin [105, 191], ibuprofen [192], or 
micro-dialysis delivery of the non-specific inhibitor of COX ketorolac [184, 193]. 
5.2.3 Further study of vasomotion 
Mouse vasomotion 
The results from this study have outlined an important role of both endothelial 
and slow metabolic oscillators in the modulation of PE-induced vasomotion. As 
future perspective, the role of these oscillators and their interactions should be 
investigated for vasomotion processes induced by pharmacological agents 
different from PE (i.e. ACh), to obtain a full picture on the involvement of these 
factors in vasomotion. Additionally, the characterisation of fast metabolic 
oscillators may be useful to investigate their relationship with microvascular 
oscillations and their role in mouse vasomotion. 
Human vasomotion 
Human work has suggested that the phase coherence between EDHF and RR 
MO-1 oscillators may reflect the degree of activation/inactivation of the EETs 
pathway during PORH vasomotion. Moreover, the results suggest that the EDHF 
mechanism activated after a prolonged ischaemia period (> 3 min) might be 
mainly mediated by EETs metabolites. In contrast, in smokers the activity of EETs 
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metabolites may be reduced in favour of mechanisms of activation of EDHF 
involving gap junctions and K+ channels. However, although the integration of 
multi-parameter findings in this dissertation seems to be consistent with these 
interpretations, further experiments should be performed to confirm these 
hypotheses. Specifically, all these aspects can be elucidated better by the 
assessment of metabolic and EDHF oscillators’ dynamics in the forearm during 
PORH vasomotion in response to both ischaemic periods < 3 min and > 3 min, in 
combination with the local delivery of fluconazole or sulfaphenazole for the 
inhibition of EDHF signalling mediated by EETs [193], and TEA for the inhibition 
of the EDHF signalling mediated by KCa potassium channels [195]. Additionally, 
the characterisation of fast metabolic oscillators may be useful to investigate their 
relationship with microvascular oscillations and their role in human vasomotion. 
5.2.4 Further exploration of the nonlinear markers of microcirculation and 
cell energy metabolism as predictors of CVD risk 
Testing additional mouse phenotypes 
In this work, the comparison of data between WT mice and the baseline 
phenotype of Nrf2-/- animals have outlined relevant differences for the local 
microvascular oscillators (especially the EDHF), the RR MO-1 metabolic 
oscillator, and the interaction (phase coherence) between EDHF and RR MO-1. 
However, the lack of antioxidant protection of the Nrf2-/- mice has not been fully 
tested with additional oxidative stress loads (e.g. treatment with high fat diet). 
Therefore, to reveal the full picture on the dynamics of microvascular and cell 
metabolic oscillators in response to oxidative stress, future studies are required 
on larger groups of mice under HFD regime. Moreover, the biomarkers should be 
tested also on animals affected by metabolic and cardiovascular illness to clarify 
further these aspects. Additionally, also the potential use of LDF attractors as 
predictors of risk associated with oxidative stress and vascular/metabolic illness 
may be tested in mouse models. 
Testing microvascular and metabolic oscillators in human cohorts affected by 
risk factors different from smoking 
The obtained results suggest that the applicability of microvascular and metabolic 
dynamic biomarkers as preclinical predictors of CVD risk may vary depending on 
the features of the tested subjects. The increase of wavelet energy of local 
microvascular oscillators and of the respiratory oscillator, oxygen consumption 
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(VO2), and various attractors seem to be the promising early dynamic biomarkers 
of risk for healthy smokers. However, these nonlinear markers may acquire a 
different importance for cohorts of subjects with different risk factors. For 
example, comparing healthy normal-weight subjects with a cohort of healthy 
overweight individuals might evidence differences in the dynamics of metabolic 
oscillators as well as differences in local microvascular oscillators. Therefore, 
testing several cohorts of healthy subjects affected by risk factors different from 
smoke (e.g. high BMI, physical inactivity, family history of CVD, hypertension, 
etc.) may help to determine the specific patterns of dynamic biomarkers 
associated with each risk factor. 
Testing the attractors in human cohorts affected by various risk factors or 
patients with CVD and respiratory illness. 
The correlation analysis has revealed that the quantitative growth/decrease of the 
attractors may reflect multiple physiological processes, including changes in the 
cardiac output, control of the SBP, or microvascular and metabolic dynamics. 
Therefore, based on the results of the correlation analysis the following 
hypotheses may be tested in the future: (1) D and H as predictors of risk for 
hypertensive non-smokers or smokers. (2) D2, H0 and Hi as discrimination factors 
for patients with cardiovascular disorders characterised by increase of heart rate. 
(3) D and Hi as discrimination factors for patients affected by peripheral 
microvascular disease. (4) H as predictor of risk for subjects with high BMI, or as 
discriminatory factor for patients with metabolic disorders. 
Adding the nonlinear dynamic biomarkers to existent risk functions 
Finally, after the selection of the best microvascular and metabolic nonlinear 
dynamic biomarkers of risk, it would be appropriate the combination of these 
parameters to create an index usable for the preclinical prediction of risk or 
diagnostic purposes, and adding these factors to the existent risk functions. In 
addition, considering that this research was more focused on women and female 
mice, the potential biomarkers found in this study may be eligible as non-
traditional risk factors for women who are characterised by a different aetiology 
and incidence of CVD compared to men that frequently cannot be explained by 
traditional risk factor.
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This section contains the manuscripts, part of this doctoral project, which have 
been published or submitted to peer-reviewed journals by July 2018. 
I. In-vivo assessment of microvascular functional dynamics by combination 
of cmOCT and wavelet transform 
This proceeding paper has been presented in San Francisco (US) at the SPIE 
BiOS 2018, Dynamics and Fluctuations in Biomedical Photonics XV Conference 
in January 2018, and published in February 2018. The content of the paper is 
related to additional experimental work that was carried out in collaboration with 
the Tissue Optics and Microcirculation Imaging group of the National University 
of Ireland Galway (NUIG), which was involved in this doctoral project as 
associated partner. The topic of the paper is the validation of the correlation 
mapping optical coherence tomography (cmOCT) imaging method for the 
concurrent assessment of microcirculation structure and microvascular functional 
dynamics (vasomotion), thanks to the combination with the post-occlusive 
reactive hyperaemia (PORH) challenging test and the continuous wavelet 
transform (CWT) spectral analysis. 
II. Application of cmOCT and continuous wavelet transform analysis to the 
assessment of skin microcirculation dynamics 
This is a full-length paper published in the Journal of Biomedical Optics (JBO) in 
July 2018. The content of this manuscript is an extended and completed version 
of the proceeding paper number I, containing additional data analyses and results 
from a major number of examined subjects. 
III. In-vivo multi-parameter optical measurements show correlations between 
skin metabolic oscillations and vasomotion 
This is a full-length paper submitted to the journal Scientific Reports in May 2018 
and currently under peer review. The content of this manuscript is related to the 
results reported in the Chapter 3 of this thesis about the role of metabolic 
oscillators in mouse cutaneous vasomotion induced by α-adrenergic stimulation 
with phenylephrine (PE).
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ABSTRACT 
The cutaneous microcirculation represents an index of the health status of the cardiovascular system. 
Conventional methods to evaluate skin microvascular function are based on measuring blood flow by laser 
Doppler in combination with reactive tests such as post-occlusive reactive hyperaemia (PORH). Moreover, 
the spectral analysis of blood flow signals by continuous wavelet transform (CWT) reveals nonlinear 
oscillations reflecting the functionality of microvascular biological factors, e.g. endothelial cells (ECs). 
Correlation mapping optical coherence tomography (cmOCT) has been previously described as an efficient 
methodology for the morphological visualisation of cutaneous micro-vessels. Here, we show that cmOCT 
flow maps can also provide information on the functional components of the microcirculation. A spectral 
domain optical coherence tomography (SD-OCT) imaging system was used to acquire 90 sequential 3D 
OCT volumes from the forearm of a volunteer, while challenging the micro-vessels with a PORH test. The 
volumes were sampled in a temporal window of 25 minutes, and were processed by cmOCT to obtain flow 
maps at different tissue depths. The images clearly show changes of flow in response to the applied 
stimulus. Furthermore, a blood flow signal was reconstructed from cmOCT maps intensities to investigate 
the microvascular nonlinear dynamics by CWT. The analysis revealed oscillations changing in response to 
PORH, associated with the activity of ECs and the sympathetic innervation. 
The results demonstrate that cmOCT may be potentially used as diagnostic tool for the assessment of 
microvascular function, with the advantage of also providing spatial resolution and structural information 
compared to the traditional laser Doppler techniques. 
Keywords: microcirculation imaging; cmOCT; continuous wavelet transform; nonlinear dynamics; 
cardiovascular risk;  
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1. INTRODUCTION 
1.1 Cutaneous microcirculation for the assessment of cardiovascular risk 
The microcirculation is a network of tiny blood vessels distributed in all the tissues of the body, which 
ensure the normal perfusion of the organs, the maintenance of a normal blood pressure, and the exchange 
of nutritive substances and waste metabolites between blood and tissue1,2. Microvascular dysfunction is 
involved in the development of several diseases, such as cardiovascular complications of diabetes, 
cardiomyopathy, and hypertension1. Therefore, the evaluation of the microcirculation is a powerful 
modality for the assessment of cardiovascular disease (CVD) risk, which could find potential diagnostic 
applications1. Nonetheless, the examination of microvascular function in-vivo relies on invasive techniques 
such as coronary angiography1. This problem may be addressed by using non-invasive methodologies for 
the in-vivo examination of microcirculation from peripheral organs, i.e. skin1,3,4. Indeed, several studies 
have demonstrated that skin microcirculation reflects the health status of the coronary microvasculature4, 
and could be used as biomarker of CVD risk. For this reason, over the past number of years, many non-
invasive technologies have been developed for either the evaluation of skin microvascular function or the 
imaging of skin microvascular structure. 
1.2 Examination of cutaneous microvascular function by Laser Doppler and LSCI 
The conventional methods for the evaluation of skin microvascular function are laser Doppler or laser 
speckle contrast imaging (LSCI) in combination with functional tasks, e.g. post-occlusive reactive 
hyperaemia (PORH). Laser Doppler techniques are generally classified in laser Doppler flowmetry (LDF) 
and laser Doppler imaging (LDI), based on sensing the Doppler shift of red or infrared light backscattered 
by moving red blood cells (RBCs) for the calculation of the mean blood perfusion in small tissue areas2,3,5,6. 
LDF allows the continuous measurement of blood flow by a single-point laser probe in direct contact with 
the cutaneous tissue5. The application of spectral analytical methods, i.e. the continuous wavelet transform 
(CWT), on LDF time series is powerful to investigate  the nonlinear dynamics of blood flow providing 
information on the function of biological microvascular factors, such as endothelial cells (ECs), vascular 
smooth muscle cells (VSMCs), and the microvascular sympathetic nerves7,8. Nonetheless, LDF has low 
reproducibility because of the heterogeneous structure of skin compared to the small area analysed by the 
single-point probe2,3,5,6. This shortcoming is addressed by LDI, a contactless method that employs a laser 
placed at a distance above the skin to generate two-dimensional perfusion maps covering a larger skin 
region3,5,6. However, LDI cannot be used for the study of flow nonlinear fluctuations due to the slow 
sampling frequency of discrete perfusion maps during the measurements3. LSCI is a contactless technique 
based on sensing the reduction of the speckle contrast pattern caused by moving RBCs when a laser beam 
hits the skin, for estimating a perfusion value proportional to RBCs velocity5,6. The advantage of LSCI is 
providing both temporal and spatial resolution, however the method has low penetration depth compared 
to laser Doppler, and is highly sensitive to movement artefacts5,6. Furthermore, both of laser Doppler and 
LSCI do not allow the visualisation of micro-vessels2,5,6. Laser Doppler and LSCI blood flow data are 
expressed in perfusion arbitrary units (PU), making it necessary the combination of measurements with 
reactive tasks for assessing the relative changes of flow while challenging blood vessels with a variety of 
stimuli5,6. An example of functional task is PORH, based on monitoring the blood perfusion increase 
induced by a temporary period of ischaemia obtained through the occlusion of flow in the brachial artery5,6. 
The occlusion is performed by using a pressure cuff placed on the upper part of the tested arm, and the 
microcirculation is generally monitored from the volar forearm or the fingertips5,6. 
1.3 Methods for the imaging of skin micro-vessels 
The cutaneous micro-vessels can be imaged in-vivo by a variety of techniques based on optical microscopy, 
3D photoacoustic imaging or optical coherence tomography (OCT). The optical microscopy methods, i.e. 
capillaroscopy, orthogonal polarisation spectral imaging (OPS) and sidestream dark-field imaging (SDF), 
are based on the use of a microscope provided with a light source (white or green polarised light) for the 
transmission of images to a videocamera2,6. Capillaroscopy allows mainly the imaging of the structural 
organisation of capillaries in skin sites with thinner epithelium (i.e. the nailfold)2,9. This method is limited 
by the generation of low-contrast images6 and the requirement of invasive fluorescent dyes to visualise 
blood vessels from thicker skin regions2,6. OPS and SDF provide better resolution images than 
capillaroscopy thanks to the use of non-invasive green polarised light2,10. However, both the techniques are 
sensitive to motion and pressure artefacts6 and the imaging is optimal only for thinner cutaneous areas, e.g. 
the sublingual tissue2. All the optical microscopy methods provide two-dimensional images with 
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ambiguous depth resolution leading to the impossibility of establishing the exact origin of the imaged 
microvascular layer9,11. This shortcoming has been solved by the implementation of techniques for the 
three-dimensional imaging of the microcirculation, such as 3D photoacoustic imaging and OCT9,11. The 3D 
photoacoustic imaging is a full light penetration depth method12, employing low scattering ultrasound 
waves generated in all the directions by a pulsed laser light and absorbed by haemoglobin and melanin in 
the skin to provide contrast agents for the imaging of blood vessels9,13,14. Although photoacoustic imaging 
provides a full light penetration depth, the technique is characterised by low spatial resolution associated 
with the detection of ultrasound waves leading to poor structural images9. The development of 
photoacoustic microscopy (PAM) and optical resolution photoacoustic microscopy (OR-PAM) has allowed 
addressing the problem providing high-resolution images, even though this is still restricted to superficial 
capillaries9. Furthermore, photoacoustic imaging is limited by the use of a coupling medium at direct 
contact with the skin, which can affect the microcirculation and false the results9. OCT is a non-invasive 
method that uses a broadband near infrared light source placed at a distance above the skin to generate a 
low coherence gate for the selection of backscattered light from different tissue depths, providing two-
dimensional and three-dimensional in-vivo morphological images15. OCT allows overcoming some 
shortcomings of photoacoustic imaging, by providing cross-sectional images comparable to conventional 
optical biopsies with high structural resolution in the order of micrometers16,17. However, OCT suffers of 
poor penetration depth compared to photoacoustic imaging18. 
1.4 Simultaneous assessment of microcirculation morphology and function 
The advantage of laser Doppler and LSCI compared to the techniques for the visualisation of micro-vessels 
is the possibility to detect functional information that may be used for diagnostic purposes. Indeed, 
microvascular dysfunction is an early factor preceding the morphological damage to micro-vessels, which 
characterises the initial stages of cardiovascular pathologies1,3. However, LDI and LSCI are not suitable for 
a complete evaluation of the microcirculation because they do not allow micro-vessels visualisation and 
are characterised by uncertain spatial and depth resolution. For these reasons, many methods for the 
morphological imaging of the microcirculation have been implemented further to allow the simultaneous 
assessment of microvascular function and structure. For example, photoacoustic imaging may provide 
functional information associated to the oxygenation of the examined microvascular area, by tracing the 
light absorbed by haemoglobin at different wavelengths19. Additional examples are the improvements of 
OCT, adding contrast mechanisms based on the Doppler shift (DOCT)20 and the speckle variance 
(svOCT)21 principles to image blood flow, or by the development of data processing methods based on the 
discrimination of static and flow dynamic regions of the skin, i.e. Doppler optical micro-angiography 
(DOMAG)22. Nonetheless, the mentioned methods are not optimal for different reasons, such as angular 
dependence of the acquisitions leading to the production of incomplete flow maps (DOCT)9,11, requirement 
of previous knowledge of the morphology to trace blood flow (svOCT)9, and long post-processing time 
required for obtaining blood flow maps (DOMAG)9. To address these shortcomings, recently a novel 
technique for the in-vivo visualisation of micro-vessels named correlation mapping OCT (cmOCT) has 
been developed, which provides high-resolution structural maps of the microcirculation with potential to 
gain also functional information9,11. The technique is based on correlation coefficient statistics to detect 
blood flow from the OCT signal9,11, by discriminating the moving scatters characterising the cutaneous 
areas containing active blood vessels and the stationary scatters in the skin locations lacking of blood 
vessels9,11. This is achieved by performing the cross-correlation analysis between adjacent two-dimensional 
B-frames of an OCT volume sampled from the skin, which returns high correlation coefficients for the 
static areas similar between different B-frames, and low correlation coefficients for the microvascular areas 
characterised by the presence of blood flow9,11. The correlation map generated from the analysis reveals the 
location of blood flow allowing the visualisation of the micro-vessels9,11. The benefits of cmOCT are the 
apparent angle independence of the method11, the fact that it is not required the previous knowledge of the 
microvascular morphology to determine blood flow areas, and fast data processing to generate the flow 
maps9. 
1.5 Goal and findings of the research 
Despite the suitability of cmOCT for the imaging of microvascular structure has been demonstrated9,11, less 
proof is reported about the use of this method for the study of microvascular function. In this work, we 
show that cmOCT can be applied successfully for the study of microvascular function. We demonstrate 
that collecting many sequential low-resolution 3D OCT volumes from the human forearm during PORH 
functional task and processing the volumes by cmOCT it is possible to generate sequential blood flow maps 
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at several tissue depths clearly tracing the temporal changes of flow typical of PORH test. Furthermore, the 
intensity of cmOCT flow maps was used to reconstruct a continuous time series for the study of blood flow 
nonlinear fluctuations by the application of the CWT spectral analysis. The wavelet examination of the 
reconstructed signal revealed blood flow oscillations associated with the physiological activity of biological 
factors playing a fundamental role in microvascular function: oscillations related to endothelial vasodilatory 
mechanisms mediated by ECs, and the neurogenic oscillation that reflects the contribution of the 
microvascular sympathetic nerves to vasomotion. The CWT oscillators displayed changes in their spectral 
energy during reactive hyperaemia similar to those described in literature for the LDF signal. Therefore, 
our results demonstrate that cmOCT is suitable for the simultaneous evaluation of microcirculation 
structure and function. Next step will be the application of the technique to a larger number of subjects for 
testing the reproducibility of cmOCT and its applicability to clinical studies. 
2. METHODS 
2.1 Images acquisition 
Data were collected from the volar forearm of a healthy woman aged 28, which signed an informed consent 
form. The experiment was performed in a laboratory room with controlled temperature (20 ± 1°C), allowing 
15-20 min of acclimatisation of the subject. The scans were obtained from the left volar forearm while the 
volunteer was laying in a clinical bed. The tested arm was fixed by employing a house-designed soft support 
to ensure a static and comfortable position during the examination preventing motion artefacts. The location 
for the acquisitions was selected avoiding hairy and injured areas. A pressure cuff was fixed in the upper 
part of the arm for performing a PORH functional test during the acquisition of the images. PORH response 
was induced by blocking blood flow through the brachial artery by applying a pressure of 200 mmHg. A 
spectral domain (SD) OCT device (TEL2200C1, Thorlabs Inc., USA) was employed for imaging three-
dimensional skin volumes. The system is provided with a superluminescent diode (SLD) with a center 
wavelength of 1300 nm, supporting a maximum imaging depth of 3.5 mm in non-scattering samples, an 
axial acquisition rate between 5.5 and 76 kHz, and an axial resolution of 5.5 µm in non-scattering samples. 
The sample arm contains a LSM003 (Thorlabs Inc., USA) scanning lens supporting a transverse resolution 
of 13 µm in air. An initial volume of 1.50 × 1.50 × 1.82 mm3 was sampled from the forearm at a speed of 
48 kHz with a sampling density of 1024 (length) × 1024 (width) × 512 (depth) pixels, to image the 
microvascular morphology of the examined location. The time employed for the acquisition of the structural 
volume was 50.9 s, which is too long for the evaluation of functional dynamics. Thus, the study of 
functional dynamics was performed by decreasing the scanning density to 256 × 256 × 512 pixels that can 
be acquired in ~6 s, allowing the fast collection of consecutive OCT volumes suitable for assessing 
microvascular function. Moreover, a fundamental requirement for visualising blood flow by cmOCT is a 
dense sampling below the lateral resolution of the consecutive 2D B-scans of the OCT volume, which 
guarantees a robust correlation between the motionless scatters of the adjacent B-scans. Thus, to ensure a 
spatial separation between the B-scans suitable for the cmOCT analysis the sampled area was reduced to 
0.75 × 0.75 × 1 .82 mm3, corresponding to a spatial separation of 2.9 µm. Although the possibility of 
acquiring each scan in ~6 s, the samples were collected at a rate of one volume every 16.6 s because the 
software associated with the OCT system (ThorImage OCT 4.3, Thorlabs Inc., USA) required around 10.6 
s for saving each sample. In total, 90 consecutive low-resolution volumes were acquired from the forearm 
of the volunteer in a temporal period of ~25 min, while performing the PORH functional task. An initial 10 
min collection of 36 OCT volumes was carried out to establish the blood flow at rest, then 18 volumes were 
collected for a 5 min occlusion period, and finally 36 volumes were collected for 10 min after the removal 
of the occlusion for tracking blood flow dynamic changes during PORH response. 
2.2 cmOCT analysis 
The cmOCT analysis to extract blood flow maps at different tissue depths from each OCT volume was 
carried out by using the Java algorithm implemented by Enfield et al.9 and Jonathan et al.11. The algorithm 
is able to estimate the correlation coefficients between consecutive two-dimensional B-frames extracted 
from the OCT volume, by calculating the cross-correlation of a square grid from the first B-scan 1 (I1) to 
the same grid from the adjacent B-scan 2 (I2), as follow, 
cmOCT(x,y) = ∑ ∑
[I1(x+p,y+q)-I1(x,y)̅̅ ̅̅ ̅̅ ̅̅ ][I2(x+p,y+q)-I2(x,y)̅̅ ̅̅ ̅̅ ̅̅ ]
√(I1(x+p,y+q)-I1(x,y)̅̅ ̅̅ ̅̅ ̅̅ )
2
(I2(x+p,y+q)-I2(x,y)̅̅ ̅̅ ̅̅ ̅̅ )
2 
N
q=0
M
p=0                      (1) 
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where M and N define the dimension of the grid, and 𝐼 ̅is the mean intensity of the grid. The grid is shifted 
along all the pixels of the B-frames to generate a 2D map with correlation coefficients between 0 and 1. 
The low correlation regions are displayed as bright areas representing blood flow, while the high correlation 
regions associated to the motionless scatters of the tissue are displayed as dark background areas of the 
map. A 7 × 7 kernel dimension of the grid was used to produce the cmOCT maps, which ensures a good 
sensitivity to blood flow without loss of spatial resolution due to kernal size. The maps were generated as 
maximum intensity projection (MIP) images, which allow a better visualisation of microvascular structure 
and the detection of the maximum flow intensity. To study micro-vessels from different cutaneous 
microvascular layers, the flow maps were produced from different depths of the OCT volumes, i.e. in the 
en face plane. This was achieved by determining the location of skin surface from the structural images, 
and employing the superficial region as a reference to determine the various depths of the underlying tissue. 
The typical anatomic morphology of cutaneous microcirculation was visualised, characterised by the 
presence of capillaries at a depth of 80-180 µm (dermal-epidermal junction) and  horizontal micro-vessels 
at a depth of  300-400 µm (dermal plexus). 
2.3 Reconstruction of blood flow time series 
To test the suitability of cmOCT for the study of microvascular flow nonlinear dynamics by CWT spectral 
analysis, a continuous time series of blood flow was reconstructed from the cmOCT maps. First, the average 
image intensity was extracted by Matlab R2015a software from 90 sequential flow maps produced at the 
cutaneous depth of 300-400 µm during PORH test. Then, the intensity values were used as discrete data 
points to reconstruct a continuous signal, covering the 25 minutes time used in the experiment for collecting 
the volumes. The reconstruction was performed by piecewise cubic spline interpolation using Matlab 
R2015a, applying a temporal interval of 16.6 s between each pair of discrete data points that corresponds 
to the sampling frequency employed during the collection of the OCT volumes. The spline interpolation is 
a mathematical procedure to approximate a function by interpolating equally spaced discrete data points of 
the function. The technique uses a low-degree piecewise polynomial named spline, which reduces the 
interpolation error compared to the normal polynomial interpolation. The method is advantageous for the 
approximation of a function over large intervals, which is not optimal by using a single polynomial that 
would require a large degree of the approximating polynomial introducing oscillatory artefacts (Runge’s 
phenomenon) during the interpolation process. The spline interpolation addresses this problem by 
subdividing the interval [a,b] where the function f is continuous in smaller sub-intervals, and approximating 
f in every sub-interval by the use of low-degree polynomial pieces that define a composite spline function 
s. In this study, a third-degree cubic natural spline was used which allows the reconstruction of continuous 
processes reproducing the smooth curvature of the function to be approximated. As displayed by equation 
2, the cubic spline function employs four terms to define a piecewise cubic polynomial between each pair 
of data points, 
p3(x) = ax3 + bx2 + cx + d ,                                                                                                                          (2 ) 
where p3 is the piecewise cubic polynomial, and a, b, c and d are the four coefficients defining p3. The final 
curve is the result of the sum of many pieces reconstructed between each pair of data points. The 
reconstruction was carried out by employing the cftool instrument in Matlab R2015a, which allows 
performing the cubic spline interpolation by entering the vectors of time and experimental data points. 
Specifically, we have used a time vector of 90 time points defining an acquisition rate of each flow 
measurement every 16.6 s and a vector containing the 90 flow intensity values extracted from the sequential 
cmOCT maps. The values of the continuous signal obtained from the reconstruction were saved for the 
subsequent application of the CWT analysis. As discussed previously, a benefit of spline interpolation is 
that the approximation process does not produce oscillatory artefacts. Thus, applying this technique we 
have ensured that the results of the subsequent CWT analysis were representative of the real fluctuations 
of microvascular flow detected by cmOCT, without the effect of artefacts introduced during the 
reconstruction. However, a shortcoming of spline interpolation is the low accuracy in the reconstruction of 
the right and left ends of the function, due to the presence of a single known data point at each extremity. 
To prevent the generation of artefacts at the extremities of the reconstructed signal, the curve was broken 
off at the left and right tips ensuring that the beginning and termination of the signal were corresponding 
respectively to the initial and final experimental data points. Finally, it should be clarified that in this work, 
the spline interpolation was not employed as a numerical analysis to fit a model but the method was used 
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as a technical procedure to obtain a continuous signal, which is a compulsory requirement to allow 
performing the CWT spectral analysis. 
2.4 CWT spectral analysis 
The continuous wavelet transform technique allows the study of microvascular flow nonlinear dynamics, 
revealing the contribution of specific components in the microcirculation (i.e. ECs, VSMCs, and 
sympathetic nerves) to the temporal dynamic changes of flow. The method is advantageous for the analysis 
of the oscillatory behaviour of signals showing heterogeneous oscillations over a large range of frequencies, 
e.g. the LDF signal, providing a good time-frequency resolution7,8. Here, the CWT was used for analysing 
the dynamic fluctuations of a blood flow signal reconstructed from the cmOCT maps generated at a skin 
tissue depth of 300-400 µm, to prove that cmOCT can provide functional microvascular information related 
to vasomotion. The method allowed the detection of fluctuations in the frequency ranges 21-52 × 10-3 Hz, 
9.5-21 × 10-3 Hz and 5-9.5 × 10-3 Hz that respectively reflect the neurogenic activity of sympathetic nerves, 
the ECs activity nitric oxide (NO)-dependent, and the ECs activity NO-independent8. The myogenic 
oscillation related to VSMCs function was not detected because the OCT volumes were sampled at a 
frequency of each volume every 16.6 s, restricting the study to fluctuations up to ~60 × 10-3 Hz that is not 
enough to cover the entire myogenic frequency range located between 52-145 × 10-3 Hz 8. The CWT 
analysis was implemented by using Matlab R2015a, according to the principles described by Stefanovska 
et al.7,8. The method is based on the employment of a set of non-orthogonal basic functions Ψs,t providing 
a large frequency window scaled and shifted along the time domain for the extraction of the CWT ensuring 
an optimal time-frequency resolution8. The functions Ψs,t for the calculation of the CWT of blood flow 
signals is obtained according to equation 3, by using a Morlet mother wavelet ψ scaled in the temporal 
domain by a factor s and a center time t, providing a window size suitable for the analysis of highly time-
varying signals8, 
 Ψs,t (u) = |s|-1/2 ψ (
u-t
s
),                                                                                                                                                          (3) 
where the Morlet mother wavelet ψ is estimated as displayed in equation 4 8, 
ψ(u) = 
1
√𝜋
e-iue-u
2/2.                                                                                                                                                                     (4) 
The CWT spectrum of a signal g(u) is then extracted as shown in equation 5 8, 
g̃(s,t) = ∫ Ψ̅s,t
∞
-∞
 (u)g(u)du,                                                                                                                                                   (5) 
where Ψ̅ is a complex conjugate of the basic window function removing any dependence of the technique 
from frequency scales, and g̃(s,t) is the CWT spectral function defined by the scale s and time t 8. The 
obtained CWT spectrum is characterised by a power/energy distributed at various frequencies, indicating 
the amount of signal located at specific frequencies at the time t. Explained in physiological terms, the 
CWT energy indicates the contribute of each microvascular oscillator (i.e. ECs) associated with a specific 
frequency range to blood flow changes at a precise time that for example may be the stage of a reactive 
test. Monitoring the changes of the CWT energy from specific frequency intervals allows the assessment 
of the function of specific microvascular components with potential clinical diagnostic applications. 
3. RESULTS 
3.1 Visualisation of skin microcirculation morphology 
A first three-dimensional OCT volume was acquired from a 1.50 × 1.50 × 1.82 mm3 area in the volar 
forearm of the volunteer to visualise the microcirculation morphology. The acquisition was performed in 
50.9 s employing 1024 × 1024 A-scans, and the MIP flow maps were extracted at different tissue depths 
by cmOCT analysis. Figure 1 shows the structural enface MIPs at three different tissue depths obtained 
from the volunteer, displaying the classical cutaneous microvascular morphology described by Enfield et 
al.9. 
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Figure 1 Morphological visualisation of skin micro-vessels from the forearm. (a) 2D structural B-scan from a 1.50 
× 1.50 × 1.82 mm3 OCT volume. The red area outlines the epidermis surface, the yellow region defines the dermal-
epidermal junction, and the green area marks a part of the dermal plexus. (b) Enface 1.50 × 1.50 mm2 MIP of the 
epidermis (0-40 µm). (c) Enface 1.50 × 1.50 mm2 MIP of the dermal-epidermal junction (80-180 µm) where the 
capillaries are located. The smaller yellow square marks the 750 × 750 µm2 region selected to study capillaries function. 
(d) Enface 1.50 × 1.50 mm2 MIP of the dermal plexus (300-400 µm) characterised by a horizontal network of micro-
vessels. The smaller green square marks the 750 × 750 µm2 area selected to study arterioles/venules function. 
Figure 1 (a) shows a structural 2D B-frame of the OCT volume, displaying a longitudinal view of the 
locations from which the cmOCT maps were produced. Figure 1 (b) displays the MIP enface map from the 
epidermis (0-40 µm) that, as expected, was characterised by absence of micro-vessels. Figure 1 (c) shows 
the MIP generated from a depth of 80-180 µm (dermal-epidermal junction), displaying the presence of 
micro-vessels with vertical direction corresponding to the capillary loops originated from the ascending 
blood vessels of the dermal layer, and appearing as red points in a black background. Figure 1 (d) shows 
an enface MIP of the skin at a depth of 300-400 µm (dermal plexus), displaying a network of arterioles and 
venules orientated horizontally from which, respectively, the nutritive substances are transferred to the 
capillaries and the waste metabolites to the venous system. To study microvascular function from 80-180 
µm and 300-400 µm tissue depths, an enface plane of 0.75 × 0.75 mm2 was selected from the structural 
images to perform sequential temporal acquisitions of 3D OCT volumes during reactive hyperaemia task. 
Figure 1 (c) and (d) illustrate the 750 × 750 µm2 areas selected for monitoring capillaries and 
arterioles/venules functional dynamics, respectively marked by yellow and green squares. 
3.2 Examination of blood flow functional dynamics from cmOCT maps 
Ninety low-resolution volumes of the 0.75 × 0.75 × 1.82 mm3 yellow/green regions shown in Figure 1 (c-
d) were collected from the forearm of the volunteer during a 25 min PORH test, sampling each volume 
every 16.6 s. First, 36 samples were collected during a 10 min resting period, then 18 samples were acquired 
during a 5 min occlusion of blood flow, and finally 36 samples were collected in a 10 min period after the 
removal of the occlusion for monitoring flow changes during PORH response. The volumes were processed 
by cmOCT to obtain consecutive flow maps at 80-180 µm and 300-400 µm cutaneous depths for tracing, 
respectively, the flow dynamics of capillaries (Figure 2) and arterioles/venules (Figure 3). 
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Figure 2 and Figure 3 display the enface MIPs obtained from 24 volumes of the total 90 temporal samples, 
which represent the most important stages of PORH test. Although the quality of the maps was not optimal 
compared to the morphological images, they clearly traced the flow changes typical of PORH reactive task. 
The capillaries did not show relevant flow changes during occlusion (Figure 2, occlusion 1-8) compared to 
the flow at rest (Figure 2, baseline 1-8), while the micro-vessels in the dermal plexus showed a relevant 
decrease and disappearance of flow during occlusion (Figure 3, occlusion 1-8) compared to the flow at rest 
(Figure 3, baseline 1-8). These findings may indicate the delivery of the residual blood flow from arterioles 
to capillaries during the occlusion period, ensuring the feeding of the epidermis during ischaemia. On the 
other hand, a relevant growth of the flow typical of the hyperaemic response was observed during PORH 
either for the capillaries or the dermal micro-vessels (Figures 2-3, porh 1-8), related to the vascular 
reactivity for the restoration of a normal blood flow after removal of the occlusion. These findings prove 
that cmOCT allows tracking the microcirculatory dynamics and may be used for the investigation of 
microvascular function. 
 
Figure 2 Consecutive cmOCT flow maps obtained at a depth of 80-180 µm from OCT volumes collected during 
PORH task. Temporal enface MIPs from the 750 × 750 µm2 yellow region marked in Figure 1 (c) for the examination 
of capillaries microvascular function. The MIPs were generated from 0.75 × 0.75 × 1.82 mm3 volumes collected every 
16.6 s with a sampling density of 256 × 256 A-scans. The baseline 1-8 maps illustrate the flow detected at baseline 
before the application of  the occlusion, the occlusion 1-4 and 5-8 maps correspond respectively to the flow detected  
after the beginning of the occlusion and before the end of the occlusion, and the porh 1-8 maps show the flow detected 
during the hyperaemic response. 
 
3.3 Reconstruction of blood flow signal from cmOCT maps 
To demonstrate further the applicability of cmOCT for the study of microvascular function, the cmOCT 
maps were employed for tracing the nonlinear dynamics of blood flow to detect the oscillatory activity of 
microvascular components contributing to the rhythmic vaso-relaxation induced by PORH stimulation. The 
task was achieved by reconstructing a continuous flow signal from the intensities of the sequential temporal 
cmOCT maps and processing the obtained time series by CWT spectral analysis. The reconstruction process 
was a fundamental step to allow performing the CWT analysis, which is a technique applicable only on 
continuous time-varying signals. Figure 4 shows the blood flow time series obtained by using the mean 
intensity values extracted from the 90 sequential cmOCT maps generated at a depth of 300-400 µm as 
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discrete data points to reconstruct  a curve covering the 25 min period of the reactive test. The reconstruction 
was performed by piecewise cubic spline interpolation method that is advantageous because no oscillatory 
artefacts are introduced between each pair of discrete data points during the reconstruction process. The 
curve in Figure 4 clearly outlines the classic flow trend of the reactive hyperaemia task, showing a decrease 
of blood flow during the ischaemic period, and a relevant increase of flow during PORH vasodilation 
response up to a maximal peak before the gradual restoration of the baseline flow. This is a further proof 
that cmOCT is suitable for the study of functional dynamics. 
 
Figure 3 Consecutive cmOCT flow maps obtained at a depth of 300-400 µm from OCT volumes collected during 
PORH task. Temporal enface MIPs from the 750 × 750 µm2 green region marked in Figure 1 (d) for the examination 
of arterioles/venules microvascular function. The MIPs were generated from 0.75 × 0.75 × 1.82 mm3 volumes collected 
every 16.6 s with a sampling density of 256 × 256 A-scans. The baseline 1-8 maps illustrate the flow detected at baseline 
before the application of  the occlusion, the occlusion 1-4 and 5-8 maps correspond respectively to the flow detected  
after the beginning of the occlusion and before the end of the occlusion, and the porh 1-8 maps show the flow detected 
during the hyperaemic response. 
 
Figure 4 Reconstruction of a continuous blood flow signal from cmOCT maps. Blood flow curve reconstructed by 
piecewise cubic spline interpolation of the discrete average intensity values obtained from 90 sequential cmOCT maps 
produced at a cutaneous depth of 300-400 µm. A time interval of 16.6 s was applied between each pair of discrete data 
points to cover the 25 min period of the PORH functional task. The flow is expressed in arbitrary units (AU). 
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3.4 CWT spectral analysis of the blood flow signal reconstructed from cmOCT maps 
The CWT analysis of the signal reconstructed from cmOCT maps revealed oscillations in the frequency 
ranges 21-52 × 10-3 Hz, 9.5-21 × 10-3 Hz and 5-9.5 × 10-3 Hz, which respectively reflect the neurogenic 
modulation of microvascular tone mediated by the sympathetic nerves, and the regulation of microvascular 
tone mediated by ECs through NO-dependent and NO-independent pathways8. Figure 5 displays the CWT 
analysis of the reconstructed flow signal shown in Figure 4. Figure 5 (a) displays the CWT scalogram chart 
that shows a gradient coloured map representing the distribution of the wavelet energy of the signal in the 
time-frequency domain. The dark blue regions represent the lowest energies and the dark red areas the 
highest energies. The chart clearly outlines the growth of energy during PORH response in all the identified 
oscillatory frequency intervals, reflecting the endothelial and sympathetic modulatory mechanisms 
activated during vasodilation. The time-averaged CWT spectrum in Figure 5 (b) distinguishes the maximum 
wavelet energy peaks at various frequency intervals corresponding to the specific microvascular oscillators 
(neurogenic, ECs NO-dependent, ECs NO-independent). This allows tracking the activity of each oscillator 
and making comparisons between different individuals, by extracting values of the maximal energy 
(amplitude), the overall energy (area under the curve), and the frequency from each wavelet peak during 
the different stages of PORH task. For example, in Figure 5 (b) an increase of the amplitude and energy of 
all the oscillators was clearly observed during PORH response (black line) compared to occlusion (red line) 
and baseline (blue line). These data are in agreement with the results reported for the spectral analysis of 
LDF signals measured during PORH functional test23. Indeed, the growth of energy reflects the vasodilation 
modulated by ECs, VSMCs and the neurogenic control to allow the reperfusion of the cutaneous tissue after 
an occlusion period. The CWT spectral analysis showed results in agreement with the current techniques 
for the examination of microvascular nonlinear fluctuations. Therefore, this is an additional evidence of the 
suitability of cmOCT for monitoring microvascular function. 
 
 
Figure 5 CWT spectral analysis of a blood flow signal reconstructed from cmOCT maps produced at a depth of 
300-400 µm. (a) CWT scalogram displaying the distribution of the wavelet power in the time-frequency domain 
represented by a coloured gradient map ranging from dark blue (low power) to dark red (high power). The coloured 
areas in the scalogram are part of the “cone of influence”, which is a time-frequency region where distortions of the 
wavelet transform due to the finite duration of the signal are irrelevant24. In contrast, the transparent regions in the 
corners at the bottom of the chart are regions outside of the cone in proximity of the time edges of the signal, where the 
CWT is characterised by boundary effects making the calculations from these areas uncertain24. (b) Time-averaged 
CWT spectra estimated for all the steps of PORH functional task.  The graphs discriminate the CWT maximum 
amplitude peak and overall energy (area under the curve of the peak) related to each specific microvascular oscillator. 
The neurogenic (21-52 × 10-3 Hz), ECs NO-dependent (9.5-21 × 10-3 Hz), and ECs NO-independent (5-9.5 × 10-3 Hz) 
oscillators were detected. 
4. DISCUSSION AND CONCLUSIONS 
In this study, we have shown that cmOCT method allows the simultaneous imaging of skin microcirculation 
morphology and monitoring of microvascular function. Although the resolution of the functional temporal 
cmOCT maps was low,  they allowed tracking the overall microvascular dynamics with spatial resolution 
at various tissue depths, showing results similar to those reported for the conventional techniques employed 
to study microvascular function (i.e. LDF). This is demonstrated by the blood flow trend typical of PORH 
reactive test observed on the cmOCT maps (Figures 2-3), and also reflected on the reconstructed flow signal 
displayed in Figure 4. Furthermore, additional evidence was provided by the identification of dynamic 
microvascular oscillators characterising the reconstructed signal associated with biological components in 
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the microcirculation (Figure 5), which displayed trends of the wavelet spectral energy similar to those 
reported for the spectral analysis of LDF time series recorded  during PORH test. The CWT analysis did 
not allow the detection of the myogenic oscillator related to the activity of VSMCs, which are implicated 
in the mechanical modification of micro-vessels diameter during vasomotion. This was due to the long time 
required by the ThorImage software (Thorlabs Inc., USA) for saving the OCT volumes during the 
acquisition of the images, allowing a scanning rate of one volume every 16.6 s that was not sufficient to 
detect the myogenic oscillation. The use of a more powerful computer in the future may help to improve 
the performance of the software, allowing a faster data storage to increase the sampling frequency and 
detect the myogenic oscillator. Overall, the findings from this study suggest that cmOCT may be used as a 
tool for the study of microvascular function with possible diagnostic applications. However, further 
experiments in a larger number of subjects are required to demonstrate the robustness of the method and 
the eligibililty for clinical studies. In addition, the combination of cmOCT with the CWT spectral analysis 
may find several applications. For example, this may help to establish the contribution of each 
microvascular bed to vasomotion and clarify which layer is more involved in cutaneous PORH response, 
by comparing the spectral analysis of cmOCT blood flow signals reconstructed from different skin tissue 
depths. Another application may be the examination of endothelial function for diagnostic purposes by 
comparing the endothelial wavelet energy between healthy individuals and patients affected by 
cardiovascular disease (CVD). 
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ABSTRACT 
Correlation mapping optical coherence tomography (cmOCT) is a powerful technique for the imaging of 
skin micro-vessels structure, based on the discrimination of the static and dynamic regions of the tissue. 
Although the suitability of cmOCT to visualize the microcirculation has been proved in humans and animal 
models, less evidence has been provided about its application to examine functional dynamics. Therefore, 
the goal of this research was validating the cmOCT method for the investigation of microvascular function 
and vasomotion. 
A spectral domain optical coherence tomography (SD-OCT) device was employed to image 90 sequential 
three-dimensional OCT volumes from the forearm of 12 volunteers during a 25 minutes post-occlusive 
reactive hyperaemia (PORH) test. The volumes were processed using cmOCT to generate blood flow maps 
at selected cutaneous depths. The maps clearly trace flow variations during the PORH response for both 
capillaries and arterioles/venules microvascular layers. 
Continuous blood flow signals were reconstructed from cmOCT maps to study vasomotion by applying 
wavelet transform spectral analysis, which revealed fluctuations of flow during PORH, reflecting the 
regulation of microvascular tone mediated by endothelial cells and sympathetic nerves. The results clearly 
demonstrate that cmOCT allows the generation of functional information that may be used for diagnostic 
applications. 
Keywords: cmOCT; skin microvascular function; vasomotion; wavelet transform; nonlinear dynamics. 
 
1. INTRODUCTION 
1.1 Conventional methods for the assessment of skin microvascular function 
The examination of the microcirculation is a promising tool for the establishment of novel biomarkers of 
cardiovascular disease (CVD) risk, which may help to improve the diagnosis, prognosis and early 
preclinical assessment of vascular pathologies1. However, the direct assessment of the microcirculation in-
vivo is limited by the requirement of invasive methods based on catheterization, e.g. coronary angiography 
and intracoronary Doppler1. In contrast, the examination of the microcirculation from peripheral organs, 
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i.e. skin, represents a better modality to investigate microvascular function based on the use of non-invasive 
imaging laser technologies1,2,3. 
The conventional methods for the evaluation of skin microvascular function are laser Doppler and laser 
speckle contrast imaging (LSCI) in combination with reactive tests. Laser Doppler techniques rely on the 
detection of the Doppler shift of red or infrared light backscattered by moving erythrocytes for the 
estimation of the average blood flow in small tissue volumes2,4,5. Within these methods, laser Doppler 
flowmetry (LDF) is used for the continuous monitoring of microvascular perfusion through single-point 
laser probes in direct contact with the skin5. An advantage of LDF is the high temporal data acquisition that 
allows studying the nonlinear fluctuations of blood flow6. This can be achieved by applying the continuous 
wavelet transform (CWT) spectral analysis on LDF time series7,8, which reveals indirectly the activity of 
specific biological factors in the microcirculation, e.g. endothelial cells (ECs), vascular smooth muscle cells 
(VSMCs) and the local sympathetic innervation. However, relevant limitations of laser Doppler and LSCI 
are the impossibility to visualize blood vessels and the expression of data in arbitrary units making it 
possible only relative assumptions based on the combination of perfusion measurements with reactive 
tests4,5,6. An example of a widely used reactive test for the examination of human cutaneous 
microcirculation is the post-occlusive reactive hyperaemia (PORH), which evaluates the increase in blood 
perfusion from the forearm or fingertips after a temporary period of ischaemia stimulated by artificial 
occlusion of the brachial artery5,6. 
1.2 Techniques for the examination of cutaneous microvascular structure 
Skin microvascular structure can be visualized in-vivo by several methods based on optical microscopy, 3D 
photoacoustic imaging or optical coherence tomography (OCT). A common relevant limitation of the 
optical microscopy techniques is the generation of 2D images with uncertain depth resolution9,10. 3D 
photoacoustic imaging is based on the generation of pressure acoustic waves in all the directions employing 
a pulsed laser light absorbed by chromophores in the skin that act as contrast agents to visualize micro-
vessels11,12. The main benefit of photoacoustic imaging is the full light penetration depth13. However, the 
method suffers from poor spatial resolution, even though this aspect has been improved by implementing 
the optical resolution photoacoustic microscopy (OR-PAM)9. Moreover, the method requires a coupling 
medium in direct contact with the tissue, which is a drawback for several applications, i.e. image-guided 
brain surgery14,15, wounds/burns assessment16 and ophthalmology14,15. This might also be a limitation to 
assess the activity of skin micro-vessels, which is sensitive to the local cutaneous temperature17 and may 
be affected by the temperature of the coupling medium. However, the recent implementation of contact-
free PAM18,19,20 is promising to overcome this shortcoming. Additionally, some limits of photoacoustic 
imaging have been solved with the further implementation of OCT method to allow micro-vessels imaging. 
OCT is a non-invasive contactless technology employing a broadband near infrared light source to provide 
a low coherence gate for the selection of backscattered light from different tissue depths, producing in-vivo 
2D and 3D structural images21. The main advantage of OCT is the generation of cross-sectional images 
comparable to conventional optical biopsies with micrometer-level structural resolution22,23. However, the 
technique is limited by low penetration depth (~1-2 mm)24. 
1.3 Concurrent evaluation of microvascular structure and function 
Although the visualization of microvascular structure is powerful for the detection of specific organisational 
patterns or damage to the microvasculature that may be associated with CVD, laser Doppler and LSCI are 
still the preferential choice for the examination of skin microvascular function. The reason is that functional 
abnormalities in the microcirculation precede structural changes and clinical manifestations, thus 
representing a hallmark of the early stages of the pathology suitable for the preclinical prediction of CVD 
risk1,2. However, laser Doppler and LSCI are limited by both ambiguous spatial and depth resolution. 
Therefore, the ideal tool for a complete assessment of the microcirculation would be a technology providing 
simultaneous functional and structural information. Extensions of OCT utilize the Doppler shift (DOCT)25 
and the speckle variance (svOCT)26 principles for providing a contrast mechanism to visualize blood flow, 
or processing techniques relying on the separation of static areas and flow dynamic regions of the tissue, 
i.e. Doppler optical microangiography (DOMAG)27. The combination of OMAG with the PORH reactive 
test has been described previously as an optimal method for providing quantitative functional data of the 
human peripheral skin microcirculation28. 
Another technique for the in-vivo imaging of the microcirculation is correlation mapping OCT (cmOCT). 
This method employs correlation coefficient statistics to determine blood flow from the intensity of the 
reflected OCT signal9,10, taking advantage of the time-varying speckle of moving scatters in skin regions 
containing active blood vessels and the constant reflectance of the stationary scatters in the bulk tissue 
lacking of blood vessels9,10. Therefore, the correlation map obtained from the cross-correlation analysis is 
able to visualize the location of blood flow9,11. The advantages of cmOCT compared to DOCT, svOCT and 
DOMAG respectively are the apparent angle independence of the technique10, non-requirement of previous 
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knowledge of the structure to determine flow regions, and very fast data processing to obtain the flow 
maps9. However, cmOCT is limited by high decorrelation caused by noisy background regions in the 
images, which can be misinterpreted as blood flow signal. This necessitates the use of a binary mask to 
suppress these regions9 leading to reduced quality images compared to those generated with OMAG or 
svOCT techniques. 
1.4 Aims of the study 
The objectives of this research were providing evidence on the potential application of cmOCT for 
assessing microvascular function, and demonstrating for the first time that OCTA techniques are suitable 
to monitor vasomotion and the activity of specific biological factors of the microcirculation. This was 
achieved by generating sequential cmOCT blood flow maps from the human forearm at different cutaneous 
depths during a 25 min PORH reactive test, and applying the CWT spectral analysis on continuous blood 
flow signals reconstructed from cmOCT maps. 
The results displayed that cmOCT is able to detect functional flow dynamics and vasomotion oscillatory 
patterns reflecting the activity of the microvascular endothelium and local sympathetic innervation. Our 
results demonstrate that the study of microvascular function by OCTA techniques is not restricted only to 
the general observation of flow dynamics but can be extended for gaining information on the behaviour of 
specific biological components in the microcirculation network. 
2. METHODS 
2.1 Study population 
The experiments were performed on 8 women and 4 men with an average age of 33 ± 10 years old, which 
signed an informed consent form according to the rules of the Declaration of Helsinki. The measurements 
were collected in the morning time in a laboratory with a constant temperature (20 ± 1 °C), allowing at least 
15-20 min of acclimatisation of the subjects. The volunteers were asked to observe a fasting period of 4-6 
hours prior to the examination to avoid physiological differences related to nutritional habits. The 
measurements were performed from the left volar forearm maintained at heart level, while the volunteer 
was laying in supine position in a clinical bed. A custom-built soft support was used to fix the arm, ensuring 
a static and comfortable position during the test to avoid bias in the experimental data due to movement 
artefacts (Fig. 1). The skin site for the measurements was chosen while avoiding hairy and injured regions. 
A pressure cuff was placed in the upper part of the left arm for performing the PORH test during the 
acquisition period of the images. The occlusion of the brachial artery to stimulate PORH response was 
induced by inflating the pressure cuff at 200 mmHg. 
 
Fig. 1 Experimental setup. A custom-built mount was used to immobilize the arm as much as possible during testing. 
A contact support was applied in the skin surface with gentle pressure to stabilize the scan location between data sets 
avoiding mismatches. The OCT probe was placed above the contact support to collect data from the chosen region. 
The image shows also additional equipment (a LDF optical probe and a camera) that is not relevant for the research 
presented in this work. 
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2.2 OCT device for images acquisition 
A commercial OCT system (TEL2200C1, Thorlabs Inc., USA) was used for imaging 3D volumes of the 
cutaneous tissue. This spectral domain (SD) device consists of a superluminescent diode (SLD) with a 
center wavelength of 1300 nm, which supports an imaging depth up to 3.5 mm (in non-scattering samples), 
an axial scan rate from 5.5 to 76 kHz, and an axial resolution of 5.5 µm in air. The sample arm contains a 
LSM003 (Thorlabs Inc., USA) scanning lens providing a transverse resolution of 13 µm in air. Fig. 1 
displays the experimental setup employed to collect OCT data. For each volunteer tested in the study, an 
initial 3D volume of 1.50 × 1.50 × 1.82 mm3 was acquired at a speed of 48 kHz with a scanning density of 
1024 (length) × 1024 (width) × 512 (depth) pixels, to visualize the microvascular structure of the volar 
forearm. The time employed for the acquisition of the structural volume was ~51 s, which is too long for 
the assessment of blood flow functional dynamics. For this reason, the examination of microvascular 
dynamics was performed by reducing the sampling density to 256 × 256 × 512 pixels that can be acquired 
at a temporal rate of ~6 s, allowing the fast scanning of sequential 3D volumes suitable for the assessment 
of microvascular function. However, an important requirement for visualizing blood flow by cmOCT is a 
dense sampling below the lateral resolution of the adjacent B-frames of the OCT volume, which ensures a 
strong correlation between the stationary scatters of consecutives B-scans. Therefore, to maintain a spatial 
separation between the B-frames suitable for the cmOCT analysis the size of the sampled area was reduced 
to 0.75 × 0.75 × 1.82 mm3, which means a spatial separation of 2.9 µm. Although the possibility of 
performing each scan in ~6 s, the volumes were acquired with a sampling frequency of one volume every 
16.6 s because the software provided with the OCT device (ThorImage OCT 4.3, Thorlabs Inc., USA) 
required ~10.6 s for saving each volume. In total, 90 sequential low-resolution volumes were acquired from 
the forearm of each volunteer in a time window of ~25 min, while performing the PORH reactive test. An 
initial 10 min acquisition of 36 volumes was performed to determine the baseline flow, then 18 volumes 
were recorded for a 5 min ischaemia period stimulated by blocking blood flow through the brachial artery, 
and finally 36 volumes were acquired for further 10 min to monitor flow dynamic changes during the 
hyperaemic response. 
2.3 cmOCT data processing 
The cmOCT analysis to generate blood flow maps at different depths from each 3D OCT volume was 
performed by employing the same in-house designed Java algorithm and principles described by Enfield et 
al.9 and Jonathan et al.10. The software is able to perform the correlation analysis between consecutive 
adjacent 2D B-scans extracted from the 3D OCT volume, by estimating the cross-correlation of a square 
grid from the first B-scan 1 (I1) to the same grid from the adjacent B-scan 2 (I2), according to the following 
formula, 
cmOCT(x,y) = ∑ ∑
[I1(x+p,y+q)-I1(x,y)̅̅ ̅̅ ̅̅ ̅̅ ][I2(x+p,y+q)-I2(x,y)̅̅ ̅̅ ̅̅ ̅̅ ]
√(I1(x+p,y+q)-I1(x,y)̅̅ ̅̅ ̅̅ ̅̅ )
2
(I2(x+p,y+q)-I2(x,y)̅̅ ̅̅ ̅̅ ̅̅ )
2 
N
q=0
M
p=0                      (1) 
where M and N represent the size of the square grid, and 𝐼 ̅the average intensity value of the grid. The grid 
is shifted along all the pixels of the B-scans to produce a two-dimensional map with correlation coefficients 
between 0 and 1, associated respectively with low and high correlation. The low correlation areas 
(coefficient < 0.6) in the map are shown as bright coloured regions representing blood flow, while the strong 
correlation sections (coefficient > 0.6) related to the stationary bulk of the tissue appear as the background 
of the image.  
A 7 × 7 kernel size of the grid was employed to generate the correlation maps, which represents an 
optimal compromise of producing good sensitivity to blood flow without loss of spatial resolution due to 
kernal size. As mentioned in the introduction, the cmOCT maps are affected by a background noise with 
low correlation coefficients between consecutive B-scans that makes the identification of the flow regions 
difficult. The noise was removed by processing the correlation maps with a structural mask, produced from 
the original OCT structural images by the application of a kernel blur and binary threshold. The maps were 
presented as maximum intensity projection (MIP) images, which allow at the same time a better 
visualization of micro-vessels morphology and location, and the detection of the maximum flow intensity. 
To examine blood vessels from different skin microvascular beds (capillaries and arterioles/venules), the 
cmOCT maps were extracted from different depths (80-180 µm, 180-280 µm, 300-400 µm) of the OCT 
volumes, i.e. in the enface plane. This was obtained by determining the position of skin surface from the 
structural images, and using the superficial location as a reference to establish the various depths of the 
underlying tissue. 
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2.4 Reconstruction of blood flow time series 
The CWT spectral analysis for the study of vasomotion can be applied exclusively on continuous time-
varying signals. Therefore, to investigate the nonlinear dynamics by wavelet analysis, continuous time 
series of microvascular blood flow at different tissue depths were reconstructed from the cmOCT maps 
using the same methodology previously described by our group29. First, the average blood flow was 
estimated from each of the 90 sequential MIP maps generated at different tissue depths during the reactive 
hyperaemia test. This was achieved by calculating the mean value across the ROI of each map. Then, the 
mean values of flow extracted from the sequential MIP maps were employed as discrete data points to 
reconstruct a continuous curve, covering the 25 min time window used in the experiment. The 
reconstruction was performed by piecewise cubic spline interpolation29 method using the cftool instrument 
in Matlab R2015a. Specifically, we have created a vector containing the 90 sequential average values of 
blood flow extracted from the cmOCT maps, and a time vector defining an interval of 16.6 s between each 
pair of discrete data points corresponding to the sampling frequency adopted during the temporal 
acquisition of the 3D OCT volumes. More details on the principles of spline interpolation can be found in 
our previous publication29. 
2.5 CWT spectral analysis 
The continuous wavelet transform is a widespread method for the investigation of blood flow fluctuations, 
revealing the contribution of specific biological components in the microcirculation to the nonlinear 
dynamic changes of microvascular flow. In this work, the application of CWT on blood flow signals 
reconstructed from the cmOCT maps allowed the identification of oscillations in the frequency intervals 
21-52 × 10-3 Hz, 9.5-21 × 10-3 Hz and 5-9.5 × 10-3 Hz. According to the literature8,30, these oscillations 
reflect respectively the activity of local sympathetic nerves, the ECs activity nitric oxide (NO)-dependent 
and the ECs activity NO-independent. 
The CWT analysis was performed according to the principles described by Stefanovska et al.7,8,30. The 
method is based on the use of the Morlet mother wavelet function ψ scaled by a factor s and a time t to 
provide an adequate frequency window, which is shifted along the time domain of the analysed signal for 
obtaining an optimal time-frequency resolution7,8,30. The CWT spectrum of a signal g(u) is calculated as 
follow7,8,30, 
g(s,t) =
1
√𝑠
∫ 𝜓
  ∞
-∞
 (
 𝑢−𝑡
𝑠
) g(u)du,                                                                                                                                  (2) 
where g(s, t) is the wavelet spectral function defined by s and t. The obtained spectrum is characterized by 
a power/energy distributed at various frequencies, which is a measure of how much of the signal is located 
at a specific frequency range of an oscillator at the time t. 
In this work, a central frequency f of the Morlet wavelet equal to 1 was used30, noting that the scale 
parameter s and f were related according to the following equation30, s=1/f. Specifically, a logarithmic scale 
array of 346 scales ranging from 0.5 to 200 with Morlet factor 1.03 was used, which corresponds to a 
frequency interval between 5-2000 × 10-3 Hz. The minimum size of the time window used in the study was 
~200 s to allow the investigation of the slowest oscillations of interest (frequencies up to 5 × 10-3 Hz). A 
time scale of minutes is sufficient to detect oscillatory phenomena with a period of 200 s. However, while 
for periodic signals a single period is sufficient to observe the phenomenon under investigation, this is not 
true for nonlinear quasiperiodic time series, i.e. blood flow signals8. In this case the period of a specific 
phenomenon fluctuates constantly, thus the trace should be long enough to contain at least several periods8.  
For this reason, here a 25 min time window was used for data collection to sample a sufficient number of 
periods for observing oscillations up to 5 × 10-3 Hz. 
3. RESULTS 
3.1 Visualization of microvascular structure 
To select the cutaneous areas for the study of functional dynamics, an initial 3D OCT volume was acquired 
from a 1.50 × 1.50 × 1.82 mm3 region in the volar forearm of each volunteer to visualize microvascular 
structure. The acquisition was performed in ~51 s employing 1024 × 1024 A-scans, and the MIP flow maps 
were obtained at different tissue depths by cmOCT data processing using a 7 × 7 kernel grid. Fig. 2 shows 
examples of structural enface MIPs at three different depths obtained from a volunteer, describing the 
typical skin microvascular structure reported by Enfield et al.9, even if in this case the size of the analysed 
region was smaller. 
Fig. 2a displays a structural 2D B-scan of the OCT volume, showing a longitudinal view of the tissue 
regions from which the MIPs were generated. The depths were selected by using the skin surface, marked 
with a green line, as a reference for the estimation of the specific microvascular beds. Fig. 2b illustrates the 
MIP map from the epidermal surface at 0-40 µm that, as expected, does not show any flow region due to 
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the absence of blood vessels. Fig. 2c displays the MIP generated from the dermal-epidermal junction, which 
is located around a depth of 80-180 µm. The image shows small blood vessels with vertical orientation 
corresponding to the finger-like capillary loops arising from the ascending micro-vessels of the dermal 
layer and appearing as coloured spots in the blue background. The function of the capillary loops is the 
nourishment of the epidermal layer that is lacking of blood vessels. Fig. 2d represents a MIP projection of 
the skin layer around 300-400 µm corresponding to the dermal plexus. This microvascular bed is 
characterized by a network of arterioles and venules with horizontal orientation from which, respectively, 
the nutrients are delivered to the capillaries and the waste products directed to the venous system. To study 
the microvascular dynamics from the dermal-epidermal junction and dermal plexus regions, an enface plane 
of 0.75 × 0.75 mm2 was selected from the structural images to perform sequential temporal acquisitions of 
3D OCT volumes during PORH test. Fig. 2c-d show examples of 750 × 750 µm regions selected for the 
study of capillary loops and arterioles/venules functional dynamics, respectively marked by yellow and red 
squares. 
 
Fig. 2 Structural visualization of cutaneous micro-vessels from the volar forearm. (a) 2D structural B-frame from 
a 1.50 × 1.50 × 1.82 mm3 3D OCT volume. The region marked in green indicates the epidermal surface (0-40 µm), the 
yellow area represents roughly the location of the dermal-epidermal junction (80-180 µm) and the red region outlines 
a part of the dermal plexus (300-400 µm). (b) Enface MIP projection of the epidermal surface at 0-40 µm. (c) Enface 
MIP projection of the dermal-epidermal junction around 80-180 µm where the capillary loops are located. The small 
yellow square indicates the 750 × 750 µm area chosen for the study of capillaries functional dynamics. (d) Enface MIP 
projection of the dermal plexus at a depth of 300-400 µm characterized by a horizontal network of micro-vessels. The 
small red square outlines the 750 × 750 µm region chosen for the study of arterioles/venules functional dynamics. 
3.2 Assessment of flow dynamics from cmOCT maps 
Ninety sequential volumes (256 × 256 × 512 pixels, 0.75 × 0.75 × 1.82 mm3) of the small yellow/red area 
selected in Fig. 2c-d were acquired from each volunteer during a 25 min PORH functional test at a sampling 
rate of 16.6 s. The first 36 volumes were acquired during a 10 min resting period to determine the baseline 
flow, 18 volumes were collected during a 5 min occlusion of blood flow through the brachial artery, and 
36 volumes were acquired for 10 min after the removal of the occlusion for monitoring blood flow changes 
during PORH response. The volumes were processed by cmOCT to obtain sequential flow maps of the 
dermal-epidermal junction (80-180 µm) and dermal plexus (300-400 µm) regions for tracking the temporal 
flow changes of capillaries (Fig. 3a) and arterioles/venules (Fig. 3b), respectively. 
For simplicity, in Fig. 3a-b are displayed only the cmOCT maps extracted from 12 volumes of the total 
90 temporal samples, which represent the key steps of the reactive test. The maps were characterised by 
residual background noise represented by small snow-like dots (see the ISCHAEMIA MIPs in Fig. 3a-b), 
which may be confused and misinterpreted as capillary blood flow at the 80-180 μm depth. Nonetheless, 
the relevant increase of flow observed in specific points of the MIP maps at 80-180 μm during PORH 
response (Fig. 3a, PORH 1-4) was helpful to identify the specific regions of the images containing the 
capillaries. 
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Fig. 3 Sequential cmOCT flow maps generated at different tissue depths from the OCT volumes acquired during 
PORH test. (a) Temporal enface MIPs from the 750 × 750 µm yellow area selected in Fig. 2c for the study of skin 
capillaries microvascular dynamics at a depth of 80-180 µm. (b) Temporal enface MIPs from the 750 × 750 µm red 
area selected in Fig. 2d for the study of cutaneous arterioles/venules microvascular dynamics at a depth of 300-400 µm. 
The maps were obtained from 0.75 × 0.75 × 1.82 mm3 volumes sampled every 16.6 s with a scanning density of 256 × 
256 A-scans. The BASELINE 1-4 MIPs describe the flow at rest detected prior to the occlusion stage of the PORH 
functional test, the ISCHAEMIA 1-2 and 3-4 MIPs refer respectively to the flow detected immediately after the 
beginning of the occlusion process and before the removal of the occlusion, and the PORH 1-4 MIPs outline the flow 
detected during PORH response. The images contain residual background noise, which is clearly visible in the 
ISCHAEMIA MIPs at both 80-180 µm and 300-400 µm cutaneous depths. 
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Additionally, because all the MIPs were characterised by the same degree of background noise at all the 
stages of the reactive test, this made it possible monitoring reliably the relative dynamic changes of blood 
flow over time. Indeed, although the images were characterized by poor resolution and residual background 
noise compared to the structural images, they clearly outlined the temporal flow changes associated with 
the different stages of the functional task. In details, the capillaries did not show relevant changes during 
occlusion (Fig. 3a, ISCHAEMIA 1-4) compared to baseline (Fig. 3a, BASELINE 1-4), while the network 
of blood vessels in the dermal plexus displayed a clear reduction and disappearance of blood flow during 
occlusion (Fig. 3b, ISCHAEMIA 1-4) compared to baseline (Fig. 3b, BASELINE 1-4). These observations 
probably reflect the delivery of the residual flow from arterioles to capillaries during the 5 min ischaemia 
period, ensuring the nourishment of the epidermal tissue under hypoxic stress conditions. In contrast, a 
massive increase of flow intensity typical of the hyperaemic response was detected during PORH for both 
capillaries and arterioles/venules (Fig. 3a-b, PORH 1-4), associated with the vessels reactivity for the 
restoration of a normal microcirculation after removal of the occlusion. These results demonstrate that 
cmOCT is suitable for tracking the general microvascular functional dynamics. 
3.3 Reconstruction of time series from cmOCT maps 
In this study, the cmOCT flow maps were also employed to detect the key contribution of biological 
components in the microcirculation to the rhythmic variations in vessels diameter (vasomotion) in response 
to PORH stimulus. The goal was achieved by reconstructing continuous time series of blood flow at 
different depths from the intensities of the sequential temporal cmOCT maps (see paragraph 2.4 in methods 
for more details), and processing the reconstructed signals with the CWT spectral analysis that is a 
widespread method for the study of microvascular oscillations. Fig. 4a displays an example of continuous 
time series obtained by using the average flow extracted from 90 sequential cmOCT MIP maps as discrete 
data points for the reconstruction of a curve covering the 25 min period of the PORH test. The method 
employed for the reconstruction process was the piecewise cubic spline interpolation that is advantageous 
because no oscillation artefacts are introduced between each pair of discrete data points. This means that 
the obtained time series reflects the real dynamics of the process under investigation. The reconstructed 
curve in Fig. 4a clearly shows the typical trend of the reactive hyperaemia test, characterized by a reduction 
of blood flow during ischaemia and a massive increase of flow during PORH response reaching a peak 
before the gradual restoration of the normal microcirculation. This is a further confirmation that cmOCT is 
able to detect microvascular functional dynamics. 
For each volunteer enrolled in the study, the microvascular flow was reconstructed from cmOCT maps 
generated at three different depths: 80-180 µm (dermal-epidermal junction), 180-280 µm (upper dermal 
plexus), and 300-400 µm (median dermal plexus). Fig. 4b-c display respectively the absolute and relative 
average reconstructed blood flow at the selected depths for the 12 tested individuals. As shown in Fig. 4b, 
the absolute flow reflects the increasing density of blood vessels in the deepest layers of the cutaneous 
tissue. Indeed, the absolute flow intensity was greater in the deepest microvascular beds at all the stages of 
PORH test. The relative average blood flow in Fig. 4c, expressed as a function of the baseline, provides a 
more reliable comparison of flow dynamics from different tissue depths in response to the reactive test. The 
graph shows the same findings discussed for Fig. 3a-b, consistent with the maintenance of a normal flow 
in the capillaries and a gradual reduction of the flow intensity going deeper in the tissue during ischaemia. 
This may reflect the delivery of the residual flow from the deeper arterioles network to the upper capillaries 
for feeding the epidermis during ischaemia. In contrast, PORH response was characterized by higher flow 
intensity and peak response in the deepest vascular beds, reflecting the path of flow directed from the 
deepest network of arterioles to the superficial capillaries and a major vasodilator response in the deepest 
layers associated with greater size and density of micro-vessels. 
3.4 CWT spectral analysis of the flow signal reconstructed from cmOCT maps 
The study of vasomotion at different tissue depths was performed applying the CWT spectral analysis on 
the reconstructed time series. The method allowed the identification of oscillations in the frequency ranges 
21-52 × 10-3 Hz (neurogenic), 9.5-21 × 10-3 Hz (endothelial NO-dependent) and 5-9.5 × 10-3 Hz (endothelial 
NO-independent)8,30. Fig. 5 illustrates an example of CWT analysis of the blood flow signal reconstructed 
from a tissue depth of 180-280 µm. Fig. 5a displays the CWT scalogram graph that describes the 
distribution of the wavelet power of the signal in the time-frequency domain, visualized as a gradient 
coloured map. The graph clearly shows an increase of power (increase of brightness) during PORH 
response in all the oscillatory frequency ranges under investigation, reflecting the activation of the 
endothelial and sympathetic control mechanisms associated with vasodilation. The time-averaged spectrum 
in Fig. 5b discriminates the maximum wavelet power peaks at various frequency intervals corresponding 
to the specific blood flow oscillators. This allows monitoring the activity of each oscillator and making 
comparisons between different subjects, by extracting values of the maximum amplitude Ai and energy Ei 
(area under the curve) from each wavelet peak during the various steps of the reactive test. For instance, in 
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Fig. 5b an increase of the wavelet maximum amplitude and power of all the oscillators was clearly observed 
during PORH (black line) compared to ischaemia (dark red line) and baseline (dark blue line). 
Fig. 6 displays the median time-averaged CWT spectra obtained from the 12 healthy volunteers, by 
wavelet analysis of the cutaneous flow signals reconstructed at 80-180 µm (yellow line), 180-280 µm (blue 
line) and 300-400 µm (red line) tissue depths. The CWT spectral power was normalized as a function of 
the minimum baseline power, to compare the relative spectral energy between different cutaneous depths 
during PORH test. All the wavelet oscillators showed greater power with increasing depth at all the stages 
of the reactive hyperaemia task (Fig. 6a-c): baseline, ischaemia, and PORH. These observations may be 
explained by a major number of micro-vessels involved in vasomotion in the deepest cutaneous layers due 
to greater vessels density. 
 
Fig. 4 Reconstruction of continuous time series from cmOCT maps. (a) Example of curve reconstruction by 
piecewise cubic spline interpolation of the discrete average flow values estimated from the ROI of  the 90 sequential 
cmOCT MIP maps generated at a tissue depth of 300-400 µm. A time interval of 16.6 s between each pair of data points 
was applied to cover the 25 min period of the PORH test. The flow is expressed in arbitrary units (AU). (b) Average 
absolute blood flow from 12 healthy subjects during reactive hyperaemia test reconstructed at three different tissue 
depths. The flow is expressed in AU. (c) Average relative blood flow from 12 healthy volunteers during PORH test 
reconstructed at three different depths. The flow is expressed as a function of baseline. 
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Fig. 5 CWT analysis of a continuous blood flow signal reconstructed from cmOCT maps generated at a depth 
of 180-280 µm. (a) CWT scalogram showing the distribution of the wavelet power in the time-frequency domain using 
a coloured map ranging from dark (low energy) to bright (high energy) colours. The coloured areas in the scalogram 
outline the “cone of influence”, which is a time-frequency area where distortions of the CWT due to the limited duration 
of the time series are not relevant31. In contrast, the transparent areas at the bottom-right and bottom-left of the graph 
represent regions external to the cone in proximity of the time edges of the signal, where the wavelet transform is 
characterized by boundary effects making the estimations from these regions ambiguous31. (b) Time-averaged wavelet 
spectra computed for all the stages of the reactive hyperaemia test.  The plots distinguish the CWT maximal amplitude 
peak and energy (area under the curve of the peak) associated with each specific blood flow oscillator. The neurogenic 
(21-52 × 10-3 Hz), ECs NO-dependent (9.5-21 × 10-3 Hz), and ECs NO-independent (5-9.5 × 10-3 Hz) oscillators were 
identified. 
The wavelet energy Ei and amplitude Ai of all the oscillators, extracted from the time-averaged CWT spectra 
according to the principles described by Shiogai et al.8, were significanty increased during PORH response 
compared to baseline for all the analysed tissue dephts (Table 1), which is in agreement with the results 
reported for the spectral analysis of LDF signals recorded during the hyperaemic challenge32. 
Although OCTA methods are flow-based imaging tools not suitable to monitor the architecture of blood 
vessels, the increase of blood perfusion observed in this study during PORH response should reflect 
vasodilation dynamics. Indeed, literature reports have demonstrated that the increase of flow observed 
during cutaneous PORH is mediated by the activation of vasodilator mechanisms regulated through the 
major activity of the endothelium and the sympathetic nerves5. This is also supported by the results of the 
wavelet spectral analysis of cmOCT blood flow signals discussed in Table 1. The wavelet analysis is a 
method suitable for the indirect detection of vasomotion dynamics by its application on blood flow signals 
that do not contain architectural information, i.e. LDF signal7,8,30. Therefore, the increase of wavelet spectral 
power observed for the endothelial and neurogenic oscillators should reflect indirectly the rythmic vaso-
relaxation process mediated by ECs, VSMCs and sympathetic nerves for the fast reperfusion of the tissue 
after an ischaemic period. Damages to the microvascular endothelium may impact negatively the 
hyperaemic response with a reduction of the endothelial-mediated vasodilation, which can be reflected in 
the wavelet spectrum as a reduced increase of the endothelial wavelet power. 
Mechanisms at the basis of the vasomotor perturbations of skin blood flow signal. The endothelial and 
neurogenic oscillators and the myogenic oscillation, which was not detected in this study, are classified as 
low-frequency dynamic patterns of flow motion associated with local vasomotor phenomena occurring on 
the time scale of blood distribution to the tissue surrounding micro-vessels8,33. These slow vasomotor 
rhythms cause changes in the vascular diameter as part of the local regulation of microvascular flow, and 
they are reflected in the blood flow signal as naturally occurring perturbations representing a correlation of 
volumetric flow to a third-order blood pressure wave33. The vasoconstriction or vasodilation induced by 
these regulatory rhythms has an effect on red blood cells (RBCs) velocity with a consequent decrease or 
increase of velocity leading to lower or higher blood perfusion to tissue34, respectively. These oscillatory 
phenomena have been detected also on capillary blood flow, as confirmed by our results (Fig. 6), probably 
reflecting the degree of vasomotion in the terminal arterioles connected to the capillary loops34. 
The mechanism at the basis of the vasomotor perturbations of blood flow signal is the mechanical 
contraction or relaxation of VSMCs, due respectively to depolarization or hyperpolarization induced by 
cellular rhythmic fluctuations of Ca2+ concentrations throughout voltage-dependent channels in the plasma 
membrane and sarcoplasmic reticulum35,36. This process may be modulated through different regulatory 
mechanisms (Fig. 7), which are characterised by a different oscillatory rhythm reflected by the low-
frequency vasomotor waves detected in the blood flow signal: 
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(1) Myogenic mechanism (52-145 × 10-3 Hz), based on spontaneous contraction/relaxation of VSMCs in 
response to changes of the intra-arteriolar blood pressure8,34,35. 
(2) Neurogenic mechanism (21-52 × 10-3 Hz), based on a feedback between VSMCs and the local 
sympathetic or parasympathetic innervation34. The nerves are activated by changes in the intravascular 
pressure and/or tissue perfusion34, which cause the release of substances targeting VSMCs to regulate 
the vascular diameter8. 
(3) Endothelial mechanisms (5-21 × 10-3 Hz), based on a feedback between VSMCs and ECs8,34. The 
activity of ECs may be stimulated by the concentration of metabolic mediators in the blood or by the 
shear stress8,37, which cause the release of vasoactive substances modulating the relaxation/contraction 
of VSMCs. 
 
Fig. 6 Median relative time-averaged CWT spectra of reconstructed flow signals from 12 healthy subjects during 
PORH test. (a) Baseline median CWT spectra of blood flow time series reconstructed from cmOCT maps generated 
at 80-180 µm, 180-280 µm and 300-400 µm. (b) Median CWT spectra during ischaemia. (c) Median CWT spectra 
during PORH response. All the spectra were normalized by the respective minimum baseline spectral power to compare 
the relative increase of wavelet energy during the hyperaemic response between different cutaneous depths. 
Physiological origin of the endothelial NO-independent oscillator. Table 2 reports the percentage relative 
increase of the wavelet power for each oscillator analysed in this study. The endothelial NO-independent 
oscillator showed the greatest percentage increase of energy at all depths, suggesting a fundamental role of 
this component in the vasomotion phenomenon associated with cutaneous hyperaemic response. The origin 
of this oscillator is uncertain because the endothelial NO-independent modulation may be mediated by 
different mechanisms such as the endothelial-derived hyperpolarizing factor (EDHF) or prostaglandins 
(PGs) cellular pathways (Fig. 7). However, the inhibition of PGs mechanism by aspirin did not alter the 
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oscillatory peak in the endothelial NO-independent range38, suggesting a more likely EDHF origin of this 
oscillator. Moreover, spectral LDF data obtained at our laboratories from animal models and human 
subjects, which will be published elsewhere, also suggest an EDHF origin of the wavelet component in the 
5-9.5 × 10-3 Hz, and for these reasons we have named this oscillator as EDHF. This hypothesis is supported 
further in this work because the EDHF mechanism is considered as a major mediator of the cutaneous 
microvascular PORH response5, and the endothelial NO-independent component was indeed the oscillator 
displaying the greatest percentage increase of wavelet power during reactive hyperaemia (Table 2). 
Overall, the CWT spectral analysis of time series reconstructed from cmOCT flow maps showed results 
in agreement with the current methods to assess microvascular flow nonlinear oscillations. Therefore, this 
supports the powerful application of cmOCT and all the OCTA techniques for the study of microcirculation 
nonlinear dynamics, allowing the investigation of the activity of key factors involved in vasomotion either 
for elucidating the mechanisms underlying this phenomenon or for clinical diagnostic applications. 
Table 1 Comparison of the amplitude and power of the wavelet oscillators between baseline and PORH time 
points. The variables were non-parametric, thus data are expressed as median (inter-quartile range). The amplitude Ai 
represents the maximum wavelet power in the interval of interest, while the energy Ei is the overall wavelet power in 
the frequency range under investigation. The comparison was performed at all the analysed depths: 80-180 µm, 180-
280 µm, 300-400 µm. The p-values (p) were estimated by paired Wilcox test performed using the software R-Studio. 
***p < 0.001. ECs = Endothelial cells. NO = Nitric oxide. EDHF = Endothelial-derived hyperpolarizing factor. 
80-180 µm (n=12) Baseline PORH p 
Ai Neurogenic 6.10 (5.20-11.0) × 10-5  3.80 (2.20-4.00) × 10-3  < 0.001*** 
Ai ECs NO-dependent 7.10 (6.00-10.3) × 10-5 4.70 (3.40-5.10) × 10-3 < 0.001*** 
Ai ECs NO-independent (EDHF) 5.50 (4.30-7.50)  × 10-5 4.90 (3.90-6.70)  × 10-3 < 0.001*** 
Ei Neurogenic 7.20 (4.40-13.7) × 10-7  3.70 (3.40-5.00) × 10-6  < 0.001*** 
Ei ECs NO-dependent 6.60 (5.10-8.00) × 10-7 2.60 (2.30-3.10) × 10-6 < 0.001*** 
Ei ECs NO-independent (EDHF) 1.50 (1.40-1.90)  × 10-7 0.90 (0.70-1.20)  × 10-6 < 0.001*** 
180-280 µm (n=12) Baseline PORH p 
Ai Neurogenic 12.4 (7.50-14.1) × 10-5  3.10 (2.00-4.20) × 10-3  < 0.001*** 
Ai ECs NO-dependent 10.0 (7.80-12.0) × 10-5 3.30 (2.70-5.00) × 10-3 < 0.001*** 
Ai ECs NO-independent (EDHF) 5.20 (3.90-7.70)  × 10-5 4.40 (3.40-7.80)  × 10-3 < 0.001*** 
Ei Neurogenic 10.3 (6.70-13.0)  × 10-7 4.30 (3.60-5.20) × 10-6  < 0.001*** 
Ei ECs NO-dependent 9.60 (7.50-10.0)  × 10-7 2.00 (1.40-3.20) × 10-6 < 0.001*** 
Ei ECs NO-independent (EDHF) 1.70 (1.20-2.10)  × 10-7 0.80 (0.60-1.40)  × 10-6 < 0.001*** 
300-400 µm (n=12) Baseline PORH p 
Ai Neurogenic 6.10 (5.00-8.80) × 10-5  2.70 (1.70-4.30) × 10-3  < 0.001*** 
Ai ECs NO-dependent 7.20 (5.30-8.70) × 10-5 3.20 (2.00-4.10) × 10-3 < 0.001*** 
Ai ECs NO-independent (EDHF) 5.20 (4.50-5.80)  × 10-5 3.80 (2.80-8.00)  × 10-3 < 0.001*** 
Ei Neurogenic 10.5 (7.80-12.9)  × 10-7 4.90 (3.00-6.30) × 10-6  < 0.001*** 
Ei ECs NO-dependent 6.00 (4.70-7.00)  × 10-7 2.20 (1.50-3.10) × 10-6 < 0.001*** 
Ei ECs NO-independent (EDHF) 1.60 (1.40-1.90)  × 10-7 0.70 (0.50-1.40)  × 10-6 < 0.001*** 
 
Table 2 Percentage increase of wavelet power. Data are reported as mean ± standard deviation (SD), and reflect the 
percentage growth of the CWT spectral energy of each analysed oscillator during PORH response compared to baseline. 
The percentage increase was estimated for all the dephts under investigation. 
Wavelet oscillators 80-180 µm (n=12) 180-280 µm (n=12) 300-400 µm (n=12) 
Ei Neurogenic increase [%] 29.7 ± 13.3 16.2 ± 10.2 17.0 ± 12.2 
Ei ECs NO-dependent increase [%] 28.6 ± 11.2 26.6 ± 11.4 37.2 ± 16.1 
Ei ECs NO-independent (EDHF) increase [%] 41.6 ± 21.2 57.1 ± 18.2 45.8 ± 24.2 
258 
 
_______________________________________________________________
Appendix – II. Application of cmOCT and continuous wavelet transform analysis 
to the assessment of skin microcirculation dynamics 
 
Fig. 7 Mechanisms causing the vasomotor perturbations of blood flow signal. The slow vasomotor waves of skin 
microvascular flow are caused by changes in the vascular diameter mediated through three main mechanisms occurring 
with different rhythms: (1) The spontaneous myogenic contraction/relaxation of VSMCs in the micro-vessel wall 
induced by changes in the intra-arteriolar blood pressure8,34,35. (2) The neurogenic feedback between the local nerves 
and VSMCs stimulated by changes in intra-arteriolar blood pressure or blood perfusion34, which cause the release of 
substances from the nerves modulating the contraction/relaxation of VSMCs8. (3) The myoendothelial feedback 
between the ECs and VSMCs8,34. The activity of ECs may be stimulated by changes in the concentration of metabolic 
substances in the blood or by shear stress8,37, which cause the release of vasoactive agents to modulate VSMCs tone, 
i.e. NO, PGs, EDHF (mediated by release of metabolites), endothelin-1 or electric signals, e.g. EDHF (mediated by 
gap junctions signalling). The endothelial oscillations of blood flow signal may reflect the rate of release of vasoactive 
agents targeting VSMCs, or the rhythmic response of a cellular oscillator in the VSMCs (e.g. Ca2+) to these 
substances37. NO = Nitric oxide. PGs = Prostaglandins. EDHF = Endothelial-derived hyperpolarizing factor. 
4. DISCUSSION AND CONCLUSIONS 
In this work, we have demonstrated that cmOCT is a suitable non-invasive method for the concurrent 
visualization of microcirculation structure and assessment of microvascular functional dynamics. Although 
the resolution of the functional OCT images generated in this research was not optimal,  the cmOCT 
temporal maps allowed to trace clearly the overall flow dynamics with spatial resolution at different selected 
depths, providing results that reproduce reliably the same patterns observed with the conventional methods 
for the study of microvascular function. This is extensively proved by the typical reactive hyperaemia trend 
observed on the reconstructed time series from different tissue depths (Fig. 4), which showed dynamic 
patterns reflecting the spatial distribution of micro-vessels in the various cutaneous layers. Therefore, the 
results demonstrate that the technique provides functional information from the flow maps even when the 
visualization of blood vessels is not optimal. However, this may represent a limit when the goal of the study 
is focusing on the functional analysis of a specific micro-vessel selected from the cmOCT maps, especially 
when the size of the vessel is small. In this case, the visualization of micro-vessels in the sequential cmOCT 
maps may be improved by the choice of a better compromise during the acquisition of the OCT volumes 
between the sampling density, the speed of acquisition and the size of the sampled volumes, to ensure at 
the same time a fast scanning rate and a spatial separation between the B-frames avoiding an excessive 
oversampling that may lead to the mask of smaller blood vessels in the final cmOCT map. 
Our results also demonstrate that cmOCT is suitable for the study of vasomotion. Indeed, dynamic 
oscillators associated with biological components of the micro-vessels were detected by wavelet analysis 
of cmOCT blood flow signals (Fig. 5-6), which showed spectral power patterns comparable to those 
observed for LDF signals during PORH vasomotion response (Fig. 6 and Tables 1-2). However, we were 
not able to detect the myogenic CWT oscillation associated with the spontaneous activity of VSMCs, which 
represent an important microvascular component involved in the mechanical constriction and enlargement 
of vessels diameter. This was due to an additional time of 10.6 s during the acquisition of each OCT volume 
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employed by the ThorImage software (Thorlabs Inc., USA) for saving the data, extending the time of each 
scan from 6 s to 16.6 s that is not enough to sample the myogenic oscillation (52-145 × 10-3 Hz)8. The 
problem may be addressed in the future by using a more powerful computer to maximise the performance 
of the software ensuring a faster data storage. 
Although other OCTA methods such as OMAG may also be suitable for the application of the wavelet 
analysis and the study of vasomotion, in this work we used cmOCT because it was a readily accessible 
technique at our facilities providing some benefits. Indeed, in order to detect vasomotion dynamics a fast 
acquisition time is necessary and the use of cmOCT was advantageous because only the intensity 
information is needed, allowing a faster data collection at such short time intervals compared to OMAG 
which uses complex OCT signals requiring the acquisition of both the intensity and the phase. Moreover, 
because a very large amount of volumes was sampled over time, the employment of cmOCT, which is a 
lower computationally intensive technique compared to the competing OCTA methods, allowed a quick 
reduction in size of the overall data volume. 
Finally, an important aspect to consider when studying the microcirculation is that the functional 
impairment of micro-vessels precedes any morphological change, thus representing a hallmark of the early 
stages of CVD. Therefore, our results outline the eligibility of cmOCT and in general all the OCTA methods 
as preclinical diagnostic tools for the assessment of CVD risk, with the advantage of providing non-invasive 
acquistitions from an easy accessible region such as the cutaneous microvascular tissue that represents a 
surrogate marker reflecting the health status of the central vascular system. The size of the region imaged 
in this study to track functional dynamics was 750 × 750 µm. Imaging such a small area was advantageous 
to allow the fast collection of OCT volumes for monitoring the nonlinear dynamics of skin microvascular 
flow, and to make wavelet data comparable with those reported for LDF that is the conventional technique 
used in combination with CWT analysis for the indirect assessment of skin vasomotion dynamics. Indeed, 
LDF probes provide functional data from quite small regions of ~1 × 1 mm. Although the data generated 
in this work display that functional information can be extracted by imaging small regions of the skin, this 
is an obvious shortcoming from a clinical perspective that does not allow to draw relevant clinical 
conclusions and may lead to variable results due to the heterogeneous structure of the cutaneous tissue. 
Therefore, this point must be addressed before translating the method to any clinical research study. A 
possible solution may be the acquisition of OCT volumes at a speed faster than the 48 kHz used in this 
work, which would allow to enlarge the size of the imaged region maintaining a suitable sampling frequency 
(16.6 s or below) for tracking vasomotion dynamics. 
The experiments were carried out successfully from a group of 12 healthy individuals, showing that the 
technique can be applied easily on large groups of subjects providing quite reproducible results. Therefore, 
the future perspective is the extension of the method to clinical studies for the exploration of potential 
diagnostic applications to monitor the onset and progression of cardiovascular disease. 
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Arterioles in the cutaneous microcirculation frequently display an oscillatory phenomenon 
defined vasomotion, consistent with periodic diameter variations in the micro-vessels 
associated with particular physiological or abnormal conditions. The driving mechanisms at 
cellular level underlying the fluctuations of vascular diameter and their physiological role have 
not been completely elucidated. Various mechanisms were demonstrated, based on cell Ca2+ 
oscillations determined by the activity of channels in the plasma membrane and sarcoplasmic 
reticulum cellular compartments. However, the possible engagement in vasomotion of cell 
metabolic oscillations of mitochondrial or glycolytic origin has been poorly explored. Metabolic 
oscillations associated with the production of ATP energy were previously described in cells. 
Nevertheless, little focus has been committed to the investigation of these fluctuations in-vivo. 
We present a method to characterise low-frequency metabolic oscillations from live mouse skin, 
based on the combination of fluorescence spectroscopy and wavelet transform signal 
processing technique. Furthermore, the relationships between metabolic and microvascular 
oscillators during phenylephrine-induced vasoconstriction were examined. Relevant 
correlations were found in normal mice, while animals with altered antioxidant defence 
presented a different oscillatory behaviour and set of correlations. These evidences raise 
interest in the possible metabolic origin of Ca2+ oscillations driving arterioles motion in specific 
physiological conditions. 
Introduction 
The term vasomotion indicates rhythmic oscillations of blood vessels diameter responsible for 
changes in the vascular tone and blood perfusion to tissue1,2. The physiological role of these 
oscillations is unclear, with contrasting studies supporting the development of vasomotion in 
both diseased and healthy conditions2. The origin of the oscillations is mainly determined by the 
local contraction and relaxation of vascular smooth muscle cells (VSMCs), which act as 
synchronised pacemakers in the vessels wall1,2,3. Although in several arteries (e.g. rat aorta) the 
oscillations may depend exclusively on the activity of VSMCs1, in other vascular beds (i.e. rat 
mesenteric artery) the most internal layer of blood vessels (endothelium) plays an important 
modulatory role during arterial motion4,5. Vasomotion is more prominent in small resistance 
micro-vessels2 such as skin arterioles that represent an optimal sample for the in-vivo 
examination of this phenomenon reflecting the general health conditions of the cardiovascular 
system6. 
Non-invasive observation of skin vasomotion can be achieved by direct methods measuring 
vessels diameter, e.g. intravital video-microscopy3,7,8, or by indirect techniques such as Laser 
Doppler Flowmetry (LDF) based on monitoring the heterogeneous fluctuations of microvascular 
blood perfusion signal2. The combination of LDF with wavelet transform signal processing 
analysis has revealed oscillations in the human cutaneous microcirculation that relate to 
physiological phenomena: myogenic (52-145 × 10-3 Hz), neurogenic (21-52 × 10-3 Hz), endothelial 
nitric oxide (NO)-dependent (9.5-21 × 10-3 Hz), and endothelial NO-independent (5-9.5 × 10-3 
Hz)4,9. 
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For the explanation of the cellular mechanisms causing the oscillations of vessels diameter 
observed during vasomotion, three different kinds of cellular oscillators have been proposed as 
possible drivers of this phenomenon: cytosolic oscillator, membrane oscillator and metabolic 
oscillator1,2. The importance of the cooperation between cytosolic and membrane oscillators to 
enhance the VSMCs synchronisation responsible for vasomotion has been largely explored and 
recognised1,2,10,11,12,13. They act inducing Ca2+ fluctuations in VSMCs, respectively through the 
oscillatory release of Ca2+ from the sarcoplasmic reticulum1,11,12, and via the opening activity of 
voltage-dependent Ca2+ channels and large-conductance K+ channels of the plasma 
membrane1,2,13. Furthermore, Ca2+ and membrane potential oscillations have been described in 
endothelial cells (ECs), suggesting that in some vascular beds (i.e. rat mesenteric artery)  in 
response to specific stimuli (e.g. α-adrenergic stimulation) a primary oscillation from ECs and 
the interaction with VSMCs might be essential for vasomotion14,15,16. 
A third hypothesised driving mechanism is the presence of a metabolic oscillator represented 
by oscillations in the activity of the glycolytic enzyme phosphofructokinase (PFK) that cause 
fluctuations in glycolysis, ATP levels and in the activity of plasma membrane ion channels and 
membrane potential17,18,19. This mechanism has never been considered important because of 
limited experimental evidence for the involvement of PFK in glycolytic and Ca2+ fluctuations1,2. 
However, recent studies have strongly suggested the participation of PFK in reactions 
responsible for glycolysis and Ca2+ oscillations20,21,22, with a possible driving effect exerted in-vivo 
by external glucose availability and uptake22,23,24,25. Furthermore, metabolic mitochondrial 
oscillations have also been reported, mainly associated with fluctuations of the mitochondrial 
membrane potential ∆Ψm that may be mediated by calcium26,27,28. The external oxygen required 
for sustaining the electron transport chain has been proposed as the driving force for the 
mitochondrial oscillator22. All these evidences suggest that the energetic and oxygen tissue 
requirements might stimulate vasomotion phenomena associated with Ca2+ oscillations of 
metabolic origin, which may involve the intercellular communication between heterogeneous 
groups of cells (e.g. ECs, VSMCs and cells of the tissue surrounding blood vessels). 
Metabolic oscillations have been studied in different cell types, i.e. yeast Saccharomyces 
cerevisiae23,26, cardiac myocytes29, β-cells28,30, and can be detected indirectly by measuring the 
fluctuations in the autofluorescence of the intermediate product of energy metabolism NAD(P)H 
(nicotamide adenine dinucleotide). However, there are limited studies describing metabolic 
oscillations in live tissue. Mitochondrial fast oscillations have been reported in-vivo in rat, and 
detected by intravital two-photon (2P) microscopy measurements of NAD(P)H31. Nevertheless, 
to our knowledge, the slow metabolic NAD(P)H oscillations described in many in-vitro or ex-vivo 
cell studies20,28 have not been investigated in-vivo. 
In the present study, we have utilised skin tissue from live mice to simultaneously measure 
NAD(P)H and microvascular blood flow respectively by laser fluorescence spectroscopy (LFS) and 
LDF, under physiological conditions and during α-adrenergic stimulation with the 
vasoconstrictor drug phenylephrine (PE). Data were processed by continuous wavelet transform 
(CWT) spectral analysis to characterise heterogeneous oscillations of NAD(P)H and LDF signals. 
We found low-frequency oscillations of NAD(P)H autofluorescence with periods of ~2.4 min, ~5 
min and ~10 min. To our knowledge, this is the first study in live skin tissue of slow NAD(P)H 
oscillations previously described in cells. Furthermore, we found relevant correlations between 
metabolic and vasomotion oscillations suggesting a link between these processes. Therefore, 
our results support the idea of vasomotion as a dynamic process in the context of a metabolically 
active microvascular network involving the cooperation of different cell types and vascular 
segments2,16, and a possible driving mechanism of metabolic origin. 
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Results 
Nrf2-/- (Nuclear factor-erythroid 2 p45-related factor 2) knockout (KO) model. Experiments 
were performed on 5 wild type (WT) control and 6 Nrf2-/- mice. The Nrf2 transcription factor is 
a key regulator of the cell redox state, involved in the resistance to oxidative stress by activating 
the cellular antioxidant defence32. Nrf2 knockout leads to abnormal mitochondrial activity, 
altered redox status, increased oxidative stress, and has an impact on cardiovascular 
dynamics32,33. We used the Nrf2-/- strain to investigate the differences in metabolic and vascular 
dynamics between normal mice and animals with impaired antioxidant defence that may favour 
the development of metabolic and cardiovascular disorders. Fig. 1 shows the experimental setup 
(Fig. 1a), and examples of simultaneous LFS and LDF signals (Fig. 1c-d) from the flank of a mouse 
at baseline (10 min) and during vasoconstriction induced by local administration of PE (10 min). 
Because of the small number of animals available in the study, the experiments were repeated 
in duplicate for each mouse and the average value of each variable between the two 
experiments was taken as final value for data analysis. Data of all the variables analysed in this 
study are summarised in Table 1 at the end of the results section. 
Microvascular biomarkers. Results of blood perfusion and oxygen saturation (SO2) are shown in 
Fig. 2a-b. Blood perfusion decreased to a similar degree in WT (p=0.046) and Nrf2-/- (p=0.007) 
mice during PE-induced vasoconstriction, however, a stronger p-value was found in KO mice. 
SO2, measured by reflectance spectroscopy (RS), was similar between groups and decreased 
slightly following vasoconstriction without statistical significance. 
Metabolic biomarkers. LFS skin irradiation by UV light stimulates the autofluorescence emission 
of multiple fluorophores, including NAD(P)H (490 nm), flavin adenine dinucleotide (FAD+, 550 
nm) and elastin (450 nm) (Fig. 1b). Although the NAD(P)H central emission peak represents the 
highest contribution to the spectrum, we took advantage of the overlapping contributions from 
FAD+ and elastin, respectively to estimate the redox ratio (RR) index and to normalise NAD(P)H 
fluorescence: 
 
RR=
NAD(P)H amplitude
𝐹𝐴𝐷+amplitude
                                                                                                                                      (1) 
NAD(P)Hnormalised=
NAD(P)H amplitude
Elastin amplitude
                                                                                                         (2) 
RR is a measure of the mitochondrial redox state, reflecting the mitochondrial balance between 
the reduced NAD(P)H and the oxidised FAD+ coenzymes. Comparing this index between WT and 
Nrf2-/- mice should provide discriminatory data, confirming that the Nrf2-/- phenotype is 
characterised by altered mitochondrial function due to impaired antioxidant defence and higher 
oxidative stress. NAD(P)H autofluorescence was normalised by elastin’s fluorescence peak to 
reduce blood volume effects (see more details in the supplementary information online). During 
each experiment, 20 UV spectra were collected in 20 min at a rate of a spectrum every minute, 
10 at baseline and 10 during PE administration. RR and NAD(P)Hnormalised values were estimated 
from each spectrum and used to reconstruct continuous signals (Fig. 1c) for applying the CWT 
spectral analysis. Fig. 2c-d describe the average trends of NAD(P)Hnormalised and RR signals. 
NAD(P)Hnormalised did not show significant statistical differences between groups, while RR was 
significantly lower in Nrf2-/- mice (p=0.016) confirming that KO animals were affected by altered 
redox state and higher oxidative stress. 
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Fig. 1 Example of data collection from mouse skin. (a) Experimental setup for simultaneous LFS 
and LDF recordings during local transdermal administration of 1% phenylephrine by 
iontophoresis method. The reason for using PE is that, according to Okazaki et al.5, this 
vasoactive agent is able to stimulate a vasomotion phenomenon mediated by endothelial cells. 
Thus, the use of PE provided the opportunity to study at the same time the role of the 
endothelium in vasomotion and its relationship with metabolic oscillations. (b) Example of single 
UV discrete autofluorescence spectrum measured by LFS. (c) Example of 20 min NAD(P)H 
continuous signal reconstructed by piecewise cubic spline interpolation of NAD(P)Hnormalised 
values extracted from 10 baseline UV spectra and 10 UV spectra collected during PE 
administration. (d) Example of 20 min blood flow continuous tracing measured by LDF during 
iontophoresis test. 
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Fig. 2 General trends of microvascular and metabolic biomarkers. (a) Average blood flow (PU). 
(b) Average oxygen saturation (%). (c) Average NAD(P)Hnormalised (dimensionless). (d) Average RR 
index (dimensionless). The software R-Studio was used to perform the statistical analyses. The 
Shapiro-Wilk test revealed normal distributions for all the variables, thus data are reported as 
bar plots of the mean values. Error bars are referred to two standard errors (SE), corresponding 
approximately to a 95% confidence interval (CI). Black bars = Baseline. White bars = PE 
administration. WT = Control mice. NRF2 KO = Knockout mice. Black lines/asterisks = Significant 
changes during delivery of PE estimated by paired t-test. Red lines/asterisks = Significant 
differences between mice groups estimated by unpaired t-test. The t-test was considered 
significant at p (p-value) < 0.05 with a statistical power of 0.8 determined by R-Studio. *p < 0.05, 
**p < 0.01. 
Reproduction of the LDF oscillators reported in the literature. Vasomotion oscillations were 
assessed by combining LDF and CWT techniques4,34,35,36,37,38,. We found oscillatory frequency 
intervals related to tissue/cell activity similar to those reported in human studies: myogenic (50-
150 × 10-3 Hz), neurogenic (20-50 × 10-3 Hz), endothelial NO-dependent (9-20 × 10-3 Hz), 
endothelial NO-independent (5-9 × 10-3 Hz) (Fig. 3a). In contrast, cardiac (1350-5000 × 10-3 Hz) 
and respiratory (150-1350 × 10-3 Hz) components showed higher frequency ranges (Fig. 3a), 
confirming the faster heart and breathing rates expected for mice39,40. Although the magnitude 
of the oscillations could be reduced due to the effects of anaesthesia41, we used a light isoflurane 
anaesthesia to avoid major systemic effects on the circulation. Additionally, all mice were 
scanned under the same conditions thus making it possible to compare differences between 
groups. 
CWT allows the identification of two oscillators reflecting ECs activity. While the biological link 
between the 9-20 × 10-3 Hz oscillator and the endothelial NO mechanism has been 
demonstrated37, the origin of the 5-9 × 10-3 Hz oscillator (endothelial NO-independent) is 
ambiguous. However, our results and literature reports suggest indirectly an association with 
the endothelial-derived hyperpolarizing factor (EDHF) vasodilation mechanism, thus here we 
will refer to the endothelial NO-independent component as EDHF. The reasons supporting this 
hypothesis are explained in the supplementary information online. 
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Fig. 3 CWT data processing of LDF and NAD(P)H signals. (a) Example of CWT scalogram (left) 
and corresponding time-averaged spectrum (right) from LDF signal. The scalogram describes the 
distribution of the wavelet spectral power/energy in the time-frequency domain using a 
gradient coloured map ranging from dark blue (low energy) to dark red (high energy). The chart 
displays a high-energy continuous band in the cardiac frequency interval, confirming that data 
were collected correctly. Physiologically, the wavelet energy represents a measure of how much 
a physiological component defined by a specific frequency interval contributes to blood flow 
signal at a specific time. The two transparent regions at the bottom-right and bottom-left of the 
scalogram represent regions outside of the “cone of influence” where data might not be reliable 
(frequencies < 5 × 10-3 Hz). The cone of influence is a time-frequency region where distortions 
of the CWT due to the finite temporal period of the measured signal are not relevant42. Instead, 
the areas outside of the cone are close to the time limits of the time series, where the wavelet 
transform is affected by boundary effects making the calculations from this time-frequency 
region imprecise42. The time-averaged spectrum (right graph) allows discriminating the wavelet 
energy peaks of the different oscillators at specific frequency intervals. As shown by the 
coloured tags in the legend, we identified the typical oscillators reported in literature: (I) cardiac, 
(II) respiratory, (III) myogenic, (IV) neurogenic, (V) endothelial NO-dependent, (VI) endothelial 
NO-independent (EDHF). Comparing the wavelet components between mice groups is powerful 
to distinguish healthy and diseased vascular conditions by quantifying the contribution of 
specific biological components. (b) Example of CWT analysis of the NAD(P)H reconstructed 
signal. Three low-frequency metabolic oscillators were characterised: Metabolic oscillator-1 
(MO-1), MO-2 and MO-3. These oscillators might reflect specific dynamic patterns of ATP energy 
production in the cutaneous tissue, which may be variable depending on the presence of healthy 
or diseased conditions. In this study, we focused on the dynamics of MO-1 because MO-2 and 
MO-3 intervals are located outside of the cone of influence where data might be inaccurate. 
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Characterisation of metabolic fluctuations. In-vivo metabolic oscillations were detected by CWT 
analysis of NAD(P)H and RR reconstructed signals. Fig. 3b shows an example of CWT scalogram 
and the corresponding time-averaged spectrum from NAD(P)H signal. High spectral energy was 
found in the low-frequency ranges, thus slow oscillators dominate the reconstructed tracing. 
Although time resolution is scarce in the low frequencies, we clearly identified three 
heterogeneous oscillatory intervals defined metabolic oscillator-1 (MO-1) (5-9 × 10-3 Hz), 
metabolic oscillator-2 (MO-2) (2.5-5 × 10-3 Hz), metabolic oscillator-3 (MO-3) (1.5-2.5 × 10-3 Hz). 
However, we will discuss only results of MO-1 because MO-2 and MO-3 frequency ranges fall 
largely at the edges of the cone of influence region in the CWT scalogram, where data might not 
be reliable42 (see caption of Fig. 3 for more details). 
LDF oscillators’ changes during vasomotion and comparison between groups. Fig. 4 describes 
the quantitative results of the relative spectral energy ei and frequency f extracted from the 
time-averaged wavelet peak of each LDF oscillator. The relative ei, to allow comparisons between 
groups, was obtained by normalising the absolute energy extracted from the peak of each 
oscillator (Ei, area under the curve) by the total absolute energy Etot of the wavelet spectrum and 
the number of frequencies in the interval of the oscillator. The spectral ei and frequency of the 
EDHF endothelial oscillator were significantly greater in WT mice at baseline (energy p=0.03, 
frequency p=0.005). The EDHF energy and frequency changed significantly in both groups during 
PE stimulation following opposite trends. The values increased in Nrf2-/- mice (energy p=0.01, 
frequency p=0.02) and decreased in controls (energy p=0.008, frequency p=0.04). The 
endothelial NO oscillator displayed the same trends observed for the EDHF oscillation. However, 
we found statistical significance only for the decrease of energy during phenylephrine delivery 
in WT mice (p=0.008). The neurogenic and myogenic components showed patterns similar to 
those of the endothelial oscillations. The energy was reduced in normal mice after PE 
administration, with a good p-value for the neurogenic oscillator (p=0.04) and a p-value close to 
statistical significance for the myogenic component (p=0.08). We evaluated also the relative 
maximal amplitude ai of the wavelet peaks, estimated by normalising the absolute amplitude Ai 
of each oscillator by the total amplitude Atot of the wavelet spectrum and the number of 
frequencies in the interval of the oscillator. The data of ai are summarised in Table 1 and 
displayed the same patterns found for ei but with lower statistical significance. 
These results outline opposite microvascular reactivity to PE in WT and Nrf2-/- mice, especially 
for the endothelial components that are key factors determining microvascular function. This 
suggests that oxidative stress may affect endothelial function and the overall cardiovascular 
dynamics in the long term. 
In general, the increase of LDF oscillators’ spectral energy reflects vasodilation 
dynamics4,36,38,43, thus the expected oscillatory pattern during mild vasoconstriction (1% PE) 
should be a decrease of ei, as observed in WT animals. In contrast, Nrf2-/- mice displayed an 
increase of LDF oscillators’ ei during phenylephrine administration. The reason for this behaviour 
might be the activation of an endothelial-mediated vasomotion resistance mechanism to 
attenuate vasoconstriction defined myoendothelial feedback16, consistent with the alternation 
of vasoconstriction and vasodilation induced respectively by simultaneous targeting of VSMCs 
with PE and EDHF/NO endothelial signalling. The cause for the activation of this mechanism may 
be a general major vasoconstriction in micro-vessels affected by oxidative stress. We cannot 
exclude that also WT mice may activate this mechanism in response to higher vasoconstriction 
stimuli (PE > 1%). 
Metabolic oscillations’ changes and comparison between groups. Data of the spectral ei, ai and 
f of NAD(P)H MO-1 and RR MO-1 wavelet peaks are summarised in Fig. 5a-c. Only WT mice 
showed a statistically significant increase of NAD(P)H MO-1 ei (p=0.01) and RR MO-1 ai (p=0.04) 
during PE delivery. The baseline RR MO-1 amplitude ai was lower in WT compared to Nrf2-/- mice 
with a p-value approaching statistical significance (p=0.097). Differences in frequencies were not 
relevant. 
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Fig. 4 Results of LDF oscillators. (a) Mean relative energy ei  (dimensionless units) of the wavelet 
peaks. (b) Mean frequency f (Hz) of the wavelet peaks. The software R-Studio was used to 
perform all the statistical analyses. The Shapiro-Wilk test revealed normal distributions for all 
the variables, thus data are reported as bar plots of the mean values. Error bars are referred to 
two standard errors (SE), corresponding approximately to a 95% confidence interval (CI). Black 
bars = Baseline. White bars = PE administration. WT = Control mice. NRF2 KO = Knockout mice. 
Black lines/asterisks = Significant changes during administration of PE estimated by paired t-test. 
Red lines/asterisks = Significant differences between mice groups estimated by unpaired t-test. 
The t-test was considered significant at p < 0.05 with a statistical power of 0.8 determined by R-
Studio. *p < 0.05, **p < 0.01. 
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NAD(P)H and RR oscillations reflect the cellular oxido-reductive dynamics, consistent with the 
turnover between the oxidised and reduced forms of NAD(P)H and FADH2 coenzymes as part of 
the cyclic reactions for the production of ATP energy during glycolysis and oxidative 
phosphorylation (OXPHOS) processes. The results of the spectral analysis outline different 
dynamics of metabolic oscillators in WT and Nrf2-/- mice, especially for the RR MO-1. Considering 
that RR reflects mitochondrial function, the major discriminatory power of RR MO-1 may 
indicate abnormal mitochondrial energetic dynamics in Nrf2-/- mice due to increased amounts of 
reactive oxygen species (ROS) affecting the electron transport chain. 
Wavelet phase coherence (WPCO). The WPCO analysis allows investigating the phase 
relationship Cɸ(ωk) between oscillations in a specific frequency range of two signals measured 
simultaneously. We used WPCO to explore the phase interaction between the endothelial EDHF 
oscillator and the MO-1 of NAD(P)H (Cɸ(ωk)NAD(P)H MO-1/EDHF) or RR (Cɸ(ωk)RR MO-1/EDHF) signals, 
which fall in the same low-frequency interval (5-9 × 10-3 Hz). Because our analysis does not 
include the surrogate data testing described recently by Gruszecki et al.44, we cannot make 
reliable assumptions on the degree of coherence at rest due to bias affecting the low 
frequencies. However, we can cautiously compare differences between mice phenotypes and 
changes in response to PE stimulation. Non-significant differences were found for the 
Cɸ(ωk)NAD(P)H MO-1/EDHF (Fig. 5d). In contrast, baseline Cɸ(ωk)RR MO-1/EDHF was significantly lower in 
Nrf2-/- mice (p=0.005), and changed significantly in both groups during PE administration 
showing a decrease in the WT (p=0.01) and an increase in the KO (p=0.003) (Fig. 5d). These 
results outline again a major discriminatory power of RR MO-1 compared to NAD(P)H MO-1, 
suggesting that oxidative stress may impact the interaction/coupling between mitochondrial 
reactions and the EDHF vasodilation mechanism affecting vascular reactivity to PE. 
Relevant correlations in WT mice. Fig. 6a displays the correlations between microvascular and 
metabolic variables observed in WT mice. We found strong negative correlations between the 
EDHF ei and both NAD(P)H MO-1 ei (r=-0.82, p=0.003) and RR MO-1 ai (r=-0.80, p=0.002). 
NAD(P)H MO-1 ei showed also high negative correlations with the energy of endothelial NO (r=-
0.77, p=0.008), neurogenic (r=-0.70, p=0.02) and myogenic (r=-0.70, p=0.03) oscillators, and the 
RR MO-1 ai was negatively related to blood perfusion (r=-0.70, p=0.03). None of these 
correlations were observed in Nrf2-/- mice. These results outline a robust association between 
the oxido-reductive fluctuations of NAD(P)H and FADH2 involved in ATP biosynthesis and the 
activation/inactivation of microvascular regulatory mechanisms. Indeed, the correlations 
indicate that in response to 1% PE the spectral energy of vascular oscillators decreases as the 
energy of slow metabolic oscillators increases. This may reflect a change in the turnover 
between NAD(P)+ and NAD(P)H promoting the inhibition of EDHF/NO endothelial-mediated 
vasodilation, and the enhancement of VSMCs-mediated vasoconstriction. 
Relevant correlations in Nrf2-/- mice. The main correlations in knockout animals were related to 
the wavelet frequency f of the endothelial NO oscillator, which was positively correlated with 
NAD(P)H MO-1 ei (r=0.60, p=0.04) and negatively correlated with SO2 (r=-0.60, p=0.03) (Fig. 6b). 
These correlations might reflect the overexpression of the endothelial nitric oxide synthase 
(eNOS) enzyme described previously in Nrf2-/- mice33, leading to major production of NO 
probably to balance for dysfunction in other vasodilation pathways preserving vascular function 
in vessels affected by oxidative stress33. The correlations may be consistent with this evidence 
because both NADPH and molecular oxygen participate in the reaction for NO biosynthesis45. 
Therefore, the increase of endothelial NO frequency correlated with the decrease of SO2 and 
the increase of NAD(P)H MO-1 ei might reflect respectively growth of NO production, 
consumption of molecular oxygen and oxidation of NADPH in NADP+. We could speculate that a 
sustained NO production may compensate for dysfunction in the EDHF vasodilator activity that 
was found significantly lower at baseline in mice affected by oxidative stress compared to WT 
(Fig. 4a). 
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Fig. 5 Results of metabolic oscillators and WPCO analysis. (a) Mean energy ei (dimensionless 
units), (b) mean amplitude ai (dimensionless units), and (c) mean frequency f (Hz) of NAD(P)H 
and RR MO-1 wavelet peaks. (d) Average phase coherence Cɸ(ωk) between NAD(P)H or RR MO-
1 and the endothelial EDHF oscillator. The WPCO analysis is useful to study the phase 
relationship between low-frequency oscillators, which cannot be performed using the analysis 
of synchronisation due to the noisy background in the slow CWT components. The Shapiro-Wilk 
test revealed normal distributions for all the variables, thus data are reported as bar plots of the 
mean values. Error bars are referred to two SE, corresponding to a 95% CI. Black bars = Baseline. 
White bars = PE delivery. WT = Control mice. NRF2 KO = Knockout mice. Black lines/asterisks = 
Significant changes during delivery of PE estimated by paired t-test. Red lines/asterisks = 
Significant differences between groups estimated by unpaired t-test. The t-test was considered 
significant at p < 0.05. *p < 0.05, **p < 0.01. 
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Fig. 6 Main correlations in WT and Nrf2-/- mice. (a) Relevant correlations in the WT group. (b) 
Relevant correlations in the KO group. All the variables tested in this study were normally 
distributed. Therefore, correlations were evaluated by estimation of the parametric Pearson’s 
coefficient r using the function corr of MATLAB R2015a software. The correlations were 
considered relevant for p < 0.05 and values of the coefficient r > 0.5 or < -0.5. Black dots = 
Baseline. White triangles = PE administration. *p < 0.05, **p < 0.01. 
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Table 1. Average values of all the variables included in the study. Data are presented as mean 
± Standard Deviation (SD). 
PARAMETERS WT (Mean ± SD) Nrf2-/- (Mean ± SD) 
Variable name Baseline Phenylephrine Baseline Phenylephrine 
Blood Perfusion [PU] 174.0 ± 30.40 162.8 ± 26.80 197.6 ± 20.50 184.0 ± 16.70 
SO2 [%] 47.3 ± 9.60 44.9 ± 10.7 48.3 ± 9.60 45.5 ± 6.10 
NAD(P)Hnormalised 1.7 ± 0.2 1.7 ± 0.2 1.9 ± 0.2 1.8 ± 0.1 
Redox Ratio (RR) 2.2 ± 0.1 2.2 ± 0.1 2.0 ± 0.1 2.0 ± 0.1 
ei Endothelial EDHF (0.7 ± 0.2) × 10
-3 (0.4 ± 0.1) × 10-3 (0.4 ± 0.2) × 10-3 (0.6 ± 0.3) × 10-3 
ei Endothelial NO (1.1 ± 0.3) × 10
-3 (0.6 ± 0.2) × 10-3 (0.8 ± 0.3) × 10-3 (1.0 ± 0.5) × 10-3 
ei Neurogenic (1.9 ± 0.8) × 10
-3 (1.0 ± 0.3) × 10-3 (1.3 ± 0.4) × 10-3 (1.5 ± 0.8) × 10-3 
ei Myogenic (4.5 ± 1.5) × 10
-3 (3.2 ± 1.1) × 10-3 (3.4 ± 0.6) × 10-3 (3.8 ± 1.1) × 10-3 
ai Endothelial EDHF (11.0 ± 2.30) × 10
-3 (6.10 ± 1.50) × 10-3 (7.10 ± 4.10) × 10-3 (8.90 ± 4.00) × 10-3 
ai Endothelial NO (10.6 ± 4.40) × 10
-3 (6.00 ± 2.60) × 10-3 (7.60 ± 3.90) × 10-3 (9.50 ± 5.60) × 10-3 
ai Neurogenic (12.9 ± 7.60) × 10
-3 (5.50 ± 1.80) × 10-3 (8.40 ± 1.90) × 10-3 (8.40 ± 4.70) × 10-3 
ai Myogenic (14.8 ± 6.60) × 10
-3 (9.70 ± 4.30) × 10-3 (11.2 ± 2.40) × 10-3 (12.4 ± 5.30) × 10-3 
f Endothelial EDHF [Hz] (8.0 ± 0.6) × 10
-3 (6.9 ± 0.9) × 10-3 (6.3 ± 1.0) × 10-3 (7.7 ± 0.8) × 10-3 
f Endothelial NO [Hz] (1.4 ± 0.1) × 10
-2 (1.5 ± 0.3) × 10-2 (1.4 ± 0.2) × 10-2 (1.5 ± 0.2) × 10-2 
f Neurogenic [Hz] (2.8 ± 0.5) × 10
-2 (3.0 ± 0.7) × 10-2 (3.5 ± 1.0) × 10-2 (4.0 ± 1.0) × 10-2 
f Myogenic [Hz] (10.4 ± 1.30) × 10
-2 (9.30 ± 2.10) × 10-2 (9.20 ± 1.70) × 10-2 (9.20 ± 1.60) × 10-2 
ei NAD(P)H MO-1 (12.8 ± 1.40) × 10
-3 (16.1 ± 1.50) × 10-3 (12.3 ± 4.60) × 10-3 (15.8 ± 2.40) × 10-3 
ei RR MO-1 (11.7 ± 4.60) × 10
-3 (14.9 ± 2.50) × 10-3 (14.6 ± 3.90) × 10-3 (12.0 ± 3.10) × 10-3 
ai NAD(P)H MO-1 (10.7 ± 2.70) × 10
-3 (11.7 ± 3.50) × 10-3 (9.60 ± 5.40) × 10-3 (13.8 ± 5.50) × 10-3 
ai RR MO-1 (8.10 ± 4.40) × 10
-3 (12.4 ± 2.30) × 10-3 (11.2 ± 3.90) × 10-3 (8.60 ± 4.20) × 10-3 
f NAD(P)H MO-1 (6.1 ± 1.1) × 10
-3 (6.6 ± 0.6) × 10-3 (6.8 ± 1.4) × 10-3 (6.3 ± 0.9) × 10-3 
f RR MO-1 (6.7 ± 1.1) × 10
-3 (6.4 ± 1.2) × 10-3 (6.3 ± 0.8) × 10-3 (7.0 ± 1.3) × 10-3 
Cɸ(ωk)NAD(P)H MO-1/EDHF 0.78 ± 0.03 0.76 ± 0.05 0.76 ± 0.05 0.79 ± 0.05 
Cɸ(ωk)RR MO-1/EDHF 0.79 ± 0.04 0.76 ± 0.02 0.74 ± 0.06 0.78 ± 0.02 
Discussion 
In this work, cutaneous vasomotion and cell metabolic oscillations were examined 
simultaneously from live mice. A vasomotion phenomenon specifically mediated by NO and 
EDHF endothelial mechanisms5 was stimulated through administration of low-dose 
phenylephrine. Comparisons between Nrf2-/- mice affected by oxidative stress and WT controls 
revealed an opposite behaviour of vascular oscillations in the two models, indicating an effect 
of oxidative stress on microvascular reactivity. The most relevant differences were found 
especially for the endothelial EDHF oscillator, and vasomotion was more prominent in KO mice 
probably due to the activation of the myoendothelial feedback16 vascular modulation in 
response to oxidative stress. 
We characterised a low-frequency metabolic oscillator (MO-1) of NAD(P)H and RR signals that 
displayed different dynamics in WT and Nrf2-/- models, probably reflecting an alteration of the 
mitochondrial energetic processes due to oxidative stress. Relevant correlations were found in 
WT mice between metabolic and microvascular oscillators, highly suggesting an involvement of 
the cellular processes associated with fluctuations of NAD(P)H concentrations (i.e. OXPHOS and 
glycolysis) in microvascular reactivity. These correlations were absent in Nrf2-/- mice suggesting 
an influence of oxidative stress on the interaction/coupling between cell metabolic reactions 
and microvascular regulatory mechanisms. 
Our findings indicate indirectly that cell metabolic oscillators may have an important role in 
modulating vasomotion in response to specific stimuli at least for oscillatory processes 
endothelium-mediated. Therefore, this raises interest in the study of cell mitochondrial and 
glycolytic oscillators to elucidate further the mechanisms driving the Ca2+ oscillations at the basis 
of vasomotion. Despite ECs seemed the microcirculation component mostly associated with 
slow metabolic oscillators, metabolic fluctuations were also correlated with neurogenic and 
myogenic components indicating a global cooperation of multiple factors during vasomotion 
with higher/lower contributions depending on the type of stimulus and vascular bed. In the 
context of skin microcirculation, primary metabolic Ca2+ oscillations coming from ECs and the 
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EDHF may represent the key drivers and regulatory factors for vasomotion. Based on our results, 
vasomotion can be considered an adaptive mechanism directed by the energetic 
requirements/stimuli in the environment surrounding blood vessels aimed at ensuring an 
optimal intake of nutrients (i.e. glucose) and oxygen for the production of ATP energy, rather 
than a process leading exclusively to the spontaneous pacemaker activity of VSMCs. This 
definition could help addressing better several controversial aspects, i.e. the observation of 
vasomotion in both healthy and diseased conditions1,2, or the primary involvement of ECs or 
VSMCs in different vascular beds1,2. These contrasting observations may be the result of variable 
energetic requirements of different tissues depending on the degree of nutrition/oxygenation, 
the presence of a particular pathology, and the cell types involved. 
The methodology used in this work can be easily translated for the concurrent study of 
metabolic and microvascular dynamics in humans and the exploration of metabolic oscillators 
as cardiovascular risk factors for diagnostic purposes. The use of LFS to monitor NAD(P)H 
provided some advantages, i.e. label-free minimally invasive nature of the measurements, 
convenient combination of LFS and LDF probes for simultaneous recordings, portability of the 
technology. However, there are limitations leading to the discrete nature of LFS measurements, 
necessity to reconstruct NAD(P)H signals to characterise the oscillators, and the inability to trace 
the specific cellular origin of the oscillations. Furthermore, the technique was restricted to the 
investigation of low-frequency fluctuations due to discrete slow sampling of the spectra. More 
advanced technologies for the in-vivo imaging of NAD(P)H, i.e. fluorescence lifetime imaging 
microscopy (FLIM) and multiphoton laser scanning microscopy (MPLSM), allow a better 
monitoring and discrimination between glycolytic and mitochondrial NAD(P)H, with high spatial-
temporal resolution at cell level31,46,47,48,49,50,51. Combining these methods with CWT can help 
studying both slow and fast NAD(P)H oscillators. Nevertheless, these technologies still require 
further implementation for the application on humans and for providing continuous NAD(P)H 
recordings, they are expensive and lacking of portability and device design for combining with 
the LDF probe to study simultaneously metabolic and microvascular oscillators. 
Methods 
Animals. Animal work was conducted at the School of Medicine of the University of Dundee, 
after gaining approvals by the local ethics committee (Licence protocol n. 60/4265). Animals 
included in the research were WT (n=5) and Nrf2-/- (n=6) female mice on a C57Black/6 
background aged 36-60 weeks. Mice were maintained under a 12:12-h light/dark cycle at 22 ± 
1°C and 50% humidity, and were fed ad libitum on a standard rodents chow diet regime and 
water. 
Skin preparation and anaesthesia. LFS and LDF techniques are sensitive to light absorption by 
hair and skin pigmentation. Therefore, a hair-free non-pigmented intact skin is required to 
obtain reliable measurements. Forty-eight hours prior to performing the experiments, hair from 
the mice flanks was shaved using an electric shaver, and the residual hair was removed using 
depilatory cream (Veet®, Reckitt-Benckiser). Before collecting measurements, mice were 
anaesthetised through a standard Boyle’s Apparatus to prevent movement artefacts and were 
laid on a heat mat at 37°C, as described previously by us52. A light anaesthesia was maintained 
by delivering 1.5-2% isoflurane (Abbott Laboratories) in oxygen (1.5 L/minute) through an 
inhalation nose cone (Fig. 1a). 
Iontophoresis. Iontophoresis allows the local delivery of vasoactive drugs in the skin 
microcirculation without inducing systemic effects. The drug is transferred transdermally by the 
unidirectional movement of ions in a solution, through a continuous current generated by a 
reference electrode and a platinum electrode incorporated in a ring-shaped chamber52,53. We 
used an iontophoresis chamber (ION6 probe, Moor Instruments, UK) of 20 mm internal diameter 
attached to the mouse flank using double-adhesive tape, and a reference electrode placed 
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underside the animal. The chamber was filled with a 2 ml 1% phenylephrine solution, and LFS 
and LDF probes were placed at two adjacent sites on the skin area inside the chamber (Fig. 1a). 
LFS/LDF signals were measured simultaneously for 20 min, 10 min without application of electric 
current (baseline), and 10 min during delivery of PE by applying a continuous 100 µA anodal 
current through a controller (MIC2, Moor Instruments, UK) connected to the electrodes. 
Laser Fluorescence Spectroscopy. LFS employs a low-power laser (1-5 mW) for the in-vivo 
excitation of cell endogenous fluorophores, i.e. NAD(P)H, allowing the detection of 
autofluorescence emission peaks proportional to the tissue concentration of the 
biomarkers54,55,56. We assessed skin NAD(P)H autofluorescence with a single-point LFS probe 
(LAKK-M, Spe Lazma, Russia) provided with irradiating and detection sensors at a distance of ~1 
mm for targeting a tissue volume of ~1 mm3. Discrete 10 seconds autofluorescence spectra were 
sampled from the mouse flank by a 365 nm UV excitation light (1 mW) at a rate of one spectrum 
every minute during iontophoresis. The spectra were processed by MATLAB R2015a to extract 
the amplitudes of NAD(P)H (490 nm), FAD+ (550 nm), and elastin (450 nm) peaks (Fig. 1b). The 
redox ratio and normalised NAD(P)H autofluorescence were estimated respectively according 
to equations 1 and 2. For the study of NAD(P)H and RR oscillations by CWT, 20 min continuous 
signals were reconstructed from the discrete data points (Fig. 1c) using the piecewise cubic 
spline interpolation method that we have previously described for reconstructing blood flow 
signals57. More details on signals reconstruction and NAD(P)H autofluorescence normalisation 
are provided in the supplementary information online. 
Laser Doppler Flowmetry. LDF allows the indirect measurement of blood perfusion by sensing 
the Doppler-shift in wavelength generated when a monochromatic and coherent light is 
backscattered by moving blood cells4,9,36,37,39,53. We measured skin blood flow using a laser 
Doppler flowmeter (LAKK-M, Spe Lazma, Russia) provided with a probe identical to the LFS probe 
described above, which was calibrated with a fluoroplastic oscillating disk simulating Brownian 
motion. A 20 min LDF signal was measured during iontophoresis (Fig. 1d) using a 1064 nm laser 
with sampling frequency of 20 Hz. The multifunctional probe was also provided with 630 nm and 
532 nm lasers, which allowed measuring the percentage skin oxygen saturation (SO2) according 
to the reflectance spectroscopy principles58. 
Continuous Wavelet Transform. The CWT method is largely employed to analyse blood 
perfusion vasomotion dynamics in the time-frequency domain34,37, providing optimal frequency 
resolution for low frequencies and good time resolution for high frequencies. We employed this 
method to investigate heterogeneous oscillations of LDF, NAD(P)H and RR signals, using a CWT 
with scaling factor s, time t, Morlet wavelet function ψ and central frequency 1 35,36,37: 
 𝑔 (𝑠, 𝑡) =
1
√𝑠
∫ 𝜑 (
𝑢−𝑡
𝑠
) 𝑔(𝑢)𝑑𝑢
∞
−∞
                                                                                                           (3) 
CWT and the extraction of the spectral energy Ei36, amplitude Ai36 and frequency f 36 from the 
time-averaged wavelet peaks were performed using MATLAB R2015a. Fig. 3 shows examples of 
CWT scalograms and corresponding time-averaged spectra from LDF and NAD(P)H signals. 
Wavelet phase coherence. The WPCO analysis provides information on the phase relationship 
Cɸ(ωk) between oscillators in the same frequency interval of two signals recorded 
simultaneously59. The analysis returns values between 0 and 1, where Cɸ(ωk) ≈ 0 indicates 
absence of coherence, Cɸ(ωk) ≈ 1 complete coherence, and 0 < Cɸ(ωk) < 1 partial coherence59. 
We investigated the coherence between MO-1 of metabolic signals and the LDF EDHF oscillator 
that are located in the same frequency range. The analysis was performed through the WPCO 
code provided in the Lancaster University website http://py-biomedical.lancaster.ac.uk by 
Professor Aneta Stefanovska research group, which estimates Cɸ(ωk) according to the principles 
described by Bandrivskyy et al. and Clemson et al.59,60. 
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Biological origin of the LDF endothelial nitric oxide (NO)-independent wavelet 
oscillator 
The physiological origin of the endothelial NO-independent wavelet oscillator (5-9.5 × 10-3 Hz) of skin 
LDF signals has not been completely elucidated. The endothelial origin of this oscillator has been proved 
by experiments showing relevant changes of its wavelet amplitude during the cutaneous administration 
of acetylcholine (ACh) [1, 2], a vasoactive agent able to stimulate multiple endothelial-mediated 
vasodilation mechanisms including NO, prostaglandins (PGs) and the endothelial-derived hyperpolarizing 
factor (EDHF) pathways. Moreover, blocking both NO or PGs mechanisms respectively by administration 
of L-NMMA (NG-monomethyl-l-arginine) and aspirin did not affect the endothelial NO-independent 
oscillation [1, 2]. These evidences suggest indirectly a more likely biological link of this oscillator with an 
endothelial vasodilator mechanism different from NO and PGs that could be with high probability the 
EDHF pathway. The results that we have presented in this paper might support indirectly this hypothesis. 
Indeed, according to Okazaki et al. [3], the vasoconstriction stimulated by administration of phenylephrine 
(PE) in rat mesenteric artery is able to enhance a vasomotion phenomenon mediated specifically by NO 
and EDHF mechanisms but not by PGs. Even if in this work we have tested micro-vessels different from 
the rat mesenteric artery (skin micro-vessels), the results seem to agree with what has been reported by 
Okazaki et al. [3]. Indeed, as we have discussed in Figure 4 of this paper, the oscillators showing the most 
statistically significant changes during PE stimulation were the endothelial NO and endothelial NO-
independent components. Considering that the NO origin of the 9-20 × 10-3 Hz oscillation has been already 
recognised [4], by exclusion, the high significant changes that we found in the 5-9 × 10-3 Hz interval after 
PE stimulation should be ascribed to the EDHF activity. 
Furthermore, according to the literature EDHF plays a more important role than NO in the reactivity of 
small resistance arterioles [5, 6, 7, 8]. Our results, discussed in Figure 4 of the manuscript, have displayed 
changes that are more significant for the endothelial NO-independent frequency range compared to the 
endothelial NO interval, which would support an EDHF origin of this oscillator and its major involvement 
in the reactivity of small arterioles [5, 6, 7, 8]. 
Additional indirect proof of the possible EDHF origin for the endothelial NO-independent oscillator was 
also provided by experimental data that we have obtained from human subjects. We have measured 
blood flow signals by LDF method from the forearm of 40 individuals during a 25 min post-occlusive 
reactive hyperaemia (PORH) functional test, using the same LDF single-point probe employed in this study 
(LAKK-M, Spe Lazma, Russia) that we have already described in the methods section. All of the tested 
subjects signed an informed consent form before performing the experiment, as part of a research project 
approved by the University of Dundee Research Ethics Committee (UREC, Study n. 15064) according to 
the guidelines of the declaration of Helsinki. The PORH test was divided in three main steps 
(supplementary Figure S1): 
(1) Measurement of the LDF signal for 10 min at rest (baseline). 
(2) Blocking blood flow through the brachial artery for 5 min, by inflating a pressure cuff placed in the 
upper part of the tested arm at 200 mmHg. This step is characterised by a massive decrease of LDF 
signal because of a temporary ischaemia condition induced by the occlusion of flow. 
(3) Release of the cuff’s pressure and monitoring for 10 min the PORH response stimulated by the 
previous occlusion of flow. PORH response is consistent with a massive increase of blood flow up to 
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a peak for the fast reperfusion of the cutaneous tissue after a temporary period of occlusion, and the 
subsequent restoration of the basal blood flow. 
All the LDF signals collected during PORH stimulation from the 40 tested subjects were processed by 
continuous wavelet transform (CWT) spectral analysis to determine the contribution of each LDF oscillator 
to skin PORH response. The CWT analysis was performed according to the same methodology that we 
have already discussed in the methods section of this paper. The results have revealed a median 
percentage increase of wavelet amplitude/energy during PORH compared to baseline much higher for the 
endothelial NO-independent (EDHF) oscillator (58.3-72.3%) compared to the other LDF oscillators 
(supplementary Table S1). According to the literature, the EDHF mechanism is the major mediator 
contributing to human skin PORH response [9], thus considering that the endothelial NO-independent 
wavelet peak showed the highest contribution to the cutaneous hyperaemic response our findings 
represent a robust indirect proof of the EDHF origin of this oscillator. As future perspective, direct proof 
may be provided from either mouse models or humans by monitoring the behaviour of this LDF wavelet 
oscillator during the inhibition of the EDHF vasodilation mechanism. This task can be achieved in mouse 
models by blocking EDHF through a combination of the inhibitors of K+ channels apamin (APA) and 
charybdotoxin (ChTX) [10]. Examples of pharmacological agents that might be applied for the same 
purpose in human skin are the fluconazole or sulfaphenazole for blocking locally the EDHF mechanism 
mediated by the epoxyeicosatrienoic metabolites (EETs) [11], and the tetraethylammonium (TEA) for the 
local inhibition of the EDHF mechanism mediated by KCa channels [12]. 
 
Figure S1. Example of LDF signal collected from the human forearm during PORH test. Data are expressed in 
perfusion arbitrary units (PU). The graph shows the typical trend of LDF signal during a 25 min PORH test. The first 10 
min represent the baseline blood flow. Then the pressure cuff was inflated at 200 mmHg to induce an ischaemia 
period of 5 min characterised by decrease of flow. Finally, the pressure of the cuff was released to monitor PORH 
response and the restoration of resting blood flow for 10 min. 
Table S1. Percentage increase of the relative wavelet amplitude ai and energy ei of LDF oscillators during skin PORH 
response. The Shapiro-Wilk test performed by R-Studio software has revealed non-parametric distributions for all the 
variables. Thus, data are reported as median (inter-quartile range). n = Number of tested subjects. The increase of 
wavelet amplitude/energy was evaluated as percentage growth during PORH response compared to baseline. 
PARAMETERS n=40 
Variable name Median (inter-quartile range) 
ei Endothelial EDHF increase [%] 58.3 (48.3-79.3) 
ei Endothelial NO increase [%] 27.2 (14.0-33.1) 
ei Neurogenic increase [%] 5.60 (1.70-11.2) 
ei Myogenic increase [%] 5.50 (0.90-7.00) 
ai Endothelial EDHF increase [%] 72.3 (57.7-89.8) 
ai Endothelial NO increase [%] 18.3 (8.10-28.0) 
ai Neurogenic increase [%] 1.30 (0.10-7.50) 
ai Myogenic increase [%] 2.40 (0.50-6.00) 
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Reconstruction of NAD(P)H and RR continuous time series by piecewise cubic spline 
interpolation 
In this work, the in-vivo investigation of metabolic oscillations from mice skin was achieved by the 
application of the CWT spectral analysis on NAD(P)H and RRindex signals. Considering that the CWT can be 
applied only on continuous time series, the reconstruction of NAD(P)H and RRindex signals from discrete 
UV autofluorescence spectra was a key step to allow the characterisation of metabolic oscillations. The 
reconstruction was performed in two steps by using the software Matlab R2015a, according to the same 
methodology previously described by us for the reconstruction of continuous blood flow signals from 
discrete data points [13]. First, the discrete values of NAD(P)Hnormalised (equation 2 in the manuscript) and 
RRindex (equation 1 in the manuscript) were extracted from the 20 sequential UV autofluorescence spectra 
measured over time during iontophoresis test. Finally, the values were used as discrete data points to 
reconstruct a continuous curve covering the whole 20 min period used in the experiment for acquiring 
the spectra. The reconstruction was performed by piecewise cubic spline interpolation, applying an 
interval of 1 min between each pair of data points that corresponds to the sampling frequency adopted 
during the temporal collection of the spectra. 
The spline interpolation technique is a mathematical procedure based on the use of a piecewise low-
degree polynomial called spline for the approximation of a continuous function g by interpolating equally 
spaced discrete data points of the function [13]. The main advantage of this technique is the accurate 
approximation of a function over large intervals, avoiding and reducing errors during the interpolation 
process, i.e. the introduction of oscillatory artefacts between each pair of data points (Runge’s 
phenomenon) which is typical of interpolation processes performed by using a single high-degree 
polynomial [13]. The spline interpolation process consists in subdividing the interval [a, b] where g is 
continuous in smaller sub-intervals, and approximating g in each sub-interval using low-degree 
polynomial pieces that define a composite spline function s [13]. In this work, we used a cubic (third-
degree) spline function which is suitable for reconstructing continuous natural processes, and requires 
four terms to define a piecewise polynomial between each pair of data points, as displayed by the 
supplementary equation S1 [13], 
p3(x) = ax3 + bx2 + cx + d,                                                                                                                                         (S1) 
where p3 is the piecewise third-degree polynomial, and a, b, c and d are the four terms defining p3. The 
final curve resulting from the cubic spline interpolation process is made of a number of pieces 
reconstructed between each pair of data points equal to 1-n, where n is the number of data points [13]. 
Therefore, considering that the number of NAD(P)Hnormalised and RRindex discrete values used in this study 
during the interpolation process was 20, we have obtained NAD(P)H and RRindex reconstructed curves 
made of 19 pieces (supplementary Figure S2). 
Considering that the cubic spline interpolation method does not introduce oscillatory artefacts in the 
reconstructed signal [13], by using this technique we have ensured that the results of the subsequent 
CWT spectral analysis were reflecting the real oscillatory behaviour of NAD(P)H and RRindex detected by 
autofluorescence recordings. Nonetheless, a limit of this technique is poor accuracy in the reconstruction 
of the right and left extremities of the signal [13]. Thus, to avoid artefacts at the edges of the signal the 
time series was cut at the extremities making sure that the starting and ending points of the curve were 
corresponding respectively to the first and last experimental discrete data points [13]. 
Normalisation of NAD(P)H to reduce blood volume and skin pigmentation effects 
As already explained in the methods section of this paper, we have evaluated the relative changes of 
NAD(P)H concentrations and mitochondrial function (RRindex) from live mice skin by ratiometric 
normalisation of  NAD(P)H fluorescence, respectively by the autofluorescence of the structural protein 
elastin (450 nm) and of the coenzyme FAD+ (550 nm). The reason for the normalisation was reducing the 
effect of blood volume and cutaneous melanin on NAD(P)H autofluorescence signal for obtaining a more 
accurate assessment of cellular metabolic oscillations over time. Indeed, a major problem when 
evaluating the UV autofluorescence from in-vivo skin is that the signal is highly affected by artefacts due 
to absorption of UV light by cutaneous chromophores, i.e. haemoglobin (Hb) in the blood of micro-vessels 
and melanin pigmentation [14, 15]. This is clearly visible in supplementary Figure S3a-b and 
supplementary Figure S4a-b, which show respectively the effects of blood volume changes and melanin 
on the reconstructed NAD(P)H autofluorescence signal obtained from measurements collected using the 
LAKK-M probe (Spe Lazma Ltd, Russia). 
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Figure S2. Examples of signals reconstructed by cubic spline interpolation of discrete data points. (a) 20 min 
NAD(P)H signal reconstructed using NAD(P)Hnormalised values extracted from 20 sequential discrete UV 
autofluorescence spectra measured from the flank of a mouse during a 20 min iontophoresis test. (b) 20 min RRindex 
continuous signal obtained using RRindex values estimated from 20 sequential discrete UV autofluorescence spectra 
measured from the flank of a mouse during a 20 min iontophoresis test. An interval of 1 min was applied between 
each pair of data points, which corresponds to the sampling frequency used for the temporal acquisition of the UV 
spectra (1 spectrum per minute). Both the reconstructed signals are made of 19 pieces (n-1, where n is the number 
of discrete data points) with the starting and ending points of the curve corresponding to the first and last 
experimental data points used for the reconstruction to avoid the presence of oscillatory artefacts at the extremities 
of the time series. 
Supplementary Figure S3 displays the trends of simultaneous median LDF (Figure S3a) and 
reconstructed NAD(P)H autofluorescence (Figure S3b) signals that we have measured from the forearm 
of human subjects (n=16) during a 25 min PORH test. The graphs clearly show a massive decrease of 
NAD(P)H autofluorescence signal intensity concurrent to the increase of blood flow/volume during PORH 
response. This observation clearly outlines the negative effect of blood volume changes on NAD(P)H signal 
due to absorption of UV light by Hb, which makes the measurements unreliable for the evaluation of 
NAD(P)H oscillations over time. 
Supplementary Figure S4 displays the trends of simultaneous median LDF (Figure S4a) and 
reconstructed NAD(P)H autofluorescence (Figure S4b) signals that we have measured from the forearm 
of subjects with dark skin (n=8) and white skin (n=8) during a 25 min PORH test. The graphs clearly show 
that while the colour of skin does not affect LDF measurements, the intensity of NAD(P)H 
autofluorescence signal is highly reduced in individuals with dark skin that is characterised by a major 
content of melanin pigmentation. However, while melanin absorption may represent a major problem for 
the evaluation of the absolute quantitative concentrations of NAD(P)H, also in this case the effect of blood 
volume seems to be the major obstacle for making a reliable assessment of the relative oscillatory changes 
of NAD(P)H over time which was the main goal of this work. 
A widespread method used for the correction of NAD(P)H UV autofluorescence artefacts is the 1:1 ratio 
with another variable affected by the same artefacts, e.g. skin reflectance signal [14], in order to 
compensate for NAD(P)H unrelated factors obtaining a normalised signal which should reflect more 
reliably the relative temporal trends of NAD(P)H. In this work, we did not have the chance to measure skin 
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reflectance signal, thus we have taken advantage of the overlapping contributions in the UV spectrum of 
elastin and FAD+ autofluorescence to perform 1:1 ratiometric corrections of NAD(P)H autofluorescence. 
 
Figure S3. Correction of NAD(P)H autofluorescence signal to reduce blood volume effects. Examples of simultaneous 
median (a) LDF (PU) and (b) reconstructed NAD(P)H autofluorescence (AU) signals measured from the forearm of 16 
human subjects during a 25 min PORH test. The graphs clearly display the absorption of UV light by Hb affecting 
NAD(P)H autofluorescence signal during PORH response due to increase of blood perfusion/volume. (c) 1:1 
ratiometric normalisation of NAD(P)H signal by the autofluorescence of the structural protein elastin 
[NAD(P)Hnormalised expressed in dimensionless units]. (d) 1:1 ratiometric normalisation of NAD(P)H signal by the 
autofluorescence of FAD+ coenzyme (RRindex expressed in dimensionless units). Normalised signals reflect more 
reliably the trends of NAD(P)H and mitochondrial oxido-reductive dynamics expected during PORH functional test. 
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Figure S4. Effects of melanin pigmentation on NAD(P)H autofluorescence signal. Examples of simultaneous median 
(a) LDF (PU) and (b) reconstructed NAD(P)H autofluorescence (AU) signals measured from the forearm of 8 subjects 
with white skin (dark red lines) and 8 individuals with dark skin (dark blue lines) during a 25 min PORH test. The graphs 
clearly display that the LDF signal is not affected by different amounts of cutaneous melanin pigmentation. In contrast, 
the intensity of NAD(P)H autofluorescence signal was highly reduced in subjects with dark skin due to the major 
content of melanin absorbing UV light. (c) 1:1 ratiometric normalisation of NAD(P)H signals by the autofluorescence 
of the structural protein elastin [NAD(P)Hnormalised expressed in dimensionless units]. (d) 1:1 ratiometric normalisation 
of NAD(P)H signal by the autofluorescence of FAD+ coenzyme (RRindex expressed in dimensionless units). Normalised 
signals were characterised by reduced blood volume effect reflecting more reliably the trends of NAD(P)H and 
mitochondrial oxido-reductive dynamics expected during PORH functional test, and seemed to be suitable for making 
acceptable comparisons of temporal oscillatory dynamics between subjects with different skin pigmentation. 
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Elastin is an abundant structural component in the connective tissue of the dermal cutaneous layer [15, 
16]. The reason for using the autofluorescence of this protein as correction factor is that being a structural 
component it should maintain a constant amount in the cutaneous tissue during the temporal period 
employed for the collection of autofluorescence data. Therefore, normalising the autofluorescence by 
elastin represents an intra-subject compensation for micro-environmental factors unrelated to NAD(P)H, 
i.e. Hb and melanin absorption, and the resulting signal should be more representative of NAD(P)H 
temporal dynamics considering the constant amounts of elastin in the tissue during the temporal 
acquisition of UV spectra. The autofluorescence emission wavelength of elastin after excitation with UV 
light is between 400-450 nm and could be affected by an overlapping contribution of collagen 
autofluorescence (390-460 nm) [15, 16]. However, considering that also collagen is a structural 
component abundant in the dermal connective tissue this should not represent a major problem because 
also this protein should present constant amounts in the skin during the temporal window employed for 
acquiring the UV spectra. Figure S3c shows the trend of NAD(P)H signal during PORH test after 
normalisation by elastin autofluorescence. The graph clearly displays a reduction of blood volume effect 
compared to Figure S3b, and a temporal trend of NAD(P)H which seems to reflect more reliably the 
relative changes in the concentrations of this coenzyme during PORH test. Indeed, NAD(P)Hnormalised signal 
increased during the 5 min occlusion of blood flow, probably reflecting the uncoupling of the electron 
transport chain and the inhibition of ATP production through the oxidative phosphorylation (OXPHOS) 
mitochondrial process due to reduced intake of oxygen and accumulation of reduced NAD(P)H [14]. In 
contrast, the moderate decrease of NAD(P)H during PORH response in this case may reflect the oxidation 
of NAD(P)H in NAD(P)+ due to the restoration of a normal aerobic metabolism and increased production 
of ATP [14] rather than an artefact due to Hb absorption. Similar results are shown in Figure S4c 
demonstrating that NAD(P)Hnormalised signal is not affected by skin pigmentation and seems more reliable 
to compare the temporal oscillatory behaviour of NAD(P)H between cutaneous samples with different 
amounts of melanin. 
The estimation of the redox ratio (RRindex) by normalising NAD(P)H autofluorescence for the 
fluorescence of the coenzyme FAD+ provided also optimal results. This index is a measure of the balance 
between the reduced form of NAD(P)H and the oxidised FAD+, which reflects specifically the activity of 
the mitochondrial electron transport chain and the degree of ATP energy production through the OXPHOS 
process [14, 17]. The interpretation of RRindex values may vary depending on the kind of stimulus affecting 
mitochondrial function, the degree of oxygenation, or the presence of particular pathologic conditions 
(e.g. cancer). Figure S3d displays the trend of RRindex during PORH functional test, which seems to reflect 
reliably the changes of mitochondrial activity associated with a temporary ischaemia period and PORH 
response. The relevant increase of RRindex during ischaemia may reflect a preferential production of ATP 
through the glycolysis process in the presence of lower tissue oxygenation, due to accumulation of 
mitochondrial NAD(P)H and uncoupling of the electron transport chain. In contrast, the restoration of the 
baseline RRindex trend observed during PORH response may reflect the reactivation of the aerobic 
metabolism, oxidation of NAD(P)H in NAD(P)+ and increase of ATP production through the OXPHOS cycle. 
Figure S4d displays the comparison of RRindex trends between subjects with dark coloured skin and 
individuals with white skin. The signals showed a trend similar to the RRindex signal in Figure S3d, reflecting 
the oxido-reductive mitochondrial dynamics expected during PORH test. Although the values of RR index 
were slightly higher in the group of individuals with white skin, the signals seem to be comparable for an 
acceptable evaluation of the temporal RRindex oscillatory dynamics that was the main goal of this work. 
The concurrent multi-parametric monitoring of LDF and autofluorescence signals during PORH test was 
helpful to optimise the correction of autofluorescence data, allowing the easy detection of non-
physiological responses affecting NAD(P)H autofluorescence (i.e. effect of UV light absorption by Hb) and 
a better explanation of the physiological processes reflected by NAD(P)H signal. The application of the 
ratiometric normalisation approach provided time series with an acceptable degree of reliability for the 
evaluation of temporal metabolic oscillations, thus we decided to apply the same correction method on 
mice data presented in this work. Nonetheless, although the correction techniques used in this study 
allowed performing an acceptable evaluation of NAD(P)H oscillations, the development of more accurate, 
successful, and practical correction methods is still challenging. A promising approach for the future that 
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we are pursuing is the Monte Carlo modelling of skin autofluorescence measurements to determine the 
interaction of the UV light with the cutaneous tissue, and the path of the photons detected by the single-
point probe used for the measurements. This approach may help to characterise and quantify better the 
effects of blood volume and melanin on the autofluorescence signal and the implementation of more 
precise correction methods. 
Spatial resolution of LFS measurements and cellular origin of the metabolic oscillators 
A shortcoming of laser fluorescence spectroscopy (LFS) is the inability to quantify the contribution of 
specific groups of cells to the detected autofluorescence signal, due to the uncertain spatial resolution of 
the measurements and the heterogeneous structure of skin. Indeed, the cutaneous tissue includes cells 
from different layers (e.g. epidermal cells) and functional components such as micro-vessels (i.e. 
endothelial cells and vascular smooth muscle cells). Therefore, this makes it difficult also the 
characterisation of the cellular origin of the metabolic oscillators investigated in this work. 
According to the literature, The 365 nm UVA wavelength has a penetration depth incorporating the 
human upper dermal skin layer [18, 19], where capillaries and arterioles are located. In mice, the 
epidermis is thinner than in humans [20], thus the UVA light should target the core of the dermal layer. 
This suggests that a relevant part of the detected autofluorescence signal is derived from the 
microcirculation network, which was the main tissue of interest in this research. The relevant correlations 
that we have found in this work between microvascular and metabolic oscillations may represent an 
indirect proof that part of skin metabolic oscillations is of microvascular origin, even though the 
correlations could also reflect the activation of vasomotion in response to the energetic/nutritive 
requirements and oscillatory stimuli coming from other cutaneous cell types (e.g. epidermal cells). 
Finally, according to ongoing Monte Carlo modelling studies that we are performing in collaboration 
with a research group of the University of St. Andrews (Scotland, UK), the penetration depth of the UV 
laser of the device used in this study (LAKK-M, Spe Lazma Ltd, Russia) is around 200 μm (supplementary 
Figure S5). This evidence would support both an epidermal and a dermal origin of skin autofluorescence 
stimulated by UV light. 
 
Figure S5. Monte Carlo modelling of LAKK-M UV laser (365 nm) penetration depth. The propagation of UV light was 
simulated in a five layers cutaneous model composed of stratum corneum, epidermis, papillary dermis, reticular 
dermis and hypodermis. Each layer was populated with various skin natural absorbers and scatterers: water, fat, oxy-
Hb, deoxy-Hb, eumelanin, pheomelanin, bilirubin, β-carotene and a baseline absorber. A penetration depth of ~0.2 
mm was predicted, which should correspond to the upper dermis of human skin and the median dermis of mouse 
skin. Data were kindly provided by Mr Lewis McMillan and Dr Kenneth Wood from the Astronomy group at the 
University of St. Andrews (Scotland, UK). 
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